SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
¶
– Release Delayed ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 7/16/14 John Hancock Life Ins Co of NY… B N-6/A¶ 7/15/14 10:10M Donnelley … Solutions/FA → John Hancock Life Insurance Co. of New York Separate Account B ⇒ Simplified Life |
Document/Exhibit Description Pages Size 1: N-6/A Jhny B - Simplified Life HTML 5.07M 10: CORRESP ¶ Comment-Response or Other Letter to the SEC HTML 9K 2: EX-99.(26)(D)(1) Specimen Flexible Premium Variable Universal HTML 177K Life Insurance Policy 3: EX-99.(26)(D)(2) Specimen Return of Premium Rider HTML 22K 4: EX-99.(26)(D)(3) Specimen Accelerated Benefit Rider HTML 16K 5: EX-99.(26)(E) Specimen Policy Application HTML 41K 6: EX-99.(26)(G) Specimen Reinsurance Agreement HTML 81K 7: EX-99.(26)(I) Powers of Attorney HTML 37K 8: EX-99.(26)(K) Opinion of Counsel HTML 10K 9: EX-99.(26)(N) Consents of Independent Registered Public HTML 8K Accounting Firm
JHNY B - Simplified Life |
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-6
SEC File No 811-8329
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Pre-Effective Amendment No. 1 [X]
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940
AMENDMENT NO. 58 [X]
John Hancock Life Insurance Company of New York Separate Account B
(Exact Name of Registrant)
John Hancock Life Insurance Company of New York
(Name of Depositor)
197 Clarendon Street
Boston, MA
02116
(Complete address of depositor’s principal executive offices)
Depositor’s Telephone Number: 617-572-6000
JAMES C. HOODLET
John
Hancock Life Insurance Company of New York
U.S. INSURANCE LAW
JOHN HANCOCK PLACE
BOSTON, MA 02117
(Name and complete address of agent for service)
It is proposed that this filing will become effective as soon as practicable after the effective date of the Registration Statement.
Pursuant to the provisions of Rule 24f-2, Registrant has registered an indefinite amount of the securities under the Securities Act of 1933.
Prospectus dated July 25, 2014
for interests in
John Hancock Life Insurance Company of New York Separate Account B
Interests are made available under
SIMPLIFIED LIFE
a flexible premium variable universal life insurance policy
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
(“John Hancock NY”)
The policy provides the following investment accounts:
500 Index B Active Bond All Cap Core Alpha Opportunities American Asset Allocation American Global Growth American Growth American Growth-Income American International American New World Blue Chip Growth Bond Capital Appreciation Capital Appreciation Value Core Bond Core Strategy Emerging Markets Value Equity-Income Financial Services Franklin Templeton Founding Allocation Fundamental All Cap Core |
Fundamental Large Cap Value Fundamental Value Global Global Bond Health Sciences High Yield International Core International Equity Index B International Growth Stock International Small Company International Value Investment Quality Bond Lifestyle Aggressive MVP Lifestyle Balanced MVP Lifestyle Conservative MVP Lifestyle Growth MVP Lifestyle Moderate MVP Mid Cap Index Mid Cap Stock Mid Value |
Money Market B Natural Resources PIMCO VIT All Asset Real Estate Securities Real Return Bond Science & Technology Short Term Government Income Small Cap Growth Small Cap Index Small Cap Opportunities Small Cap Value Small Company Value Strategic Income Opportunities Total Bond Market B Total Return Total Stock Market Index Ultra Short Term Bond U.S. Equity Utilities Value |
* * * * * * * * * * * *
Please note that the Securities and Exchange Commission (“SEC”) has not approved or disapproved these securities, or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
This prospectus is arranged in the following way:
Prior to making any investment decisions, you should carefully review this product prospectus and all applicable supplements. In addition, you will receive the prospectuses for the underlying funds that we make available as investment options under the policies. The funds’ prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the funds. In the case of any of the portfolios that are operated as feeder funds, the prospectus for the corresponding master fund is also provided. If you need to obtain additional copies of any of these documents, please contact your John Hancock NY representative or contact our Service Office at the address and telephone number on the back page of this product prospectus.
The policy’s primary purpose is to provide lifetime protection against economic loss due to the death of the insured person. The policy is unsuitable as a short-term savings vehicle because of the substantial policy-level charges. We are obligated to pay all amounts promised under the policy. The value of the amount you have invested under the policy may increase or decrease daily based upon the investment results of the investment accounts that you choose. This policy does not offer a fixed account option upon which you can invest. The amount we pay to the policy’s beneficiary on the death of the insured person (we call this the “death benefit”) may be similarly affected. That’s why the policy is referred to as a “variable” life insurance policy. We call the investments you make in the policy “premiums” or “premium payments.” The amount we require as your first premium depends upon the specifics of your policy and the insured person. Except as noted in the “Detailed Information” section of this prospectus, you can make any other premium payments you wish at any time. That’s why the policy is called a “flexible premium” policy.
You should discuss your insurance needs and financial objectives with your registered representative before purchasing any life insurance product.
When the insured person dies, we will pay the death benefit minus any policy debt and unpaid fees and charges. There are two ways of calculating the death benefit (Option 1 and Option 2), as described below.
Your policy will be issued with death benefit Option 2. After the first policy year, you may request to change the death benefit from Option 2 to Option 1.
You may surrender the policy in full at any time. If you do, we will pay you the policy value less any outstanding policy debt and less any surrender charge that then applies. This is called your “net cash surrender value.” You must return your policy when you request a surrender.
If you have not taken a loan on your policy, the “policy value” of your policy will, on any given date, be equal to:
If you take a loan on your policy, your policy value will be computed somewhat differently (see “Effects of policy loans”).
After the first policy year, you may make a withdrawal of part of your net cash surrender value. Generally, each withdrawal must be at least $500. Your policy value is automatically reduced by the amount of the withdrawal and any surrender charge that then applies. A withdrawal may also reduce the Face Amount (see “Surrender and withdrawals — Withdrawals”). We also reserve the right to refuse any withdrawal that would cause the policy’s Face Amount to fall below $50,000.
If your policy is in force and has sufficient policy value, you may borrow from it at any time by completing the appropriate form. Generally, the minimum amount of each loan is $500. The maximum amount you can borrow is determined by a formula as described in your policy. Interest is charged on each loan. You can pay the interest or allow it to become part of the outstanding loan balance. You can repay all or part of a loan at any time. If there is an outstanding loan when the insured person dies, it will be deducted from the death benefit. Policy loans permanently affect the calculation of your policy value, and may also result in adverse tax consequences.
Optional supplementary benefit riders
When you apply for the policy, you can request any of the optional supplementary benefit riders that we make available. Charges for most riders will be deducted monthly from the policy value. Some riders may not be available in combination with other riders or benefits (see “Other policy benefits, rights and limitations — Optional supplementary benefit riders you can add”).
The policy offers a number of variable investment options, as listed on page 1 of this prospectus. These variable investment options are subaccounts of John Hancock Life Insurance Company of New York Separate Account B (“Separate Account”), a separate account operated by us under New York law. The variable investment options have returns that vary depending upon the investment results of underlying portfolios. These options are referred to in this prospectus as “investment accounts.” The investment accounts cover a broad spectrum of investment styles and strategies. Although the portfolios of the series funds that underlie those investment accounts operate like publicly traded mutual funds, there are important differences between the investment accounts and publicly traded mutual funds. You can transfer money from one investment account to another without tax liability. Moreover, any dividends and capital gains distributed by each underlying portfolio are automatically reinvested and reflected in the portfolio’s value and create no taxable event for you. If and when policy earnings are distributed (generally as a result of a surrender or withdrawal), they will be treated as ordinary income instead of as capital gains. Also, you must keep in mind that you are purchasing an insurance policy and you will be assessed charges at the policy level as well as at the fund level. Such policy level charges, in aggregate, are significant and will reduce the investment performance of your policy.
If the net cash surrender value is insufficient to pay the charges when due and the No-Lapse Guarantee is not in effect, your policy can terminate (i.e. “lapse”). This can happen because you haven’t paid enough premium or because the investment performance of the investment accounts you’ve chosen has been poor or because of a combination of both factors. You will be given a “grace period” within which to make additional premium payments to keep the policy in effect. If lapse occurs, you may be given the opportunity to reinstate the policy by making the required premium payments and satisfying certain other conditions (see “Lapse and reinstatement”).
Since withdrawals reduce your policy value, withdrawals increase the risk of lapse. Policy loans also increase the risk of lapse.
As mentioned above, the investment performance of any investment account may be good or bad. Your policy value will rise or fall based on the investment performance of the investment accounts you’ve chosen. Some investment accounts are riskier than others. These risks (and potential rewards) are discussed in detail in the prospectuses of the underlying portfolios.
There is a risk that you will not be able to transfer your policy value from one investment account to another because of limitations on the dollar amount or frequency of transfers you can make.
There are surrender charges assessed if you surrender your policy in the first ten policy years. Surrender charges may also apply to a Face Amount decrease (see “The death benefit — Requesting a decrease in coverage”). Depending on the policy value at the time you are considering surrender, there may be little or no surrender value payable to you.
Market timing and disruptive trading risks
The policy is not designed for professional market timers or highly active traders, including persons or entities that engage in programmed, large or frequent transfers among the investment accounts or between the investment accounts and any available fixed account. The policy is also not designed to accommodate trading that results in transfers that are large in relation to the total assets of the underlying portfolio.
Variable investment accounts in variable life insurance products can be a prime target for abusive transfer activity because these products value their investment accounts on a daily basis and allow transfers among investment accounts without immediate tax consequences. As a result, some investors may seek to frequently transfer into and out of investment accounts or to make large transfers in reaction to market news or to exploit a perceived pricing inefficiency. Whatever the reason, long-term investors in an investment account can be harmed by large or frequent transfer activity. For example, such activity may expose the investment account’s underlying portfolio to increased portfolio transaction costs and/or disrupt the portfolio manager’s ability to effectively manage the portfolio’s investments in accordance with the portfolio’s investment objectives and policies. This could include causing the portfolio to maintain higher levels of cash than would otherwise be the case, or liquidating investments prematurely. Accordingly, frequent or large transfers may result in dilution with respect to interests held for long-term investment and adversely affect policy owners, beneficiaries and the underlying portfolios.
To discourage market timing and disruptive trading activity, we impose restrictions on transfers (see “Transfers of existing policy value”) and reserve the right to change, suspend or terminate telephone, facsimile and internet transaction privileges (see “How you communicate with us”). In addition, we reserve the right to take other actions at any time to restrict trading, including, but not limited to:
(i) restricting the number of transfers made during a defined period,
(ii) restricting the dollar amount of transfers,
(iii) restricting transfers into and out of certain investment accounts,
(iv) restricting the method used to submit transfers, and
(v) deferring a transfer at any time we are unable to purchase or redeem shares of the underlying portfolio.
We may also impose additional administrative conditions upon, or prohibit a transfer request made by a third party giving instructions on behalf of multiple policies, whether owned by the same owner or different owners. If you engage a third party for asset allocation services, then you may be subject to these transfer restrictions because of the actions of that party in providing those services. We will notify the third party you have engaged if we exercise this right.
While we seek to identify and prevent disruptive trading activity, it may not always be possible to do so. Therefore, no assurance can be given that the restrictions we impose will be successful in preventing all disruptive trading and avoiding harm to long-term investors.
Life insurance death benefits are ordinarily not subject to income tax. Other Federal and state taxes may apply as further discussed below. In general, you will be taxed on the amount of lifetime distributions that exceed the premiums paid under the policy. Any taxable distribution will be treated as ordinary income (rather than as capital gains) for tax purposes.
In order for you to receive the tax benefits extended to life insurance under the Internal Revenue Code, your policy must comply with certain requirements of the Code. We will monitor your policy for compliance with these requirements, but a policy might fail to qualify as life insurance in spite of our monitoring. If this were to occur, you would be subject to income tax on the income credited to your policy for the period of disqualification and all subsequent periods. The tax laws also contain a so-called “7 pay limit” that limits the amount of premium that can be paid in relation to the policy’s death benefit. If the limit is violated, the policy will be treated as a “modified endowment contract,” which can have adverse tax consequences. There are also certain Treasury Department rules referred to as the “investor control rules” that determine whether you would be treated as the “owner” of the assets underlying your policy. If that were determined to be the case, you would be taxed on
any income or gains those assets generate. In other words, you would lose the value of the so-called “inside build-up” that is a major benefit of life insurance.There is a tax risk associated with policy loans. Although no part of a loan is treated as income to you when the loan is made unless your policy is a “modified endowment contract,” surrender or lapse of the policy would result in the loan being treated as a distribution at the time of lapse or surrender. This could result in a considerable tax bill. Under certain circumstances involving large amounts of outstanding loans and an insured person of advanced age, you might find yourself having to choose between high premium requirements to keep your policy from lapsing and a significant tax burden if you allow the lapse to occur.
Tax consequences of ownership or receipt of policy proceeds under Federal, state and local estate, inheritance, gift and other tax laws can vary greatly depending upon the circumstances of each owner or beneficiary. There can also be unfavorable tax consequences on such things as the change of policy ownership or assignment of ownership interests. For these and all the other reasons mentioned above, we recommend you consult with a qualified tax adviser before buying the policy and before exercising certain rights under the policy.
This section contains tables that describe all of the fees and expenses that you will pay when buying, owning and surrendering the policy. In the first three tables, certain entries show the minimum charge, the maximum charge and the charge for a representative insured person. Other entries show only the maximum charge we can assess and are labeled as such. Except where necessary to show a rate greater than zero, all rates shown in the tables have been rounded to two decimal places as required by prospectus disclosure rules. Consequently, the actual rates charged may be slightly higher or lower than those shown in the tables.
The first table below describes the fees and expenses that you will pay at the time that you pay a premium, surrender the policy, lapse the policy or transfer policy value between investment accounts. A portion of the premium charge is used to cover premium taxes. Currently, the premium tax in New York is 0.7% of each premium payment.
Transaction Fees | ||
Charge | When Charge is Deducted | Amount Deducted |
Maximum premium charge(1) | Upon payment of premium | 8% of each premium paid |
Surrender charge(2) | Upon surrender, policy lapse or reduction in Face Amount | |
Minimum charge | $12.30 per $1,000 of Face Amount | |
Maximum charge | $45.59 per $1,000 of Face Amount | |
Charge for representative insured person | $26.91 per $1,000 of Face Amount | |
Maximum transfer fee(3) | Upon each transfer into or out of an investment account beyond an annual limit of not less than twelve | $25 (currently $0) |
(1) | The maximum premium charge on premiums paid is 6% in year 2-10 and 2% in years 11 and thereafter. |
(2) | A surrender charge is applicable for ten policy years from the Policy Date, and varies based upon the sex, issue age and duration, risk classification of the insured person, the death benefit option elected, any riders elected under the policy, and premiums paid under the policy. The minimum charge shown in the table is for a 30 year old female smoker underwriting risk with death benefit Option 2 for which the guideline single premium has been paid in the first policy year. The maximum charge shown in the table is the amount shown in month one in the first policy year for a 59 year old male non-smoker underwriting risk with death benefit Option 2 for which the Minimum Initial Premium under the policy has been paid. The charge for the representative insured shown in the table is the amount for a 45 year old male nonsmoker underwriting risk with death benefit Option 2 for which the Target Premium in policy year 1 has been paid. (For more information about the surrender charge, see “Deductions from policy value - - Surrender charge.”) The charges shown in this table may not be particularly relevant to your current situation. For more information, contact your John Hancock NY representative. |
(3) | This charge is not currently imposed, but we reserve the right to do so in the policy. |
The next two tables describe the charges and expenses that you will pay periodically during the time you own the policy . These tables do not include fees and expenses paid at the portfolio level. The second table is devoted only to optional supplementary rider benefits. For more information about the cost of insurance rates and other charges talk to your John Hancock NY representative.
Periodic Charges Other Than Fund Operating Expenses | ||
Charge | When Charge is Deducted | Amount Deducted |
Cost of insurance charge(1) | Monthly | |
Minimum charge | $0.05 per $1,000 of NAR | |
Maximum charge | $83.33 per $1,000 of NAR | |
Charge for representative insured person | $0.22 per $1,000 of NAR | |
Face Amount charge(2) | Monthly for ten policy years from the Policy Date | |
Minimum charge | $0.14 per $1,000 of Face Amount | |
Maximum charge | $2.00 per $1,000 of Face Amount | |
Charge for representative insured person | $0.30 per $1,000 of Face Amount | |
Administrative charge | Monthly | $20 |
Asset-based risk charge(3) | Monthly | 0.025% of policy value |
Maximum policy loan interest rate(4) | Accrues daily Payable annually |
3.50% |
(1) | The cost of insurance charge is determined by multiplying the net amount of insurance for which we are at risk (the net amount at risk or “NAR”) by the applicable cost of insurance rate. The rates vary widely depending upon the length of time the policy has been in effect, the insurance risk characteristics of the insured person and (generally) the gender of the insured person. The minimum guaranteed rate shown in the table is the rate in the first policy year for a policy issued to cover a 30 year old female non-smoker underwriting risk. The maximum guaranteed rate shown in the table is the rate in the fifty-third policy year for a policy issued to cover a 60 year old male non-smoker underwriting risk. The representative insured person referred to in the table is a 45 year old male non-smoker underwriting risk with a policy in the first policy year. The charges shown in this table may not be particularly relevant to your current situation. For more information, contact your John Hancock NY representative. |
(2) | This charge is determined by multiplying the Face Amount at issue by the applicable rate. The rates vary by the sex, age, death benefit option, and risk classification at issue of the insured person. The charge also varies by policy year. The minimum guaranteed rate shown in the table is for a 35 year old female non-smoker underwriting risk electing death benefit Option 2. The maximum guaranteed rate shown in the table is for a 60 year old male smoker electing death benefit Option 2, and the representative insured person referred to in the table is a 45 year old male non-smoker electing death benefit Option 2. The charges shown in this table may not be particularly relevant to your current situation. For more information, contact your John Hancock NY representative. |
(3) | This charge only applies to that portion of the policy value held in the investment accounts. This charge is not currently imposed, but we reserve the right to do so in the policy. |
(4) | 3.50% is the maximum effective annual interest rate we can charge and applies only during policy years 1-10. The effective annual interest rate is 2.00% thereafter (although we reserve the right to increase the rate after the tenth policy year to as much as 2.25%). The amount of any loan is transferred from the investment accounts to a special loan account which earns interest at an effective annual rate of 2.00%. Therefore, the cost of a loan is the difference between the loan interest we charge and the interest we credit to the special loan account. |
Rider Charges | ||
Charge | When Charge is Deducted | Amount Deducted |
Overloan Protection Rider(1) | At exercise of benefit | |
Minimum charge | 0.04% | |
Maximum charge | 2.50% | |
Accelerated Benefit Rider(2) | At exercise of benefit | $150.00 |
(1)The charge for this rider is determined as a percentage of unloaned investment account value. The rates vary by the attained age of the insured person at the time of exercise. The rates also differ according to the tax qualification test elected at issue. The guaranteed minimum rate for the guideline premium test is 0.04% and the guaranteed maximum rate is 2.50%. The minimum rate shown in the table is for an insured person who has reached attained age 100 and the guideline premium test has been elected. The maximum rate shown is for an insured person who has reached attained age 75 and the guideline premium test has been elected.
(2)This charge is not currently imposed, but we reserve the right to do so in the policy.
The next table describes the minimum and maximum portfolio level fees and expenses charged by any of the portfolios underlying a variable investment option offered through this prospectus, expressed as a percentage of average net assets (rounded to two decimal places). These expenses are deducted from portfolio assets. For more information, please refer to the prospectus for the portfolio.
Total Annual Portfolio Operating Expenses | Minimum | Maximum |
Range of expenses, including management fees, distribution and/or service (12b-1) fees, and other expenses1 | 0.48% | 1.64% |
1 Certain of the portfolios’ advisers or subadvisers have contractually agreed to reimburse or waive certain portfolio level expenses. The minimum and maximum expenses shown do not reflect these contractual expense reimbursements or waivers. If such reimbursements or waivers were reflected, the minimum and maximum expenses would be 0.25% and 1.52%, respectively.
The next table describes the fees and expenses for each portfolio underlying a variable investment option offered through this prospectus. None of the portfolios charge a sales load or surrender fee. The fees and expenses do not reflect the fees and expenses of any variable insurance contract or qualified plan that may use the portfolio as its underlying investment medium. Except for the American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International, American New World and PIMCO VIT All Asset portfolios, all of the portfolios shown in the table are NAV class shares that are not subject to Rule 12b-1 fees. Except as indicated in the footnotes appearing at the end of the table, the expense ratios are based upon the portfolio’s actual expenses for the year ended December 31, 2013.
Portfolio Annual Expenses
(as a percentage of portfolio average net assets,
rounded to two decimal places)
Portfolio | Management Fees |
12b-1 Fees |
Other Expenses |
Acquired Fund Fees and Expenses |
Total Fund Operating Expenses |
500 Index B1 | 0.46% | 0.00% | 0.02% | 0.00% | 0.48% |
Active Bond2 | 0.60% | 0.00% | 0.04% | 0.01% | 0.65% |
All Cap Core2 | 0.78% | 0.00% | 0.04% | 0.01% | 0.83% |
Alpha Opportunities | 0.97% | 0.00% | 0.05% | 0.00% | 1.02% |
American Asset Allocation3 | 0.28% | 0.60% | 0.05% | 0.00% | 0.93% |
American Global Growth3 | 0.52% | 0.60% | 0.07% | 0.00% | 1.19% |
American Growth3 | 0.33% | 0.60% | 0.04% | 0.00% | 0.97% |
American Growth-Income3 | 0.27% | 0.60% | 0.04% | 0.00% | 0.91% |
American International3 | 0.49% | 0.60% | 0.08% | 0.00% | 1.17% |
American New World3 | 0.73% | 0.60% | 0.12% | 0.00% | 1.45% |
Blue Chip Growth | 0.78% | 0.00% | 0.04% | 0.00% | 0.82% |
Bond | 0.57% | 0.00% | 0.03% | 0.00% | 0.60% |
Capital Appreciation | 0.70% | 0.00% | 0.04% | 0.00% | 0.74% |
Capital Appreciation Value2 | 0.81% | 0.00% | 0.05% | 0.02% | 0.88% |
Core Bond2 | 0.59% | 0.00% | 0.03% | 0.01% | 0.63% |
Portfolio | Management Fees |
12b-1 Fees |
Other Expenses |
Acquired Fund Fees and Expenses |
Total Fund Operating Expenses |
Core Strategy2 | 0.04% | 0.00% | 0.03% | 0.54% | 0.61% |
Emerging Markets Value | 0.95% | 0.00% | 0.13% | 0.00% | 1.08% |
Equity-Income2 | 0.78% | 0.00% | 0.04% | 0.01% | 0.83% |
Financial Services | 0.78% | 0.00% | 0.08% | 0.00% | 0.86% |
Franklin Templeton Founding Allocation2 | 0.04% | 0.00% | 0.03% | 0.90% | 0.97% |
Fundamental All Cap Core | 0.67% | 0.00% | 0.04% | 0.00% | 0.71% |
Fundamental Large Cap Value | 0.65% | 0.00% | 0.04% | 0.00% | 0.69% |
Fundamental Value | 0.76% | 0.00% | 0.04% | 0.00% | 0.80% |
Global4 | 0.81% | 0.00% | 0.10% | 0.00% | 0.91% |
Global Bond | 0.70% | 0.00% | 0.10% | 0.00% | 0.80% |
Health Sciences | 0.97% | 0.00% | 0.07% | 0.00% | 1.04% |
High Yield | 0.67% | 0.00% | 0.07% | 0.00% | 0.74% |
International Core | 0.89% | 0.00% | 0.13% | 0.00% | 1.02% |
International Equity Index B1 | 0.53% | 0.00% | 0.03% | 0.00% | 0.56% |
International Growth Stock2 | 0.79% | 0.00% | 0.13% | 0.01% | 0.93% |
International Small Company | 0.95% | 0.00% | 0.17% | 0.00% | 1.12% |
International Value | 0.80% | 0.00% | 0.12% | 0.00% | 0.92% |
Investment Quality Bond | 0.58% | 0.00% | 0.06% | 0.00% | 0.64% |
Lifestyle Aggressive MVP2,5 | 0.04% | 0.00% | 0.04% | 0.88% | 0.96% |
Lifestyle Balanced MVP2,5 | 0.04% | 0.00% | 0.02% | 0.68% | 0.74% |
Lifestyle Conservative MVP2,5 | 0.04% | 0.00% | 0.02% | 0.65% | 0.71% |
Lifestyle Growth MVP2,5 | 0.04% | 0.00% | 0.02% | 0.70% | 0.76% |
Lifestyle Moderate MVP2,5 | 0.04% | 0.00% | 0.02% | 0.67% | 0.73% |
Mid Cap Index2,6 | 0.48% | 0.00% | 0.02% | 0.01% | 0.51% |
Mid Cap Stock | 0.83% | 0.00% | 0.04% | 0.00% | 0.87% |
Mid Value2 | 0.95% | 0.00% | 0.04% | 0.01% | 1.00% |
Money Market B1 | 0.50% | 0.00% | 0.04% | 0.00% | 0.54% |
Natural Resources | 1.00% | 0.00% | 0.11% | 0.00% | 1.11% |
PIMCO VIT All Asset7 | 0.43% | 0.45% | 0.76% | 0.00% | 1.64% |
Real Estate Securities | 0.70% | 0.00% | 0.05% | 0.00% | 0.75% |
Real Return Bond8 | 0.70% | 0.00% | 0.24% | 0.00% | 0.94% |
Science & Technology2 | 1.03% | 0.00% | 0.05% | 0.01% | 1.09% |
Short Term Government Income | 0.56% | 0.00% | 0.04% | 0.00% | 0.60% |
Small Cap Growth | 1.06% | 0.00% | 0.04% | 0.00% | 1.10% |
Small Cap Index2,9 | 0.49% | 0.00% | 0.03% | 0.09% | 0.61% |
Small Cap Opportunities2,4 | 1.00% | 0.00% | 0.06% | 0.03% | 1.09% |
Small Cap Value2 | 1.04% | 0.00% | 0.04% | 0.04% | 1.12% |
Small Company Value2 | 1.03% | 0.00% | 0.05% | 0.21% | 1.29% |
Strategic Income Opportunities | 0.64% | 0.00% | 0.09% | 0.00% | 0.73% |
Total Bond Market B2 | 0.47% | 0.00% | 0.02% | 0.01% | 0.50% |
Total Return4 | 0.68% | 0.00% | 0.04% | 0.00% | 0.72% |
Total Stock Market Index | 0.48% | 0.00% | 0.03% | 0.00% | 0.51% |
Ultra Short Term Bond | 0.55% | 0.00% | 0.07% | 0.00% | 0.62% |
U.S. Equity2 | 0.75% | 0.00% | 0.03% | 0.01% | 0.79% |
Utilities | 0.83% | 0.00% | 0.07% | 0.00% | 0.90% |
Value2 | 0.70% | 0.00% | 0.04% | 0.01% | 0.75% |
1 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its advisory fee (or, if necessary, reimburse expenses of the portfolio) in an amount so that the portfolio’s net Total Fund Operating Expenses do not exceed its “Total Fund
Operating Expenses” as shown in the table above. A portfolio’s “Total Fund Operating Expenses” includes all of its operating expenses including advisory and Rule 12b-1 fees, but excludes taxes, brokerage commissions, interest, short dividends, acquired fund fees, litigation and indemnification expenses and extraordinary expenses of the portfolio not incurred in the ordinary course of the portfolio’s business. JHIMS’ obligation to provide this waiver or reimbursement will remain in effect until April 30, 2015 unless renewed by mutual agreement of the fund and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver or reimbursement. If this waiver or reimbursement had been reflected, the “Total Fund Operating Expenses” for the portfolios would be as indicated below. For more information, please refer to the prospectus for the portfolio.
Portfolio | Total Fund Operating Expenses |
500 Index B | 0.25% |
International Equity Index B | 0.34% |
Money Market B | 0.28% |
Total Bond Market B | 0.26% |
2 “Acquired Fund Fees and Expenses” are based on indirect net expenses associated with the portfolio’s investments in underlying funds (each an “Acquired Fund”) and are included in the portfolio’s “Total Fund Operating Expenses.” The “Total Fund Operating Expenses” shown may not correlate to the portfolio’s ratio of expenses to average net assets shown in the Financial Highlights section of the prospectus for the portfolio, which does not include “Acquired Fund Fees and Expenses.” For more information, please refer to the prospectus for the portfolio.
3 The table reflects the combined fees of the feeder fund and the master fund.
4 John Hancock Investment Mangement Services, LLC (“JHIMS”) has contractually agreed to waive its advisory fee so that the amount retained by JHIMS after payment of the subadvisory fees for the portfolio does not exceed 0.45% of the portfolio’s average net assets. The current expense limitation agreement expires on April 30, 2015 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this expense waiver. If this expense waiver had been reflected, the “Total Fund Operating Expenses” for the Global and Small Cap Opportunities portfolios would be 0.90% and 1.00%, respectively. For more information, please refer to the prospectus for the portfolio.
5 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to reduce its management fee and/or make payment to the portfolio in an amount equal to the amount by which “Other Expenses” of the fund exceed 0.00% of the average annual net assets (on an annualized basis) of the portfolio. “Other Expenses” means all of the expenses of the portfolio, excluding certain expenses such as advisory fees, taxes, brokerage commissions, interest expense, litigation and indemnification expenses and other extraordinary expenses not incurred in the ordinary course of the portfolio’s business, distribution and service (Rule 12b-1) fees, printing and postage, underlying fund expenses (acquired fund fees), and short dividend expense. The current expense limitation agreement expires on April 30, 2017 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. JHIMS may recapture operating expenses reimbursed or fees waived under previous expense limitation or waiver arrangements for a period of three years following the month in which the reimbursements or waivers occurred to the extent that the portfolio is below its expense limitation during this period. The fees shown in the table do not reflect this expense waiver or reimbursement. If this waiver or reimbursement had been reflected, the “Total Fund Operating Expenses” for the portfolios would be as indicated below. For more information, please refer to the prospectus for the portfolio.
Portfolio | Total Fund Operating Expenses |
Lifestyle Aggressive MVP | 0.92% |
Lifestyle Balanced MVP | 0.72% |
Lifestyle Conservative MVP | 0.69% |
Lifestyle Growth MVP | 0.74% |
Lifestyle Moderate MVP | 0.71% |
6 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its management fee by 0.10% as a percentage of the portfolio’s average annual net assets. The current expense limitation agreement expires on April 30, 2015 unless renewed by mutual agreement of the portfolio and JHIMS based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver. If this waiver had been reflected, the “Total Fund Operating Expenses” for the portfolio would be 0.41%. For more information, please refer to the prospectus for the portfolio.
7 Pacific Investment Management Company LLC (“PIMCO”) has contractually agreed through May 1, 2015, to reduce its management fee to the extent that the underlying fund expenses attributable to management, supervisory and administrative fees exceeds 0.64% of the total assets invested in the underlying funds. PIMCO may recoup these waivers in future periods, not exceeding three years, provided total expenses, including such recoupment, do not exceed the annual expense limit. The fee reduction is implemented based on a calculation of underlying fund expenses attributable to management, supervisory and administrative fees that is different from the calculation of “Acquired Fund Fees and Expenses” shown in the table. “Acquired Fund Fees and Expenses” include interest expense of 0.01%. Interest expense is based on the amount incurred during an underlying fund’s most recent fiscal year as a result of entering into certain investments, such as reverse repurchase agreements. Interest expense is required to be treated as an expense of the underlying fund for accounting purposes and is not payable to PIMCO. The amount of interest expense (if any) will vary based on the underlying fund’s use of such investments as an
investment strategy. “Total Fund Operating Expenses” excluding interest expense of the underlying fund is 1.64%. The fees shown in the table do not reflect the expense waiver. If this expense waiver had been reflected, the “Total Fund Operating Expenses” (excluding the interest expense of the underlying funds) would be 1.52%. The “Total Fund Operating Expenses” shown may not correlate to the portfolio’s ratio of expense to average net assets shown in the Financial Highlights section of the prospectus for the portfolio, which does not include “Acquired Fund Fees and Expenses.” For more information, please refer to the prospectus for the portfolio.8 “Other Expenses” reflect interest expense resulting from the portfolio’s use of certain investments such as reverse repurchase agreements or sale-buybacks. Such expense is required to be treated as a portfolio expense for accounting purposes. Any interest expense amount will vary based on the portfolio’s use of those investments as an investment strategy. Had these expenses been excluded, “Other Expenses” would be 0.11%. For more information, please refer to the prospectus for the portfolio.
9 John Hancock Investment Management Services, LLC (“JHIMS”) has contractually agreed to waive its management fee by 0.05% as a percentage of the portfolio’s average annual net assets. The current expense limitation agreement expires on April 30, 2015 unless renewed by mutual agreement of the fund and the advisor based upon a determination that this is appropriate under the circumstances at that time. The fees shown in the table do not reflect this waiver. If this waiver had been reflected, the “Total Fund Operating Expenses” for the portfolio would be 0.56%. For more information, please refer to the prospectus for the portfolio.
This section of the prospectus provides additional detailed information that is not contained in the Summary of Benefits and Risks section.
Table of Investment Options and Investment Subadvisers
When you select a Separate Account investment option, we invest your money in shares of a corresponding portfolio of the John Hancock Variable Insurance Trust (the “Trust” or “JHVIT”) (or the PIMCO Variable Insurance Trust (the “PIMCO Trust”) with respect to the PIMCO VIT All Asset portfolio) and hold the shares in a subaccount of the Separate Account. The Fee Tables show the investment management fees, Rule 12b-1 fees and other operating expenses for these portfolio shares as a percentage (rounded to two decimal places) of each portfolio’s average net assets for 2013, except as indicated in the footnotes appearing at the end of the table. Fees and expenses of the portfolios are not fixed or specified under the terms of the policies and may vary from year to year. These fees and expenses differ for each portfolio and reduce the investment return of each portfolio. Therefore, they also indirectly reduce the return you will earn on any Separate Account investment options you select.
The JHVIT and the PIMCO Trust are so-called “series” type mutual funds and each is registered under the Investment Company Act of 1940 (“1940 Act”) as an open-end management investment company. John Hancock Investment Management Services, LLC (“JHIMS”) provides investment advisory services to the Trust and receives investment management fees for doing so. JHIMS pays a portion of its investment management fees to other firms that manage the Trust’s portfolios. We are affiliated with JHIMS and may indirectly benefit from any investment management fees JHIMS retains. The PIMCO VIT All Asset portfolio of the PIMCO Trust receives investment advisory services from Pacific Investment Management Company LLC (“PIMCO”) and pays investment management fees to PIMCO.
Each of the American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International and American New World portfolios invests in Series 1 shares of the corresponding investment portfolio of the Trust. The American Asset Allocation, American Global Growth, American Growth, American Growth-Income, American International and American New World portfolios (“American Portfolios”) operate as “feeder funds,” which means that the portfolios do not buy investment securities directly. Instead, they invest in a “master fund” which in turn purchases investment securities. Each of the American feeder fund portfolios has the same investment objective and limitations as its master fund. The prospectus for the American Fund master fund is included with the prospectuses for the underlying funds. We pay American Funds Distributors, Inc., the principal underwriter for the American Funds Insurance Series, a percentage of some or all of the amounts allocated to the American Portfolios of the Trust for the marketing support services it provides.
The portfolios pay us or certain of our affiliates compensation for some of the distribution, administrative, shareholder support, marketing and other services we or our affiliates provide to the portfolios. The amount of this compensation is based on a percentage of the assets of the portfolios attributable to the variable insurance products that we and our affiliates issue. These percentages may differ from portfolio to portfolio and among classes of shares within a portfolio. In some cases, the compensation is derived from the Rule 12b-1 fees that are deducted from a portfolio’s assets for the services we or our affiliates provide to that portfolio. These compensation payments do not, however, result in any charge to you in addition to what is shown in the Fee Tables.
The following table provides a general description of the portfolios that underlie the variable investment options we make available under the policy. You bear the investment risk of any portfolio you choose as an investment option for your policy. You can find a full description of each portfolio, including the investment objectives, policies, restrictions, and risks, in the prospectus for that portfolio. You should read the portfolio’s prospectus carefully before investing in the corresponding variable investment option.
The investment options in the Separate Account are not publicly traded mutual funds. The investment options are only available to you as investment options in the policies, or in some cases through other variable annuity contracts or variable life insurance policies issued by us or by other life insurance companies. In some cases, the investment options also may be available through participation in certain qualified pension or retirement plans. The portfolios’ investment advisers and managers (i.e. subadvisers) may manage publicly traded mutual funds with similar names and investment objectives. However, the portfolios are not directly related to any publicly traded mutual fund. You should not compare the performance
of any investment option described in this prospectus with the performance of a publicly traded mutual fund. The performance of any publicly traded mutual fund could differ substantially from that of any of the investment options of our Separate Account.The portfolios available under the policies, the portfolio managers (engaged by JHIMS or PIMCO) and the investment objective for the portfolio are as described in the following table:
Portfolio
Portfolio Manager
Investment Objective
500 Index B
John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited
To approximate the aggregate total return of a broad-based U.S. domestic equity market index.
Active Bond
Declaration Management & Research LLC; and John Hancock Asset Management, a division of Manulife Asset Management (US) LLC
To seek to provide income and capital appreciation.
All Cap Core
QS Investors, LLC
To seek to provide long-term growth of capital.
Alpha Opportunities
Wellington Management Company, LLP
To seek to provide long-term total return.
American Asset Allocation
Capital Research and Management Company (Adviser to the American Funds Insurance Series)
To seek to provide high total return (including income and capital gains) consistent with preservation of capital over the long-term.
American Global Growth
Capital Research and Management Company (Adviser to the American Funds Insurance Series)
To seek to provide long-term growth of capital.
American Growth
Capital Research and Management Company (Adviser to the American Funds Insurance Series)
To seek to provide growth of capital.
American Growth–Income
Capital Research and Management Company (Adviser to the American Funds Insurance Series)
To seek to provide growth of capital and income.
American International
Capital Research and Management Company (Adviser to the American Funds Insurance Series)
To seek to provide long-term growth of capital.
American New World
Capital Research and Management Company (Adviser to the American Funds Insurance Series)
To seek to provide long-term capital appreciation.
Blue Chip Growth
T. Rowe Price Associates, Inc.
To seek to provide long-term growth of capital. Current income is a secondary objective.
Bond
John Hancock Asset Management, a division of Manulife Asset Management (US) LLC
To seek to provide income and capital appreciation.
Capital Appreciation
Jennison Associates LLC
To seek to provide long-term growth of capital.
Capital Appreciation Value
T. Rowe Price Associates, Inc.
To seek to provide long-term capital appreciation.
Core Bond
Wells Capital Management, Incorporated
To seek to provide total return consisting of income and capital appreciation.
Core Strategy
John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset
Management (North America) Limited
To seek to provide long-term growth of capital. Current income is also a consideration.
Emerging Markets Value
Dimensional Fund Advisors LP
To seek to provide long-term capital appreciation.
Equity-Income
T. Rowe Price Associates, Inc.
To seek to provide substantial dividend income and also long-term growth of capital.
Financial Services
Davis Selected Advisers, L.P.
To seek to provide growth of capital.
Portfolio | Portfolio Manager | Investment Objective |
Franklin Templeton Founding Allocation | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC | To seek to provide long-term growth of capital. |
Fundamental All Cap Core | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC | To seek to provide long-term growth of capital. |
Fundamental Large Cap Value | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC | To seek to provide long-term capital appreciation. |
Fundamental Value | Davis Selected Advisers, L.P. | To seek to provide capital growth. |
Global | Templeton Global Advisors Limited | To seek to provide long-term capital appreciation. |
Global Bond | Pacific Investment Management Company LLC | To seek to provide maximum total return, consistent with preservation of capital and prudent investment management. |
Health Sciences | T. Rowe Price Associates, Inc. | To seek to provide long-term capital appreciation. |
High Yield | Western Asset Management Company | To seek to provide an above-average total return over a market cycle of 3 to 5 years, consistent with reasonable risk. |
International Core | Grantham, Mayo, Van Otterloo & Co. LLC | To seek to provide high total return. |
International Equity Index B | SSgA Funds Management, Inc. | To seek to track the performance of a broad-based equity index of foreign companies primarily in developed countries and, to a lesser extent, in emerging markets. |
International Growth Stock | Invesco Advisers, Inc. | To seek to provide long-term growth of capital. |
International Small Company | Dimensional Fund Advisors LP | To seek to provide long-term capital appreciation. |
International Value | Templeton Investment Counsel, LLC | To seek to provide long-term growth of capital. |
Investment Quality Bond | Wellington Management Company, LLP | To seek to provide a high level of current income consistent with the maintenance of principal and liquidity. |
Lifestyle Aggressive MVP | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to provide long-term growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses. |
Lifestyle Balanced MVP | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to provide growth of capital and current income while seeking to both manage the volatility of return and limit the magnitude of portfolio losses. |
Lifestyle Conservative MVP | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to provide current income and growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses. |
Lifestyle Growth MVP | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to provide long-term growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses. |
Lifestyle Moderate MVP | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC; and John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to provide current income and growth of capital while seeking to both manage the volatility of return and limit the magnitude of portfolio losses. |
Portfolio | Portfolio Manager | Investment Objective |
Mid Cap Index | John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to approximate the aggregate total return of a medium-capitalization U.S. domestic equity market index. |
Mid Cap Stock | Wellington Management Company, LLP | To seek to provide long-term growth of capital. |
Mid Value | T. Rowe Price Associates, Inc. | To seek to provide long-term capital appreciation. |
Money Market B |
John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to obtain maximum current income consistent with preservation of principal and liquidity. Certain market conditions may cause the return of the portfolio to become low or possibly negative. |
Natural Resources | Wellington Management Company, LLP | To seek to provide long-term total return. |
PIMCO VIT All Asset (a series of PIMCO Variable Insurance Trust) (only Class M is available) | Pacific Investment Management Company LLC | To seek to provide maximum real return, consistent with preservation of real capital and prudent investment management. |
Real Estate Securities | Deutsche Investment Management Americas Inc. | To seek to provide a combination of long-term capital appreciation and current income. |
Real Return Bond | Pacific Investment Management Company LLC | To seek to provide maximum real return, consistent with preservation of real capital and prudent investment management. |
Science & Technology | T. Rowe Price Associates, Inc.; and Allianz Global Investors U.S. LLC | To seek to provide long-term growth of capital. Current income is incidental to the portfolio’s objective. |
Short Term Government Income | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC | To seek to provide a high level of current income consistent with preservation of capital. Maintaining a stable share price is a secondary goal. |
Small Cap Growth | Wellington Management Company, LLP | To seek to provide long-term capital appreciation. |
Small Cap Index | John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to approximate the aggregate total return of a small-capitalization U.S. domestic equity market index. |
Small Cap Opportunities | Dimensional Fund Advisors LP; and Invesco Advisers, Inc. | To seek to provide long-term capital appreciation. |
Small Cap Value | Wellington Management Company, LLP | To seek to provide long-term capital appreciation. |
Small Company Value | T. Rowe Price Associates, Inc. | To seek to provide long-term growth of capital. |
Strategic Income Opportunities | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC | To seek to provide a high level of current income. |
Total Bond Market B |
Declaration Management & Research LLC | To seek to track the performance of the Barclays U.S. Aggregate Bond Index.* |
Total Return | Pacific Investment Management Company LLC | To seek to provide maximum total return, consistent with preservation of capital and prudent investment management. |
Total Stock Market Index | John Hancock Asset Management, a division of Manulife Asset Management (North America) Limited | To seek to approximate the aggregate total return of a broad U.S. domestic equity market index. |
Ultra Short Term Bond | John Hancock Asset Management, a division of Manulife Asset Management (US) LLC | To seek to provide a high level of current income consistent with the maintenance of liquidity and the preservation of capital. |
U.S. Equity | Grantham, Mayo, Van Otterloo & Co. LLC | To seek to provide long-term capital appreciation. |
Utilities | Massachusetts Financial Services Company | To seek to provide capital growth and current income (income above that available from the portfolio invested entirely in equity securities). |
Value | Invesco Advisers, Inc. | To seek to provide an above-average total return over a market cycle of 3 to 5 years, consistent with reasonable risk. |
*The U.S. Aggregate Bond Index is a broad-based benchmark that measures the investment grade, U.S. dollar-denominated, fixed-rate taxable bond market, including Treasuries, government-related and corporate securities, MBS (agency fixed-rate and hybrid ARM pass throughs), ABS, and CMBS.
If the shares of a portfolio are no longer available for investment or in our judgment investment in a portfolio becomes inappropriate, we may eliminate the shares of a portfolio and substitute shares of another portfolio of the Trust or another open-end registered investment company. Substitution may be made with respect to both existing investments and the investment of future purchase payments. However, we will make no such substitution without first notifying you and obtaining approval of the appropriate insurance regulatory authorities and the SEC (to the extent required by the 1940 Act).
We will purchase and redeem series fund shares for the Separate Account at their net asset value without any sales or redemption charges. Shares of a series fund represent an interest in one of the funds of the series fund which corresponds to a subaccount of the Separate Account. Any dividend or capital gains distributions received by the Separate Account will be reinvested in shares of that same fund at their net asset value as of the dates paid.
On each business day, shares of each series fund are purchased or redeemed by us for each subaccount based on, among other things, the amount of net premiums allocated to the subaccount, distributions reinvested, and transfers to, from and among subaccounts, all to be effected as of that date. Such purchases and redemptions are effected at each series fund’s net asset value per share determined for that same date. A “business day” is any date on which the New York Stock Exchange is open for trading. We compute policy values for each business day as of the close of that day (usually 4:00 p.m. Eastern time).
We will vote shares of the portfolios held in the Separate Account at the shareholder meetings according to voting instructions timely received from persons having the voting interest under the policies. We will determine the number of portfolio shares for which voting instructions may be given not more than 90 days prior to the meeting. Proxy material will be distributed to each person having the voting interest under the policy together with appropriate forms for giving voting instructions. We will vote all portfolio shares that we hold in the Separate Account for policy owners in proportion to the instructions timely received by us from policy owners from all our Separate Accounts that are registered with the SEC under the 1940 Act. We will vote all portfolio shares that we otherwise are entitled to vote (including our own shares) on any matter in proportion to the instructions timely received by us and any affiliated insurance companies with respect to the matter from policy owners in Separate Accounts of these insurance companies that are registered with the SEC under the 1940 Act. The effect of this proportional voting is that a small number of policy owners can determine the outcome of a vote.
We determine the number of a series fund’s shares held in a subaccount attributable to each owner by dividing the amount of a policy’s investment account value held in the subaccount by the net asset value of one share in the series fund. Fractional votes will be counted. We determine the number of shares as to which the owner may give instructions as of the record date for a series fund’s meeting. Owners of policies may give instructions regarding the election of the Board of Trustees or Board of Directors of a series fund, ratification of the selection of independent auditors, approval of series fund investment advisory agreements and other matters requiring a shareholder vote. We will furnish owners with information and forms to enable owners to give voting instructions. However, we may, in certain limited circumstances permitted by the SEC’s rules, disregard voting instructions. If we do disregard voting instructions, you will receive a summary of that action and the reasons for it in the next semi-annual report to owners.
The voting privileges described above reflect our understanding of applicable Federal securities law requirements. To the extent that applicable law, regulations or interpretations change to eliminate or restrict the need for such voting privileges, we reserve the right to proceed in accordance with any such revised requirements. We also reserve the right, subject to compliance with applicable law, including approval of owners if so required, (1) to transfer assets determined by John Hancock NY to be associated with the class of policies to which your policy belongs from the Separate Account to another separate account or subaccount, (2) to deregister the Separate Account under the 1940 Act, (3) to substitute for the fund shares held by a subaccount any other investment permitted by law, and (4) to take any action necessary to comply with or obtain any exemptions from the 1940 Act. Any such change will be made only if, in our judgment, the change would best serve the interests of owners of policies in your policy class or would be appropriate in carrying out the purposes of such policies. We would notify owners of any of the foregoing changes and to the extent legally required, obtain approval of affected owners and any regulatory body prior thereto. Such notice and approval, however, may not be legally required in all cases.
Description of John Hancock NY
John Hancock NY is a stock life insurance company organized under the laws of New York on February 10, 1992. Our principal office is located at 100 Summit Lake Drive, Second Floor, Valhalla, New York 10595. We are a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.). Our ultimate parent is Manulife Financial Corporation (“MFC”), a publicly traded company based in Toronto, Canada. MFC is the holding company of The Manufacturers Life Insurance Company and its subsidiaries, collectively known as Manulife Financial. However, neither John Hancock NY nor any of its affiliated companies guarantees the investment performance of the Separate Account.
We are ranked and rated by independent financial rating services, which may include Moody’s, Standard & Poor’s, Fitch and A.M. Best. The purpose of these ratings is to reflect the financial strength or claims-paying ability of the company, but they do not specifically relate to its products, the performance (return) of these products, the value of any investment in these products upon withdrawal or to individual securities held in any portfolio. These ratings do not apply to the safety and performance of the Separate Account.
Description of Separate Account B
The investment accounts shown on page 1 are in fact subaccounts of John Hancock Life Insurance Company of New York Separate Account B, a separate account operated by us under New York law. The Separate Account meets the definition of “separate account” under the Federal securities laws and is registered as a unit investment trust under the 1940 Act. Such registration does not involve supervision by the SEC of the management of the Separate Account or of us.
The Separate Account’s assets are our property. Each policy provides that amounts we hold in the Separate Account pursuant to the policies cannot be reached by any other persons who may have claims against us and can’t be used to pay any indebtedness of John Hancock NY other than those arising out of policies that use the Separate Account. Income, gains and losses credited to, or charged against, the Separate Account reflect the Separate Account’s own investment experience and not the investment experience of John Hancock NY’s other assets. John Hancock NY is obligated to pay all amounts promised to policy owners under the policies.
New subaccounts may be added and made available to policy owners from time to time. Existing subaccounts may be modified or deleted at any time.
In your application for the policy, you will tell us how much life insurance coverage you want on the life of the insured person. This is called the “Face Amount.”
When the insured person dies, we will pay the death benefit minus any outstanding policy debt and unpaid fees and charges. There are two ways of calculating the death benefit, as described below.
For the same premium payments, the death benefit under Option 2 will tend to be higher than the death benefit under Option 1. On the other hand, the Face Amount charge and resulting cost of insurance charges (based on the higher net amount at risk) will be higher under Option 2. Because of that, the policy value will tend to be higher under Option 1 than under Option 2 for the same premium payments.
Your policy will be issued with death benefit Option 2. After the first policy year, you may request to change the death benefit from Option 2 to Option 1.
Limitations on payment of death benefit
If the insured person commits suicide within certain time periods (generally within two years from the Issue Date of the policy), the amount payable will be equal to the premiums paid, less the amount of any policy debt on the date of death, and less any withdrawals.
Also if an application misstated the age or sex of the insured person, we will adjust, if necessary, the Face Amount and every other benefit to that which would have been purchased at the correct age or sex by the most recent cost of insurance charge.
In order for a policy to qualify as life insurance under Federal tax law, there has to be a minimum amount of insurance in relation to policy value. The Federal tax law test that will be applied to determine whether your policy qualifies for life insurance is the “guideline premium test.” (see “Tax considerations”)
Under the guideline premium test, we compute the minimum death benefit each business day by multiplying the policy value on that date by the death benefit factor applicable on that date. Factors for some ages are shown in the table below:
Attained Age | Applicable Factor |
40 and under | 250% |
45 | 215% |
50 | 185% |
55 | 150% |
60 | 130% |
65 | 120% |
70 | 115% |
75 | 105% |
90 | 105% |
95 and above | 100% |
A table showing the factor for each age will appear in the policy.
To the extent that the calculation of the minimum death benefit under the guideline premium test causes the death benefit to exceed our limits, we reserve the right to return premiums or distribute a portion of the policy value so that the resulting amount of insurance is maintained within our limits. Alternatively, if we should decide to accept the additional amount of insurance, we may require additional evidence of insurability.
Provided the policy is in force at and after the life insured’s age 121:
Requesting a decrease in coverage
After the first policy year, we may approve a reduction in the Face Amount, but only if:
A pro-rata portion of the surrender charge will be payable upon any approved reduction in the Face Amount that reduces the Face Amount to an amount that is below the Face Amount at issue (see “Surrender charge”). For Face Amount reductions, an additional 10% of the Face Amount at issue is also exempt from the partial surrender charge. This 10% surrender charge
exemption does not apply to full surrenders or net cash surrender withdrawals (see “Surrenders and withdrawals – Withdrawals”). An approved decrease will take effect on the monthly deduction date on or next following the date we approve the request.Change of death benefit option
Your policy will be issued with death benefit Option 2. Under our current administrative rules, we permit the death benefit option to be changed from 2 to Option 1 after the first policy year. If you request in writing, and we approve a change from Option 2 to Option 1, your Face Amount after the change will equal your Face Amount before the change plus the policy value as of the effective date of the change. If you change from Option 2 to Option 1, your death benefit at death may be lower than what it was if your policy had remained as death benefit option 2. This means, your death benefit will change from one that may increase over time due to the investment experience of the underlying investment accounts to one that is a level death benefit. Changing from Option 2 to Option 1 can also lower the monthly Cost of Insurance charge since this charge is lowered when the Net Amount At Risk is reduced; all other charges under the policy would remain the same. We reserve the right to limit a request for a change if the change would cause the policy to fail to qualify as life insurance for tax purposes.
A change in the death benefit option will result in a change in the policy’s Face Amount, in order to avoid any change in the amount of the death benefit. The new Face Amount will be equal to the Face Amount prior to the change plus the policy value as of the date of the change. The change will take effect on the monthly deduction date on or next following the date the written request for the change is received at our Service Office.
Tax consequences of coverage changes
If you change the death benefit option after the first policy year from Option 2 to Option 1, the “guideline premium test” will continue to apply. Please read “The minimum death benefit” for more information about these Federal tax law tests.
A change in the death benefit option or Face Amount will often change the policy’s limits under the “guideline premium test.” To avoid having the policy cease to qualify as life insurance for tax purposes, we reserve the right to (i) refuse or limit a change in the death benefit option or Face Amount and (ii) change the Guideline Single Premium or Guideline Level Premium, as applicable. Please read “Tax considerations” to learn about possible tax consequences of changing your insurance coverage under the policy.
You name your beneficiary when you apply for the policy. The beneficiary is entitled to the proceeds we pay following the insured person’s death. You may change the beneficiary during the insured person’s lifetime. Such a change requires the consent of any named irrevocable beneficiary. A new beneficiary designation will not affect any payments we make before we receive it. If no beneficiary is living when the insured person dies, we will pay the insurance proceeds to the owner or the owner’s estate.
Ways in which we pay out policy proceeds
You may choose to receive proceeds from the policy as a single sum. This includes proceeds that become payable because of death or surrender. As permitted by state law and our current administrative procedures, death claim proceeds may be placed into an interest-bearing John Hancock retained asset account in the beneficiary’s name. The interest earned in a John Hancock retained asset account is normally subject to income tax. You should consult with your tax advisor if you have any questions regarding taxation of the interest earned. We will provide the beneficiary with a checkbook, so checks may be written for all or a part of the proceeds. The retained asset account is part of our general account and is subject to the claims of our creditors. It is not a bank account and it is not insured by the FDIC. We may receive a benefit from managing proceeds held in a retained asset account. Alternatively, you can elect to have proceeds of $1,000 or more applied to any of the other payment options we may offer at the time. You cannot choose an option if the monthly payments under the option would be less than $50. We will issue a supplementary agreement when the proceeds are applied to any alternative payment option. That agreement will spell out the terms of the option in full. Please contact our Service Office for more information.
You can change the payment option at any time before the proceeds are payable. If you haven’t made a choice, the payee of the proceeds has a prescribed period in which he or she can make that choice.
Tax impact of payment option chosen
There may be tax consequences to you or your beneficiary depending upon which payment option is chosen. You should consult with a qualified tax adviser before making that choice.
The Policy Specifications page of your policy will show the “Planned Premium” for the policy. You choose this amount in the policy application. You will also choose how often to pay premiums — annually, semi-annually or quarterly. You may also choose to pay premiums by monthly electronic funds transfers. The premium reminder notice we send you is based on the amount and period you choose. However, payment of Planned Premiums is not necessarily required. You need only pay enough premium to keep the policy in force (see “Lapse and reinstatement”).
The Minimum Initial Premium is set forth in the Policy Specifications page of your policy. After the payment of the initial premium, premiums may be paid at any time and in any amount until the insured person’s attained age 121, subject to the need to pay enough premium to keep the policy in force, and to the limitations on maximum premium amount described below.
Federal tax law limits the amount of premium payments you can make relative to the amount of your policy’s insurance coverage. We will not knowingly accept any amount by which a premium payment exceeds this limit. If you exceed certain other limits, the law may impose a penalty on amounts you take out of your policy. More discussion of these tax law requirements is provided under “Tax considerations.”
Large premium payments may expose us to unanticipated investment risk. In addition, in order to limit our investment risk exposure under certain market conditions, we may refuse to accept additional premium payments. Excessive allocations may also interfere with the effective management of our variable investment account portfolios, if we are unable to make an orderly investment of the additional premium into the portfolios. Also, we may refuse to accept or limit an amount of premium if the amount of the premium would increase our insurance risk exposure, and the insured person doesn’t provide us with adequate evidence that he or she continues to meet our requirements for issuing insurance.
We will notify you in writing of our refusal to accept premium under these provisions within three days following the date that it is received by us, and will promptly thereafter take the necessary steps to return the premium to you. Notwithstanding the foregoing limits on the premium that we will accept, we will not refuse to accept any premium necessary to prevent the policy from terminating.
No premiums will be accepted prior to our receipt of a completed application at our Service Office. All premiums received prior to the Issue Date of the policy will be held in the general account and credited with interest from the date of receipt at the rate of return then being earned on amounts allocated to the Money Market B investment account. After the Issue Date but prior to the Allocation Date, premiums received are allocated to the Money Market B investment account. The “Allocation Date” of the policy is the tenth day after the Issue Date. The Issue Date is shown on the Policy Specifications page of the policy. On the Allocation Date, the Net Premiums paid plus interest credited, if any, will be allocated among the investment accounts in accordance with the policy owner’s instructions. The “Net Premium” is the premium paid less the applicable premium charges we deduct from it.
Any Net Premium received on or after the Allocation Date will be allocated among investment accounts as of the business day on or next following the date the premium is received at the Service Office. Monthly deductions are normally due on the Policy Date and at the beginning of each policy month thereafter. However, if the monthly deductions are due prior to the Contract Completion Date, they will be deducted from policy value on the Contract Completion Date instead of the dates they were due (see “Procedures for issuance of a policy” for the definition of “Contract Completion Date”).
Payment of premiums will not guarantee that the policy will stay in force. Conversely, failure to pay premiums will not necessarily cause the policy to lapse. However, in states where permitted, the policy will have a No-Lapse Guarantee which would prevent the policy from lapsing during the guarantee period, provided certain criteria are satisfied.
If you pay premiums by check or money order, they must be drawn on a U.S. bank in U.S. dollars and made payable to “John Hancock.” We will not accept credit card checks. We will not accept starter or third party checks if they fail to satisfy our administrative requirements. Premiums after the first must be sent to the John Hancock NY Service Office at the appropriate address shown on the back cover of this prospectus.
We will also accept premiums:
Unless the No-Lapse Guarantee is in effect, a policy will go into default if at the beginning of any policy month the policy’s net cash surrender value would be zero or below after deducting the monthly deductions then due. Therefore, a policy could lapse eventually if increases in policy value (prior to deduction of policy charges) are not sufficient to cover policy charges. A lapse could have adverse tax consequences as described under “Tax considerations.” We will notify you of the default and will allow a 61 day grace period in which you may make a premium payment sufficient to bring the policy out of default. The required payment will be equal to the amount necessary to bring the net cash surrender value to zero, if it was less than zero on the date of default, plus an amount equal to three times the monthly deductions due on the date of default, plus any applicable premium charge. If the required payment is not received by the end of the grace period, the policy will terminate (i.e., “lapse”) with no value.
In those states where it is permitted, as long as the cumulative premium test is satisfied during the No-Lapse Guarantee Period, as described below, we will guarantee that the policy will not go into default, even if adverse investment experience or other factors should cause the policy’s surrender value to fall to zero or below during such period.
The monthly No-Lapse Guarantee Premium is one-twelfth of the No-Lapse Guarantee Premium. The No-Lapse Guarantee Premium is not a charge assessed against the policy value. It is an amount used in determining whether the cumulative premium test has been satisfied.
The No-Lapse Guarantee Premium is set at issue on the basis of the Face Amount of the policy, and reflects the age, sex and risk class of the proposed insured, the death benefit option, as well as any additional rating and supplementary benefits, if applicable. It is subject to change if (i) the Face Amount of the policy is changed, (ii) there is a death benefit option change, (iii) there is a decrease in the Face Amount of insurance, or (iv) there is any change in the supplementary benefits added to the policy or in the risk classification of the insured person.
The No-Lapse Guarantee Period is set at issue and is stated in the policy. Certain state limitations may apply, but generally the No-Lapse Guarantee Period for the Face Amount is five years.
While the No-Lapse Guarantee is in effect, we will determine at the beginning of the policy month that your policy would otherwise be in default whether the cumulative premium test, described below, has been met. If the test has not been satisfied, we will notify you of that fact and allow a 61-day grace period in which you may make a premium payment sufficient to keep the policy from going into default. This required payment, as described in the notification, will be equal to the lesser of:
(a) | the outstanding premium requirement to satisfy the cumulative premium test at the date of default, plus the monthly No-Lapse Guarantee Premium due for the next three policy months, or |
(b) | the amount necessary to bring the Net Cash Surrender Value to zero plus an amount equal to three times the monthly deductions due on the date of default, plus the applicable premium charge. |
If the required payment is not received by the end of the grace period, the No-Lapse Guarantee and the policy will terminate. If you make the required payment under (a) described above, only the Face Amount will remain in effect, and any supplementary benefit riders (unless otherwise stated therein) will terminate as of the end of the grace period.
The cumulative premium test is satisfied if, as of the beginning of the policy month that your policy would otherwise be in default, the sum of all premiums paid to date less any withdrawals taken on or before the date of the test and less any policy debt is equal to or exceeds the sum of the monthly No-Lapse Guarantee Premium due from the Policy Date to the date of the test.
If the insured person should die during the grace period, the policy value used in the calculation of the death benefit will be the policy value as of the date of default, and the death benefit will be reduced by any outstanding monthly deductions due at the time of death.
By making a written request, you can reinstate a policy that has gone into default and terminated at any time within the three-year period following the date of termination subject to the following conditions:
(a) | You must provide to us evidence satisfactory to us that the insured person is insurable, which may include our full underwriting standards, including a medical examination; and |
(b) | You must pay a premium equal to the amount that was required to bring the policy out of default immediately prior to termination, plus the amount needed to keep the policy in force for at least the next three policy months. |
If the reinstatement is approved, the date of reinstatement will be the later of the date we approve your request or the date the required payment is received at our Service Office. In addition, any surrender charges will be reinstated to the amount they were at the date of default. The policy value on the date of reinstatement, prior to the crediting of any Net Premium paid in connection with the reinstatement, will be equal to the policy value on the date the policy terminated. Any policy debt not paid upon termination of a policy will be reinstated if the policy is reinstated.
The incontestability provisions will apply from the effective date of reinstatement. A surrendered policy cannot be reinstated.
From each premium payment you make, we deduct the applicable premium charges described under “Deduction from premium payments.” We invest the rest (known as the “Net Premium”) in the investment accounts you’ve elected. Special investment rules apply to premiums processed prior to the Allocation Date (see “Processing premium payments”).
Over time, the amount you’ve invested in any investment account will increase or decrease the same as if you had invested the same amount directly in the corresponding underlying portfolio and had reinvested all portfolios’ dividends and distributions in additional portfolio shares, except that we will deduct certain additional charges which will reduce your policy value. We describe these charges under “Description of charges at the policy level.” Starting in policy year eleven, we may also credit your policy value with an asset credit (see “Asset credit”).
We calculate the unit values for each investment account once every business day as of the close of trading on the New York Stock Exchange, usually 4:00 p.m. Eastern time. Sales and redemptions within any investment account will be transacted using the unit value next calculated after we receive your request either in writing or other form that we specify. If we receive your request before the close of our business day, we’ll use the unit value calculated as of the end of that business day. If we receive your request at or after the close of our business day, we’ll use the unit value calculated as of the end of the next business day. If a scheduled transaction falls on a day that is not a business day, we’ll process it as of the end of the next business day.
Starting in the eleventh policy year, we will credit your policy value monthly, on the date we calculate your monthly deductions, with an amount equal to the percentage credit listed below multiplied by the policy value in your investment accounts on this date. The asset credit does not apply to the loan account. The asset credit percentage is 0.0125% per month in policy year eleven and thereafter and ceasing at attainment of age 121. We add the credit to the same investment accounts from which we take your monthly deductions.
Allocation of future premium payments
At any time, you may change the investment accounts in which future premium payments will be invested. You make the original allocation in the application for the policy. The percentages you select must be in whole numbers and must total 100%.
Transfers of existing policy value
You may also transfer your existing policy value from one investment account to another, subject to the limitations discussed below. To do so, you must tell us how much to transfer, either as a whole number percentage or as a specific dollar amount. A confirmation of each transfer will be sent to you. Without our approval, the maximum amount you may transfer to or from any investment account in any policy year is $1,000,000.
The policies are not designed for professional market timing organizations or highly active traders, including persons or entities that engage in programmed, large or frequent transfers among investment accounts. As a consequence, we have reserved the right to impose certain restrictions on transfers as described in the “Market timing and disruptive trading risks” section of this prospectus. We also reserve the right to impose a fee of up to $25 for any transfer beyond an annual limit (which will not be less than twelve).
Limitations on transfers to or from an investment account . Our current practice is to restrict transfers into or out of investment accounts to two per calendar month (except with respect to those policies described in the following paragraphs). For purposes of this restriction, and in applying the limitation on the number of free transfers, any transfers made during the period from the opening of a business day (usually 9:00 a.m. Eastern time) to the close of that business day (usually 4:00 p.m. Eastern time) are considered one transfer. You may, however, transfer to the Money Market B investment account even if the two transfer per month limit has been reached, but only if 100% of the investment account value in all investment accounts is transferred to the Money Market B investment account. If such a transfer to the Money Market B investment account is made, then for the 30 calendar day period after such transfer no transfers from the Money Market B investment account to any other investment account may be made. If your policy offers a dollar cost averaging or automatic asset allocation rebalancing program, any transfers pursuant to such program are not considered transfers subject to these restrictions on frequent trading. The restrictions described in this paragraph will be applied uniformly to all policy owners subject to the restrictions.
Policies such as yours may be purchased by a corporation or other entity as a means to informally finance the liabilities created by an employee benefit plan, and to this end the entity may aggregately manage the policies purchased to match its liabilities under the plan. Policies sold under these circumstances are subject to special transfer restrictions. In lieu of the two transfers per month restriction, we will allow the policy owner under these circumstances to rebalance the investment options in its policies within the following limits: (i) during the 10 calendar day period after any policy values are transferred from one investment account into a second investment account, the values can only be transferred out of the second investment account if they are transferred into the Money Market B investment account; and (ii) any policy values that would otherwise not be transferable by application of the 10 day limit described above and that are transferred into the Money Market B investment account may not be transferred out of the Money Market B investment account into any other investment account for 30 calendar days. The restrictions described in this paragraph will be applied uniformly to all policy owners subject to the restrictions.
Subject to our approval, we may offer policies purchased by a corporation or other entity that has purchased policies to match its liabilities under an employee benefit plan, as described above, the ability to electronically rebalance the investment options in its policies. Under these circumstances, in lieu of imposing any specific limit upon the number and timing of transfers, we will monitor aggregate trades among the subaccounts for frequency, pattern and size for potentially harmful investment practices. If we detect trading activity that we believe may be harmful to the overall operation of any investment account or underlying portfolio, we may impose conditions on policies employing electronic rebalancing to submit trades, including setting limits upon the number and timing of transfers, and revoking privileges to make trades by any means other than written communication submitted via U.S. mail.
While we seek to identify and prevent disruptive frequent trading activity, it may not always be possible to do so. Therefore no assurance can be given that the restrictions we impose will be successful in preventing all disruptive frequent trading and avoiding harm to long-term investors. The restrictions described in these paragraphs will be applied uniformly to all policy holders subject to the restrictions.
Rule 22c-2 under the 1940 Act requires us to provide tax identification numbers and other policy owner transaction information to the Trust or to other investment companies in which the Separate Account invests, at their request. An investment company will use this information to identify any pattern or frequency of investment account transfers that may violate their frequent trading policy. An investment company may require us to impose trading restrictions in addition to those described above if violations of their frequent trading policy are discovered.
Dollar cost averaging . We may offer policy owners a dollar cost averaging (“DCA”) program. Under the DCA program, you will designate an amount that will be transferred monthly from one investment account into any other investment account(s). If insufficient funds exist to effect a DCA transfer, the transfer will not be effected and you will be so notified. No fee is charged for this program.
We reserve the right to cease to offer this program as of 90 days after written notice is sent to you.
Asset allocation balancer transfers . Under the asset allocation balancer program you will designate an allocation of policy value among investment accounts. We will move amounts among the investment accounts at specified intervals you select - annually, semi-annually, quarterly or monthly. A change to your premium allocation instructions will automatically result in a change in asset allocation balancer instructions so that the two are identical unless you either instruct us otherwise or have elected the dollar cost averaging program. No fee is charged for this program.
We reserve the right to cease to offer this program as of 90 days after written notice is sent to you.
You may surrender your policy in full at any time. If you do, we will pay you the policy value less any policy debt and surrender charge that then applies. This is called your “net cash surrender value.” You must return your policy when you request a surrender. We will process surrenders on the day we receive the surrender request (unless such day is not a business day, in which case we will process surrenders as of the business day next following the date of the receipt).
After the first policy year, you may make a withdrawal of part of your net cash surrender value once in each policy month. Generally, each withdrawal must be at least $500. If the withdrawal reduces the Face Amount to an amount that is less than the Face Amount at issue (“Face Amount issued”), a charge equal to a pro-rata portion of any surrender charge will be applied during the surrender charge period to the amount surrendered that falls below the Face Amount issued. We will automatically reduce the policy value of your policy by the amount of the withdrawal. Unless otherwise specified by you, each investment account will be reduced in the same proportion as the policy value is then allocated among them. We will not permit a withdrawal if it would cause your surrender value to fall below three months’ worth of monthly deductions (see “Deductions from policy value”). We also reserve the right to refuse any withdrawal that would cause the policy’s Face Amount to fall below $50,000.
Because it reduces the policy value, any withdrawal will reduce your death benefit under either Option 1 or Option 2 (see “The death benefit”). If death benefit Option 1 is in effect at the time of the withdrawal, such withdrawal may reduce the Face Amount. If such a reduction in Face Amount would cause the policy to fail the Internal Revenue Code’s definition of life insurance, we will not permit the withdrawal. As noted above, if the withdrawal reduces the Face Amount to an amount that is less than the Face Amount issued, a charge equal to a pro-rata portion of any surrender charge will be applied during the surrender charge period to the amount surrendered that falls below the Face Amount issued (see “Surrender charge”).
For example, assume the owner of a policy issued with death benefit Option 2 requests a withdrawal of $25,000 on a policy with a Face Amount of $200,000 and a current surrender charge of $10,000. The policy value would be reduced by $25,000 but the Face Amount would remain unchanged, therefore no surrender charge would be applied. If the policy owner had changed the death benefit option from Option 2 to Option 1 after the first policy year, but prior to the withdrawal, and the Face Amount after the death benefit option change were $210,000, then the Face Amount would be reduced by the withdrawal
amount of $25,000, which is attributed first to the $10,000 of the increased portion of Face Amount resulting from the death benefit option change, and then to $15,000 of the Face Amount issued. Furthermore, the $15,000 reduction of Face Amount issued from $200,000 to $185,000 is subject to a partial surrender charge equal to the surrender charge times the proportionate reduction in Face Amount, in this case equal to $10,000 x ($15,000/$200,000) or $750. The surrender charge after the withdrawal would be equal to $10,000 minus $750 or $9,250.You may borrow from your policy at any time by completing a form satisfactory to us. The maximum amount you can borrow is the greater of (i) 90% of net cash surrender value and (ii) the amount determined as set out below.
The minimum amount of each loan is $500. The interest charged on any loan is an effective annual rate of 3.25% in the first ten policy years, but we reserve the right to increase the annual rate to 3.50% during that time. After the tenth policy year, the effective annual rate is 2.00%, however, we reserve the right to increase the percentage to as much as 2.25%. Accrued interest will be added to the loan daily and will bear interest at the same rate as the original loan amount. Unless otherwise specified by you, the amount of the loan is deducted from the investment accounts in the same proportion as the policy value is then allocated among them. The amount of the loan is then placed in a special loan account. This special loan account will earn interest at an effective annual rate of 2.00%. The tax consequences of a loan interest credited differential of 0% are unclear. You should consult a tax adviser before effecting a loan to evaluate possible tax consequences. If we determine that a loan will be treated as a taxable distribution because of the differential between the loan interest rate and the rate being credited on the special loan account, we reserve the right to increase the rate charged on the loan to a rate that would, in our reasonable judgment, result in the transaction being treated as a loan under Federal tax law. The right to increase the rate charged on a loan is restricted in New York. We will not decrease the annual rate charged to less than 2.00%. Please see your John Hancock NY representative for details. We process policy loans as of the business day on or next following the day we receive the loan request.
You can repay all or part of a loan at any time. Each repayment will be allocated among the investment accounts in the same way a new premium payment would be allocated (unless specified by you). While you have a loan outstanding, we will treat any amounts you pay as premium, unless you submit a written request to us that they be treated as loan repayments.
Loan repayments received prior to the close of the New York Stock Exchange will be applied on the same day it was received. Loan repayments received after the close of the New York Stock Exchange will be applied as of the next business day.
The policy value, the net cash surrender value, and any death benefit are permanently affected by any loan, whether or not it is repaid in whole or in part. This is because the amount of the loan is deducted from the accounts and placed in a special loan account. The investment accounts and the special loan account will generally have different rates of investment return.
The amount of the outstanding loan (which includes accrued and unpaid interest) is subtracted from the amount otherwise payable when the policy proceeds become payable.
Taking out a loan on the policy increases the risk that the policy may lapse because of the difference between the interest rate charged on the loan and the interest rate credited to the special loan account. Also, when a loan is outstanding, the amount in the loan account is not available to help pay for any policy charges. If, after deducting your policy loan, there is not enough policy value to cover the policy charges, your policy could lapse. Whenever the outstanding loan equals or exceeds your policy value after the insured person reaches age 121, the policy will terminate 31 days after we have mailed notice of
termination to you (and to any assignee of record at such assignee’s last known address) specifying the amount that must be paid to avoid termination, unless a repayment of at least the amount specified is made within that period. Policy loans may also result in adverse tax consequences under certain circumstances (see “Tax considerations”).Description of charges at the policy level
Deduction from premium payments
(a) is the death benefit as of the first day of the Policy Month, divided by 1.0016516; and
(b) is the policy value as of the first day of the Policy Month after the deduction of all other monthly deductions.
Since the net amount at risk for death benefit Option 1 is based on a formula that includes as factors the death benefit and the policy value, the net amount at risk is affected by the investment performance of the investment accounts chosen, payment of premiums and charges assessed.
If the minimum death benefit is greater than the Face Amount, the cost of insurance charge will reflect the amount of that additional benefit.
For death benefit Option 2, the net amount at risk is equal to the Face Amount of insurance divided by 1.0016516.
The surrender charge is equal to the lesser of (a) and (b), multiplied by the Surrender Charge Grading Factor in your policy, where
(a) is a surrender charge for the Face Amount at issue, indicated in the Policy Specifications page of the policy, less the result of 4.11% multiplied by the sum of premiums paid in the first policy year, and
(b) is an alternate surrender charge for the Face Amount at issue, also indicated in the Policy Specifications page of the policy
Both calculations (a) and (b) are intended to enable us to recoup acquisition expenses incurred in relation to the sale of your policy. The calculation in (a) limits the surrender charge amount in some cases to make sure that your policy conforms to applicable state non-forfeiture laws.
For an example showing how the surrender charge is determined, assume a policy on a male age 45 nonsmoker, providing a $1,000,000 death benefit Option 2 with no riders, paying a Target Premium of $19,790 as of policy year 1, and subject to an applicable Surrender Charge Grading Factor of 100% in policy year 1.
To determine the surrender charge in (a), we subtract from $27,720 the product of 4.11% multiplied by the sum of premiums paid in policy year 1 ($19,790). The result is $26,906.63 – i.e., $27,720 – 4.11% x $19,790 = $26,906.63. We then compare this to the surrender charge amount in (b) indicated in the Policy Specifications page. In our example above, the surrender charge amount in (b) is $34,820.
The lesser of the amounts in (a) and (b) is the $26,906.63, which is the amount derived from the calculation in (a), and thus, that is the amount of the surrender charge that would be applied. In this example, where the surrender occurs in the first policy year, the Surrender Charge Grading Factor that would be applied to the surrender charge is 100%, and therefore the surrender charge for this example is $26,906.63– i.e., $26,906.63 x 100% = $26,906.63. The surrender charge is dependent upon the policy year during which a reduction in Face Amount, lapse or surrender occurs, and the Surrender Charge Grading Factor percentage is graded down over the policy duration until the tenth policy year.
Policy Year | Percentage Applied |
1 | 100% |
2 | 96% |
3 | 92% |
4 | 89% |
5 | 85% |
6 | 81% |
7 | 77% |
8 | 67% |
9 | 55% |
10 | 38% |
11+ | 0% |
The above table applies only if the insured person is age 45 at issue. A pro-rata portion of the surrender charge will be payable upon any approved reduction in the Face Amount that reduces the Face Amount to an amount that is below the Face Amount at issue (see “Surrender charge”). For Face Amount reductions, an additional 10% of the Face Amount at issue is also exempt from the partial surrender charge. This 10% surrender charge exemption does not apply to full surrenders or net cash surrender withdrawals (see “Surrenders and withdrawals – Withdrawals” and “Requesting a decrease in coverage”). The pro-rata charge is calculated by dividing the reduction in Face Amount by the Face Amount immediately prior to the reduction and then multiplying the applicable surrender charge by that ratio.
Additional information about how certain policy charges work
Sales expenses and related charges
The premium and Face Amount charges help to compensate us for the cost of selling our policies (see “Description of charges at the policy level”). The amount of the charges in any policy year does not specifically correspond to sales expenses
for that year. We expect to recover our total sales expenses over the life of the policies. To the extent that the premium and Face Amount charges do not cover total sales expenses, the sales expenses may be recovered from other sources, including the asset-based risk charge and other charges with respect to the policies, or from our general assets. Similarly, administrative expenses not fully recovered by the administrative charge may also be recovered from such other sources.We deduct the monthly deductions described in the Fee Tables section from your policy’s investment accounts in proportion to the amount of policy value you have in each, unless otherwise specified by you.
Special purchase programs for eligible classes
With respect to policies issued to a class of associated individuals or to a trustee, employer or similar entity where we anticipate that the sales to the members of the class will result in lower than normal sales or administrative expenses, lower taxes or lower risks to us, we may offer the policies with reduced charges or with additional or enhanced features or benefits. We will make these programs available in accordance with our established administrative procedures in effect at the time of the application for a policy. The factors we consider in determining the eligibility of a particular group for such a program are: (i) the nature of the association and its organizational framework; (ii) the method by which sales will be made to the members of the class; (iii) the facility with which premiums will be collected from the associated individuals and the association’s capabilities with respect to administrative tasks; (iv) the anticipated lapse and surrender rates of the policies; (v) the size of the class of associated individuals and the number of years it has been in existence; (vi) the aggregate amount of premiums paid; and (vii) any other such circumstances which result in a reduction in sales or administrative expenses, lower taxes or lower risks. Any reduction in charges or feature or benefit enhancement will be reasonable and will apply uniformly to all prospective policy purchasers in the class and will not unfairly discriminate against any owner.
The Statement of Additional Information (the “SAI”) contains additional information about any special purchase program we currently make available. For information as to how you may obtain a copy of the SAI, please see the last page of this prospectus.
Other charges we could impose in the future
Except for a portion of the premium charge, we currently make no charge for our Federal income taxes. However, if we incur, or expect to incur, income taxes attributable to any subaccount of the Separate Account or this class of policies in future years, we reserve the right to make a charge for such taxes. Any such charge would reduce what you earn on any affected fixed or investment accounts. However, we expect that no such charge will be necessary.
A portion of the premium charge is used to cover premium taxes. Currently, the premium tax in New York is 0.7% of each premium payment.
Under current laws, we may incur state and local taxes (in addition to premium taxes) in several states. At present, these taxes are not significant. If there is a material change in New York state or local tax laws, we may make charges for such taxes.
Description of charges at the portfolio level
The portfolios must pay investment management fees and other operating expenses. These fees and expenses (shown in the tables of portfolio annual expenses under “Fee Tables”) are different for each portfolio and reduce the investment return of each portfolio. Therefore, they also indirectly reduce the return you will earn on any investment accounts you select. Expenses of the portfolios are not fixed or specified under the terms of the policy, and those expenses may vary from year to year.
Other policy benefits, rights and limitations
Optional supplementary benefit riders you can add
When you apply for a policy, you can request any of the optional supplementary benefit riders that we then make available. Our rules and procedures will govern eligibility for any rider and, in some cases, the configuration of the actual rider benefits. Each rider contains specific details that you should review before you decide to choose the rider. Charges for the riders will be deducted from the policy value. We may change these charges (or the rates that determine them), but not
above any applicable maximum amount stated in the Policy Specifications page of your policy. We may add to, delete from or modify the list of optional supplementary benefit riders.When the Overloan Protection Benefit in this rider is invoked, all values in the investment accounts are immediately transferred to the fixed account, described below, and will continue to grow at the current fixed account interest rate. Transfer fees do not apply to these transfers. Thereafter, policy changes and transactions are limited as set forth in the rider; for example, death benefit increases or decreases, additional premium payments, policy loans, withdrawals, surrender and transfers are no longer allowed. Any outstanding policy debt will remain. Interest will continue to be charged at the policy’s specified loan interest rate, and the policy’s loan account will continue to be credited with the policy’s loan interest credited rate. Any applicable No-Lapse Guarantee under the policy no longer applies, and any supplementary benefit rider requiring a monthly deduction will automatically be terminated.
When the Overloan Protection Rider causes the policy to be converted into a fixed policy, there is risk that the Internal Revenue Service could assert that the policy has been effectively terminated and that the outstanding loan balance should be treated as a distribution. Depending on the circumstances, all or part of such deemed distribution may be taxable as income. You should consult a tax adviser as to the risks associated with the Overloan Protection Rider.
Our obligations under the fixed account are backed by our general account assets. Our general account consists of assets owned by us other than those in the Separate Account and in other separate accounts that we may establish. Subject to applicable law, we have sole discretion over the investment of assets of the general account and policy owners do not share in the investment experience of, or have any preferential claim on, those assets. Instead we guarantee that the policy value allocated to any fixed account will accrue interest daily at an effective annual rate that we determine without regard to the actual investment experience of the general account. The effective annual rate we declare for the fixed account will never be less than 2%. Because of exemptive and exclusionary provisions, interests in our fixed account have not been and will not be registered under the Securities Act of 1933 (“1933 Act”) and our general account has not been registered as an investment company under the 1940 Act.
If you satisfy the above conditions, we will pay you 50% of the eligible death benefit, up to a maximum of $1,000,000. We will not make a payment if it would be less than $10,000. Payment of the benefit will reduce your death benefit and any cash value or loan value under your policy. You should consult your tax adviser and social service agencies before you decide to receive the benefit under this rider. This rider is only available with policies that are individually owned.
We may vary the charges and other terms of our policies where special circumstances result in sales or administrative expenses, mortality risks or other risks that are different from those normally associated with the policies. These include the type of variations discussed under “Special purchase programs for eligible classes.” No variation in any charge will exceed any maximum stated in this prospectus with respect to that charge.
Any variation discussed above will be made only in accordance with uniform rules that we adopt and that we apply fairly to our customers.
Procedures for issuance of a policy
Generally, the policy is available with a minimum Face Amount at issue of $50,000. At the time of issue, the insured person must have an attained age of no more than 90. The insured person must meet certain health and other insurance risk criteria called “underwriting standards.” Our underwriting standards for the issuance of the policy do not require the proposed insured to undergo a medical examination. Although these standards are more convenient, the policy charges are set to reflect a higher risk assumed by us under a policy underwritten in this way, and you may find that a policy subject to a more rigorous (“full”) underwriting is more appropriate for you. Please discuss these considerations with your registered representative.
Commencement of insurance coverage
After you apply for a policy, it can take up to several weeks for us to gather and evaluate all the information we need to decide whether to issue a policy to you and, if so, what the insured person’s risk classification should be. After we approve an application for a policy and assign an appropriate insurance risk classification, we will prepare the policy for delivery. We will not pay a death benefit under a policy unless the policy is in effect when the insured person dies (except for the circumstances described under “Temporary coverage prior to policy delivery” below).
The policy will take effect only if all of the following conditions are satisfied:
The date all of the above conditions are satisfied is referred to in this prospectus as the “Contract Completion Date.” If all of the above conditions are satisfied, the policy will take effect on the date shown in the policy as the “Policy Date.” That is the date on which we begin to deduct monthly charges. Policy months, policy years and policy anniversaries are all measured from the Policy Date.
Under limited circumstances, we may backdate a policy, upon request, by assigning a Policy Date earlier than the date the application is signed. However, in no event will a policy be backdated earlier than six months from the date of application for the policy, the earliest date allowed by New York state law. The most common reasons for backdating are to preserve a younger age at issue for the insured person or to retain a common monthly deduction date in certain corporate-owned life insurance cases involving multiple policies issued over time. If used to preserve age, backdating will result in lower insurance charges. However, monthly deductions will begin earlier than would otherwise be the case. Monthly deductions for the period the Policy Date is backdated will actually be deducted from policy value on the Contract Completion Date.
Temporary coverage prior to policy delivery
If a specified amount of premium is paid with the application for a policy and other conditions are met, we will provide temporary term life insurance coverage on the insured person for a period prior to the time coverage under the policy takes effect. Such temporary term coverage will be subject to the terms and conditions described in the Temporary Life Insurance Agreement and Receipt attached to the application for the policy, including conditions to coverage and limits on amount and duration of coverage.
Each charge that we deduct monthly is assessed against your policy value at the close of business on the Policy Date and at the close of the first day in each subsequent policy month.
Changes that we can make as to your policy
We reserve the right to make any changes in the policy necessary to ensure the policy is within the definition of life insurance under the Federal tax laws and is in compliance with any changes in Federal or state tax laws.
In our policies, we reserve the right to make certain changes if they would serve the best interests of policy owners or would be appropriate in carrying out the purposes of the policies. These changes include the following:
Any such changes will be made only to the extent permitted by applicable laws and only in the manner permitted by such laws. When required by law, we will obtain your approval of the changes and the approval of any appropriate regulatory authority.
Who owns the policy? That’s up to the person who applies for the policy. The owner of the policy is the person who can exercise most of the rights under the policy, such as the right to choose the investment accounts in which to invest or the right to surrender the policy. In many cases, the person buying the policy is also the person who will be the owner. However, the application for a policy can name another person or entity (such as a trust) as owner. Whenever we’ve used the term “you” in this prospectus, we’ve assumed that the reader is the person who has whatever right or privilege is being discussed. There may be tax consequences if the owner and the insured person are different, so you should discuss this issue with your tax adviser.
While the insured person is alive, you will have a number of options under the policy. These options include those listed below:
It is possible to name so-called “joint owners” of the policy. If more than one person owns a policy, all owners must join in most requests to exercise rights under the policy.
You have the right to cancel your policy within ten days after you receive it (the period may be longer in some states). This is often referred to as the “free look” period. During this period, your premiums will be allocated as described under “Processing premium payments” in this prospectus. To cancel your policy, simply deliver or mail the policy to:
The date of cancellation will be the date of such mailing or delivery. You will receive a refund of any premiums you’ve paid.
At least annually, we will send you a statement setting forth at least the following information as of the end of the most recent reporting period: the amount of the death benefit, the portion of the policy value in each investment account, premiums received and charges deducted from premiums since the last report, any outstanding policy loan (and interest charged for the preceding policy year), and any further information required by law. Moreover, you also will receive confirmations of premium payments, transfers among investment accounts, policy loans, partial withdrawals and certain other policy transactions.
Semi-annually we will send you a report containing the financial statements of the portfolios, including a list of securities held in each portfolio.
You may assign your rights in the policy to someone else as collateral for a loan or for some other reason. Assignments do not require the consent of any revocable beneficiary. A copy of the assignment must be forwarded to us. We are not responsible for any payment we make or any action we take before we receive a copy of the assignment at our Service Office.
Nor are we responsible for the validity of the assignment or its efficacy in meeting your objectives. An absolute assignment is a change of ownership. All collateral assignees of record must usually consent to any surrender, withdrawal or loan from the policy.We will ordinarily pay any death benefit, withdrawal, surrender value or loan within seven days after we receive the last required form or request (and, with respect to the death benefit, any other documentation that may be required). If we don’t have information about the desired manner of payment within seven days after the date we receive documentation of the insured person’s death, we will pay the proceeds as a single sum.
We may challenge the validity of your insurance policy based on any material misstatements made to us in the application for the policy. We cannot make such a challenge, however, beyond the time limit that is specified in your policy, which is generally two years from the Issue Date.
We reserve the right to defer payment of that portion of your policy value that is attributable to a premium payment made by check for a reasonable period of time (not to exceed fifteen days) to allow the check to clear the banking system. We will not delay payment longer than necessary for us to verify a check has cleared the banking system.
Delay of separate account proceeds
We reserve the right to defer payment of any death benefit, loan or other distribution that is derived from an investment account if (1) the New York Stock Exchange is closed (other than customary weekend and holiday closings) or trading on the New York Stock Exchange is restricted; (2) an emergency exists, as determined by the SEC, as a result of which disposal of securities is not reasonably practicable or it is not reasonably practicable to fairly determine the policy value; or (3) the SEC by order permits the delay for the protection of owners. Transfers and allocations of policy value among the investment accounts may also be postponed under these circumstances. If we need to defer calculation of separate account values for any of the foregoing reasons, all delayed transactions will be processed at the next values that we do compute.
You should mail or express all checks and money orders for premium payments and loan repayments to the John Hancock NY Service Office at the appropriate address shown on the back cover.
Under our current rules, certain requests must be made in writing and be signed and dated by you. Those requests include the following.
The following requests may be made either in writing (signed and dated by you) or by telephone or fax or through the Company’s secured website, if a special form is completed (see “Telephone, facsimile and internet transactions” below).
You should mail or express all written requests to our Service Office at the appropriate address shown on the back cover. You should also send notice of the insured person’s death and related documentation to our Service Office. We do not consider that we’ve “received” any communication until such time as it has arrived at the proper place and in the proper and complete form.
We have special forms that should be used for a number of the requests mentioned above. You can obtain these forms from our Service Office or your John Hancock NY representative. Each communication to us must include your name, your policy number and the name of the insured person. We cannot process any request that doesn’t include this required information. Any communication that arrives after the close of our business day, or on a day that is not a business day, will be considered “received” by us on the next following business day. Our business day currently closes at 4:00 p.m. Eastern time, but special circumstances (such as suspension of trading on a major exchange) may dictate an earlier closing time.
Telephone, facsimile and internet transactions
If you complete a special authorization form, you can request transfers among accounts and changes of allocation among investment accounts simply by telephoning us at 1-877-391-3748, Option 4, or by faxing us at 1-416-926-5809 or through the Company’s secured website. Any fax or internet request should include your name, daytime telephone number, policy number and, in the case of transfers and changes of allocation, the names of the investment accounts involved. We will honor telephone and internet instructions from anyone who provides the correct identifying information, so there is a risk of loss to you if this service is used by an unauthorized person. However, you will receive written confirmation of all telephone/internet transactions. There is also a risk that you will be unable to place your request due to equipment malfunction or heavy phone line or internet usage. If this occurs, you should submit your request in writing.
If you authorize telephone or internet transactions, you will be liable for any loss, expense or cost arising out of any unauthorized or fraudulent telephone or internet instructions which we reasonably believe to be genuine, unless such loss, expense or cost is the result of our mistake or negligence. We employ procedures which provide safeguards against the execution of unauthorized transactions which are reasonably designed to confirm that instructions received by telephone or internet are genuine. These procedures include requiring personal identification, the use of a unique password for internet authorization, recording of telephone calls, and providing written confirmation to the owner. If we do not employ reasonable procedures to confirm that instructions communicated by telephone or internet are genuine, we may be liable for any loss due to unauthorized or fraudulent instructions.
As stated earlier in this prospectus, the policies are not designed for professional market timing organizations or other persons or entities that use programmed, large or frequent transfers among investment options. To discourage disruptive trading, we have imposed certain transfer restrictions (see “Transfers of existing policy value”). In addition, we also reserve the right to change our telephone, facsimile and internet transaction privileges outlined in this section at any time, and to suspend or terminate any or all of those privileges with respect to any owners who we feel are abusing the privileges to the detriment of other owners.
John Hancock Distributors LLC (“JH Distributors”), a Delaware limited liability company affiliated with us, is the principal distributor and underwriter of the securities offered through this prospectus and of other annuity and life insurance products we and our affiliates offer. JH Distributors also acts as the principal underwriter of the Trust, whose securities are used to fund certain investment accounts under the policies and under other annuity and life insurance products we offer.
JH Distributors’ principal address is 601 Congress Street, Boston, MA 02210 and it also maintains offices with us at 197 Clarendon Street, Boston, Massachusetts 02116. JH Distributors is a broker-dealer registered under the Securities Exchange Act of 1934 (the “1934 Act”) and a member of the Financial Industry Regulatory Authority (“FINRA”).
We offer the policies for sale through individuals who are licensed as insurance agents and who are registered representatives of broker-dealers that have entered into selling agreements with JH Distributors. Our affiliate, Signator Investors, Inc., is one such broker-dealer. In addition, we, either directly or through JH Distributors, have entered into agreements with other financial intermediaries that provide marketing, sales support and certain administrative services to help promote the policies (“financial intermediaries”). In a limited number of cases, we have entered into loans, leases or other financial agreements with these broker-dealers or financial intermediaries or their affiliates.
The broker-dealers and other financial intermediaries that distribute or support the marketing of our policies may be compensated by means of various compensation and revenue sharing arrangements. A general description of these arrangements is set out below under “Standard compensation” and “Additional compensation and revenue sharing.” These arrangements may differ between firms, and not all broker-dealers or financial intermediaries will receive the same compensation and revenue sharing benefits for distributing our policies. Also, a broker-dealer may receive more or less compensation or other benefits for the promotion and sale of our policy than it would expect to receive from another issuer.
Under their own arrangements, broker-dealers determine how much of any amounts received from us is to be paid to their registered representatives. Our affiliated broker-dealer, Signator Investors, Inc., may pay its registered representatives additional compensation and benefits, such as bonus payments, expense payments, health and retirement benefits or the waiver of overhead costs or expenses in connection with the sale of the policies that they would not receive in connection with the sale of policies issued by unaffiliated companies.
Policy owners do not pay any compensation or revenue sharing benefits directly. These payments are made from JH Distributors’ and our own revenues, profits or retained earnings, which may be derived from a number of sources, such as fees received from an underlying fund’s distribution plan (“12b-1 fees”), the fees and charges imposed under the policy and other sources.
You should contact your registered representative for more information on compensation arrangements in connection with your purchase of a policy. We provide additional information on special compensation or reimbursement arrangements involving broker-dealers and other financial intermediaries in the Statement of Additional Information, which is available upon request.
Standard compensation. JH Distributors pays compensation to broker-dealers for the promotion and sale of the policies, and for providing ongoing service in relation to policies that have already been purchased. We may also pay a limited number of broker-dealers commissions or overrides to “wholesale” the policies; that is, to provide marketing support and training services to the broker-dealer firms that do the actual selling.
The compensation JH Distributors pays to broker-dealers may vary depending on the selling agreement. The compensation paid is not expected to exceed 137% of target premium paid in the first policy year, 30% of target premium paid in year 2 and 8% of target premium paid in years 3-10. Compensation paid on any premium in excess of target will not exceed 10% in any year. This compensation schedule is exclusive of additional compensation and revenue sharing and inclusive of overrides and expense allowances paid to broker-dealers for sale of the policies (not including riders).
Additional compensation and revenue sharing. To the extent permitted by SEC and FINRA rules and other applicable laws and regulations, we may enter into special compensation or reimbursement arrangements (“revenue sharing”), either directly or through JH Distributors, with selected broker-dealers and other financial intermediaries. In consideration of these arrangements, a firm may feature our policy in its sales system, give us preferential access to sales staff, or allow JH Distributors or its affiliates to participate in conferences, seminars or other programs attended by the firm’s sales force. We hope to benefit from these revenue sharing and other arrangements through increased sales of our policies.
Selling broker-dealers and other financial intermediaries may receive, directly or indirectly, additional payments in the form of cash, other compensation or reimbursement. These additional compensation or reimbursement arrangements may include, for example, payments in connection with the firm’s “due diligence” examination of the policies, payments for providing conferences or seminars, sales or training programs for invited registered representatives and other employees, payment for travel expenses, including lodging, incurred by registered representatives and other employees for such seminars or training programs, seminars for the public or client seminars, advertising and sales campaigns regarding the policies, payments to assist a firm in connection with its systems, operations and marketing expenses and/or other events or activities sponsored by the firms. We may contribute to, as well as sponsor, various educational programs, sales promotions, and/or other contests in which participating firms and their sales persons may receive gifts and prizes such as merchandise, cash or other rewards as may be permitted under FINRA rules and other applicable laws and regulations.
This description of Federal income tax consequences is only a brief summary and is neither exhaustive nor authoritative. It was written to support the promotion of our products. It does not constitute legal or tax advice, and it is not intended to be used and cannot be used to avoid any penalties that may be imposed on you. Tax consequences will vary based on your own
particular circumstances, and for further information you should consult a qualified tax adviser. Federal, state and local tax laws, regulations and interpretations can change from time to time. As a result, the tax consequences to you and the beneficiary may be altered, in some cases retroactively. The policy may be used in various arrangements, including non-qualified deferred compensation or salary continuation plans, split dollar insurance plans, executive bonus plans, retiree medical benefit plans and others. The tax consequences of such plans may vary depending on the particular facts and circumstances of each individual arrangement. Therefore, if the value of using the policy in any such arrangement depends in part on the tax consequences, a qualified tax adviser should be consulted for advice.We are taxed as a life insurance company. Under current tax law rules, we include the investment income (exclusive of capital gains) of the Separate Account in our taxable income and take deductions for investment income credited to our policy holder reserves. We are also required to capitalize and amortize certain costs instead of deducting those costs when they are incurred. We do not currently charge the Separate Account for any resulting income tax costs, other than a charge we may impose against the Separate Account to compensate us for the cost of a delay in the deductibility of deferred acquisition costs (the “DAC tax” adjustment) pursuant to section 848 of the Internal Revenue Code. We also claim certain tax credits or deductions relating to foreign taxes paid and dividends received by the series funds. These benefits can be material. We do not pass these benefits through to the Separate Account, principally because: (i) the deductions and credits are allowed to us and not the policy owners under applicable tax law; and (ii) the deductions and credits do not represent investment return on the Separate Account assets that is passed through to policy owners.
The policies permit us to deduct a charge for any taxes we incur that are attributable to the operation or existence of the policies or the Separate Account. Currently, we do not anticipate making any specific charge for such taxes other than any DAC tax charge and premium taxes where applicable. If the level of the current taxes increases, however, or is expected to increase in the future, we reserve the right to make a charge in the future.
Death benefit proceeds and other policy distributions
Generally, death benefits paid under policies such as yours are not subject to income tax unless policy ownership has been transferred in exchange for payment. Earnings on your policy value are ordinarily not subject to income tax as long as we don’t pay them out to you. If we do pay out any amount of your policy value upon surrender or partial withdrawal, all or part of that distribution would generally be treated as a return of the premiums you’ve paid and not subjected to income tax. Any portion not treated as a return of your premiums would be includible in your income.
Please note that certain distributions associated with a reduction in death benefit or other policy benefits within the first fifteen years after issuance of the policy are ordinarily taxable in whole or in part. Amounts you borrow are generally not taxable to you. However, some of the tax rules change if your policy becomes a modified endowment contract. This can happen if you’ve paid premiums in excess of limits prescribed by the tax laws. In that case additional taxes and penalties may be payable for policy distributions of any kind, including loans. (See “7-pay premium limit and modified endowment contract status” below.)
We expect the policy to receive the same Federal income and estate tax treatment as fixed benefit life insurance policies. Section 7702 of the Internal Revenue Code defines a life insurance contract for Federal tax purposes. For a policy to be treated as a life insurance contract, it must satisfy the guideline premium test. This test limits the amount of premium that you may pay into the policy. We will monitor compliance with this standard. If we determine that a policy does not satisfy section 7702, we may take whatever steps are appropriate and reasonable to bring it into compliance with section 7702.
If the policy complies with section 7702, the death benefit proceeds under the policy ordinarily should be excludable from the beneficiary’s gross income under section 101 of the Internal Revenue Code. (As noted above, a transfer of the policy for valuable consideration may limit the exclusion of death benefits from the beneficiary’s income.)
Increases in policy value as a result of interest or investment experience will not be subject to Federal income tax unless and until values are received through actual or deemed distributions. In general, unless the policy is a modified endowment contract, the owner will be taxed only on the amount of distributions that exceed the premiums paid under the policy. An exception to this general rule occurs in the case of a decrease in the policy’s death benefit or any other change that reduces benefits under the policy in the first fifteen years after the policy is issued and that results in a cash distribution to the policy owner. Changes that reduce benefits include partial withdrawals, death benefit option changes, and distributions required to
keep the policy in compliance with section 7702. For purposes of this rule any distribution within the two years immediately before a reduction in benefits will also be treated as if it were a result of the reduction. A cash distribution that reduces policy benefits will be taxed in whole or in part (to the extent of any gain in the policy) under rules prescribed in section 7702. The taxable amount is subject to limits prescribed in section 7702(f)(7). Any taxable distribution will be ordinary income to the owner (rather than capital gain).Distributions for tax purposes include amounts received upon surrender or partial withdrawals. You may also be deemed to have received a distribution for tax purposes if you assign all or part of your policy rights or change your policy’s ownership.
It is possible that, despite our monitoring, a policy might fail to qualify as a life insurance contract under section 7702 of the Internal Revenue Code. This could happen, for example, if we inadvertently failed to return to you any premium payments that were in excess of permitted amounts, or if any of the funds failed to meet certain investment diversification or other requirements of the Internal Revenue Code. If this were to occur, you would be subject to income tax on the income credited to the policy from the date of issue to the date of the disqualification and for subsequent periods.
Tax consequences of ownership or receipt of policy proceeds under Federal, state and local estate, inheritance, gift and other tax laws will depend on the circumstances of each owner or beneficiary. If the person insured by the policy is also its owner, either directly or indirectly through an entity such as a revocable trust, the death benefit will be includible in his or her estate for purposes of the Federal estate tax. If the owner is not the person insured, the value of the policy will be includible in the owner’s estate upon his or her death. Even if ownership has been transferred, the death proceeds or the policy value may be includible in the former owner’s estate if the transfer occurred less than three years before the former owner’s death or if the former owner retained certain kinds of control over the policy. You should consult your tax adviser regarding these possible tax consequences.
Because there may be unfavorable tax consequences (including recognition of taxable income and the loss of income tax-free treatment for any death benefit payable to the beneficiary), you should consult a qualified tax adviser prior to changing the policy’s ownership or making any assignment of ownership interests.
We expect that, except as noted below (see “7-pay premium limit and modified endowment contract status”), loans received under the policy will be treated as indebtedness of an owner and that no part of any loan will constitute income to the owner. However, if the policy terminates for any reason other than the payment of the death benefit, an amount equal to any outstanding loan that was not previously considered income will be treated as if it had been distributed to the owner upon such termination. This could result in a considerable tax bill. Under certain circumstances involving large amounts of outstanding loans, you might find yourself having to choose between high premiums required to keep your policy from lapsing and a significant tax burden if you allow the lapse to occur.
Diversification rules and ownership of the Separate Account
Your policy will not qualify for the tax benefits of a life insurance contract unless the Separate Account follows certain rules requiring diversification of investments underlying the policy. In addition, the rules require that the policy owner not have “investor control” over the underlying assets.
In certain circumstances, the owner of a variable life insurance policy may be considered the owner, for Federal income tax purposes, of the assets of the Separate Account used to support the policy. In those circumstances, income and gains from the Separate Account assets would be includible in the policy owner’s gross income. The Internal Revenue Service (“IRS”) has stated in published rulings that a variable policy owner will be considered the owner of Separate Account assets if the policy owner possesses incidents of ownership in those assets, such as the ability to exercise investment control over the assets. A Treasury Decision issued in 1986 stated that guidance would be issued in the form of regulations or rulings on the “extent to which Policyholders may direct their investments to particular sub-accounts of a Separate Account without being treated as owners of the underlying assets.” As of the date of this prospectus, no comprehensive guidance on this point has been issued. In Rev. Rul. 2003-91, however, the IRS ruled that a contract holder would not be treated as the owner of assets underlying a variable life insurance or annuity contract despite the owner’s ability to allocate funds among as many as twenty subaccounts.
The ownership rights under your policy are similar to, but different in certain respects from, those described in IRS rulings in which it was determined that policyholders were not owners of Separate Account assets. Since you have greater
flexibility in allocating premiums and policy values than was the case in those rulings, it is possible that you would be treated as the owner of your policy’s proportionate share of the assets of the Separate Account.We do not know what future Treasury Department regulations or other guidance may require. We cannot guarantee that the funds will be able to operate as currently described in the series funds’ prospectuses, or that a series fund will not have to change any fund’s investment objectives or policies. We have reserved the right to modify your policy if we believe doing so will prevent you from being considered the owner of your policy’s proportionate share of the assets of the Separate Account, but we are under no obligation to do so.
7-pay premium limit and modified endowment contract status
At the time of policy issuance, we will determine whether the Planned Premium schedule will exceed the 7-pay limit discussed below. If so, our standard procedures prohibit issuance of the policy unless you sign a form acknowledging that fact.
The 7-pay limit at any time during the first seven contract years is the total of net level premiums that would have been payable at or before that time under a comparable fixed policy that would be fully “paid-up” after the payment of seven equal annual premiums. “Paid-up” means that no further premiums would be required to continue the coverage in force until maturity, based on certain prescribed assumptions. If the total premiums paid at any time during the first seven policy years exceed the 7-pay limit, the policy will be treated as a modified endowment contract, which can have adverse tax consequences.
Policies classified as modified endowment contracts are subject to the following tax rules:
These exceptions to the 10% additional tax do not apply in situations where the policy is not owned by an individual.
Furthermore, any time there is a “material change” in a policy, the policy will begin a new 7-pay testing period as if it were a newly-issued policy. The material change rules for determining whether a policy is a modified endowment contract are complex. In general, however, the determination of whether a policy will be a modified endowment contract after a material change depends upon the relationship among the death benefit of the policy at the time of such change, the policy value at the time of the change, and the additional premiums paid into the policy during the seven years starting with the date on which the material change occurs.
Moreover, under a policy insuring a single life, if there is a reduction in benefits (such as a reduction in the death benefit or the reduction or cancellation of certain rider benefits) during a 7-pay testing period, the 7-pay limit will generally be recalculated based on the reduced benefits and the policy will be re-tested, from the beginning of the 7-pay testing period using the lower limit. If the premiums paid to date at any point during the 7-pay testing period are greater than the recalculated 7-pay limit, the policy will become a modified endowment contract. If your policy is a survivorship policy, a reduction in benefits under the policy at any time will require re-testing. For such a policy the 7-pay limit will generally be recalculated based on the reduced benefits and the policy will be re-tested, using the lower limit, from the date it was issued.
If your policy is issued as a result of an exchange subject to section 1035 of the Internal Revenue Code, it may be considered to be a modified endowment contract if the death benefit under the new policy is smaller than the death benefit
under the exchanged policy, or if you reduce coverage in your new policy after it is issued. Therefore, if you desire to reduce the face amount as part of a 1035 exchange, a qualified tax adviser should be consulted for advice. A new policy issued in exchange for a modified endowment contract will also be a modified endowment contract regardless of any change in the death benefit.All modified endowment contracts issued by the same insurer (or its affiliates) to the same owner during any calendar year generally are required to be treated as one contract for the purpose of applying the rules on taxation of withdrawals from modified endowment contracts. You should consult your tax adviser if you have questions regarding the possible impact of the 7-pay limit on your policy.
Corporate and H.R. 10 retirement plans
The policy may be acquired in connection with the funding of retirement plans satisfying the qualification requirements of section 401 of the Internal Revenue Code. If so, the Internal Revenue Code provisions relating to such plans and life insurance benefits thereunder should be carefully scrutinized. We are not responsible for compliance with the terms of any such plan or with the requirements of applicable provisions of the Internal Revenue Code.
To the extent that policy distributions to you are taxable, they are generally subject to withholding for your Federal income tax liability. However if you reside in the United States, you can generally choose not to have tax withheld from distributions. Electing to have no withholding will not reduce your tax liability and may expose you to penalties under the rules governing payment of estimated taxes.
Life insurance purchases by residents of Puerto Rico
In Rev. Rul. 2004-75, 2004-31 I.R.B. 109, the Internal Revenue Service ruled that income received by residents of Puerto Rico under a life insurance policy issued by a United States company is U.S.-source income that is subject to United States Federal income tax.
Life insurance purchases by non-resident aliens
If you are not a U.S. citizen or resident, you will generally be subject to U.S. Federal withholding tax on taxable distributions from life insurance policies at a 30% rate, unless a lower treaty rate applies. In addition, you may be subject to state and/or municipal taxes and taxes imposed by your country of citizenship or residence. You should consult with a qualified tax adviser before purchasing a policy.
Life insurance owned by citizens or residents living abroad
If you are a U.S. citizen or permanent resident living outside the United States, you are still subject to income taxation by the United States. Since many countries tax on the basis of domicile, you may also be subject to tax in the country or territory in which you are living. The tax-deferred accumulation of gain that a life insurance policy provides under United States tax law may not be available under the tax laws of the country in which you are living. If you are living outside the United States or planning to do so, you should consult with a qualified tax adviser before purchasing or retaining ownership of a policy.
Financial statements reference
The financial statements of John Hancock NY and the Separate Account can be found in the Statement of Additional Information. The financial statements of John Hancock NY should be distinguished from the financial statements of the Separate Account and should be considered only as bearing upon the ability of John Hancock USA to meet its obligations under the policies. Our general account is comprised of securities and other investments, the value of which may decline during periods of adverse market conditions.
Registration statement filed with the SEC
This prospectus omits certain information contained in the Registration Statement which has been filed with the SEC. More details may be obtained from the SEC upon payment of the prescribed fee.
Independent registered public accounting firm
The financial statements of John Hancock Life Insurance Company of New York at December 31, 2013 and 2012, and for each of the three years in the period ended December 31, 2013, and the financial statements of John Hancock Life Insurance Company of New York Separate Account B at December 31, 2013, and for each of the two years in the period ended December 31, 2013, appearing in the Statement of Additional Information of the Registration Statement have been audited by Ernst &Young LLP, independent registered public accounting firm, as set forth in their reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.
In addition to this prospectus, John Hancock NY has filed with the SEC a Statement of Additional Information (the “SAI”) which contains additional information about John Hancock NY and the Separate Account, including information on our history, services provided to the Separate Account, legal and regulatory matters and the audited financial statements for John Hancock NY and the Separate Account. The SAI and personalized illustrations of death benefits, policy values and surrender values are available, without charge, upon request. You may obtain the personalized illustrations from your John Hancock NY representative. The SAI may be obtained by contacting the John Hancock NY Service Office. You should also contact the John Hancock NY Service Office to request any other information about your policy or to make any inquiries about its operation.
JOHN HANCOCK NY SERVICE OFFICE | |
Principal Office & Express Delivery | Mail Delivery |
197 Clarendon Street Boston, MA 02116-5010 |
1 John Hancock Way, Suite 1350 Boston, MA 02217-1099 |
Phone: | Fax: |
1-877-391-3748, Option 4 | 1-617-572-1571 |
Information about the Separate Account (including the SAI) can be reviewed and copied at the SEC’s Public Reference Branch, 100 F Street, NE, Room 1580, Washington, DC, 20549. Information
on the operation of the Public Reference Room may be obtained by calling the SEC at 202-551-8090. Reports and other information about the Account are available on the SEC’s Internet website at http://www.sec.gov. Copies of
such information may be obtained, upon payment of a duplicating fee, by writing the Public Reference Section of the SEC at 100 F Street, NE, Washington, DC 20549-0102.
1940 Act File No. 811-8329 — 1933 Act File No.
333-194819
Statement of Additional Information for interests in John Hancock Life Insurance Company of New York Separate Account B JOHN
HANCOCK LIFE INSURANCE COMPANY OF NEW YORK This is a Statement of Additional Information (“SAI”). It is not the prospectus. The prospectus, dated the same date as this SAI, may be obtained from a John Hancock NY representative or by contacting the John Hancock NY Service Office at 1-877-391-3748 Option 4. | |
Contents of this SAI | Page No. |
Description of the Depositor |
2 |
Description of the Registrant |
2 |
Services |
2 |
Independent registered public accounting firm |
2 |
Legal and Regulatory Matters |
2 |
Principal Underwriter/Distributor |
2 |
Additional Information About Charges |
3 |
Reduction in Charges |
4 |
Financial Statements of Registrant and Depositor |
F-1 |
Under the Federal securities laws, the entity responsible for organization of the registered separate account underlying the variable life insurance policy is known as the “Depositor.” The Depositor is John Hancock NY, a stock life insurance company organized under the laws of New York in 1992. We are a licensed life insurance company in the state of New York. Until 2004, John Hancock NY had been known as The Manufacturers Life Insurance Company of New York.
John Hancock NY is a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.), a life insurance company domiciled in Michigan. Our ultimate parent is Manulife Financial Corporation (“MFC”), a publicly traded company based in Toronto, Canada. MFC is the holding company of The Manufacturers Life Insurance Company and its subsidiaries, collectively known as Manulife Financial.
Under the Federal securities laws, the registered separate account underlying the variable life insurance policy is known as the “Registrant.” John Hancock Life Insurance Company of New York Separate Account B (the “Registrant” or “Separate Account”), is a separate account established by the Depositor under NY law. The variable investment options shown on page 1 of the prospectus are subaccounts of the Separate Account. The Separate Account meets the definition of “separate account” under the Federal securities laws and is registered as a unit investment trust under the Investment Company Act of 1940 (“1940 Act”). Such registration does not involve supervision by the Securities and Exchange Commission (“SEC”) of the management of the Separate Account or of the Depositor.
New subaccounts may be added and made available to policy owners from time to time. Existing subaccounts may be modified or deleted at any time.
Administration of policies issued by the Depositor and of registered separate accounts organized by the Depositor may be provided by other affiliates. Neither the Depositor nor the separate accounts are assessed any charges for such services.
The Depositor, located at 197 Clarendon St., Boston, MA 02116, is the custodian of the assets of the Separate Account. The Depositor has custody of all cash of the Separate Account and handles the collection of proceeds of shares of the underlying funds bought and sold by the Separate Account.
Independent registered public accounting firm
The financial statements of John Hancock Life Insurance Company of New York at December 31, 2013 and 2012, and for each of the three years in the period ended December 31, 2013, and the financial statements of John Hancock Life Insurance Company of New York Separate Account B at December 31, 2013, and for each of the two years in the period ended December 31, 2013, appearing in the Statement of Additional Information of the Registration Statement have been audited by Ernst &Young LLP, independent registered public accounting firm, as set forth in their reports thereon appearing elsewhere herein, and are included in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.
There are no legal proceedings to which the Depositor, the Separate Account or the principal underwriter is a party or to which the assets of the Separate Account are subject that are likely to have a material adverse effect on the Separate Account or the ability of the principal underwriter to perform its contract with the Separate Account or of the Depositor to meet its obligations under the policies.
Principal Underwriter/Distributor
John Hancock Distributors LLC (“JH Distributors”), a Delaware limited liability company affiliated with the Depositor, is the principal distributor and underwriter of the securities offered through the prospectus. JH Distributors acts as the principal distributor of a number of other life insurance and annuity products we and our affiliates offer or maintain. JH
Distributors also acts as the principal underwriter of John Hancock Variable Insurance Trust (the “Trust”), whose securities are used to fund certain variable investment options under the policies and under other life insurance and annuity products we offer or maintain.JH Distributors’ principal address is 601 Congress Street, Boston, MA 02210, and it also maintains offices with us at 197 Clarendon Street, Boston, MA 02116. JH Distributors is a broker-dealer registered under the Securities Act of 1934 (the “1934 Act”) and is a member of the Financial Industry Regulatory Authority (“FINRA”).
We offer the policies for sale through individuals who are licensed as insurance agents and who are registered representatives of broker-dealers that have entered into selling agreements with JH Distributors. Our affiliate Signator Investors, Inc. is one such broker-dealer.
The aggregate dollar amount of underwriting commissions paid to JH Distributors by the Depositor and its affiliates in connection with the sale of variable life products in 2013, 2012 and 2011 was $119,574,297, $156,801,522, and $158,741,294 respectively. JH Distributors did not retain any of these amounts during such periods.
The registered representative through whom your policy is sold will be compensated pursuant to the registered representative’s own arrangement with his or her broker-dealer. Compensation to broker-dealers for the promotion and sale of the policies is not paid directly by policy owners but will be recouped through the fees and charges imposed under the policy.
Additional compensation and revenue sharing arrangements may be offered to certain broker-dealer firms and other financial intermediaries. The terms of such arrangements may differ among firms we select based on various factors. In general, the arrangements involve three types of payments or any combination thereof:
Our affiliated broker-dealer, Signator Investors, Inc., may pay its respective registered representatives additional cash incentives, such as bonus payments, expense payments, health and retirement benefits or the waiver of overhead costs or expenses in connection with the sale of the policies that they would not receive in connection with the sale of policies issued by unaffiliated companies.
Additional Information About Charges
A policy will not be issued until the underwriting process has been completed to our satisfaction. The underwriting process generally includes the obtaining of information concerning your age, medical history, occupation and other personal information. This information is then used to determine the cost of insurance charge.
The policy may be available for purchase by corporations and other groups or sponsoring organizations. Group or sponsored arrangements may include reduction or elimination of withdrawal charges and deductions for employees, officers, directors, agents and immediate family members of the foregoing. We reserve the right to reduce any of the policy’s charges on certain cases where it is expected that the amount or nature of such cases will result in savings of sales, underwriting, administrative, commissions or other costs. Eligibility for these reductions and the amount of reductions will be determined by a number of factors, including the number of lives to be insured, the total premiums expected to be paid, total assets under management for the policyowner, the nature of the relationship among the insured individuals, the purpose for which the policies are being purchased, expected persistency of the individual policies, and any other circumstances which we believe to be relevant to the expected reduction of its expenses. Some of these reductions may be guaranteed and others may be subject to withdrawal or modifications, on a uniform case basis. Reductions in charges will not be unfairly discriminatory to any policyowners. We may modify from time to time, on a uniform basis, both the amounts of reductions and the criteria for qualification.
333-85296 | 333-131134 |
333-88972 | 333-132905 | 333-152408 |
333-33504 | 333-141693 | 333-153253 |
333-100664 | 333-148992 | 333-157213 |
333-127543 | 333-151631 | 333-179571 |
333-131139 | 333-194819 |
AUDITED FINANCIAL STATEMENTS
John Hancock Life Insurance Company of New York
For the Years Ended December 31, 2013, 2012 and 2011
With Report of Independent Auditors
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
INDEX TO AUDITED FINANCIAL STATEMENTS
F-1 | ||||
Audited Consolidated Financial Statements |
||||
Balance Sheets- |
F-2 | |||
Statements of Operations- |
F-4 | |||
Statements of Comprehensive Income (Loss)- |
F-5 | |||
Statements of Changes in Shareholder’s Equity- |
F-6 | |||
Statements of Cash Flows- |
F-7 | |||
F-9 |
Report of Independent Auditors
The Board of Directors
John Hancock Life Insurance Company of New York
We have audited the accompanying financial statements of John Hancock Life Insurance Company of New York, which comprise the balance sheets as of December 31, 2013 and 2012, and the related statements of operations, comprehensive income (loss), changes in shareholder’s equity and cash flows for each of the three years in the period ended December 31, 2013, and the related notes to the financial statements.
Management’s Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these financial statements in conformity with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free of material misstatement, whether due to fraud or error.
Auditor’s Responsibility
Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Opinion
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of John Hancock Life Insurance Company of New York at December 31, 2013 and 2012, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2013, in conformity with U.S. generally accepted accounting principles.
/s/ Ernst & Young LLP
Boston, Massachusetts
F-1
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
BALANCE SHEETS
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Assets |
||||||||
Investments |
||||||||
Fixed maturities: |
||||||||
Available-for-sale—at fair value |
$ | 5,871 | $ | 6,629 | ||||
Held-for-trading—at fair value |
338 | 372 | ||||||
Equity securities: |
||||||||
Available-for-sale—at fair value |
- | 1 | ||||||
Investment in unconsolidated affiliate |
1 | 1 | ||||||
Mortgage loans on real estate |
1,155 | 977 | ||||||
Investment real estate, agriculture, and timber |
270 | 81 | ||||||
Policy loans |
143 | 138 | ||||||
Short-term investments |
1 | 38 | ||||||
Other invested assets |
72 | 5 | ||||||
|
|
|
|
|||||
Total Investments |
7,851 | 8,242 | ||||||
Cash and cash equivalents |
59 | 495 | ||||||
Accrued investment income |
110 | 118 | ||||||
Value of business acquired |
6 | 12 | ||||||
Deferred policy acquisition costs and deferred sales inducements |
495 | 428 | ||||||
Amounts due from and held for affiliates |
898 | 286 | ||||||
Reinsurance recoverable |
450 | 417 | ||||||
Derivative assets |
435 | 654 | ||||||
Amounts on deposit with reinsurers |
1,586 | 1,701 | ||||||
Deferred tax asset |
37 | - | ||||||
Other assets |
105 | 61 | ||||||
Separate account assets |
8,313 | 7,687 | ||||||
|
|
|
|
|||||
Total Assets |
$ | 20,345 | $ | 20,101 | ||||
|
|
|
|
The accompanying notes are an integral part of these financial statements.
F-2
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
BALANCE SHEETS – (CONTINUED)
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Liabilities and Shareholder’s Equity |
||||||||
Liabilities |
||||||||
Future policy benefits |
$ | 3,942 | $ | 3,960 | ||||
Policyholders’ funds |
2,295 | 2,473 | ||||||
Unearned revenue |
70 | 40 | ||||||
Unpaid claims and claim expense reserves |
40 | 37 | ||||||
Policyholder dividends payable |
1 | 2 | ||||||
Amounts due to affiliates |
378 | 166 | ||||||
Current income tax payable |
46 | 85 | ||||||
Deferred income tax liability |
- | 69 | ||||||
Coinsurance funds withheld |
2,418 | 2,329 | ||||||
Payables for collateral on derivatives |
51 | 158 | ||||||
Derivative liabilities |
508 | 698 | ||||||
Deferred gains |
112 | 117 | ||||||
Other liabilities |
87 | 89 | ||||||
Separate account liabilities |
8,313 | 7,687 | ||||||
|
|
|
|
|||||
Total Liabilities |
18,261 | 17,910 | ||||||
Shareholder’s Equity |
||||||||
Common stock ($1.00 par value; 3,000,000 shares authorized; 2,000,003 shares issued and outstanding at December 31, 2013 and 2012) |
2 | 2 | ||||||
Additional paid-in capital |
895 | 895 | ||||||
Retained earnings |
1,179 | 938 | ||||||
Accumulated other comprehensive income |
8 | 356 | ||||||
|
|
|
|
|||||
Total Company Shareholder’s Equity |
2,084 | 2,191 | ||||||
|
|
|
|
|||||
Total Liabilities and Shareholder’s Equity |
$ | 20,345 | $ | 20,101 | ||||
|
|
|
|
The accompanying notes are an integral part of these financial statements.
F-3
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
STATEMENTS OF OPERATIONS
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Revenues |
||||||||||||
Premiums |
$ | 55 | $ | 207 | $ | 74 | ||||||
Fee income |
252 | 257 | 413 | |||||||||
Net investment income |
540 | 587 | 597 | |||||||||
Net realized investment and other gains (losses) |
(133 | ) | (52 | ) | 289 | |||||||
Other revenue |
(1 | ) | 5 | - | ||||||||
|
|
|
|
|
|
|||||||
Total revenues |
713 | 1,004 | 1,373 | |||||||||
Benefits and expenses |
||||||||||||
Benefits to policyholders |
155 | 511 | 640 | |||||||||
Policyholder dividends |
5 | 6 | 6 | |||||||||
Amortization of deferred policy acquisition costs, deferred sales |
13 | 53 | 139 | |||||||||
Other operating costs and expenses |
183 | 221 | 237 | |||||||||
|
|
|
|
|
|
|||||||
Total benefits and expenses |
356 | 791 | 1,022 | |||||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes |
357 | 213 | 351 | |||||||||
Income tax expense (benefit) |
116 | 53 | 121 | |||||||||
|
|
|
|
|
|
|||||||
Net income (loss) |
$ | 241 | $ | 160 | $ | 230 | ||||||
|
|
|
|
|
|
The accompanying notes are an integral part of these financial statements.
F-4
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Net income (loss) |
$ | 241 | $ | 160 | $ | 230 | ||||||
|
|
|||||||||||
Other comprehensive income (loss), net of tax |
||||||||||||
Change in unrealized investment gains (losses): |
||||||||||||
Unrealized investment gains (losses) arising during the period |
(356 | ) | 126 | 322 | ||||||||
Reclassification adjustment for (gains) losses realized in net income |
57 | (102 | ) | (208 | ) | |||||||
Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges: |
||||||||||||
Unrealized gains (losses) on the effective portion of the change in fair value of cash flow hedges |
(42 | ) | (2 | ) | 97 | |||||||
Reclassification of net cash flow hedge (gains) losses to net income |
(7 | ) | (4 | ) | - | |||||||
|
|
|||||||||||
Total other comprehensive income (loss), net of tax |
(348 | ) | 18 | 211 | ||||||||
|
|
|||||||||||
Total comprehensive income (loss) |
$ | (107 | ) | $ | 178 | $ | 441 | |||||
|
|
|||||||||||
Income taxes included in other comprehensive income (loss) |
||||||||||||
Change in unrealized investment gains (losses): |
||||||||||||
Income tax expense (benefit) from unrealized investment gains arising during the period |
(192 | ) | 67 | 172 | ||||||||
Income tax (expense) benefit related to reclassification adjustment for gains realized in net income (loss) |
31 | (55 | ) | (111 | ) | |||||||
Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges: |
||||||||||||
Income tax expense (benefit) from unrealized gains on the effective portion of the change in fair value cash flow hedges |
(23 | ) | (1 | ) | 52 | |||||||
Income tax (expense) benefit related to reclassification of net cash flow hedge gains to net income (loss) |
(4 | ) | (2 | ) | - | |||||||
|
|
|||||||||||
Total income tax expense (benefit) in other comprehensive income (loss) |
$ | (188 | ) | $ | 9 | $ | 113 | |||||
|
|
The accompanying notes are an integral part of these financial statements.
F-5
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
STATEMENTS OF CHANGES IN SHAREHOLDER’S EQUITY
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Total Shareholder’s Equity attributable to the Company |
Outstanding Shares |
|||||||||||||||||||
|
|
|||||||||||||||||||||||
(in millions, except for shares outstanding) | (in thousands) | |||||||||||||||||||||||
Balance at January 1, 2011 |
$ | 2 | $ | 895 | $ | 548 | $ | 127 | $ | 1,572 | 2,000 | |||||||||||||
Net income (loss) |
- | - | 230 | - | 230 | |||||||||||||||||||
Other comprehensive income (loss), net of tax |
- | - | - | 211 | 211 | |||||||||||||||||||
|
|
|||||||||||||||||||||||
Balance at December 31, 2011 |
$ | 2 | $ | 895 | $ | 778 | $ | 338 | $ | 2,013 | 2,000 | |||||||||||||
|
|
|||||||||||||||||||||||
Net income (loss) |
160 | 160 | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax |
18 | 18 | ||||||||||||||||||||||
|
|
|||||||||||||||||||||||
Balance at December 31, 2012 |
$ | 2 | $ | 895 | $ | 938 | $ | 356 | $ | 2,191 | 2,000 | |||||||||||||
|
|
|||||||||||||||||||||||
Net income (loss) |
241 | 241 | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax |
(348 | ) | (348 | ) | ||||||||||||||||||||
|
|
|||||||||||||||||||||||
Balance at December 31, 2013 |
$ | 2 | $ | 895 | $ | 1,179 | $ | 8 | $ | 2,084 | 2,000 | |||||||||||||
|
|
The accompanying notes are an integral part of these financial statements.
F-6
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
STATEMENTS OF CASH FLOWS
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Cash flows from operating activities: |
||||||||||||
Net income (loss) |
$ | 241 | $ | 160 | $ | 230 | ||||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
||||||||||||
Amortization of premiums and accretion of discounts associated with investments, net |
25 | 43 | 74 | |||||||||
Net realized investments and other (gains) losses |
133 | 52 | (289 | ) | ||||||||
Amortization of deferred policy acquisition costs, deferred sales |
13 | 53 | 139 | |||||||||
Capitalization of deferred policy acquisition costs and deferred sales inducements |
(39 | ) | (40 | ) | (48 | ) | ||||||
Depreciation and amortization |
2 | - | - | |||||||||
Net cash flows from trading securities |
6 | 12 | 54 | |||||||||
(Increase) decrease in accrued investment income |
8 | (4 | ) | (6 | ) | |||||||
(Increase) decrease in other assets and other liabilities, net |
(74 | ) | (294 | ) | 284 | |||||||
Increase (decrease) in policyholder liabilities and accruals, net |
(97 | ) | 211 | 304 | ||||||||
Interest credited to policyholder liabilities |
142 | 112 | 110 | |||||||||
Increase (decrease) in deferred income taxes |
81 | (17 | ) | (10 | ) | |||||||
|
|
|||||||||||
Net cash provided by (used in) operating activities |
441 | 288 | 842 | |||||||||
Cash flows from investing activities: |
||||||||||||
Sales of: |
||||||||||||
Fixed maturities |
3,302 | 4,321 | 5,367 | |||||||||
Equity securities |
1 | - | - | |||||||||
Mortgage loans on real estate |
68 | 74 | 76 | |||||||||
Investment real estate, agriculture, and timber |
- | 6 | - | |||||||||
Maturities, prepayments, and scheduled redemptions of: |
||||||||||||
Fixed maturities |
303 | 278 | 551 | |||||||||
Mortgage loans on real estate |
24 | 25 | 23 | |||||||||
Other invested assets |
1 | - | - | |||||||||
Purchases of: |
||||||||||||
Fixed maturities |
(3,448 | ) | (4,434 | ) | (5,911 | ) | ||||||
Equity securities |
- | (1 | ) | - | ||||||||
Investment real estate, agriculture, and timber |
(191 | ) | (1 | ) | (3 | ) | ||||||
Other invested assets |
(66 | ) | (4 | ) | - | |||||||
Mortgage loans on real estate issued |
(280 | ) | (64 | ) | (330 | ) | ||||||
Net (purchases) redemptions of short-term investments |
(1 | ) | 16 | 13 | ||||||||
Policy loans advanced, net |
(5 | ) | (14 | ) | (12 | ) | ||||||
Net change in payable for undelivered securities |
(27 | ) | (4 | ) | 3 | |||||||
Net change in amount due from liquidity pool |
(381 | ) | - | - | ||||||||
Other, net |
- | 3 | - | |||||||||
|
|
|||||||||||
Net cash provided by (used in) investing activities |
(700 | ) | 201 | (223 | ) |
The accompanying notes are an integral part of these financial statements.
F-7
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
STATEMENTS OF CASH FLOWS – (CONTINUED)
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Cash flows from financing activities: |
||||||||||||
Universal life and investment-type contract deposits |
281 | 169 | 341 | |||||||||
Universal life and investment-type contract maturities and withdrawals |
(431 | ) | (378 | ) | (1,082 | ) | ||||||
Net transfers from (to) separate accounts related to universal life and investment-type contracts |
21 | 14 | 12 | |||||||||
Unearned revenue on financial reinsurance |
(48 | ) | (49 | ) | (89 | ) | ||||||
Net reinsurance recoverable |
- | - | 4 | |||||||||
|
|
|||||||||||
Net cash provided by (used in) financing activities |
(177 | ) | (244 | ) | (814 | ) | ||||||
Net increase (decrease) in cash and cash equivalents |
(436 | ) | 245 | (195 | ) | |||||||
Cash and cash equivalents at beginning of year |
495 | 250 | 445 | |||||||||
|
|
|||||||||||
Cash and cash equivalents at end of year |
$ | 59 | $ | 495 | $ | 250 | ||||||
|
|
|||||||||||
Non-cash financing activities during the year: |
||||||||||||
Transfer of assets to First Allmerica Financial Life Insurance Company |
$ | - | $ | (1,717 | ) | $ | - |
The accompanying notes are an integral part of these financial statements.
F-8
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS
Note 1 — Summary of Significant Accounting Policies
Business. John Hancock Life Insurance Company of New York (the “Company”) is a life insurance company organized on February 10, 1992 under the laws of the State of New York. The New York State Department of Financial Services (the “Department”) granted the Company a license to operate on July 22, 1992. The Company is a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.) (“JHUSA”). JHUSA is a wholly-owned subsidiary of The Manufacturers Investment Corporation (“MIC”). MIC is a wholly-owned subsidiary of John Hancock Financial Corporation (“JHFC”). JHFC is an indirect, wholly-owned subsidiary of The Manufacturers Life Insurance Company (“MLI”). MLI, in turn, is a wholly-owned subsidiary of Manulife Financial Corporation (“MFC”), a Canadian-based, publicly traded financial services holding company.
The Company provides a wide range of financial protection and wealth management products and services to both individual and institutional customers located exclusively in the State of New York (“NY”). Through its insurance operations, the Company offers a variety of individual life insurance that are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners, and direct marketing. The Company also offers a variety of retirement products to retirement plans. The Company distributes products through multiple distribution channels, including insurance agents and affiliated brokers, securities brokerage firms, financial planners, pension plan sponsors, pension plan consultants, and banks. In 2013, the Company discontinued sales of its structured settlements and single premium immediate annuity products. In 2012, the Company suspended new sales of its individual fixed and variable annuity products.
The Company manages individual and group fixed and variable annuity, and individual life insurance contracts (collectively, the contracts) for both individual and institutional customers exclusively in the State of New York. Amounts invested in the fixed portion of the contracts are allocated to the general account of the Company. Amounts invested in the variable portion of the contracts are allocated to the separate accounts of the Company. Each of these separate accounts invests in shares of one of the various portfolios of the John Hancock Variable Insurance Trust (“JHVIT”), a no-load, open-end investment management company organized as a Massachusetts business trust, or in open-end investment management companies offered and managed by unaffiliated third parties.
Effective January 1, 2014, the John Hancock Funds Board of Trustees approved John Hancock Advisers, LLC (“JHA”) as the investment adviser to John Hancock Funds II (“JHF II”) and John Hancock Funds III (“JHF III”) replacing John Hancock Investment Management Services, LLC (“JHIMS”). JHF II funds are offered to retail investors, other affiliated John Hancock Funds and separate accounts of JHUSA and JHNY as investment options for 401(k) plans sold by Retirement Plan Services. JHF III funds are offered to retail investors and other affiliated John Hancock Funds. This change transferred approximately $86 billion of assets from JHIMS to JHA. JHIMS will continue as the investment adviser for the John Hancock Variable Insurance Trust funds.
Basis of Presentation. These financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.
The Company’s 36% investment in John Hancock Investment Management Services, LLC (“JHIMS”), an affiliated company, is accounted for using the equity method of accounting and is included in investment in unconsolidated affiliate.
Reclassifications. The Company reclassified its fixed deferred annuity liabilities balance of $1,855 million at December 31, 2012 to policyholder funds on the Consolidated Balance Sheets to conform to the current year presentation. Certain other amounts have also been reclassified to conform to the current year presentation.
Investments. The Company determines the classification of its financial assets at initial recognition. Fixed maturity and equity securities are recognized initially at fair value plus, in the case of investments not held for trading, directly attributable transaction costs. The Company classifies its fixed maturity securities as either available-for-sale or held-for-trading and records these securities at fair value. The change in fair value related to available-for-sale securities is reflected in accumulated other comprehensive income (“AOCI”), net of policyholder related amounts and deferred income taxes. The change in fair value related to held-for-trading securities is reflected in net realized investment and other gains (losses).
Interest income on fixed maturity securities, other than mortgage-backed securities, is generally recognized on the accrual basis. The amortized cost of fixed maturity securities is adjusted for other-than-temporary impairments, amortization of premiums, and accretion of discounts to maturity. Amortization of premiums and accretion of discounts is on an effective
F-9
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 1 — Summary of Significant Accounting Policies - (continued)
yield basis and is included in net investment income. The Company recognizes an impairment loss only when management does not expect to recover the amortized cost of the fixed maturity security.
For mortgage-backed securities, the Company recognizes income using a constant effective yield based on anticipated prepayments and the estimated economic life of the securities. When actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date plus anticipated future payments, and any resulting adjustment is included in net investment income.
Equity securities primarily include common stock. Dividends are recorded as income on the ex-dividend date. The Company recognizes an impairment loss only when management does not expect to recover the cost of the equity security. In determining whether an equity security is impaired, the Company considers its intent and ability to hold a particular equity security for a period of time sufficient to allow for the recovery of its value. Equity securities that do not have readily determinable fair values are included in other invested assets.
Mortgage loans on real estate are carried at unpaid principal balances and are adjusted for amortization of premiums or accretion of discounts, less an allowance for probable losses. Premiums or discounts are amortized over the life of the mortgage loan contract in a manner that results in a constant effective yield. Interest income and amortization amounts and other costs that are recognized as an adjustment of yield are included as components of net investment income. When contractual payments of mortgage investments are more than 90 days in arrears or when loans are considered impaired, interest is no longer accrued. Mortgage loans on real estate are evaluated periodically as part of the Company’s loan review procedures and are considered impaired when it is probable that the Company will be unable to collect all amounts of principal and interest due according to the contractual terms of the mortgage loan agreement. The valuation allowance established as a result of impairment is based on the present value of the expected future cash flows, discounted at the loan’s original effective interest rate, or is based on the collateral value of the loan if the loan is collateral dependent. The Company estimates this level to be adequate to absorb estimated probable credit losses that exist at the balance sheet date. Any change to the valuation allowance for mortgage loans on real estate is reported as a component of net realized investment and other gains (losses). Interest received on impaired mortgage loans on real estate is applied to reduce the outstanding investment balance. Interest received on other mortgage loans that are in non-accrual status is recorded as interest income on a cash basis. If foreclosure becomes probable, the measurement method used is based on the collateral’s fair value. Foreclosed real estate is recorded at the collateral’s fair value at the date of foreclosure, which establishes a new cost basis.
Investment real estate and agriculture, which the Company has the intent to hold for the production of income, is carried at depreciated cost, using the straight-line method of depreciation, less adjustments for impairments in value. In those cases where it is determined that the carrying amount of investment real estate and agriculture is not recoverable, an impairment loss is recognized based on the difference between the depreciated cost and fair value of the asset. The Company reports impairment losses as part of net realized investment and other gains (losses).
Policy loans are carried at unpaid principal balances.
Other invested assets primarily represent investments in which the Company does not have a controlling financial interest, but has significant influence, and are recorded using the equity method of accounting. The Company records its share of earnings using the most recent financial information available, which is generally on a three month lag. Depending on the timing of receipt of the audited financial statements of these other invested assets, the investee level financial data may be up to one year in arrears.
Short-term investments, which include investments with remaining maturities of one year or less, but greater than three months, at the time of purchase, are reported at fair value.
Net realized investment and other gains (losses), other than those related to separate accounts for which the Company does not bear the investment risk, are determined on a specific identification method and are reported net of amounts credited to participating contract holder accounts.
Derivative Financial Instruments. The Company uses derivative financial instruments (“derivatives”) to manage exposures to interest rate, equity price movements, and other market risks arising from on-balance sheet financial instruments, certain insurance contract liabilities, and selected anticipated transactions. Derivatives are recorded at fair value. Derivatives with unrealized gains are reported as derivative assets and derivatives with unrealized losses are reported as derivative liabilities. Derivatives embedded in other instruments (“host instruments”), such as investment securities, reinsurance contracts, and
F-10
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 1 — Summary of Significant Accounting Policies - (continued)
certain benefit guarantees, are separately recorded as derivatives when their economic characteristics and risks are not closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the host instrument is not held-for-trading or carried at fair value.
A determination is made for each relationship as to whether hedge accounting can be applied. Where hedge accounting is not applied, changes in fair value of derivatives are recorded in net realized investment and other gains (losses).
Where the Company has elected to use hedge accounting, a hedge relationship is designated and documented at inception. Hedge effectiveness is evaluated at inception and throughout the term of the hedge, and hedge accounting is only applied when the Company expects that each hedging instrument will be highly effective in achieving offsetting changes in fair value or changes in cash flows attributable to the risk being hedged. Hedge effectiveness is assessed quarterly using a variety of consistently applied techniques, including regression analysis and cumulative dollar offset. When it is determined that the hedging relationship is no longer effective or the hedged item has been sold or terminated, the Company discontinues hedge accounting prospectively. In such cases, if the derivative hedging instruments are not sold or terminated, any subsequent changes in fair value of the derivative are recognized in net realized investment and other gains (losses).
For derivatives that are designated as hedging instruments, changes in fair value are recognized according to the nature of the risks being hedged, as discussed below.
Fair Value Hedges. In a fair value hedging relationship, changes in the fair value of the hedging derivatives are recorded in net realized investment and other gains (losses), along with changes in fair value attributable to the hedged risk. The carrying value of the hedged item is adjusted for changes in fair value attributable to the hedged risk. To the extent the changes in the fair value of derivatives do not offset the changes in the fair value of the hedged item attributable to the hedged risk in net realized investment and other gains (losses), any ineffectiveness will remain in net realized investment and other gains (losses). When hedge accounting is discontinued, the carrying value of the hedged item is no longer adjusted and the cumulative fair value adjustments are amortized to net investment income over the remaining term of the hedged item unless the hedged item is sold, at which time the balance is recognized immediately in net investment income.
Cash Flow Hedges. In a cash flow hedge relationship, the effective portion of the changes in the fair value of the hedging instrument is recorded in AOCI, while the ineffective portion is recognized in net realized investment and other gains (losses). Unrealized gains and losses recorded in AOCI are recognized in income during the same periods as the variability in the cash flows hedged or the hedged forecasted transactions are recognized.
Unrealized gains and losses on cash flow hedges recorded in AOCI are reclassified immediately to income when the hedged item is sold or the forecasted transaction is no longer expected to occur. When a hedge is discontinued, but the hedged forecasted transaction remains highly probable to occur, the amounts in AOCI are reclassified to net realized investment and other gains (losses) in the periods during which variability in the cash flows hedged or the hedged forecasted transaction is recognized in income.
Cash and Cash Equivalents. Cash and cash equivalents include cash and all highly liquid debt investments with a remaining maturity of three months or less when purchased.
Value of Business Acquired. Value of business acquired (“VOBA”) is the present value of estimated future profits of insurance policies in-force. The Company amortizes VOBA using the same methodology and assumptions used to amortize deferred policy acquisition costs (“DAC”) and tests for recoverability at least annually.
Deferred Policy Acquisition Costs, Deferred Sales Inducements and Unearned Revenue. DAC are costs that are directly related to the successful acquisition or renewal of insurance contracts. Such costs include: (1) incremental direct costs of contract acquisition, such as commissions; (2) the portion of an employee’s total compensation and benefits directly related to underwriting, policy issuance and processing, medical inspection, and contract selling of new and renewal insurance contracts with respect to actual policies acquired or renewed; (3) other costs directly related to acquisition or renewal activities that would not have been incurred had a policy not been acquired or renewed; and (4) in limited circumstances, the costs of direct response advertising whose primary purpose is to elicit sales to customers who could be shown to have responded specifically to the advertising and that results in contract acquisition. All other acquisition-related costs, including those related to general advertising and solicitation, market research, agent training, product development, unsuccessful sales and underwriting efforts, as well as all indirect costs, are expensed as incurred. Similarly, any amounts assessed as initiation fees or front-end loads are recorded as unearned revenue. The Company tests the recoverability of DAC at least annually.
F-11
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 1 — Summary of Significant Accounting Policies - (continued)
DAC related to participating traditional life insurance is amortized over the life of the policies at a constant rate based on the present value of the estimated gross margin amounts expected to be realized over the lives of the policies. Estimated gross margin amounts include anticipated premiums and investment results less claims and administrative expenses, changes in the net level premium reserve, and expected annual policyholder dividends. For annuity, universal life insurance, and investment-type products, DAC and unearned revenue are amortized generally in proportion to the change in present value of estimated gross profits arising principally from surrender charges, investment results, including realized investment and other gains (losses), and mortality and expense margins. In situations where using gross profits is not the best basis for amortizing DAC, the Company amortizes DAC and unearned revenue based on the amount of insurance in force. DAC amortization includes retrospective adjustments when estimates are revised. For annuity, universal life insurance, and investment-type products, the DAC asset is adjusted for the impact of unrealized gains (losses) on available for sale investments as if these gains (losses) had been realized, with corresponding credits or charges included in AOCI.
DAC and unearned revenue related to non-participating traditional life insurance are amortized over the premium-paying period of the related policies using assumptions consistent with those used in computing future policy benefits.
The Company offers sales inducements, including enhanced crediting rates or bonus payments, to contract holders on certain of its individual life insurance and individual and group annuity products. The Company’s deferred sales inducements (“DSI”) are amortized over the life of the underlying contracts using the same methodology and assumptions used to amortize DAC.
Reinsurance. Assets and liabilities related to reinsurance ceded contracts are reported on a gross basis. The accompanying Statements of Operations reflect premiums, benefits, and settlement expenses net of reinsurance ceded. Reinsurance premiums, commissions, expense reimbursements, benefits, and reserves related to reinsured business are accounted for on a basis consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts.
The Company utilizes reinsurance agreements to provide for greater diversification of business, allowing management to control exposure to potential losses arising from large risks, and provide additional capacity for growth. Reinsurance ceded contracts do not relieve the Company from its obligations to policyholders. The Company remains liable to its contract holders to the extent that counterparties to reinsurance ceded contracts do not meet their contractual obligations. Failure of the reinsurers to honor their obligations could result in losses to the Company; consequently, estimates are established for amounts deemed or estimated to be uncollectible. To minimize its exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from similar characteristics among the reinsurers.
When a reinsurance agreement does not subject the reinsurer to the reasonable possibility of significant loss, the Company accounts for the agreement as financial reinsurance and uses deposit-type accounting treatment with only the reinsurance risk fee being reported in other operating costs and expenses.
Separate Account Assets and Liabilities. Separate account assets and liabilities reported on the Company’s Balance Sheets represent funds that are administered and invested by the Company to meet specific investment objectives of contract holders. Net investment income and net realized investment and other gains (losses) generally accrue directly to such contract holders who bear the investment risk, subject, in some cases, to principal guarantees and minimum guaranteed rates of income. The assets of each separate account are legally segregated and are not subject to claims that arise out of any other business of the Company. Separate account assets are reported at fair value, and separate account liabilities are set equal to the fair value of the separate account assets. Deposits, surrenders, net investment income, net realized investment and other gains (losses), and the related liability changes of separate accounts are offset within the same line item in the Statements of Operations. Fees charged to contract holders, principally mortality, policy administration, investment management, and surrender charges, are included in the revenues of the Company. For the years ended December 31, 2013, 2012 and 2011 there were no gains or losses on transfers of assets from the general account to the separate account.
Future Policy Benefits and Policyholders’ Funds. Future policy benefits for participating traditional life insurance policies are based on the net level premium method. The net level premium reserve is calculated using the guaranteed mortality and dividend fund interest rates. The liability for annual dividends represents the accrual of annual dividends earned. Settlement dividends are accrued in proportion to gross margins over the life of the policies. Participating business represented 55% and 57% of the Company’s traditional life net insurance in-force at December 31, 2013 and 2012,
F-12
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 1 — Summary of Significant Accounting Policies - (continued)
respectively, and 24%, 24%, and 23% of the Company’s traditional life net insurance premiums for the years ended December 31, 2013, 2012 and 2011, respectively.
For non-participating traditional life insurance policies, future policy benefits are estimated using a net level premium method based upon actuarial assumptions as to mortality, persistency, interest, and expenses established at the policy issue or acquisition date. Assumptions established at policy issue as to mortality and persistency are based on the Company’s experience, which, together with interest and expense assumptions, include a margin for adverse deviation.
For universal life insurance products, the basic policy reserve is account value. An additional liability is established for product features which result in a pattern of profits followed by losses. The benefits covered by this liability include benefits paid under no-lapse guarantee features as well as certain other death benefits. The additional liability is calculated by multiplying the benefit ratio by the assessments recorded from contract inception accumulated with interest and subtracting the excess benefits paid from contract inception accumulated with interest. If experience or assumption changes result in a new benefit ratio, the reserves are adjusted to reflect the changes in a manner similar to the retrospective adjustment of DAC, VOBA, and unearned revenue. The assumptions used in estimating the additional liability are consistent with those used for amortizing DAC. The no-lapse guarantee benefits used in calculating the liability are based on the average benefits payable over a range of scenarios.
Policyholders’ funds are generally equal to the total of the policyholder account values before surrender charges, additional reserves established to adjust for lower market interest rates as of the acquisition date, and additional reserves established on certain guarantees offered in certain investment-type products. Fixed annuity liabilities during the accumulation period are based on the accumulated contract holders’ fund balances and after annuitization are equal to the present value of expected future payments. Policyholder account values include deposits plus credited interest or change in investment value less expense and mortality fees, as applicable, and withdrawals. Policy benefits are charged to expense and include benefit claims incurred in the period in excess of related policy account balances and interest credited to policyholders’ account balances.
Liabilities for unpaid claims and claim expense reserves include estimates of payments to be made on reported life insurance claims and estimates of incurred but not reported claims based on historical claim development patterns.
Estimates of future policy benefit reserves, claim reserves, and expenses are reviewed on a regular basis and adjusted as necessary. Any changes in estimates are reflected in current earnings.
Deferred Gains. The Company amortizes the deferred gains over 10 years using the effective interest method.
Revenue Recognition. Premiums from non-participating traditional life insurance and annuity policies with life contingencies are recognized as revenue when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any excess profit is deferred and recognized into income in a constant relationship to insurance in-force or, for annuities, the amount of expected future benefit payments.
Deposits related to universal life and investment-type products are credited to policyholders’ account balances. Revenues from these contracts, as well as annuity contracts, consist of amounts assessed against policyholders’ account balances for mortality, policy administration, and surrender charges and are recorded in fee income in the period in which the services are provided.
Fee income also includes advisory fees and administrative service fees collected from the separate accounts. Such fees are recognized in the period in which the services are performed.
Income Taxes. The provision for federal income taxes includes amounts currently payable or recoverable and deferred income taxes, computed under the liability method, resulting from temporary differences between the tax and financial statement bases of assets and liabilities. A valuation allowance is established for deferred tax assets when it is more likely than not that an amount will not be realized. In accordance with the income tax sharing agreements in effect for the applicable tax years, the Company’s income tax expense (benefit) is computed as if the Company filed separate federal income tax returns with tax benefits provided for operating losses and tax credits when utilized and settled by the consolidated group. Intercompany settlements of income taxes are made through an increase or reduction in amounts due to or from affiliates. Such settlements occur on a periodic basis in accordance with the tax sharing agreements.
F-13
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 1 — Summary of Significant Accounting Policies - (continued)
Adoption of Recent Accounting Pronouncements
Offsetting Assets and Liabilities
In December 2011 and January 2013, the Financial Accounting Standards Board (“FASB”) issued updated guidance regarding the disclosure of recognized derivative instruments (including bifurcated embedded derivatives), repurchase agreements and securities borrowing/lending transactions that are offset in the statement of financial position or are subject to an enforceable master netting arrangement or similar arrangement (irrespective of whether they are offset in the balance sheet). This new guidance requires an entity to disclose information, on both a gross and net basis, about instruments and transactions within the scope of the guidance. The Company adopted the revised accounting standard effective January 1, 2013 via retrospective adoption, as required. The expanded disclosures required by this guidance are included in the Investments Note. The adoption of the guidance did not impact the Company’s financial position or results of operations.
Fed Funds as Benchmark Interest Rate
In July 2013, the FASB issued new guidance regarding derivatives. The new guidance permits a company to designate the Fed Funds Effective Swap Rate (also referred to as the “Overnight Index Swap Rate” or “OIS”) as the hedged risk (or benchmark interest rate) in both cash flow and fair value hedges. The new guidance also removed the requirement that similar hedges designate the same benchmark rate. The new guidance is effective prospectively for qualifying new or redesignated hedging relationships commencing on or after July 17, 2013. The adoption of the guidance did not impact the Company’s financial position or results of operations.
Comprehensive Income
In February 2013, the FASB issued updated guidance regarding the presentation of comprehensive income. Under the guidance, the Company is required to separately present information about significant items reclassified out of accumulated other comprehensive income by component as well as changes in accumulated other comprehensive income balances by component in either the financial statements or the notes to the financial statements. The guidance does not change the items that are reported in other comprehensive income, does not change when an item of other comprehensive income must be reclassified to net income, and does not amend any existing requirements for reporting net income or other comprehensive income. The Company’s adoption was prospective and the disclosures required by this guidance are included in the Shareholder’s Equity Note.
Income Taxes
In July 2013, the FASB issued updated guidance regarding the presentation of an unrecognized tax benefit when a net operating loss carryforward, similar tax losses, or a tax credit carryforward exist. This guidance requires liabilities for uncertain tax positions to be presented in the financial statements as a reduction to deferred assets to the extent that the deferred tax assets are available to reduce resulting taxes payable within the same jurisdiction. The guidance is generally effective for 2014. The Company retrospectively early adopted this new guidance for its 2013 reporting. The adoption of this guidance did not impact the Company’s financial position or results of operations.
Future Adoption of Recent Accounting Pronouncements
Investment Companies
In June 2013, the FASB issued updated guidance clarifying the characteristics of an investment company and requiring new disclosures. The new guidance changes the way in which a company assesses whether it should be considered an investment company. Once deemed an investment company, the new guidelines require additional disclosures as well as changes to the reporting of interests in other investment companies. The provisions of the new guidance are effective for annual and interim reporting periods in fiscal years beginning after December 15, 2013. Upon adoption, the new guidance is not expected to materially impact the Company’s financial position or results of operations.
F-14
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments
Fixed Maturity and Equity Securities
The Company’s investments in available-for-sale fixed maturity and equity securities are summarized below:
December 31, 2013 | ||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value | Other-Than- Temporary Impairments in AOCI |
||||||||||||||||
|
|
|||||||||||||||||||
(in millions) | ||||||||||||||||||||
Fixed maturity and equity securities |
||||||||||||||||||||
Corporate debt securities |
$ | 3,578 | $ | 228 | $ | (66 | ) | $ | 3,740 | $ | - | |||||||||
Commercial mortgage-backed securities |
57 | 2 | - | 59 | - | |||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | |||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | |||||||||||||||
Other asset-backed securities |
72 | 3 | (2 | ) | 73 | - | ||||||||||||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies |
1,776 | 6 | (145 | ) | 1,637 | - | ||||||||||||||
Obligations of states and political subdivisions |
246 | 16 | (5 | ) | 257 | - | ||||||||||||||
Debt securities issued by foreign governments |
100 | 5 | - | 105 | - | |||||||||||||||
|
|
|||||||||||||||||||
Fixed maturity securities |
5,829 | 260 | (218 | ) | 5,871 | - | ||||||||||||||
Other fixed maturity securities |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity securities available-for-sale |
5,829 | 260 | (218 | ) | 5,871 | - | ||||||||||||||
Equity securities available-for-sale |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity and equity securities available-for-sale |
$ | 5,829 | $ | 260 | $ | (218 | ) | $ | 5,871 | $ | - | |||||||||
|
|
F-15
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
December 31, 2012 | ||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value | Other-Than- Temporary Impairments in AOCI |
||||||||||||||||
|
|
|||||||||||||||||||
(in millions) | ||||||||||||||||||||
Fixed maturity and equity securities |
||||||||||||||||||||
Corporate debt securities |
$ | 3,470 | $ | 406 | $ | (5 | ) | $ | 3,871 | $ | - | |||||||||
Commercial mortgage-backed securities |
222 | 8 | - | 230 | - | |||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | |||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | |||||||||||||||
Other asset-backed securities |
42 | 4 | - | 45 | - | |||||||||||||||
U.S. Treasury securities and obligations of U.S. government corporations and agencies |
2,052 | 99 | (13 | ) | 2,137 | - | ||||||||||||||
Obligations of states and political subdivisions |
236 | 51 | - | 287 | - | |||||||||||||||
Debt securities issued by foreign governments |
57 | 2 | - | 59 | - | |||||||||||||||
|
|
|||||||||||||||||||
Fixed maturity securities |
6,079 | 570 | (18 | ) | 6,629 | - | ||||||||||||||
Other fixed maturity securities |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity securities available-for-sale |
6,079 | 570 | (18 | ) | 6,629 | - | ||||||||||||||
Equity securities available-for-sale |
1 | - | - | 1 | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity and equity securities available-for-sale |
$ | 6,080 | $ | 570 | $ | (18 | ) | $ | 6,630 | $ | - | |||||||||
|
|
The amortized cost and fair value of available-for-sale fixed maturity securities at December 31, 2013, by contractual maturity, are shown below:
Amortized Cost | Fair Value | |||||||
|
|
|||||||
(in millions) | ||||||||
Fixed maturity securities |
||||||||
Due in one year or less |
$ | 185 | $ | 188 | ||||
Due after one year through five years |
1,043 | 1,086 | ||||||
Due after five years through ten years |
1,029 | 1,070 | ||||||
Due after ten years |
3,443 | 3,395 | ||||||
|
|
|||||||
5,700 | 5,739 | |||||||
Asset-backed and mortgage-backed securities |
129 | 132 | ||||||
|
|
|||||||
Total |
$ | 5,829 | $ | 5,871 | ||||
|
|
Expected maturities may differ from contractual maturities because eligible borrowers may exercise their right to call or prepay obligations with or without call or prepayment penalties. Asset-backed and mortgage-backed securities are shown separately in the table above, as they are not due at a single maturity date.
Fixed Maturity Securities Impairment Review
The Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. This process involves monitoring market events that could impact issuers’ credit ratings, business climate, management changes, litigation and government actions, and other similar factors. This process also involves monitoring late payments, downgrades by rating agencies, key financial ratios, financial statements, revenue forecasts, and cash flow projections as indicators of credit issues.
At the end of each quarter, the MFC Loan Review Committee reviews all fixed maturity securities where there is evidence of impairment or a significant unrealized loss at the balance sheet date. Generally, securities with market value less than 60 percent of amortized cost for six months or more indicate an impairment is present. Accordingly, securities in this category are normally deemed impaired unless there is clear evidence they should not be impaired. The analysis focuses on each
F-16
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
company’s or project’s ability to service its debts in a timely fashion and the length of time the security has been trading below amortized cost. The results of this analysis are reviewed by the Transaction and Portfolio Review Committee at MFC. This committee includes MFC’s Chief Financial Officer, Chief Investment Officer, Chief Risk Officer, Chief Credit Officer, and other senior management. This quarterly process includes a fresh assessment of the credit quality of each investment in the entire fixed maturity security portfolio.
The Company considers relevant facts and circumstances in evaluating whether the impairment of a fixed maturity security is other-than-temporary. Relevant facts and circumstances considered include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer, including the current and future impact of any specific events; and (3) the Company’s ability and intent to hold the fixed maturity security to maturity or until it recovers in value. If the Company intends to sell, or if it is more likely than not that it will be required to sell an impaired fixed maturity security prior to recovery of its cost basis, the security is considered other-than-temporarily impaired, and the Company records a charge to earnings for the full amount of impairment (the difference between the current carrying amount and fair value of the security). For fixed maturity securities in an unrealized loss position where the Company does not intend to sell or is not more likely than not to be required to sell, the Company determines its ability to recover the amortized cost of the security by comparing the net present value of the projected future cash flows to the amortized cost of the security. If the net present value of the cash flow is less than the security’s amortized cost, then the difference is recorded as a credit loss. The difference between the estimates of the credit loss and the overall unrealized loss on the security is the non-credit-related component. The credit loss portion is charged to net realized investment and other gains (losses) on the Statements of Operations, while the non-credit loss is charged to AOCI on the Balance Sheets.
The net present value used to determine the credit loss is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the fixed maturity security prior to impairment. The Company may use the estimated fair value of collateral as a proxy for the net present value if it believes that the security is dependent on the liquidation of collateral for recovery of its investment. The projection of future cash flows is subject to the same analysis the Company applies to its overall impairment evaluation process, as noted above, which incorporates security specific information such as late payments, downgrades by rating agencies, key financial ratios, investee financial statements, and fundamentals of the industry and geographic area in which the issuer operates, as well as overall macroeconomic conditions. The projections are estimated using assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default.
Similarly, management evaluates all facts and circumstances and exercises professional judgment in determining whether an other-than-temporary impairment of equity securities exists. The MFC Transaction and Portfolio Review Committee reviews and approves the proposed impairments based on an analysis of the evidence, including the current market price, the length of time the security has been in an unrealized loss position, forecasted earnings per share, consensus price targets, projected P/E ratios, overall financial health of each issuer, liquidity or solvency issues, announced changes in ownership structure, changes to issuer debt ratings, changes to dividend payments, changes in products, markets or competition, and other industry specific or macroeconomic factors.
There are a number of significant risks and uncertainties inherent in the process of monitoring impairments and determining if an impairment is other-than-temporary. These risks and uncertainties include (1) the risk that the Company’s assessment of an issuer’s ability to meet all of its contractual obligations will change based on changes in the credit characteristics of that issuer; (2) the risk that the economic outlook will be worse than expected or have more of an impact on the issuer than anticipated; (3) the risk that fraudulent information could be provided to the Company’s investment professionals who determine the fair value estimates and other-than-temporary impairments; and (4) the risk that new information obtained by the Company or changes in other facts and circumstances lead it to change its intent to hold the security to maturity or until it recovers in value. Any of these situations could result in a charge to earnings in a future period.
The cost amounts for fixed maturity securities are net of other-than-temporary impairment charges.
The following table shows the carrying value and gross unrealized losses aggregated by investment category and length of time that individual available-for-sale fixed maturity and equity securities have been in a continuous unrealized loss position:
F-17
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
Unrealized Losses on Fixed Maturity and Equity Securities — By Investment Age
December 31, 2013 | ||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||
Carrying Value |
Unrealized Losses |
Carrying Value |
Unrealized Losses |
Carrying Value |
Unrealized Losses |
|||||||||||||||||||
(in millions) | ||||||||||||||||||||||||
Corporate debt securities |
$ | 859 | $ | (48 | ) | $ | 118 | $ | (18 | ) | $ | 977 | $ | (66) | ||||||||||
Commercial mortgage-backed securities |
4 | - | 3 | - | 7 | - | ||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | ||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | ||||||||||||||||||
Other asset-backed securities |
25 | (2 | ) | - | - | 25 | (2) | |||||||||||||||||
US Treasury securities and obligations of US government corps and agencies |
1,199 | (64 | ) | 338 | (81 | ) | 1,537 | (145) | ||||||||||||||||
Obligations of states and political subdivisions |
57 | (3 | ) | 10 | (2 | ) | 67 | (5) | ||||||||||||||||
Debt securities issued by foreign governments |
- | - | - | - | - | - | ||||||||||||||||||
|
|
|||||||||||||||||||||||
Total fixed maturity securities available-for-sale |
2,144 | (117 | ) | 469 | (101 | ) | 2,613 | (218) | ||||||||||||||||
Equity securities available-for-sale |
- | - | - | - | - | - | ||||||||||||||||||
|
|
|||||||||||||||||||||||
Total |
$ | 2,144 | $ | (117 | ) | $ | 469 | $ | (101 | ) | $ | 2,613 | $ | (218) | ||||||||||
|
|
|||||||||||||||||||||||
December 31, 2012 | ||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||
Carrying Value |
Unrealized Losses |
Carrying Value |
Unrealized Losses |
Carrying Value |
Unrealized Losses |
|||||||||||||||||||
(in millions) | ||||||||||||||||||||||||
Corporate debt securities |
$ | 186 | $ | (4 | ) | $ | 32 | $ | (1 | ) | $ | 218 | $ | (5) | ||||||||||
Commercial mortgage-backed securities |
10 | - | - | - | 10 | - | ||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | ||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | ||||||||||||||||||
Other asset-backed securities |
- | - | - | - | - | - | ||||||||||||||||||
US Treasury securities and obligations of US government corps and agencies |
643 | (13 | ) | - | - | 643 | (13) | |||||||||||||||||
Obligations of states and political subdivisions |
12 | - | - | - | 12 | - | ||||||||||||||||||
Debt securities issued by foreign governments |
3 | - | 18 | - | 21 | - | ||||||||||||||||||
|
|
|||||||||||||||||||||||
Total fixed maturity securities available-for-sale |
854 | (17 | ) | 50 | (1 | ) | 904 | (18) | ||||||||||||||||
Equity securities available-for-sale |
- | - | - | - | - | - | ||||||||||||||||||
|
|
|||||||||||||||||||||||
Total |
$ | 854 | $ | (17 | ) | $ | 50 | $ | (1 | ) | $ | 904 | $ | (18) | ||||||||||
|
|
Unrealized losses can be created by rising interest rates or by rising credit concerns and hence widening credit spreads. Credit concerns are apt to play a larger role in the unrealized loss on below investment grade securities. Unrealized losses on investment grade securities principally relate to changes in interest rates or changes in credit spreads since the securities were acquired. Credit rating agencies’ statistics indicate that investment grade securities have been found to be less likely to develop credit concerns. The gross unrealized losses on below investment grade available-for-sale fixed maturity securities decreased to $1 million at December 31, 2013 from $1 million at December 31, 2012.
F-18
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
At December 31, 2013 and 2012, there were 306 and 62 fixed maturity securities with aggregate gross unrealized losses of $218 million and $18 million, respectively, of which the single largest unrealized loss was $78 million and $12 million, respectively. The Company anticipates that these fixed maturity securities will perform in accordance with their contractual terms and currently has the ability and intent to hold these securities until they recover or mature.
Available-for-sale securities with amortized cost of $1 million were non-income producing for the year ended December 31, 2013. Non-income producing assets represent investments that have not produced income for the twelve months preceding December 31, 2013.
Assets on Deposit and Pledged as Collateral
The Company maintains assets which are pledged as collateral in connection with various agreements and transactions. Additionally, the Company holds assets on deposit with government authorities as required by state law. The following table summarizes the fair value of the pledged or deposited assets:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Bonds pledged in support of over-the-counter derivative instruments |
$ | 28 | $ | 1 | ||||
Bonds pledged in support of exchange-traded futures and cleared derivatives |
24 | 24 | ||||||
Bonds on deposit with government authorities |
1 | 1 | ||||||
Mortgage loans pledged in support of real estate |
- | - | ||||||
Bonds held in trust |
- | - | ||||||
Pledged collateral under reinsurance agreements |
- | - | ||||||
|
|
|||||||
Total |
$ | 53 | $ | 26 | ||||
|
|
Offsetting Financial Assets and Financial Liabilities
The Company does not offset financial instruments in the Consolidated Balance Sheets, as the rights of offset are conditional.
In the case of derivatives, collateral is collected from and pledged to counterparties to manage credit exposure in accordance with Credit Support Annex agreements. Under master netting agreements, the Company has a right of offset in the event of default, insolvency, bankruptcy or other early termination.
In the case of reverse repurchase and repurchase transactions, additional collateral may be collected from or pledged to counterparties to manage credit exposure according to bilateral reverse repurchase agreements or repurchase agreements. In the event of default by a counterparty, the Company is entitled to liquidate the assets the Company holds as collateral to offset against obligations to the same counterparty.
The following table presents the effects of conditional master netting and similar arrangements. Similar arrangements may include global master repurchase agreements, global master securities lending agreements, and any related rights to financial collateral.
F-19
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
Related Amounts Not Set Off in the Consolidated Balance Sheets |
||||||||||||||||||||
Year ended December 31, 2013 | Gross Amounts of the Consolidated |
Amounts Netting or Similar |
Financial and Cash Collateral Pledged (Received)(2) |
Net Amount Including Financing Trusts(3) |
Net Amount Excluding Financing Trusts |
|||||||||||||||
(in millions) | ||||||||||||||||||||
Financial assets |
||||||||||||||||||||
Derivative assets |
$ | 432 | $ | (305 | ) | $ | (127 | ) | $ | - | $ | - | ||||||||
Securities lending |
- | - | - | - | - | |||||||||||||||
Reverse repurchase agreements |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total financial assets |
432 | (305 | ) | (127 | ) | - | - | |||||||||||||
|
|
|||||||||||||||||||
Financial liabilities |
||||||||||||||||||||
Derivative liabilities |
(335 | ) | 305 | 30 | - | - | ||||||||||||||
Repurchase agreements |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total financial liabilities |
$ | (335 | ) | $ | 305 | $ | 30 | $ | - | $ | - | |||||||||
|
|
|||||||||||||||||||
Year ended December 31, 2012 | Gross Amounts of Financial Instruments presented in the Consolidated Balance Sheets(1) |
Amounts Subject to an Enforceable Master Netting Arrangement or Similar Agreements |
Financial and Cash Collateral Pledged (Received)(2) |
Net Amount Including Financing Trusts(3) |
Net Amount Excluding Financing Trusts |
|||||||||||||||
(in millions) | ||||||||||||||||||||
Financial assets |
||||||||||||||||||||
Derivative assets |
$ | 669 | $ | (353 | ) | $ | (316 | ) | $ | - | $ | - | ||||||||
Securities lending |
||||||||||||||||||||
Reverse repurchase agreements |
||||||||||||||||||||
|
|
|||||||||||||||||||
Total financial assets |
669 | (353 | ) | (316 | ) | - | - | |||||||||||||
|
|
|||||||||||||||||||
Financial liabilities |
||||||||||||||||||||
Derivative liabilities |
(355 | ) | 353 | 2 | ||||||||||||||||
Repurchase agreements |
||||||||||||||||||||
|
|
|||||||||||||||||||
Total financial liabilities |
$ | (355 | ) | $ | 353 | $ | 2 | $ | - | $ | - | |||||||||
|
|
F-20
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
(1) | The Company does not offset financial instruments. Financial assets and liabilities in the table above include accrued interest of $(5) million and $12 million, respectively December 31, 2013 (December 31, 2012 — $15 million and $5 million, respectively). |
(2) | Financial and cash collateral excludes over-collateralization. As at December 31, 2013 the Company was over-collateralized on OTC derivative assets and OTC derivative liabilities in the amounts of $25 million and $4 million, respectively (December 31, 2012 — $29 million and $0 million, respectively). Collateral pledged (received) does not include collateral in transit on OTC instruments or include initial margin on exchange traded contracts. |
(3) | The net amount includes derivative contracts entered into between the Company and its financing trusts which it does not consolidate. The Company does not exchange collateral on derivative contracts entered into with these trusts. |
Mortgage Loans on Real Estate
At December 31, 2013 and 2012, the mortgage portfolio was diversified by specific collateral property type and geographic region as displayed below:
Collateral Property Type |
Carrying Amount |
Geographic Concentration |
Carrying Amount |
|||||||
|
|
|||||||||
(in millions) | (in millions) | |||||||||
Apartments |
$ | 292 | East North Central | $ | 175 | |||||
Industrial |
123 | East South Central | 7 | |||||||
Office buildings |
376 | Middle Atlantic | 165 | |||||||
Retail |
266 | Mountain | 54 | |||||||
Mixed use |
- | New England | 35 | |||||||
Agricultural |
- | Pacific | 419 | |||||||
Agribusiness |
10 | South Atlantic | 208 | |||||||
Other |
88 | West North Central | 42 | |||||||
West South Central | 50 | |||||||||
Canada/other | - | |||||||||
Provision for losses |
- | Provision for losses | - | |||||||
|
|
|
|
|||||||
Total |
$ | 1,155 | Total | $ | 1,155 | |||||
|
|
|
|
Collateral Property Type |
Carrying Amount |
Geographic Concentration |
Carrying Amount |
|||||||
|
|
|||||||||
(in millions) | (in millions) | |||||||||
Apartments |
$ | 201 | East North Central | $ | 146 | |||||
Industrial |
130 | East South Central | 2 | |||||||
Office buildings |
322 | Middle Atlantic | 114 | |||||||
Retail |
251 | Mountain | 48 | |||||||
Mixed use |
- | New England | 37 | |||||||
Agricultural |
- | Pacific | 333 | |||||||
Agribusiness |
2 | South Atlantic | 193 | |||||||
Other |
71 | West North Central | 39 | |||||||
West South Central | 65 | |||||||||
Canada/other | - | |||||||||
Provision for losses |
- | Provision for losses | - | |||||||
|
|
|
|
|||||||
Total |
$ | 977 | Total | $ | 977 | |||||
|
|
|
|
At the end of each quarter, the MFC Loan Review Committee reviews all mortgage loans rated BB or lower, as determined by review of the underlying collateral, and decides whether an allowance for credit loss is needed. The Company considers
F-21
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
collateral value, the borrower’s ability to pay, normal historical credit loss levels, and future expectations in evaluating whether an allowance for credit losses is required for impaired loans.
Changes in the allowance for probable losses on mortgage loans on real estate are summarized below:
Balance at Beginning of Period |
Additions | Recoveries | Charge- offs and Disposals |
Balance at End of Period |
||||||||||||||||
|
|
|||||||||||||||||||
(in millions) | ||||||||||||||||||||
Year ended December 31, 2013 |
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
Year ended December 31, 2012 |
7 | - | - | (7 | ) | - | ||||||||||||||
Year ended December 31, 2011 |
2 | 9 | - | (4 | ) | 7 |
A mortgage loan charge-off is recorded when the impaired loan is disposed or when an impaired loan is determined to be a full loss with no possibility of recovery. Charge-offs are deducted from the allowance for probable losses.
As of December 31, 2013, the carrying value for certain mortgage loans is as follows:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Non-income producing |
$ | - | $ | - | ||||
Delinquent less than 90 days |
- | - | ||||||
Delinquent greater than 90 days |
- | - |
The Company provides for credit risk on mortgage loans by establishing allowances against the carrying value of the impaired loans. The total recorded investment in mortgage loans that is considered to be impaired along with the related allowance for credit losses was as follows:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Impaired mortgage loans on real estate with provision for losses |
$ | - | $ | - | ||||
Allowance for credit losses |
- | - | ||||||
|
|
|
|
|||||
Net impaired mortgage loans on real estate |
$ | - | $ | - | ||||
|
|
|
|
The average recorded investment in impaired loans and the interest income recognized on impaired loans were as follows:
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Average recorded investment in impaired loans |
$ | - | $ | 9 | $ | 20 | ||||||
Interest income recognized on impaired loans |
- | - | - |
For mortgage loans, the Company evaluates credit quality through regular monitoring of credit related exposures, considering both qualitative and quantitative factors in assigning an internal risk rating (IRR). These ratings are updated at least annually.
F-22
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
The carrying value of mortgage loans by IRR was as follows:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
AAA |
$ | 68 | $ | 30 | ||||
AA |
175 | 125 | ||||||
A |
376 | 238 | ||||||
BBB |
530 | 562 | ||||||
BB |
6 | 22 | ||||||
B and lower and unrated |
- | - | ||||||
|
|
|
|
|||||
Total |
$ | 1,155 | $ | 977 | ||||
|
|
|
|
Investment Real Estate and Agriculture
Investment real estate and agriculture of $18 million was non-income producing for the year ended December 31, 2013. Depreciation expense on investment real estate and agriculture was $2 million, $2 million, and $2 million for the years ended December 31, 2013, 2012 and 2011 respectively. Accumulated depreciation was $6 million and $5 million at December 31, 2013 and 2012, respectively.
Other Invested Assets
The following tables summarize the Company’s investments accounted for using the equity method of accounting:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Carrying value |
$ | 66 | $ | 6 | ||||
Combined assets |
675 | 272 | ||||||
Combined liabilities |
161 | 100 | ||||||
Debt included in combined liabilities |
55 | - |
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Net investment income on the investments |
$ | 198 | $ | 183 | $ | 175 | ||||||
Combined revenues |
1,050 | 894 | 818 | |||||||||
Combined expenses |
470 | 366 | 337 | |||||||||
Combined income (loss) from operations |
580 | 528 | 481 |
F-23
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
Net Investment Income and Net Realized Investment and Other Gains (Losses)
The following information summarizes the components of net investment income and net realized investment and other gains (losses):
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Net investment income |
||||||||||||
Fixed maturity securities |
$ | 273 | $ | 333 | $ | 366 | ||||||
Equity securities |
- | - | - | |||||||||
Mortgage loans on real estate |
51 | 49 | 40 | |||||||||
Investment real estate, agriculture, and timber |
12 | 17 | 10 | |||||||||
Policy loans |
7 | 6 | 6 | |||||||||
Short-term investments |
- | 1 | 1 | |||||||||
Derivatives |
23 | 25 | 23 | |||||||||
Equity method investments and other (1) |
199 | 183 | 175 | |||||||||
|
|
|
|
|
|
|||||||
Gross investment income |
565 | 614 | 621 | |||||||||
Investment expenses |
(25 | ) | (27 | ) | (24 | ) | ||||||
|
|
|||||||||||
Net investment income |
$ | 540 | $ | 587 | $ | 597 | ||||||
|
|
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Net realized investment and other gains (losses) |
||||||||||||
Fixed maturity securities |
$ | (115 | ) | $ | 170 | $ | 337 | |||||
Equity securities |
- | - | - | |||||||||
Mortgage loans on real estate |
1 | 3 | (7 | ) | ||||||||
Derivatives |
(47 | ) | (211 | ) | (24 | ) | ||||||
Other invested assets |
- | 1 | - | |||||||||
Amounts credited to participating contract holders |
28 | (15 | ) | (17 | ) | |||||||
|
|
|||||||||||
Net realized investment and other gains (losses) |
$ | (133 | ) | $ | (52 | ) | $ | 289 | ||||
|
|
(1) | Primarily represents income earned from the Company’s investment in JHIMS. |
F-24
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 2 — Investments - (continued)
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Certain investment related activity: |
||||||||||||
Net investment income passed through to participating contract holders as interest credited to policyholders’ account balances |
$ | 20 | $ | 23 | $ | 30 | ||||||
Change in unrealized gains (losses) included in net realized investment and other gains (losses): |
||||||||||||
Fixed maturity securities held-for-trading |
(27 | ) | 10 | 13 | ||||||||
Equity securities held-for-trading |
- | - | - | |||||||||
Derivatives |
27 | (134 | ) | 14 | ||||||||
Gross gains on sales of available-for-sale securities |
41 | 190 | 345 | |||||||||
Gross losses on sales of available-for-sale securities |
134 | 51 | 26 | |||||||||
Other-than-temporary impairments on available-for-sale securities |
2 | - | - |
Note 3 — Value of Business Acquired
The balance of and changes in VOBA were as follows:
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Balance, beginning of year |
$ | 12 | $ | 30 | $ | 42 | ||||||
Amortization |
(5 | ) | (28 | ) | (8 | ) | ||||||
Change due to unrealized investment gains (losses) |
(1 | ) | 10 | (4 | ) | |||||||
|
|
|||||||||||
Balance, end of year |
$ | 6 | $ | 12 | $ | 30 | ||||||
|
|
The following table provides estimated future amortization for the periods indicated:
VOBA Amortization |
||||
(in millions) | ||||
2014 |
$ | 2 | ||
2015 |
2 | |||
2016 |
1 | |||
2017 |
1 | |||
2018 |
1 |
F-25
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 4 — Deferred Policy Acquisition Costs and Deferred Sales Inducements
The balance of and changes in deferred policy acquisition costs were as follows:
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Balance, beginning of year |
$ | 405 | $ | 397 | $ | 499 | ||||||
Capitalization |
38 | 40 | 47 | |||||||||
Amortization |
(10 | ) | (24 | ) | (124 | ) | ||||||
Change due to unrealized investment gains |
34 | (8 | ) | (25 | ) | |||||||
|
|
|||||||||||
Balance, end of year |
$ | 467 | $ | 405 | $ | 397 | ||||||
|
|
The balance of and changes in deferred sales inducements (“DSI”) were as follows:
December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Balance, beginning of year |
$ | 23 | $ | 24 | $ | 32 | ||||||
Capitalization |
1 | - | 1 | |||||||||
Amortization |
2 | (1 | ) | (7 | ) | |||||||
Change due to unrealized investment gains |
2 | - | (2 | ) | ||||||||
|
|
|||||||||||
Balance, end of year |
$ | 28 | $ | 23 | $ | 24 | ||||||
|
|
Note 5 — Related Party Transactions
Service Agreements
The Company has formal service agreements with JHUSA. Under these agreements, the Company will pay investment and operating expenses incurred by JHUSA on behalf of the Company. Services provided under the agreements include legal, personnel, marketing, investment, and certain other administrative services and are billed based on intercompany cost allocations. Costs incurred under the agreements were $65 million, $65 million, and $66 million for the years ended December 31, 2013, 2012 and 2011, respectively. As of December 31, 2013 and 2012, the Company had amounts payable of $15 million and $14 million, respectively.
Management believes the allocation methods used are reasonable and appropriate in the circumstances; however, the Company’s Balance Sheets and Statements of Operations may not necessarily be indicative of the financial condition that would have existed if the Company operated as an unaffiliated entity.
F-26
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 5 — Related Party Transactions - (continued)
Other
The Company entered into an Amended and Restated Underwriting and Distribution Agreement with John Hancock Distributors, LLC (“JHD”), effective December 1, 2009, pursuant to which JHD is appointed as the principal underwriter and exclusive distributor of the variable annuities, variable life and other products issued by the Company. For the years ended December 31, 2013, 2012 and 2011, the Company was billed by JHD for underwriting commissions of $68 million, $67 million, and $75 million, respectively. The Company had amounts payable for services provided of $4 million and $4 million at December 31, 2013 and 2012, respectively.
The Company had receivables from JHIMS relating to distributions of $17 million and $16 million, which were included in accrued investment income at December 31, 2013 and 2012, respectively.
The Company is party to the Second Restated and Amended Liquidity Pool and Loan Facility Agreement effective January 1, 2010 with JHUSA. Pursuant to the agreement, participating affiliates are permitted to invest their excess cash in the liquidity pool and earn interest calculated at a rate that is reset daily to the one-month U.S. Dollar London Inter-Bank Bid Rate (“LIBID”), subject to an aggregate limit of $5 billion and an amount not to exceed 10% of the Company’s admitted assets as shown in the last financial statement filed with the Insurance Division. The Company had $381 million and $333 million invested in this pool at December 31, 2013 and 2012, respectively.
The Company also has certain reinsurance agreements with affiliates. These are more fully described in the Reinsurance note.
Note 6 — Reinsurance
Certain premiums and benefits are assumed from or ceded to affiliate and other insurance companies under various reinsurance agreements. The Company entered into these reinsurance agreements to transfer underlying risk on certain of its products, and to improve cash flow and statutory capital. The ceded reinsurance agreements provide the Company with increased capacity to write larger risks and maintain its exposure to loss within its capital resources.
Total reinsurance amounts included in the Company’s accompanying financial statements were as follows:
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Premiums earned |
||||||||||||
Direct |
$ | 67 | $ | 89 | $ | 110 | ||||||
Assumed |
30 | 158 | 22 | |||||||||
Ceded |
(42 | ) | (40 | ) | (58 | ) | ||||||
|
|
|||||||||||
Net |
$ | 55 | $ | 207 | $ | 74 | ||||||
|
|
|||||||||||
Benefits to policyholders ceded |
$ | 224 | $ | 104 | $ | 95 |
Affiliated Reinsurance
The below table consists of the impact of the reinsurance agreements with its parents, JHUSA:
F-27
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 6 — Reinsurance - (continued)
Years ended December 31, | ||||||||||
2013 | 2012 | 2011 | ||||||||
|
| |||||||||
(in millions) | ||||||||||
Amounts due from and held for affiliates |
$ | 404 | $ | 271 | ||||||
Reinsurance recoverable |
21 | 27 | ||||||||
Amounts due to affiliates |
66 | 67 | ||||||||
Coinsurance funds withheld |
2,418 | 2,329 |
On January 1, 2010, the assets supporting the policyholders who reside in the state of New York (“NY business”) were transferred from JHUSA to the Company. The transfer included participating traditional life insurance, universal life insurance, fixed deferred and immediate annuities, participating pension contracts, and variable annuities. The NY business was transferred using assumption reinsurance, modified coinsurance and coinsurance with cut-through provisions.
The NY business related to the participating traditional life insurance policies were transferred from JHUSA to JHNY under a coinsurance agreement and was immediately retroceded back to JHUSA using a coinsurance funds withheld agreement. As the reinsurance agreements do not subject the reinsurer to reasonable possibility of significant loss, they are classified as structured reinsurance and given deposit-type accounting treatment. The Company retained the invested assets supporting this block of business. The NY business related to variable universal life was reinsured through coinsurance and modified coinsurance. The NY business related to universal life was transferred from JHUSA to JHNY under coinsurance agreements.
The NY business related to a majority of the fixed deferred annuity business was transferred from JHUSA to JHNY under an assumption reinsurance agreement. The NY business related to variable annuities and some participating pension contracts where assets were held in separate accounts were reinsured through modified coinsurance. The NY business related to fixed deferred and immediate annuities and participating pension contracts was transferred from JHUSA to JHNY under a coinsurance agreement.
The table and commentary below summarizes the impact of the reinsurance agreements with an affiliate, John Hancock Reassurance Company Limited (“JHRECO”), a wholly-owned subsidiary of MFC:
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Premiums ceded |
$ | - | $ | - | $ | 15 | ||||||
Benefits ceded |
63 | 34 | 44 | |||||||||
Amounts due from and held for affiliates |
- | 1 | ||||||||||
Reinsurance recoverable |
36 | 52 | ||||||||||
Amounts due to affiliates |
31 | 51 | ||||||||||
Other payables |
1 | 8 |
Effective January 1, 2010, the Company entered into a partition and novation reinsurance agreement with an affiliate, JHRECO, to reinsure 100% of the mortality risk arising from no lapse guarantee benefits for single and survivorship joint Universal Life policies issued from 2002 to New York residents. The reinsurance agreement is written on a coinsurance funds withheld basis.
Effective January 1, 2010, the Company entered into a partition and novation reinsurance agreement with an affiliate, JHRECO, to reinsure 20% of the risk related to payout annuity policies issued January 1, 2008 through September 30, 2008 and 65% of the risk related to payout annuity policies issued prior to January 1, 2008. The reinsurance agreement is written on a modified coinsurance basis where the assets supporting the reinsured policies remain invested with the Company. In 2013, there was a partial recapture of the payout annuity policy agreement by the Company. This recapture did not have a material impact on the Company’s results of operations.
F-28
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 6 — Reinsurance - (continued)
At December 31, 2013, any material recoveries were secured by letters of credit or assets placed in trust by the assuming company.
Included in other operating costs and expenses for the years ended December 31, 2013, 2012 and 2011, respectively is $116 million, $123 million and $129 million of separate account fee income, net investment income and realized investment and other gains (losses), which was ceded to the affiliated reinsurers noted above.
Non-Affiliated Reinsurance
The Company also entered into a coinsurance agreement with Commonwealth Annuity to reinsure 90% of its fixed deferred annuity business effective July 1, 2012. The transaction was structured such that the Company transferred the actuarial liabilities and related invested assets which included $231 million in cash and $1,481 million in fixed maturity securities. The Company incurred a pre-tax gain of $46 million in connection with the transaction. Under the terms of the agreement, the Company will maintain responsibility for servicing of the policies. In addition, the agreement does not meet the criteria for reinsurance accounting and was given deposit-type accounting treatment that resulted in the recognition of an asset for amounts on deposit with reinsurers on the Balance Sheets.
At December 31, 2013, the Company had treaties with 27 reinsurers for its life insurance business (24 non-affiliated and 3 affiliated). The per policy life risk retained by the Company is capped at a maximum of $30 million on single life policies and $35 million on survivorship life policies. The previous limit of $100 thousand, which was revised as a consequence of the transfer of NY business, continues to apply to policies and reinsurance agreements in-force as at December 31, 2009. In 2013, recoveries under these agreements totaled $182 million on $204 million of death claims. In 2012, recoveries under these agreements totaled $70 million on $92 million of death claims. In 2011, recoveries under these agreements totaled $50 million on $69 million of death claims.
Note 7 — Derivatives and Hedging Instruments
Derivatives are financial contracts, the value of which is derived from underlying interest rates, foreign exchange rates, credit, equity price movements, indices or other market risks arising from on-balance sheet financial instruments and selected anticipated transactions. The Company uses derivatives including swaps and futures agreements to manage current and anticipated exposures to changes in interest rates and equity market prices.
Over-the-counter (“OTC”) swaps are contractual agreements between the Company and a counterparty to exchange a series of cash flows based upon rates applied to a notional amount. For interest rate swaps, counterparties generally exchange fixed or floating interest rate payments based on a notional value in a single currency.
Cleared interest rate swaps are contractual agreements between the Company and a counterparty whereby the transaction must be cleared through a central clearing house, and subject to mandatory margin and reporting requirements.
Futures agreements are contractual obligations to buy or sell a financial instrument or foreign currency on a predetermined future date at a specified price. Futures agreements are contracts with standard amounts and settlement dates that are traded on regulated exchanges.
Types of Derivatives and Derivative Strategies
Interest Rate Contracts. The Company uses interest rate futures contracts, OTC interest rate swap agreements and cleared interest rate swap agreements as part of its overall strategies of managing the duration of assets and liabilities or the average life of certain asset portfolios to specified targets. Interest rate swap agreements are contracts with counterparties to exchange interest rate payments of a differing character (i.e., fixed-rate payments exchanged for variable-rate payments) based on an underlying principal balance (notional principal). The net differential to be paid or received on interest rate swap agreements is accrued and recognized as a component of net investment income.
The Company uses interest rate swap agreements in effective hedge accounting relationships. These derivatives hedge the variable cash flows associated with future fixed income asset acquisitions, which will support the Company’s life insurance business. These agreements will reduce the impact of future interest rates changes on the cost of acquiring adequate assets to support the investment income assumptions used in pricing these products. During future periods when the acquired assets
F-29
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 7 — Derivatives and Hedging Instruments - (continued)
are held by the Company, the accumulated other comprehensive income will be amortized into investment income as a yield adjustment on the assets.
In addition, the Company uses interest rate swap agreements in effective hedge accounting relationships to hedge the risk of changes in fair value of fixed rate assets and liabilities arising from changes in benchmark interest rates. The Company reclassifies the effective portion of the change in fair value of the hedged item due to interest rate risk to earnings and amortizes the basis adjustment over the life of the hedged item.
The Company also enters into basis swaps to better match the cash flows from assets and related liabilities. Basis swaps are included in interest rate swaps for disclosure purposes. The Company utilizes basis swaps in qualifying and non-qualifying hedge accounting relationships.
The Company uses exchange-traded interest rate futures primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, and to hedge against changes in interest rates on anticipated liability issuances by replicating U.S. Treasury or swap curve performance. The Company utilizes exchange-traded interest rate futures in non-qualifying hedge accounting relationships.
Equity Market Contracts. Equity index futures contracts are contractual obligations to buy or sell a specified amount of an underlying equity index at an agreed contract price on a specified date. Equity index futures are contracts with standard amounts and settlement dates that are traded on regulated exchanges. The Company utilizes equity index futures in non-qualifying hedge accounting relationships.
F-30
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 7 — Derivatives and Hedging Instruments - (continued)
The table below provides a summary of the gross notional amount and fair value of derivatives contracts for all derivatives in qualifying and non-qualifying hedge accounting relationships:
December 31, 2013 | December 31, 2012 | |||||||||||||||||||||||||
Notional Amount |
Fair Value Assets |
Fair Value Liabilities |
Notional Amount |
Fair Value Assets |
Fair Value Liabilities |
|||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Qualifying Hedge Accounting Relationships |
||||||||||||||||||||||||||
Fair value hedges |
Interest rate swaps |
$ | 212 | $ | 45 | $ | 3 | $ | 212 | $ | 32 | $ | - | |||||||||||||
Foreign currency swaps |
- | - | - | - | - | - | ||||||||||||||||||||
Cash flow hedges |
Interest rate swaps |
298 | 12 | 17 | 311 | 78 | 3 | |||||||||||||||||||
Foreign currency swaps |
- | - | - | - | - | - | ||||||||||||||||||||
Foreign currency forwards |
- | - | - | - | - | - | ||||||||||||||||||||
Equity total return swaps |
- | - | - | - | - | - | ||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||
Total Derivatives in Hedge Accounting Relationships |
$ | 510 | $ | 57 | $ | 20 | $ | 523 | $ | 110 | $ | 3 | ||||||||||||||
|
|
|
|
|||||||||||||||||||||||
Non-Qualifying Hedge Accounting Relationships |
||||||||||||||||||||||||||
Interest rate swaps |
$ | 8,175 | $ | 378 | $ | 325 | $ | 7,385 | $ | 544 | $ | 347 | ||||||||||||||
Interest rate treasury locks |
- | - | - | - | - | - | ||||||||||||||||||||
Interest rate options |
- | - | - | - | - | - | ||||||||||||||||||||
Interest rate futures |
252 | - | - | 284 | - | - | ||||||||||||||||||||
Foreign currency swaps |
- | - | - | - | - | - | ||||||||||||||||||||
Foreign currency forwards |
- | - | - | - | - | - | ||||||||||||||||||||
Foreign currency futures |
- | - | - | - | - | - | ||||||||||||||||||||
Equity total return swaps |
- | - | - | - | - | - | ||||||||||||||||||||
Equity options |
- | - | - | - | - | - | ||||||||||||||||||||
Equity index futures |
304 | - | - | 394 | - | - | ||||||||||||||||||||
Credit default swaps |
- | - | - | - | - | - | ||||||||||||||||||||
Embedded derivatives – fixed maturity securities |
- | - | - | - | - | - | ||||||||||||||||||||
Embedded derivatives – reinsurance contracts |
- | - | 163 | - | - | 348 | ||||||||||||||||||||
Embedded derivatives – participating pension contracts (1) |
- | - | 32 | - | - | 37 | ||||||||||||||||||||
Embedded derivatives – benefit |
- | 49 | 13 | - | 75 | 108 | ||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||
Total Derivatives in Non-Qualifying Hedge Accounting Relationships |
8,731 | 427 | 533 | 8,063 | 619 | 840 | ||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||
Total Derivatives (2) |
$ | 9,241 | $ | 484 | $ | 553 | $ | 8,586 | $ | 729 | $ | 843 | ||||||||||||||
|
|
|
|
(1) | Embedded derivatives related to participating pension contracts are reported as part of future policy benefits and embedded derivatives related to benefit guarantees are reported as part of reinsurance recoverable or future policy benefits on the Balance Sheets. |
(2) | The fair values of all derivatives in an asset position are reported within derivative assets on the Balance Sheets, and derivatives in a liability position are reported within derivative liabilities on the Balance Sheets, excluding embedded derivatives related to participating pension contracts and benefit guarantees. |
F-31
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 7 — Derivatives and Hedging Instruments - (continued)
Hedging Relationships
The Company generally does not enter into derivative contracts for speculative purposes. In certain circumstances, these hedges also meet the requirements for hedge accounting. Hedging relationships eligible for hedge accounting are designated as either fair value hedges or cash flow hedges, as described below.
Fair Value Hedges. The Company uses interest rate swaps to manage its exposure to changes in fair value of fixed-rate financial instruments caused by changes in interest rates.
For the years ended December 31, 2013, 2012 and 2011, the Company did not recognize any gains or losses related to the portion of the hedging instruments that were excluded from the assessment of hedge effectiveness. At December 31, 2013, the Company had no hedges of firm commitments.
The following tables show the investment gains (losses) recognized:
Year ended December 31, 2013
Derivatives in Qualifying Fair Value Hedging Relationships |
Hedged Items in Qualifying Fair Value Hedging Relationships |
Gains (Losses) Recognized on Derivatives |
Gains (Losses) Recognized for Hedged Items |
Ineffectiveness Recognized |
||||||||||
(in millions) | ||||||||||||||
Interest rate swaps |
Fixed-rate assets |
$ | 23 | $ | (27 | ) | $ | (4 | ) | |||||
Fixed-rate liabilities |
(13 | ) | 13 | - | ||||||||||
Foreign currency swaps |
Fixed-rate assets |
- | - | - | ||||||||||
Fixed-rate liabilities |
- | - | - | |||||||||||
|
||||||||||||||
Total |
$ | 10 | $ | (14 | ) | $ | (4 | ) | ||||||
|
Year ended December 31, 2012
Derivatives in Qualifying Fair Value Hedging Relationships |
Hedged Items in Qualifying Fair Value Hedging Relationships |
Gains (Losses) Recognized on Derivatives |
Gains (Losses) Recognized for Hedged Items |
Ineffectiveness Recognized |
||||||||||
(in millions) | ||||||||||||||
Interest rate swaps |
Fixed-rate assets |
$ | 7 | $ | (6 | ) | $ | 1 | ||||||
Fixed-rate liabilities |
- | - | - | |||||||||||
Foreign currency swaps |
Fixed-rate assets |
- | - | - | ||||||||||
Fixed-rate liabilities |
- | - | - | |||||||||||
|
||||||||||||||
Total |
$ | 7 | $ | (6 | ) | $ | 1 | |||||||
|
F-32
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 7 — Derivatives and Hedging Instruments - (continued)
Year ended December 31, 2011
Derivatives in Qualifying Fair Value Hedging Relationships |
Hedged Items in Qualifying Fair Value Hedging |
Gains (Losses) Recognized on Derivatives |
Gains (Losses) Recognized for Hedged Items |
Ineffectiveness Recognized |
||||||||||
(in millions) | ||||||||||||||
Interest rate swaps |
Fixed-rate assets |
$ | - | $ | - | $ | - | |||||||
Fixed-rate liabilities |
10 | (12 | ) | (2 | ) | |||||||||
Foreign currency swaps |
Fixed-rate assets |
- | - | - | ||||||||||
Fixed-rate liabilities |
- | - | - | |||||||||||
|
||||||||||||||
Total |
$ | 10 | $ | (12 | ) | $ | (2 | ) | ||||||
|
Cash Flow Hedges. The Company uses interest rate swaps to hedge the variability in cash flows from variable rate financial instruments and forecasted transactions.
For the year ended December 31, 2011, all of the Company’s hedged forecast transactions qualified as cash flow hedges. During 2012 the Company completed a review of the investment strategy for the universal life (“UL”) business. As part of this review, it was determined that it was appropriate for the UL business to begin investing in non-fixed income assets. Under the revised investment strategy, new UL cash flows will be invested in a combination of fixed income and non-fixed income assets, potentially resulting in lower cash flows available for reinvestment in fixed income assets than originally anticipated for the UL cash flow hedging program. The Company voluntarily de-designated $150 million (notional principal) of forward-starting interest rate swaps in 2012; the accumulated other comprehensive income related to these de-designated swaps continues to be deferred. During 2012, the deferred OCI related to the de-designated swaps amounted to $30 million, net of tax. If the forecasted transactions do occur as expected, these amounts will be allocated to the acquired fixed income assets in the periods during which the hedged forecasted transactions occur and amortized to earnings over the life of the underlying fixed income assets acquired. If the forecasted transactions become probable not to occur, the amounts will be reclassified to earnings in the period.
For the year ended December 31, 2013, all of the Company’s hedged forecast transactions qualified as cash flow hedges and no cash flow hedges were discontinued because it was probable that the original forecasted transactions would occur by the end of the originally specified time period documented at inception of the hedging relationship.
F-33
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 7 — Derivatives and Hedging Instruments - (continued)
The following tables present the effects of derivatives in qualifying cash flow hedging relationships on the Statements of Operations, the Statements of Comprehensive Income (Loss) and the Statements of Changes in Shareholder’s Equity:
Year ended December 31, 2013
Derivatives in Qualifying Cash Flow Hedging Relationships |
Hedged Items in Qualifying Cash Flow Hedging Relationships |
Gains (Losses) Deferred in AOCI on Derivatives (Net of Tax) |
Gains Reclassified from (Net of Tax) |
Ineffectiveness Recognized in Net Realized Investment and Other Gains (Losses) |
||||||||||
(in millions) | ||||||||||||||
Interest rate swaps |
Forecasted fixed-rate assets |
$ | - | $ | - | $ | - | |||||||
Floating rate assets |
(42 | ) | 7 | - | ||||||||||
Inflation indexed liabilities |
- | - | - | |||||||||||
Forecasted fixed-rate liabilities |
- | - | - | |||||||||||
Foreign currency swaps |
Fixed-rate assets |
- | - | - | ||||||||||
Floating rate assets |
- | - | - | |||||||||||
Floating rate liabilities |
- | - | - | |||||||||||
Foreign currency forwards |
Forecasted expenses |
- | - | - | ||||||||||
Foreign currency assets |
- | - | - | |||||||||||
Equity total return swaps |
Share-based payments |
- | - | - | ||||||||||
|
||||||||||||||
Total |
$ | (42 | ) | $ | 7 | $ | - | |||||||
|
Year ended December 31, 2012
Derivatives in Qualifying Cash Flow Hedging Relationships |
Hedged Items in Qualifying Cash Flow Hedging Relationships |
Gains (Losses) Deferred in AOCI on Derivatives (Net of Tax) |
Gains Reclassified from (Net of Tax) |
Ineffectiveness Recognized in Net Realized Investment and Other Gains (Losses) |
||||||||||
(in millions) | ||||||||||||||
Interest rate swaps |
Forecasted fixed-rate assets |
$ | (2 | ) | $ | 4 | $ | - | ||||||
Floating rate assets |
- | - | - | |||||||||||
Inflation indexed liabilities |
- | - | - | |||||||||||
Forecasted fixed-rate liabilities |
- | - | - | |||||||||||
Foreign currency swaps |
Fixed-rate assets |
- | - | - | ||||||||||
Floating rate assets |
- | - | - | |||||||||||
Floating rate liabilities |
- | - | - | |||||||||||
Foreign currency forwards |
Forecasted expenses |
- | - | - | ||||||||||
Foreign currency assets |
- | - | - | |||||||||||
Equity total return swaps |
Share-based payments |
|
- - |
|
- | - | ||||||||
|
||||||||||||||
Total |
$ | (2 | ) | $ | 4 | $ | - | |||||||
|
F-34
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 7 — Derivatives and Hedging Instruments - (continued)
Year ended December 31, 2011
Derivatives in Qualifying Cash Flow Hedging Relationships |
Hedged Items in Qualifying Cash Flow Hedging Relationships |
Gains (Losses) Deferred in AOCI on Derivatives (Net of Tax) |
Gains Reclassified from (Net of Tax) |
Ineffectiveness Recognized in Net Realized Investment and Other Gains (Losses) |
||||||||||
(in millions) | ||||||||||||||
Interest rate swaps |
Forecasted fixed-rate assets |
$ | 97 | $ | - | $ | - | |||||||
Floating rate assets |
- | - | - | |||||||||||
Inflation indexed liabilities |
- | - | - | |||||||||||
Forecasted fixed-rate liabilities |
- | - | - | |||||||||||
Foreign currency swaps |
Fixed-rate assets |
- | - | - | ||||||||||
Floating rate assets |
- | - | - | |||||||||||
Floating rate liabilities |
- | - | - | |||||||||||
Foreign currency forwards |
Forecasted expenses |
- | - | - | ||||||||||
Foreign currency assets |
- | - | - | |||||||||||
Equity total return swaps |
Share-based payments |
- | - | - | ||||||||||
|
||||||||||||||
Total |
$ | 97 | $ | - | $ | - | ||||||||
|
The Company anticipates that pre-tax net gains of $2 million will be reclassified from accumulated other comprehensive income to earnings within the next 12 months. The maximum time frame for which variable cash flows are hedged is 7 years.
For a roll forward of the net accumulated gains (losses) on cash flow hedges see Shareholder’s Equity Note.
Derivatives Not Designated in Qualifying Hedge Accounting Relationships. The Company enters into interest rate swap agreements and interest rate futures contracts to manage exposure to interest rates without designating the derivatives as hedging instruments.
The Company offers certain variable annuity products with a guaranteed minimum withdrawal benefit (“GMWB”) rider. This rider is effectively an embedded option on the basket of mutual funds which is offered to contract holders. Beginning in July 2010, for certain contracts, the Company implemented a hedging program to reduce its exposure to the GMWB rider. This dynamic hedging program uses interest rate swap agreements, equity index futures (including but not limited to the Dow Jones Industrial, Standard & Poor’s 500, Russell 2000, and Dow Jones Euro Stoxx 50 indices), and foreign currency futures to match the sensitivities of the GMWB rider liability to the market risk factors.
F-35
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 7 — Derivatives and Hedging Instruments - (continued)
For the years ended December 31, 2013, 2012 and 2011, gains and losses related to derivatives in a non-qualifying hedge accounting relationship were recognized by the Company and the components were recorded in net realized investment and other gains (losses) as follows:
Years ended December 31, | 2013 | 2012 | 2011 | |||||||||
(in millions) | ||||||||||||
Non-Qualifying Hedge Accounting Relationships |
||||||||||||
Interest rate swaps |
$ | (152 | ) | $ | (28 | ) | $ | 187 | ||||
Interest rate treasury locks |
- | - | - | |||||||||
Interest rate options |
- | - | - | |||||||||
Interest rate futures |
5 | (5 | ) | (14 | ) | |||||||
Foreign currency swaps |
- | - | - | |||||||||
Foreign currency forwards |
- | - | - | |||||||||
Foreign currency futures |
- | - | - | |||||||||
Equity total return swaps |
- | - | - | |||||||||
Equity options |
- | - | - | |||||||||
Equity index futures |
(90 | ) | (81 | ) | (23 | ) | ||||||
Credit default swaps |
- | - | - | |||||||||
Embedded derivatives |
258 | (104 | ) | (172 | ) | |||||||
|
|
|||||||||||
Total Investment Gains (Losses) from Derivatives in Non-Qualifying Hedge Accounting Relationships |
$ | 21 | $ | (218 | ) | $ | (22 | ) | ||||
|
|
Embedded Derivatives. The Company has certain embedded derivatives that are required to be separated from their host contracts and accounted for as derivatives. These host contracts include fixed maturity securities, reinsurance contracts, participating pension contracts, and certain benefit guarantees.
For more details on the Company’s embedded derivatives, see the Fair Value Measurements Note.
Credit Risk. The Company’s exposure to loss on derivatives is limited to the amount of any net gains that may have accrued with a particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in negative positions and the impact of collateral on hand. The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to the derivative financial instruments. The current credit exposure of the Company’s derivative contracts is limited to the fair value in excess of the collateral held at the reporting date.
The Company manages its credit risk by entering into transactions with creditworthy counterparties, obtaining collateral where appropriate, and entering into master netting agreements that provide for a netting of payments and receipts with a single counterparty. The Company enters into credit support annexes with its OTC derivative dealers in order to manage its credit exposure to those counterparties. As part of the terms and conditions of those agreements, the pledging and accepting of collateral in connection with the Company’s derivative usage is required. As of December 31, 2013 and 2012, the Company had accepted collateral consisting of cash of $57 million and $158 million and various securities with a fair value of $94 million and $187 million, respectively, which is held in separate custodial accounts. In addition, the Company has pledged collateral to support both the OTC derivative instruments, exchange traded futures and cleared interest rate swap transactions. For further details regarding pledged collateral see the Investments Note.
In June 2013, under US regulations, certain interest rate swap agreements were required to be cleared through central clearing houses. These transactions are contractual agreements that require initial and variation margin collateral postings and are settled on a daily basis through a clearing house. As such, they reduce the credit risk exposure in the event of default by a counterparty.
F-36
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 8 — Certain Separate Accounts
The deposits related to the variable life insurance contracts are invested in separate accounts, and the Company guarantees a specified death benefit on certain policies if specified premiums on these policies are paid by the policyholder, regardless of separate account performance.
The following table reflects variable life insurance contracts with guarantees held by the Company:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions, except for age) | ||||||||
Life insurance contracts with guaranteed benefits |
||||||||
In the event of death |
||||||||
Account value |
$ | 136 | $ | 104 | ||||
Net amount at risk related to deposits |
5 | 5 | ||||||
Average attained age of contract holders |
50 | 49 |
Many of the variable annuity contracts issued by the Company offer various guaranteed minimum death, income, and/or withdrawal benefits. Guaranteed Minimum Death Benefit (“GMDB”) features guarantee the contract holder either (a) a return of no less than total deposits made to the contract less any partial withdrawals; (b) total deposits made to the contract less any partial withdrawals plus a minimum return; (c) the highest contract value on a specified anniversary date minus any withdrawals following the contract anniversary, or (d) a combination of (b) and (c) above.
Contracts with Guaranteed Minimum Income Benefit (“GMIB”) riders provide a guaranteed lifetime annuity, which may be elected by the contract holder after a stipulated waiting period (ten years), and which may be larger than what the contract account balance would purchase at then-current annuity purchase rates.
Multiple variations of an optional GMWB rider have also been offered by the Company. The GMWB rider provides contract holders a guaranteed annual withdrawal amount over a specified time period or in some cases for as long as they live. In general, guaranteed annual withdrawal amounts are based on deposits and may be reduced if withdrawals exceed allowed amounts. Guaranteed amounts may also be increased as a result of “step-up” provisions, which increase the benefit base to higher account values at specified intervals. Guaranteed amounts may also be increased if withdrawals are deferred over a specified period. In addition, certain versions of the GMWB rider extend lifetime guarantees to spouses.
Unaffiliated reinsurance has been utilized to mitigate risk related to some of the guarantee benefit riders. Hedging has also been utilized to mitigate risk related to some of the GMWB riders.
For GMDB, the net amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance. For GMIB, the net amount at risk is defined as the excess of the current annuitization income base over the current account value. For GMWB, the net amount at risk is defined as the current guaranteed withdrawal amount minus the current account value. For all the guarantees, the net amount at risk is floored at zero at the single contract level.
The Company had the following variable annuity contracts with guarantees. Amounts at risk are shown net of reinsurance. Note that the Company’s variable annuity contracts with guarantees may offer more than one type of guarantee in each contract; therefore, the amounts listed are not mutually exclusive.
F-37
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 8 — Certain Separate Accounts - (continued)
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions, except for ages and percentages) | ||||||||
Guaranteed Minimum Death Benefit |
||||||||
Return of net deposits |
||||||||
In the event of death |
||||||||
Account value |
$ | 1,519 | $ | 1,463 | ||||
Net amount at risk — net of reinsurance |
4 | 12 | ||||||
Average attained age of contract holders |
67 | 66 | ||||||
Return of net deposits plus a minimum return |
||||||||
In the event of death |
||||||||
Account value |
$ | - | $ | - | ||||
Net amount at risk — net of reinsurance |
- | - | ||||||
Average attained age of contract holders |
- | - | ||||||
Guaranteed minimum return rate |
0 | % | 0 | % | ||||
Highest specified anniversary account value minus withdrawals post anniversary |
||||||||
In the event of death |
||||||||
Account value |
$ | 2,506 | $ | 2,493 | ||||
Net amount at risk — net of reinsurance |
28 | 67 | ||||||
Average attained age of contract holders |
66 | 66 | ||||||
Guaranteed Minimum Income Benefit |
||||||||
Account value |
$ | 415 | $ | 421 | ||||
Net amount at risk — net of reinsurance |
- | - | ||||||
Average attained age of contract holders |
64 | 63 | ||||||
Guaranteed Minimum Withdrawal Benefit |
||||||||
Account value |
$ | 3,031 | $ | 2,944 | ||||
Net amount at risk |
164 | 334 | ||||||
Average attained age of contract holders |
66 | 65 |
Account balances of variable contracts with guarantees were invested in various separate accounts with the following characteristics:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Type of Fund |
||||||||
Equity |
$ | 2,012 | $ | 2,160 | ||||
Balanced |
1,708 | 1,379 | ||||||
Bond |
478 | 535 | ||||||
Money Market |
44 | 65 | ||||||
|
|
|||||||
Total |
$ | 4,242 | $ | 4,139 | ||||
|
|
F-38
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 8 — Certain Separate Accounts - (continued)
The following table summarizes the liabilities for guarantees on variable life and annuity contracts reflected in future policy benefits in the general account:
Guaranteed Benefit |
Guaranteed Minimum Income Benefit (GMIB) |
Guaranteed Minimum Withdrawal Benefit (GMWB) |
Total | |||||||||||||
|
|
|||||||||||||||
(in millions) | ||||||||||||||||
Balance at January 1, 2013 |
$ | 28 | $ | 11 | $ | 118 | $ | 157 | ||||||||
Incurred guarantee benefits |
(1 | ) | (1 | ) | - | (2 | ) | |||||||||
Other reserve changes |
(1 | ) | (3 | ) | (100 | ) | (104 | ) | ||||||||
|
|
|||||||||||||||
Balance at December 31, 2013 |
26 | 7 | 18 | 51 | ||||||||||||
Reinsurance recoverable |
(1 | ) | (49 | ) | - | (50 | ) | |||||||||
|
|
|||||||||||||||
Net balance at December 31, 2013 |
$ | 25 | $ | (42 | ) | $ | 18 | $ | 1 | |||||||
|
|
|||||||||||||||
Balance at January 1, 2012 |
$ | 28 | $ | 10 | $ | 106 | $ | 144 | ||||||||
Incurred guarantee benefits |
(3 | ) | - | - | (3 | ) | ||||||||||
Other reserve changes |
3 | 1 | 12 | 16 | ||||||||||||
|
|
|||||||||||||||
Balance at December 31, 2012 |
28 | 11 | 118 | 157 | ||||||||||||
Reinsurance recoverable |
(1 | ) | (75 | ) | - | (76 | ) | |||||||||
|
|
|||||||||||||||
Net balance at December 31, 2012 |
$ | 27 | $ | (64 | ) | $ | 118 | $ | 81 | |||||||
|
|
The GMDB gross and ceded reserves, the GMIB gross reserves, and the life contingent portion of the GMWB reserves were determined in accordance with ASC 944, “Financial Services — Insurance”, and the GMIB reinsurance recoverable and non-life contingent GMWB gross reserves were determined in accordance with ASC 815 “Derivatives and Hedging.”
The Company regularly evaluates estimates used and adjusts the additional liability balance, with a related charge or credit to benefits to policyholders, if actual experience or other evidence suggests that earlier assumptions should be revised.
The following assumptions and methodology were used to determine the amounts above at December 31, 2013 and 2012:
• | Data used included 1,000 stochastically generated investment performance scenarios. For the GMIB reinsurance recoverable and non-life contingent GMWB gross reserve calculations, risk neutral scenarios were used. |
• | Mean return and volatility assumptions were determined by asset class. Market consistent observed volatilities were used where available for ASC 815 calculations. |
• | Annuity mortality is based on a combination of the Ruark Variable Annuity table and the Company’s actual experience between 2006 and 2010. The Ruark table is based on an industry study of variable annuity deaths in 2005 and 2006. |
• | Annuity base lapse rates vary by contract type, duration, type of living benefit or death benefit rider, and whether guaranteed withdrawals are being taken. The lapse rates range from 0.5% to 40%. |
• | The discount rates used in the GMDB gross and ceded reserves, the GMIB gross reserves, and the life contingent portion of the GMWB reserve calculations range from 6.4% to 7%. The discount rates used in the GMIB reinsurance recoverable and non-life contingent GMWB gross reserve calculations were based on the term structure of swap curves with a credit spread based on the credit standing of MFC (for GMWB) and the reinsurers (for GMIB). |
F-39
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 9 — Income Taxes
The Company is included in the consolidated federal income tax return of JHFC. Prior to the merger, the Company filed tax returns as part of the MHDLLC consolidated group.
The components of income taxes were as follows:
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Current taxes: |
||||||||||||
Federal |
$ | 35 | $ | 70 | $ | 131 | ||||||
Deferred taxes: |
||||||||||||
Federal |
81 | (17 | ) | (10 | ) | |||||||
|
|
|||||||||||
Total income tax expense (benefit) |
$ | 116 | $ | 53 | $ | 121 | ||||||
|
|
A reconciliation of income taxes at the federal income tax rate to income tax expense (benefit) charged to operations follows:
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Tax at 35% |
$ | 125 | $ | 75 | $ | 123 | ||||||
Add (deduct): |
||||||||||||
Prior year taxes |
1 | (4 | ) | 2 | ||||||||
Tax credits |
(1 | ) | (2 | ) | (1 | ) | ||||||
Dividend received deduction |
(7 | ) | (7 | ) | (6 | ) | ||||||
Change in tax reserves |
(2 | ) | (9 | ) | 3 | |||||||
Tax-exempt investment income |
- | - | - | |||||||||
Foreign tax expense gross-up |
1 | 1 | - | |||||||||
Other |
(1 | ) | (1 | ) | - | |||||||
|
|
|||||||||||
Total income tax expense (benefit) |
$ | 116 | $ | 53 | $ | 121 | ||||||
|
|
F-40
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 9 — Income Taxes - (continued)
Deferred income tax assets and liabilities result from tax affecting the differences between the financial statement values and income tax values of assets and liabilities at each Balance Sheet date. Deferred tax assets and liabilities consisted of the following:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Deferred tax assets: |
||||||||
Policy reserves |
$ | 99 | $ | 202 | ||||
Tax credits |
7 | 10 | ||||||
Unearned revenue |
23 | 7 | ||||||
Securities and other investments |
23 | - | ||||||
Other |
1 | 3 | ||||||
|
|
|||||||
Total deferred tax assets |
153 | 222 | ||||||
|
|
|||||||
Deferred tax liabilities: |
||||||||
Unrealized investment gains on securities |
4 | 192 | ||||||
Deferred policy acquisition costs |
92 | 73 | ||||||
Deferred sales inducements |
10 | 9 | ||||||
Securities and other investments |
- | 13 | ||||||
Intangibles |
2 | 4 | ||||||
Premiums receivable |
1 | - | ||||||
Other |
7 | - | ||||||
|
|
|||||||
Total deferred tax liabilities |
116 | 291 | ||||||
|
|
|||||||
Net deferred tax assets (liabilities) |
$ | 37 | $ | (69 | ) | |||
|
|
At December 31, 2013 the Company had no operating loss carry forwards. At December 31, 2013, the Company had $7 million of tax credits, which consist of $1 million of alternative minimum tax credits and $6 million of foreign tax credits. The foreign tax credits begin to expire in tax year 2016 through tax year 2023. The alternative minimum tax credits do not have an expiration date.
The Company has not recorded a valuation allowance with respect to the realizability of its deferred tax assets. In assessing the need for a valuation allowance, management considered the future reversal of taxable temporary differences, future taxable income exclusive of reversing temporary differences, taxable income in the carry back period, as well as tax planning strategies. Tax planning strategies were considered to the extent they were both prudent and feasible and if implemented, would result in the realization of deferred tax assets. Based on management’s assessment of all available information, management believes that it is more likely than not that the Company will realize the full benefit of its deferred tax assets.
Under the terms of its intercompany tax sharing agreement, the Company made federal income tax payments to its parent, JHUSA, of $73 million, $152 million, and $69 million in 2013, 2012 and 2011, respectively. In 2013 the Company made income tax payments of $1 million to the Internal Revenue Service (“IRS”).
The Company files income tax returns in the U.S. federal jurisdiction and in NY. The Company is under continuous examination by the IRS. Effective for 2010, the Company’s common parent JHFC merged into MHDLLC resulting in a new combined group. The returns for the new combined group have not yet been examined by the IRS. With respect to the legacy MHDLLC consolidated return group, the IRS audit for tax years prior to 2008 have been closed. For tax years 2008 and 2009, a refund claim is pending with the IRS Joint Committee.
F-41
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 9 — Income Taxes - (continued)
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
December 31, | ||||||||
2013 | 2012 | |||||||
|
|
|||||||
(in millions) | ||||||||
Balance, beginning of year |
$ | 9 | $ | 18 | ||||
Additions based on tax positions related to the current year |
1 | 2 | ||||||
Payments |
(2 | ) | - | |||||
Reductions for tax positions of prior years |
(3 | ) | (11 | ) | ||||
|
|
|||||||
Balance, end of year |
$ | 5 | $ | 9 | ||||
|
|
Included in the balances as of December 31, 2013 and 2012, respectively, are $5 million and $9 million of unrecognized benefits that, if recognized, would affect the Company’s effective tax rate. There are no tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.
The Company has no unrecognized tax benefits that will significantly increase or decrease in the next twelve months.
The Company recognizes interest accrued and penalties in income tax expense. For the years ended December 31, 2013 and 2012 the Company recognized approximately $2 million and $3 million of interest benefit, respectively. For the year ended December 31, 2011 the Company recognized approximately $1 million of interest expense. The Company had approximately $0 million and $1 million accrued for interest as of December 31, 2013 and 2012, respectively. The Company did not recognize material penalties for the years ended December 31, 2013, 2012 and 2011.
Note 10 — Commitments and Legal Proceedings
Commitments. The Company has extended commitments to purchase U.S. private debt and to issue mortgage loans on real estate totaling $230 million and $16 million, respectively, at December 31, 2013. The Company monitors the creditworthiness of borrowers under long-term bond commitments and requires collateral as deemed necessary. Approximately 53% of these commitments expire in 2014 and the majority of the remainder expires by 2018.
The Company leases office space under an operating lease agreement, which will expire in March 2015. Rental expenses were $61 thousand, $48 thousand, and $63 thousand for each of the years ended December 31, 2013, 2012 and 2011, respectively.
The future minimum lease payments by year and in the aggregate, under the remaining operating lease are presented below:
Operating Leases | ||||
(in thousands) | ||||
2014 |
$ | 56 | ||
2015 |
14 | |||
2016 |
- | |||
|
|
|||
Total minimum lease payments |
$ | 70 | ||
|
|
The Company does not have any sublease income related to its office space.
Legal Proceedings. The Company is regularly involved in litigation, both as a defendant and as a plaintiff. The litigation naming the Company as a defendant ordinarily involves its activities as a provider of insurance protection and wealth management products, and as a taxpayer. In addition, the NY State Department of Financial Services, the NY Attorney General, the SEC, the Financial Regulatory Authority, and other government and regulatory bodies regularly make inquiries and, from time to time, require the production of information or conduct examinations concerning the Company’s compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers. An estimation of the range of potential outcomes in any given matter is often unavailable until such matters have developed and sufficient information emerges to support an assessment of the range of possible loss, such as quantification of a damage demand from
F-42
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 10 — Commitments and Legal Proceedings - (continued)
plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals and estimates of reasonably possible losses or ranges of loss based on such reviews.
Note 11 — Shareholder’s Equity
Capital Stock
The Company has one class of capital stock, common stock. All of the outstanding common stock of the Company is owned by its parent, JHUSA.
Accumulated Other Comprehensive Income
The components of accumulated other comprehensive income (loss) were as follows:
Net Unrealized Investment Gains (Losses) |
Net Accumulated Gain (loss) on Cash Flow Hedges |
Foreign Currency Translation Adjustment |
Accumulated Other Comprehensive Income (Loss) |
|||||||||||||
|
|
|||||||||||||||
(in millions) | ||||||||||||||||
Balance at January 1, 2011 |
$ | 127 | $ | - | $ | - | $ | 127 | ||||||||
Gross unrealized investment gains (net of deferred income tax expense of $212) |
395 | 395 | ||||||||||||||
Reclassification adjustment for gains realized in net income (net of deferred income tax expense of $111) |
(208 | ) | (208 | ) | ||||||||||||
Adjustment for policyholder liabilities (net of deferred income tax benefit of $23) |
(42 | ) | (42 | ) | ||||||||||||
Adjustment for deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability (net of deferred income tax benefit of $17) |
(31 | ) | (31 | ) | ||||||||||||
|
|
|||||||||||||||
Net unrealized investment gains |
114 | 114 | ||||||||||||||
Foreign currency translation adjustment (net of deferred income tax benefit of $0) |
- | - | ||||||||||||||
Net gains on the effective portion of the change in fair value of cash flow hedges (net of deferred income tax expense of $52) |
97 | 97 | ||||||||||||||
Reclassification of net cash flow hedge losses to net income (net of deferred income tax benefit of $0) |
- | - | ||||||||||||||
|
|
|||||||||||||||
Balance at December 31, 2011 |
$ | 241 | $ | 97 | $ | - | $ | 338 | ||||||||
|
|
F-43
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 11 — Shareholder’s Equity - (continued)
Net Unrealized Investment Gains (Losses) |
Net Accumulated Gain (loss) on Cash Flow Hedges |
Foreign Currency Translation Adjustment |
Accumulated Other Comprehensive Income (Loss) |
|||||||||||||
|
|
|||||||||||||||
(in millions) | ||||||||||||||||
Balance at January 1, 2012 |
$ | 241 | $ | 97 | $ | - | $ | 338 | ||||||||
Gross unrealized investment gains (net of deferred income tax expense of $70) |
132 | 132 | ||||||||||||||
Reclassification adjustment for gains realized in net income (net of deferred income tax expense of $55) |
(102 | ) | (102 | ) | ||||||||||||
Adjustment for policyholder liabilities (net of deferred income tax benefit of $3) |
(6 | ) | (6 | ) | ||||||||||||
Adjustment for deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability (net of deferred income tax benefit of $0) |
- | - | ||||||||||||||
|
|
|||||||||||||||
Net unrealized investment gains |
24 | 24 | ||||||||||||||
Foreign currency translation adjustment (net of deferred income tax benefit of $0) |
- | - | ||||||||||||||
Net losses on the effective portion of the change in fair value of cash flow hedges (net of deferred income tax benefit of $1) |
(2 | ) | (2 | ) | ||||||||||||
Reclassification of net cash flow hedge gains to net income (net of deferred income tax expense of $2) |
(4 | ) | (4 | ) | ||||||||||||
|
|
|||||||||||||||
Balance at December 31, 2012 |
$ | 265 | $ | 91 | $ | - | $ | 356 | ||||||||
|
|
F-44
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 11 — Shareholder’s Equity - (continued)
Net Unrealized Investment Gains (Losses) |
Net Accumulated Gain (loss) on Cash Flow Hedges |
Foreign Currency Translation Adjustment |
Accumulated Other Comprehensive Income (Loss) |
|||||||||||||
|
|
|||||||||||||||
(in millions) | ||||||||||||||||
Balance at January 1, 2013 |
$ | 265 | $ | 91 | $ | - | $ | 356 | ||||||||
Gross unrealized investment losses (net of deferred income tax benefit of $208) |
(386 | ) | (386 | ) | ||||||||||||
Reclassification adjustment for losses realized in net income (net of deferred income tax benefit of $31) |
57 | 57 | ||||||||||||||
Adjustment for policyholder liabilities (net of deferred income tax benefit of $1) |
(2 | ) | (2 | ) | ||||||||||||
Adjustment for deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability (net of deferred income tax expense of $17) |
32 | 32 | ||||||||||||||
|
|
|||||||||||||||
Net unrealized investment losses |
(299 | ) | (299 | ) | ||||||||||||
Foreign currency translation adjustment (net of deferred income tax benefit of $0) |
- | - | ||||||||||||||
Net losses on the effective portion of the change in fair value of cash flow hedges (net of deferred income tax benefit of $23) |
(42 | ) | (42 | ) | ||||||||||||
Reclassification of net cash flow hedge gains to net income (net of deferred income tax expense of $4) |
(7 | ) | (7 | ) | ||||||||||||
|
|
|||||||||||||||
Balance at December 31, 2013 |
$ | (34 | ) | $ | 42 | $ | - | $ | 8 | |||||||
|
|
F-45
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 11 — Shareholder’s Equity - (continued)
Information regarding amounts reclassified out of each component of AOCI was as follows:
Amounts | ||||||
Reclassified from | ||||||
AOCI (1) | ||||||
Year Ended | Affected Line Item in | |||||
December 31, | Statement | |||||
2013 | of Operations | |||||
|
| |||||
Unrealized investment gains (losses): (2) (3) |
||||||
Net unrealized gains (losses) |
$ | (88 | ) | Other net realized investment and other gains (losses) | ||
OTTI |
- | Portion of loss recognized in other comprehensive income | ||||
|
|
|||||
Net realized gains (losses) before income tax |
(88 | ) | ||||
Income tax (expense) benefit |
31 | |||||
|
|
|||||
Net realized gains (losses), net of income tax |
$ | (57 | ) | |||
|
|
|||||
Unrealized gains (losses) on derivatives - cash flow hedges: |
||||||
Interest rate swaps |
$ | 11 | Other net realized investment and other gains (losses) | |||
Foreign currency swaps |
- | Other net realized investment and other gains (losses) | ||||
Foreign currency forwards |
- | Other net realized investment and other gains (losses) | ||||
Equity market contracts |
- | Other net realized investment and other gains (losses) | ||||
|
|
|||||
Net gains (losses) on cash flow hedges, before income tax |
11 | |||||
Income tax (expense) benefit |
(4 | ) | ||||
|
|
|||||
Net gains (losses) on cash flow hedges, net of income tax |
$ | 7 | ||||
|
|
|||||
Total reclassifications for the year, net of income tax |
$ | (50 | ) | |||
|
|
(1) | Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. |
(2) | Amounts reflect investment gains (losses) that were previously unrealized and reclassified to the Consolidated Statements of Operations during the period as realized. |
(3) | See table below for additional information on unrealized investment gains (losses), including the impact on deferred policy acquisition costs, deferred sales inducements, value of business acquired, unearned revenue liability, and policyholder liabilities. |
F-46
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 11 — Shareholder’s Equity - (continued)
Net unrealized investment gains (losses) included on the Company’s Balance Sheets as a component of shareholder’s equity are summarized below:
Years ended December 31, | ||||||||||||
2013 | 2012 | 2011 | ||||||||||
|
|
|||||||||||
(in millions) | ||||||||||||
Balance, end of year comprises: |
||||||||||||
Unrealized investment gains (losses) on: |
||||||||||||
Fixed maturity securities |
$ | 43 | $ | 552 | $ | 507 | ||||||
Equity securities |
- | - | - | |||||||||
Other investments |
2 | - | - | |||||||||
|
|
|||||||||||
Total |
45 | 552 | 507 | |||||||||
Amounts of unrealized investment gains (losses) attributable to: |
||||||||||||
Deferred policy acquisition costs, deferred sales inducements, value of business acquired, and unearned revenue liability |
(19 | ) | (70 | ) | (70 | ) | ||||||
Policyholder liabilities |
(78 | ) | (75 | ) | (66 | ) | ||||||
Deferred income taxes |
18 | (142 | ) | (130 | ) | |||||||
|
|
|||||||||||
Total |
(79 | ) | (287 | ) | (266 | ) | ||||||
|
|
|||||||||||
Net unrealized investment gains (losses) |
$ | (34 | ) | $ | 265 | $ | 241 | |||||
|
|
Statutory Results
The Company is required to prepare financial statements in accordance with accounting practices prescribed or permitted by the insurance department of its state of domicile, which is New York.
The principal differences between statutory financial statements and financial statements prepared in accordance with USGAAP are that statutory financial statements do not reflect DAC, bonds may be carried at amortized cost, assets and liabilities are presented net of reinsurance, policy and contract obligations are generally valued using more conservative assumptions and certain assets are non-admitted.
Life and health insurance companies are subject to certain risk-based capital (“RBC”) requirements as specified by the NAIC. Under those requirements, the amount of capital and surplus maintained by a life and health insurance company is to be determined based on the various risk factors related to it. At December 31, 2013, the Company met the minimum RBC requirements.
The Company’s statutory net income (loss) for the years ended December 31, 2013, 2012 and 2011 was $466 million, $69 million, and $(282) million, respectively.
The Company’s statutory capital and surplus as of December 31, 2013 and 2012 was $1,284 million and $1,005 million, respectively.
Under New York State insurance laws, no insurer may pay any shareholder dividends from any source other than statutory earned surplus without the prior approval of the Superintendent of Financial Services (the “Superintendent”). New York State law also limits the aggregate amount of dividends a life insurer may pay in any calendar year, without the prior permission of the Superintendent, to the lesser of (i) 10% of its statutory policyholders’ surplus as of the immediately preceding calendar year or (ii) the company’s statutory net gain from operations for the immediately preceding calendar year, not including realized capital gains. JHNY paid no shareholder dividends to JHUSA for the years ended December 31, 2013, 2012 and 2011.
F-47
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS - (CONTINUED)
Note 12 — Pension and Other Postretirement Benefit Plans
The Company participates in the John Hancock Pension Plan (the “Plan”), a qualified defined benefit plan sponsored by MIC. The Company also participates in the John Hancock Non-Qualified Pension Plan, a non-qualified defined benefit plan for employees whose qualified cash balance benefit is restricted by the Internal Revenue Code. The non-qualified defined benefit plan was frozen except for grandfathered participants as of January 1, 2008, and the benefits accrued under this plan continue to be subject to the plan’s provisions. The expense for these plans was charged to the Company and was not material for the years ended December 31, 2013, 2012 and 2011, respectively.
The Company participates in the John Hancock Employee Welfare Plan (the “Welfare Plan”), a postretirement medical and life insurance benefit plan for its retired employees and their spouses. The Welfare Plan is sponsored by MIC. The expense for other postretirement benefits was charged to the Company and was not material for the years ended December 31, 2013, 2012 and 2011, respectively.
The Company participates in The Investment-Incentive Plan for John Hancock Employees, a qualified defined contribution plan for its employees who meet certain eligibility requirements. The plan is sponsored by JHUSA. The expense for the defined contribution plan was charged to the Company and was not material for the years ended December 31, 2013, 2012 and 2011, respectively.
Note 13 — Fair Value Measurements
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit value. The exit value assumes the asset or liability is exchanged in an orderly transaction; it is not a forced liquidation or distressed sale.
The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:
• | Level 1 – Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Active markets are defined as having the following characteristics for the measured asset/liability; (i) many transactions, (ii) current prices, (iii) price quotes not varying substantially among market makers, (iv) narrow bid/ask spreads, and (v) most information is publicly available. Valuations are based on quoted prices reflecting market transactions involving assets or liabilities identical to those being measured. Level 1 assets primarily include separate account assets. |
• | Level 2 – Fair value measurements using inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in inactive markets, inputs that are observable that are not prices (such as interest rates, credit risks, etc.), and inputs that are derived from or corroborated by observable market data. Most fixed maturity securities and some short-term investments are classified within Level 2. Also included in the Level 2 category are financial instruments that are priced using models with observable market inputs, including most derivative financial instruments. |
• | Level 3 – Fair value measurements using significant nonmarket observable inputs. These include valuations for assets and liabilities that are derived using data, some or all of which is not market observable data, including assumptions about risk. Level 3 securities include less liquid securities. Embedded derivatives related to reinsurance agreements or product guarantees are included in this category. |
Determination of Fair Value
The valuation methodologies used to determine the fair values of assets and liabilities reflect market participant assumptions and are based on the application of the fair value hierarchy that prioritizes observable market inputs over unobservable inputs. When available, the Company uses quoted market prices to determine fair value and classifies such items within Level 1 or 2. If quoted market prices are not available, fair value is based upon valuation techniques, which discount expected cash flows utilizing independent market observable interest rates based on the credit quality and duration of the instrument. Items valued
F-48
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
using models are classified according to the lowest level input that is significant to the valuation. Thus, an item may be classified in Level 3 even though significant market observable inputs are used.
The Company utilizes a Valuation Quality Assurance (“VQA”) team of security analysts. The MFC Chief Investment Officer has ultimate responsibility over the VQA team. The team ensures quality and completeness of all daily and monthly prices. Prices are received from external pricing vendors and brokers and are put through a quality assurance process which includes review of price movements relative to the market, comparison of prices between vendors, and internal matrix pricing. All inputs to our pricing matrix are external observable inputs extracted and entered by the VQA team. Broker quotes are used only when no external public vendor prices are available.
The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:
• | Assets and Liabilities Measured and Disclosed at Fair Value on a Recurring Basis and Reported in the Balance Sheets – This category includes assets and liabilities measured at fair value on a recurring and nonrecurring basis. Financial instruments measured on a recurring basis include fixed maturity securities, short-term investments, real estate joint ventures and other limited partnership interests, derivatives, and separate account assets and liabilities. Assets measured at fair value on a nonrecurring basis include limited partnership interests, which are reported at fair value only in the period in which an impairment is recognized. |
• | Assets and Liabilities Disclosed at Fair Value on a Recurring Basis – This category includes mortgage loans on real estate, policy loans, cash and cash equivalents, and policyholders’ funds. |
Assets and Liabilities Measured and Disclosed at Fair Value on a Recurring Basis
Fixed Maturity Securities
For fixed maturity securities, including corporate debt, U.S. Treasury, commercial mortgage-backed securities, asset-backed securities, issuances by foreign governments, and obligations of state and political subdivisions, fair values are based on quoted market prices when available. When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality (matrix pricing). The significant inputs into these models include, but are not limited to, yield curves, credit risks and spreads, measures of volatility, and prepayment speeds. These fixed maturity securities are classified within Level 2. Fixed maturity securities with significant pricing inputs which are unobservable are classified within Level 3.
Equity Securities
Equity securities are comprised of common stock and are classified within Level 1, as fair values are based on quoted market prices in active markets. Common stocks not traded in active markets are classified within Level 3.
Short-Term Investments
Short-term investments are comprised of securities due to mature within one year of the date of purchase. Those that are traded in active markets are classified within Level 1, as fair values are based on quoted market prices. Securities such as commercial paper and discount notes are classified within Level 2 because these securities are typically not actively traded due to their short maturities and, as such, their cost generally approximates fair value.
Real Estate Joint Ventures and Other Limited Partnership Interests
The amounts disclosed in the following tables consist of those investments accounted for using the cost method. The estimated fair values for such cost method investments are generally based on the Company’s share of the NAV as provided in the financial statements of the investees. In certain circumstances, management may adjust the NAV by a premium or discount when it has sufficient evidence to support applying such adjustments.
F-49
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
Derivatives
The fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives or through the use of pricing models for OTC derivatives. The pricing models used are based on market standard valuation methodologies, and the inputs to these models are consistent with what a market participant would use when pricing the instruments. Derivative valuations can be affected by changes in interest rates, currency exchange rates, financial indices, credit spreads, default risk (including the counterparties to the contract), and volatility. The Company’s derivatives are generally classified within Level 2 given the significant inputs to the pricing models for most OTC derivatives are observable or can be corroborated by observable market data. Inputs that are observable generally include interest rates, foreign currency exchange rates, and interest rate curves; however, certain OTC derivatives may rely on inputs that are significant to the fair value, but are unobservable in the market or cannot be derived principally from or corroborated by observable market data and would be classified within Level 3. Inputs that are unobservable generally include broker quotes, volatilities, and inputs that are outside of the observable portion of the interest rate curve or other relevant market measures. These unobservable inputs may involve significant management judgment or estimation.
Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what market participants would use when pricing such instruments. The credit risk of both the counterparty and the Company are considered in determining the fair value for all OTC derivatives after taking into account the effects of netting agreements and collateral arrangements.
Embedded Derivatives
The Company holds assets and liabilities classified as embedded derivatives on the Balance Sheets. These assets include guaranteed minimum income benefits that are ceded under modified coinsurance reinsurance arrangements (“Reinsurance GMIB Assets”). Liabilities include policyholder benefits offered under variable annuity contracts such as GMWB with a term certain and embedded reinsurance derivatives.
Embedded derivatives are recorded on the Balance Sheets at fair value, separately from their host contract, and the change in their fair value is reflected in net income. Many observable factors including, but not limited to, market conditions, credit ratings, and risk margins related to non-capital market inputs may result in significant fluctuations in the fair value of embedded derivatives that could materially affect net income. Embedded derivatives which are valued using observable market inputs are classified within Level 2 of the fair value hierarchy. Some embedded derivatives, mainly benefit guarantees for variable annuity products, utilize significant pricing inputs which are unobservable. These unobservable inputs are received from third party valuation experts and include equity volatility, mortality rates, lapse rates and utilization rates. Embedded derivatives with significant unobservable inputs are classified within Level 3.
The fair value of embedded derivatives related to GMIB and GMWB is estimated as the present value of future benefits less the present value of future fees. The fair value calculation includes assumptions for risk margins including nonperformance risk.
Risk margins are established to capture the risks of the instrument which represent the additional compensation a market participant would require to assume the risks related to the uncertainties of such actuarial assumptions as annuitization, persistency, partial withdrawal, and surrenders. The establishment of these actuarial assumptions, risk margins, nonperformance risk, and other inputs requires the use of significant judgment.
Nonperformance risk refers to the risk that the obligation will not be fulfilled and affects the value of the liability. The fair value measurement assumes that the nonperformance risk is the same before and after the transfer; therefore, fair value reflects the reporting entity’s own credit risk.
Nonperformance risk for liabilities held by the Company is based on MFC’s own credit risk, which is determined by taking into consideration publicly available information relating to MFC’s debt, as well as its claims paying ability. Nonperformance risk is also reflected in the reinsurance GMIB assets held by the Company. The credit risk of the reinsurance companies is most representative of the nonperformance risk for the reinsurance GMIB assets and is derived from publicly available information relating to the reinsurance companies’ publicly issued debt. As such, the reinsurance contract embedded derivatives are classified within Level 2.
The fair value of embedded derivatives related to reinsurance agreements is determined based on a total return swap methodology. These total return swaps are reflected as assets or liabilities on the Balance Sheets representing the difference between the adjusted statutory book value and fair value of the related modified coinsurance assets with ongoing changes in
F-50
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
fair value recorded in net realized investment and other gains (losses). The fair value of the underlying assets is based on the valuation approach for similar assets described herein.
Separate Account Assets and Liabilities
Separate account assets are carried at fair value and reported as a summarized total on the Balance Sheets. Assets owned by the Company’s separate accounts primarily include investments in funds, short-term investments, and cash and cash equivalents. For separate accounts structured as a unitized fund, the fair value of separate account assets is based on the fair value of the underlying funds owned by the separate account. Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders whose interest in the separate account assets is recorded by the Company as separate account liabilities. Separate account liabilities are set equal to the fair value of separate account assets.
The fair value of fund investments is based upon quoted market prices or reported NAV. Fund investments that are traded in an active market and have a NAV that the Company can access at the measurement date are classified within Level 1. The fair values of fixed maturity securities, equity securities, short-term investments, and cash equivalents held by separate accounts are determined on a basis consistent with the methodologies described herein for similar financial instruments held within the Company’s general account and may be classified within Level 1, 2, or 3, accordingly.
Assets and Liabilities Disclosed at Fair Value on a Recurring Basis
Mortgage Loans on Real Estate
The fair value of unimpaired mortgage loans is estimated using discounted cash flows and takes into account the contractual maturities and discount rates, which were based on current market rates for similar maturity ranges and adjusted for risk due to the property type.
Policy Loans
These loans are carried at unpaid principal balances, which approximate their fair values.
Cash and Cash Equivalents
The carrying values for cash and cash equivalents approximate fair value due to the short-term maturities of these instruments.
Policyholders’ Funds
Policyholders’ funds include guaranteed investment contracts, fixed-rate deferred annuities, term certain and supplementary contracts without life contingencies, and certain balances that can be withdrawn by the policyholder at any time without prior notice or penalty. The fair values associated with guaranteed investment contracts, term certain and supplementary contracts without life contingencies are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC’s corporate spread. The fair value attributable to credit risk represents the present value of the spread. The fair value of fixed-rate deferred annuities is estimated by projecting multiple stochastically generated interest rate scenarios under a risk neutral environment reflecting inputs (interest rate, volatility, etc.) observable at the valuation date. For those balances that can be withdrawn by the policyholder at any time without prior notice or penalty, the fair value is the amount estimated to be payable to the policyholder as of the reporting date, which is generally the carrying value.
F-51
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
The table below presents the fair value by fair value hierarchy level for assets and liabilities that are reported at fair value in the Balance Sheets:
December 31, 2013 | ||||||||||||||||||||
Carrying Value |
Total Fair Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||
|
|
|||||||||||||||||||
(in millions) | ||||||||||||||||||||
Assets: |
||||||||||||||||||||
Fixed maturity securities available-for-sale: |
||||||||||||||||||||
Corporate debt securities (4) |
$ | 3,740 | $ | 3,740 | $ | - | $ | 3,446 | $ | 294 | ||||||||||
Commercial mortgage-backed securities |
59 | 59 | - | 49 | 10 | |||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | |||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | |||||||||||||||
Other asset-backed securities |
73 | 73 | - | 73 | - | |||||||||||||||
U.S. Treasury and agency securities |
1,637 | 1,637 | - | 1,637 | - | |||||||||||||||
Obligations of states and political subdivisions (5) |
257 | 257 | - | 250 | 7 | |||||||||||||||
Debt securities issued by foreign governments |
105 | 105 | - | 105 | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity securities available-for-sale |
5,871 | 5,871 | - | 5,560 | 311 | |||||||||||||||
Fixed maturity securities held-for-trading: |
||||||||||||||||||||
Corporate debt securities (4) |
281 | 281 | - | 274 | 7 | |||||||||||||||
Commercial mortgage-backed securities |
25 | 25 | - | 25 | - | |||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | |||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | |||||||||||||||
Other asset-backed securities |
12 | 12 | - | 12 | - | |||||||||||||||
U.S. Treasury and agency securities |
5 | 5 | - | 5 | - | |||||||||||||||
Obligations of states and political subdivisions (5) |
14 | 14 | - | 12 | 2 | |||||||||||||||
Debt securities issued by foreign governments |
1 | 1 | - | 1 | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity securities held-for-trading |
338 | 338 | - | 329 | 9 | |||||||||||||||
Equity securities available-for-sale |
- | - | - | - | - | |||||||||||||||
Equity securities held-for-trading |
- | - | - | - | - | |||||||||||||||
Short-term investments |
1 | 1 | - | 1 | - | |||||||||||||||
Other invested assets (2) |
7 | 7 | - | - | 7 | |||||||||||||||
Derivative assets (1): |
||||||||||||||||||||
Interest rate swaps |
435 | 435 | - | 435 | - | |||||||||||||||
Interest rate treasury locks |
- | - | - | - | - | |||||||||||||||
Interest rate options |
- | - | - | - | - | |||||||||||||||
Interest rate futures |
- | - | - | - | - | |||||||||||||||
Foreign currency swaps |
- | - | - | - | - | |||||||||||||||
Foreign currency forwards |
- | - | - | - | - | |||||||||||||||
Foreign currency futures |
- | - | - | - | - | |||||||||||||||
Equity total return swaps |
- | - | - | - | - | |||||||||||||||
Equity options |
- | - | - | - | - | |||||||||||||||
Embedded derivatives (3): |
||||||||||||||||||||
Reinsurance contracts |
- | - | - | - | - | |||||||||||||||
Benefit guarantees (6) |
49 | 49 | - | - | 49 | |||||||||||||||
Separate account assets |
8,313 | 8,313 | 8,313 | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total assets at fair value |
$ | 15,014 | $ | 15,014 | $ | 8,313 | $ | 6,325 | $ | 376 | ||||||||||
|
|
|||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Derivatives liabilities (1): |
||||||||||||||||||||
Interest rate swaps |
$ | 345 | $ | 345 | $ | - | $ | 345 | $ | - | ||||||||||
Interest rate treasury locks |
- | - | - | - | - | |||||||||||||||
Interest rate options |
- | - | - | - | - | |||||||||||||||
Interest rate futures |
- | - | - | - | - | |||||||||||||||
Foreign currency swaps |
- | - | - | - | - | |||||||||||||||
Foreign currency forwards |
- | - | - | - | - | |||||||||||||||
Foreign currency futures |
- | - | - | - | - | |||||||||||||||
Equity total return swaps |
- | - | - | - | - | |||||||||||||||
Equity options |
- | - | - | - | - | |||||||||||||||
Embedded derivatives (3): |
||||||||||||||||||||
Reinsurance contracts |
163 | 163 | - | 163 | - | |||||||||||||||
Participating pension contracts |
32 | 32 | - | 32 | - | |||||||||||||||
Benefit guarantees (6) |
13 | 13 | - | - | 13 | |||||||||||||||
Separate account liabilities |
8,313 | 8,313 | 8,313 | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total liabilities at fair value |
$ | 8,866 | $ | 8,866 | $ | 8,313 | $ | 540 | $ | 13 | ||||||||||
|
|
F-52
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
December 31, 2012 | ||||||||||||||||||||
Carrying Value |
Total Fair Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||
|
|
|||||||||||||||||||
(in millions) | ||||||||||||||||||||
Assets: |
||||||||||||||||||||
Fixed maturity securities available-for-sale: |
||||||||||||||||||||
Corporate debt securities (4) |
$ | 3,871 | $ | 3,871 | $ | - | $ | 3,547 | $ | 324 | ||||||||||
Commercial mortgage-backed securities |
230 | 230 | - | 227 | 3 | |||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | |||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | |||||||||||||||
Other asset-backed securities |
45 | 45 | - | 45 | - | |||||||||||||||
U.S. Treasury and agency securities |
2,137 | 2,137 | - | 2,137 | - | |||||||||||||||
Obligations of states and political subdivisions (5) |
287 | 287 | - | 271 | 16 | |||||||||||||||
Debt securities issued by foreign governments |
59 | 59 | - | 59 | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity securities available-for-sale |
6,629 | 6,629 | - | 6,286 | 343 | |||||||||||||||
Fixed maturity securities held-for-trading: |
||||||||||||||||||||
Corporate debt securities (4) |
259 | 259 | - | 249 | 10 | |||||||||||||||
Commercial mortgage-backed securities |
63 | 63 | - | 63 | - | |||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | |||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | |||||||||||||||
Other asset-backed securities |
9 | 9 | - | 9 | - | |||||||||||||||
U.S. Treasury and agency securities |
24 | 24 | - | 24 | - | |||||||||||||||
Obligations of states and political subdivisions (5) |
16 | 16 | - | 14 | 2 | |||||||||||||||
Debt securities issued by foreign governments |
1 | 1 | - | 1 | - | |||||||||||||||
|
|
|||||||||||||||||||
Total fixed maturity securities held-for-trading |
372 | 372 | - | 360 | 12 | |||||||||||||||
Equity securities available-for-sale |
1 | 1 | 1 | - | - | |||||||||||||||
Equity securities held-for-trading |
- | - | - | - | - | |||||||||||||||
Short-term investments |
38 | 38 | - | 38 | - | |||||||||||||||
Other invested assets (2) |
- | - | - | - | - | |||||||||||||||
Derivative assets (1): |
||||||||||||||||||||
Interest rate swaps |
654 | 654 | - | 654 | - | |||||||||||||||
Interest rate treasury locks |
- | - | - | - | - | |||||||||||||||
Interest rate options |
- | - | - | - | - | |||||||||||||||
Interest rate futures |
- | - | - | - | - | |||||||||||||||
Foreign currency swaps |
- | - | - | - | - | |||||||||||||||
Foreign currency forwards |
- | - | - | - | - | |||||||||||||||
Foreign currency futures |
- | - | - | - | - | |||||||||||||||
Equity total return swaps |
- | - | - | - | - | |||||||||||||||
Equity options |
- | - | - | - | - | |||||||||||||||
Equity index futures |
- | - | - | - | - | |||||||||||||||
Credit default swaps |
- | - | - | - | - | |||||||||||||||
Embedded derivatives (3): |
||||||||||||||||||||
Reinsurance contracts |
- | - | - | - | - | |||||||||||||||
Benefit guarantees (6) |
75 | 75 | - | - | 75 | |||||||||||||||
Separate account assets |
7,687 | 7,687 | 7,687 | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total assets at fair value |
$ | 15,456 | $ | 15,456 | $ | 7,688 | $ | 7,338 | $ | 430 | ||||||||||
|
|
|||||||||||||||||||
Liabilities: |
||||||||||||||||||||
Derivatives liabilities (1): |
||||||||||||||||||||
Interest rate swaps |
$ | 350 | $ | 350 | $ | - | $ | 350 | $ | - | ||||||||||
Interest rate treasury locks |
- | - | - | - | - | |||||||||||||||
Interest rate options |
- | - | - | - | - | |||||||||||||||
Interest rate futures |
- | - | - | - | - | |||||||||||||||
Foreign currency swaps |
- | - | - | - | - | |||||||||||||||
Foreign currency forwards |
- | - | - | - | - | |||||||||||||||
Foreign currency futures |
- | - | - | - | - | |||||||||||||||
Equity total return swaps |
- | - | - | - | - | |||||||||||||||
Equity options |
- | - | - | - | - | |||||||||||||||
Equity index futures |
- | - | - | - | - | |||||||||||||||
Credit default swaps |
- | - | - | - | - | |||||||||||||||
Embedded derivatives (3): |
||||||||||||||||||||
Reinsurance contracts |
348 | 348 | - | 348 | - | |||||||||||||||
Participating pension contracts |
37 | 37 | - | 37 | - | |||||||||||||||
Benefit guarantees (6) |
108 | 108 | - | - | 108 | |||||||||||||||
Separate account liabilities |
7,687 | 7,687 | 7,687 | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total liabilities at fair value |
$ | 8,530 | $ | 8,530 | $ | 7,687 | $ | 735 | $ | 108 | ||||||||||
|
|
F-53
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
(1) | Derivative assets and liabilities are presented gross to reflect the presentation in the Balance Sheets, but are presented net for purposes of the Level 3 rollforward. |
(2) | Other invested assets exclude equity method and cost accounted investments of $65 million and $5 million at December 31, 2013 and 2012, respectively. |
(3) | Embedded derivatives related to fixed maturity securities and reinsurance contracts are reported as part of the derivative asset or liability on the Balance Sheets. Embedded derivatives related to benefit guarantees are reported as part of the reinsurance recoverable or future policy benefits on the Balance Sheets. Embedded derivatives related to participating pension contracts are reported as part of future policy benefits on the Balance Sheets. |
(4) | Fair value of the Level 3 corporate debt securities is determined based on discounted cash flow models using discount rates based on credit spreads, yields, or price levels of publicly traded debt of the issuer or other comparable securities, considering illiquidity and structure. The significant unobservable input is the yield at or beyond the 30 year point and ranged from 0 to 61 basis points and 0 to 61 basis points during 2013 and 2012, respectively. |
(5) | Fair value of the Level 3 obligations of states and political subdivisions is determined based on discounted cash flow models using discount rates based on credit spreads, yields, or price levels of publicly traded debt of the issuer or other comparable securities, considering illiquidity and structure. The significant unobservable input is the yield at or beyond the 30 year point and ranged from 0 to 361 basis points and 97 to 364 basis points during 2013 and 2012, respectively. |
(6) | Fair value of the Level 3 benefit guarantees is determined based on discounted cash flow models. The significant unobservable inputs are equity implied volatility, base lapse rates, dynamic lapse rates, mortality rates, and 0% utilization rates. These inputs ranged from 0% to 37%, 1% to 40%, 0% to 50%, 0% to 40%, and 80% to 100% in 2013, respectively. These inputs ranged from 0% to 35%, 1% to 35%, 0% to 70%, 0% to 38%, and 80% to 100% in 2012, respectively. |
The table below presents the fair value by fair value hierarchy level for certain assets and liabilities that are not reported at fair value in the Balance Sheet, but are disclosed at fair value.
December 31, 2013 | ||||||||||||||||||||
Carrying Value |
Total Fair Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||
|
|
|||||||||||||||||||
(in millions) | ||||||||||||||||||||
Assets |
||||||||||||||||||||
Mortgage loans on real estate |
$ | 1,155 | $ | 1,233 | $ | - | $ | - | $ | 1,233 | ||||||||||
Policy loans |
143 | 143 | - | 143 | - | |||||||||||||||
Cash and cash equivalents |
59 | 59 | 59 | - | - | |||||||||||||||
Affiliated debt |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total Assets |
$ | 1,357 | $ | 1,435 | $ | 59 | $ | 143 | $ | 1,233 | ||||||||||
|
|
|||||||||||||||||||
Liabilities |
||||||||||||||||||||
Consumer notes |
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
Debt |
- | - | - | - | - | |||||||||||||||
Policyholders’ funds |
2,291 | 2,317 | - | 151 | 2,166 | |||||||||||||||
Affiliated debt |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total Liabilities |
$ | 2,291 | $ | 2,317 | $ | - | $ | 151 | $ | 2,166 | ||||||||||
|
|
F-54
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
December 31, 2012 | ||||||||||||||||||||
Carrying Value |
Total Fair Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||
|
|
|||||||||||||||||||
(in millions) | ||||||||||||||||||||
Assets |
||||||||||||||||||||
Mortgage loans on real estate |
$ | 977 | $ | 1,106 | $ | - | $ | - | $ | 1,106 | ||||||||||
Policy loans |
138 | 138 | - | 138 | - | |||||||||||||||
Cash and cash equivalents |
495 | 495 | 495 | - | - | |||||||||||||||
Affiliated debt |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total Assets |
$ | 1,610 | $ | 1,739 | $ | 495 | $ | 138 | $ | 1,106 | ||||||||||
|
|
|||||||||||||||||||
Liabilities |
||||||||||||||||||||
Consumer notes |
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
Debt |
- | - | - | - | - | |||||||||||||||
Policyholders’ funds |
2,470 | 2,507 | - | 153 | 2,354 | |||||||||||||||
Affiliated debt |
- | - | - | - | - | |||||||||||||||
|
|
|||||||||||||||||||
Total Liabilities |
$ | 2,470 | $ | 2,507 | $ | - | $ | 153 | $ | 2,354 | ||||||||||
|
|
Transfers of Level 1 and Level 2 Assets and Liabilities
The Company’s policy is to record transfers of assets and liabilities between Level 1 and Level 2 at their fair values as of the end of each reporting period, consistent with the date of the determination of fair value. Assets are transferred out of Level 1 when they are no longer transacted with sufficient frequency and volume in an active market. During the years ended December 31, 2013 and 2012, the Company did not have any transfers from Level 1 to Level 2. Conversely, assets are transferred from Level 2 to Level 1 when transaction volume and frequency are indicative of an active market. The Company did not transfer assets from Level 2 to Level 1 during the years ended December 31, 2013 and 2012.
F-55
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
Level 3 Assets and Liabilities
The changes in Level 3 financial instruments measured at fair value on a recurring basis for the years ended December 31, 2013, 2012 and 2011 are summarized as follows:
Balance at |
Net realized/unrealized gains (losses) included in: |
Purchases |
Issuances |
Sales |
Settlements |
Transfers | Balance at |
Change
in |
||||||||||||||||||||||||||||||||||||
Earnings (1) |
AOCI (2) |
Into Level 3 (3) |
Out of Level 3 (3) |
|||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale: |
||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities |
$ | 324 | $ | (1 | ) | $ | (29 | ) | $ | 57 | $ | - | $ | - | $ | (2 | ) | $ | 57 | $ | (112 | ) | $ | 294 | $ | - | ||||||||||||||||||
Commercial mortgage-backed securities |
3 | - | - | 7 | - | - | - | - | - | 10 | - | |||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Other asset-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
US Treasury securities and obligations of US govt corporation and agencies (AFS) |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Obligations of states and political subdivisions |
16 | - | (1 | ) | - | - | - | - | - | (8 | ) | 7 | - | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities available-for-sale |
343 | (1 | ) | (30 | ) | 64 | - | - | (2 | ) | 57 | (120 | ) | 311 | - | |||||||||||||||||||||||||||||
Fixed maturity securities held-for-trading: |
||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities |
10 | (1 | ) | - | 2 | - | - | - | - | (4 | ) | 7 | (1 | ) | ||||||||||||||||||||||||||||||
Commercial mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Other asset-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Obligations of states and political subdivisions |
2 | - | - | - | - | - | - | - | - | 2 | - | |||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities held-for-trading |
12 | (1 | ) | - | 2 | - | - | - | - | (4 | ) | 9 | (1 | ) | ||||||||||||||||||||||||||||||
Other invested assets |
- | - | 2 | 5 | - | - | - | - | - | 7 | - | |||||||||||||||||||||||||||||||||
Net derivatives |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Net embedded derivatives (4) |
(33 | ) | 69 | - | - | - | - | - | - | - | 36 | 69 | ||||||||||||||||||||||||||||||||
Assets held in trust |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Separate account assets/liabilities (5) |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total |
$ | 322 | $ | 67 | $ | (28 | ) | $ | 71 | $ | - | $ | - | $ | (2 | ) | $ | 57 | $ | (124 | ) | $ | 363 | $ | 68 | |||||||||||||||||||
|
|
F-56
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
Balance at |
Net realized/unrealized gains (losses) included in: |
Purchases |
Issuances |
Sales |
Settlements |
Transfers | Balance at |
Change
in |
||||||||||||||||||||||||||||||||||||
Earnings (1) |
AOCI (2) |
Into Level 3 (3) |
Out of Level 3 (3) |
|||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale: |
||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities |
$ | 371 | $ | 1 | $ | 5 | $ | 106 | $ | - | $ | (96 | ) | $ | (6 | ) | $ | 6 | $ | (63 | ) | $ | 324 | $ | - | |||||||||||||||||||
Commercial mortgage-backed securities |
- | - | - | 3 | - | - | - | - | - | 3 | - | |||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Other asset-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Obligations of states and political subdivisions |
12 | - | - | 11 | - | (7 | ) | - | - | - | 16 | - | ||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities available-for-sale |
383 | 1 | 5 | 120 | - | (103 | ) | (6 | ) | 6 | (63 | ) | 343 | - | ||||||||||||||||||||||||||||||
Fixed maturity securities held-for-trading |
||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities |
7 | - | - | 5 | - | - | - | - | (2 | ) | 10 | - | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Other asset-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Obligations of states and political subdivisions |
2 | - | - | - | - | - | - | - | - | 2 | - | |||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities held-for-trading |
9 | - | - | 5 | - | - | - | - | (2 | ) | 12 | - | ||||||||||||||||||||||||||||||||
Other invested assets |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Net derivatives |
37 | - | - | - | - | - | - | - | (37 | ) | - | - | ||||||||||||||||||||||||||||||||
Net embedded derivatives (4) |
(28 | ) | (5 | ) | - | - | - | - | - | - | - | (33 | ) | (5 | ) | |||||||||||||||||||||||||||||
Assets held in trust |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Separate account |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total |
$ | 401 | $ | (4 | ) | $ | 5 | $ | 125 | $ | - | $ | (103 | ) | $ | (6 | ) | $ | 6 | $ | (102 | ) | $ | 322 | $ | (5 | ) | |||||||||||||||||
|
|
F-57
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
Net realized/unrealized gains (losses) included in: |
Transfers | Change in |
||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2011 |
Earnings (1) |
AOCI (2) |
Purchases | Issuances | Sales | Settlements | Into Level 3 |
Out of Level 3 (3) |
Balance at December 31, 2011 |
|||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale: |
||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities |
$ | 255 | $ | - | $ | 19 | $ | 66 | $ | - | $ | - | $ | (6 | ) | $ | 41 | $ | (4 | ) | $ | 371 | $ | - | ||||||||||||||||||||
Commercial mortgage-backed securities |
10 | - | - | - | - | - | (10 | ) | - | - | - | - | ||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Other asset-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Obligations of states and political subdivisions |
7 | - | 1 | 4 | - | - | - | - | - | 12 | - | |||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities available-for-sale |
272 | - | 20 | 70 | - | - | (16 | ) | 41 | (4 | ) | 383 | - | |||||||||||||||||||||||||||||||
Fixed maturity securities held-for-trading |
||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities |
3 | 1 | - | 5 | - | - | - | - | (2 | ) | 7 | 1 | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Residential mortgage-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Collateralized debt obligations |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Other asset-backed securities |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Obligations of states and political subdivisions |
- | - | - | 2 | - | - | - | - | - | 2 | - | |||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total fixed maturity securities held-for-trading |
3 | 1 | - | 7 | - | - | - | - | (2 | ) | 9 | 1 | ||||||||||||||||||||||||||||||||
Other invested assets |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Net derivatives |
- | - | 37 | - | - | - | - | - | - | 37 | - | |||||||||||||||||||||||||||||||||
Net embedded derivatives (4) |
10 | (38 | ) | - | - | - | - | - | - | - | (28 | ) | (38 | ) | ||||||||||||||||||||||||||||||
Assets held in trust |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
Separate account assets/liabilities (5) |
- | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Total |
$ | 285 | $ | (37 | ) | $ | 57 | $ | 77 | $ | - | $ | - | $ | (16 | ) | $ | 41 | $ | (6 | ) | $ | 401 | $ | (37 | ) | ||||||||||||||||||
|
|
F-58
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 13 — Fair Value Measurements - (continued)
(1) | This amount is included in net realized investment and other gains (losses) on the Statements of Operations. |
(2) | This amount is included in net unrealized investment gains (losses) within AOCI on the Balance Sheets. |
(3) | For financial assets that are transferred into and/or out of Level 3, the Company uses the fair value of the assets at the beginning of the reporting period. |
(4) | The earnings amount is included in benefits to policyholders on the Statements of Operations. |
(5) | Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders whose liability is reflected within separate account liabilities. |
The Company may hedge positions with offsetting positions that are classified in a different level. For example, the gains and losses for assets and liabilities in the Level 3 category presented in the tables above may not reflect the effect of offsetting gains and losses on hedging instruments that have been classified by the Company in the Level 1 and Level 2 categories.
The transfers into Level 3 primarily result from securities that were impaired during the year or securities where a lack of observable market data (versus the previous year) resulted in reclassifying assets into Level 3. The transfers out of Level 3 primarily result from observable market data becoming available for that asset, thus eliminating the need to extrapolate market data beyond observable points.
Assets Measured at Fair Value on a Nonrecurring Basis
Certain assets are reported at fair value on a nonrecurring basis, including investments such as, limited partnership interests, which are reported at fair value only in the period in which an impairment is recognized. The fair is calculated using models that are widely accepted in the financial services industry. During the reporting period, there were no assets measured at fair value on a nonrecurring basis.
Note 14 — Segment Information
The Company operates in the following three business segments: (1) Insurance and (2) Wealth Management, which primarily serve retail and institutional customers and (3) Corporate.
The Company’s reportable segments are strategic business units offering different products and services. The reportable segments are managed separately, as they focus on different products, markets, and distribution channels.
Insurance Segment. Offers a variety of individual life insurance products. Products are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners, and direct marketing.
Wealth Management Segment. Offers annuities and a variety of retirement products to group benefit plans. Annuity contracts provide non-guaranteed, partially guaranteed, and fully guaranteed investment options through general and separate account products. These businesses distribute products through multiple distribution channels, including insurance agents and brokers affiliated with the Company, securities brokerage firms, financial planners, pension plan sponsors, pension plan consultants, and banks. As discussed in the Summary of Significant Accounting Policies Note, the Company suspended sales of all its individual and group fixed and variable annuities.
Corporate. Includes corporate operations primarily related to certain financing activities and income on capital not specifically allocated to the operating segments.
The accounting policies of the segments are the same as those described in the Summary of Significant Accounting Policies Note. Allocations of net investment income are based on the amount of assets allocated to each segment. Other costs and operating expenses are allocated to each segment based on a review of the nature of such costs, cost allocations utilizing time studies, and other relevant allocation methodologies.
F-59
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 14 — Segment Information - (continued)
The following table summarizes selected financial information by segment for the periods indicated:
Insurance | Wealth Management |
Corporate and Other |
Total | |||||||||||||
|
|
|||||||||||||||
(in millions) | ||||||||||||||||
2013 |
||||||||||||||||
Revenues from external customers |
$ | 181 | $ | 127 | $ | (2 | ) | $ | 306 | |||||||
Net investment income |
185 | 148 | 207 | 540 | ||||||||||||
Net realized investment and other gains (losses) |
(200 | ) | (154 | ) | 221 | (133 | ) | |||||||||
Inter-segment |
- | - | - | - | ||||||||||||
|
|
|||||||||||||||
Revenues |
$ | 166 | $ | 121 | $ | 426 | $ | 713 | ||||||||
|
|
|||||||||||||||
Net income (loss) |
$ | (43 | ) | $ | 7 | $ | 277 | $ | 241 | |||||||
|
|
|||||||||||||||
Supplemental Information: |
||||||||||||||||
Equity in net income (loss) of investees accounted for under the equity method |
$ | 1 | $ | 28 | $ | 169 | $ | 198 | ||||||||
Carrying value of investments under the equity method |
55 | 10 | 1 | 66 | ||||||||||||
Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired |
(16 | ) | 28 | 1 | 13 | |||||||||||
Goodwill impairment |
- | - | - | - | ||||||||||||
Interest expense |
- | - | - | - | ||||||||||||
Income tax expense (benefit) |
(24 | ) | (10 | ) | 150 | 116 | ||||||||||
Segment assets |
5,387 | 12,164 | 2,794 | 20,345 | ||||||||||||
Insurance | Wealth Management |
Corporate and Other |
Total | |||||||||||||
|
|
|||||||||||||||
(in millions) | ||||||||||||||||
2012 |
||||||||||||||||
Revenues from external customers |
$ | 187 | $ | 283 | $ | (1 | ) | $ | 469 | |||||||
Net investment income |
167 | 204 | 216 | 587 | ||||||||||||
Net realized investment and other gains (losses) |
(73 | ) | (18 | ) | 39 | (52 | ) | |||||||||
Inter-segment |
- | - | - | - | ||||||||||||
|
|
|||||||||||||||
Revenues |
$ | 281 | $ | 469 | $ | 254 | $ | 1,004 | ||||||||
|
|
|||||||||||||||
Net income (loss) |
$ | (56 | ) | $ | 48 | $ | 168 | $ | 160 | |||||||
|
|
|||||||||||||||
Supplemental Information: |
||||||||||||||||
Equity in net income (loss) of investees accounted for under the equity method |
$ | 1 | $ | 26 | $ | 156 | $ | 183 | ||||||||
Carrying value of investments under the equity method |
4 | 1 | 1 | 6 | ||||||||||||
Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired |
24 | 29 | - | 53 | ||||||||||||
Goodwill impairment |
- | - | - | - | ||||||||||||
Interest expense |
- | - | - | - | ||||||||||||
Income tax expense (benefit) |
(31 | ) | (1 | ) | 85 | 53 | ||||||||||
Segment assets |
5,553 | 11,989 | 2,559 | 20,101 |
F-60
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
NOTES TO FINANCIAL STATEMENTS – (CONTINUED)
Note 14 — Segment Information - (continued)
Insurance | Wealth Management |
Corporate and Other |
Total | |||||||||||||
|
|
|||||||||||||||
(in millions) | ||||||||||||||||
2011 |
||||||||||||||||
Revenues from external customers |
$ | 340 | $ | 144 | $ | 3 | $ | 487 | ||||||||
Net investment income |
161 | 235 | 201 | 597 | ||||||||||||
Net realized investment and other gains (losses) |
229 | 65 | (5 | ) | 289 | |||||||||||
Inter-segment revenues |
- | - | - | - | ||||||||||||
|
|
|||||||||||||||
Revenues |
$ | 730 | $ | 444 | $ | 199 | $ | 1,373 | ||||||||
|
|
|||||||||||||||
Net income (loss) |
$ | 90 | $ | 14 | $ | 126 | $ | 230 | ||||||||
|
|
|||||||||||||||
Supplemental Information: |
||||||||||||||||
Equity in net income (loss) of investees accounted for under the equity method |
$ | - | $ | 25 | $ | 150 | $ | 175 | ||||||||
Amortization of deferred policy acquisition costs, deferred sales inducements, and value of business acquired |
61 | 78 | - | 139 | ||||||||||||
Goodwill impairment |
- | - | - | - | ||||||||||||
Interest expense |
- | - | - | - | ||||||||||||
Income tax expense (benefit) |
48 | 1 | 72 | 121 |
The Company operates primarily in the United States and has no reportable major customers.
Note 15 — Subsequent Events
The Company evaluated the recognition and disclosure of subsequent events for its December 31, 2013 financial statements through the date on which the financial statements were issued. The Company did not have any subsequent events requiring disclosure.
F-61
John Hancock Life Insurance Company of New York Separate Account B
Audited Financial Statements
Year ended December 31, 2013 with Report of Independent Registered Public Accounting Firm
John Hancock Life Insurance Company of New York Separate Account B
Audited Financial Statements
Year ended December 31, 2013
Contents
5 | ||||
8 | ||||
Statements of Operations and Changes in Contract Owners’ Equity |
12 | |||
66 | ||||
66 | ||||
67 | ||||
69 | ||||
69 | ||||
69 | ||||
72 | ||||
72 | ||||
73 | ||||
74 |
Report of Independent Registered Public Accounting Firm
Board of Directors of the John Hancock Life Insurance Company New York and Contract Owners of John Hancock Life Insurance Company New York Separate Account B
“Active” sub-accounts |
||
500 Index Trust B Series 0 | Global Bond Trust Series 0 | |
Active Bond Trust Series 0 | Global Bond Trust Series 1 | |
Active Bond Trust Series 1 | Global Trust Series 0 | |
All Cap Core Trust Series 0 | Global Trust Series 1 | |
All Cap Core Trust Series 1 | Health Sciences Trust Series 0 | |
Alpha Opportunities Trust Series 0 | Health Sciences Trust Series 1 | |
American Asset Allocation Trust Series 1 | High Yield Trust Series 0 | |
American Global Growth Trust Series 1 | High Yield Trust Series 1 | |
American Growth Trust Series 1 | International Core Trust Series 0 | |
American Growth-Income Trust Series 1 | International Core Trust Series 1 | |
American International Trust Series 1 | International Equity Index Trust B Series 0 | |
American New World Trust Series 1 | International Equity Index Trust B Series 1 | |
Blue Chip Growth Trust Series 0 | International Growth Stock Trust Series 0 | |
Blue Chip Growth Trust Series 1 | International Growth Stock Trust Series 1 | |
Bond Trust Series 0 | International Small Company Trust Series 0 | |
Bond Trust Series 1 | International Small Company Trust Series 1 | |
Capital Appreciation Trust Series 0 | International Value Trust Series 0 | |
Capital Appreciation Trust Series 1 | International Value Trust Series 1 | |
Capital Appreciation Value Trust Series 0 | Investment Quality Bond Trust Series 0 | |
Core Bond Trust Series 0 | Investment Quality Bond Trust Series 1 | |
Core Bond Trust Series 1 | Lifestyle Aggressive Trust Series 0 | |
Core Strategy Trust Series 0 | Lifestyle Aggressive Trust Series 1 | |
Emerging Markets Value Trust Series 0 | Lifestyle Balanced Trust Series 0 | |
Emerging Markets Value Trust Series 1 | Lifestyle Balanced Trust Series 1 | |
Equity-Income Trust Series 0 | Lifestyle Conservative Trust Series 0 | |
Equity-Income Trust Series 1 | Lifestyle Conservative Trust Series 1 | |
Financial Services Trust Series 0 | Lifestyle Growth Trust Series 0 | |
Financial Services Trust Series 1 | Lifestyle Growth Trust Series 1 | |
Franklin Templeton Founding Allocation Trust Series 0 | Lifestyle Moderate Trust Series 0 | |
Franklin Templeton Founding Allocation Trust Series 1 | Lifestyle Moderate Trust Series 1 | |
Fundamental All Cap Core Trust Series 0 | Mid Cap Index Trust Series 0 | |
Fundamental All Cap Core Trust Series 1 | Mid Cap Index Trust Series 1 | |
Fundamental Large Cap Value Trust Series 0 | Mid Cap Stock Trust Series 0 | |
Fundamental Large Cap Value Trust Series 1 | Mid Cap Stock Trust Series 1 | |
Fundamental Value Trust Series 0 | Mid Value Trust Series 0 | |
Fundamental Value Trust Series 1 | Mid Value Trust Series 1 |
5
Report of Independent Registered Public Accounting Firm
Money Market Trust B Series 0 | Small Company Value Trust Series 1 | |
Money Market Trust Series 1 | Strategic Income Opportunities Trust Series 0 | |
Natural Resources Trust Series 0 | Strategic Income Opportunities Trust Series 1 | |
Natural Resources Trust Series 1 | Total Bond Market Trust B Series 0 | |
Real Estate Securities Trust Series 0 | Total Return Trust Series 0 | |
Real Estate Securities Trust Series 1 | Total Return Trust Series 1 | |
Real Return Bond Trust Series 0 | Total Stock Market Index Trust Series 0 | |
Real Return Bond Trust Series 1 | Total Stock Market Index Trust Series 1 | |
Science & Technology Trust Series 0 | Ultra Short Term Bond Trust Series 0 | |
Science & Technology Trust Series 1 | U.S. Equity Trust Series 0 | |
Short Term Government Income Trust Series 0 | U.S. Equity Trust Series 1 | |
Short Term Government Income Trust Series 1 | Utilities Trust Series 0 | |
Small Cap Growth Trust Series 0 | Utilities Trust Series 1 | |
Small Cap Growth Trust Series 1 | Value Trust Series 0 | |
Small Cap Index Trust Series 0 | Value Trust Series 1 | |
Small Cap Index Trust Series 1 | All Asset Portfolio | |
Small Cap Opportunities Trust Series 0 | Brandes International Equity | |
Small Cap Opportunities Trust Series 1 | Frontier Capital Appreciation | |
Small Cap Value Trust Series 0 | Large Cap Growth | |
Small Cap Value Trust Series 1 | Large Cap Value | |
Small Company Value Trust Series 0 | ||
“Closed” sub-accounts |
||
All Cap Value Trust Series 0 | Disciplined Diversification Trust Series 0 | |
All Cap Value Trust Series 1 | Fundamental Holdings Trust Series 1 | |
American Global Small Capitalization Trust Series 1 | Global Diversification Trust Series 1 | |
American High-Income Bond Trust Series 1 | Smaller Company Growth Trust Series 0 | |
Core Allocation Plus Trust Series 0 | Smaller Company Growth Trust Series 1 |
6
Report of Independent Registered Public Accounting Firm
We have audited the accompanying statements of assets and contract owners’ equity of John Hancock Life Insurance Company of New York Separate Account B (the “Account”), comprised of the active sub-accounts as of December 31, 2013, and the related statements of operations and changes in contract owners’ equity of the active and closed sub-accounts for each of the two years in the period then ended (or years since inception), and the financial highlights for each of the five years in the period then ended (or years since inception). These financial statements and financial highlights are the responsibility of the Account’s management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. We were not engaged to perform an audit of the Account’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Account’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements and financial highlights, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of December 31, 2013, by correspondence with the custodian or fund manager of the underlying portfolios. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of each of the active sub-accounts constituting John Hancock Life Insurance Company of New York Separate Account B at December 31, 2013, and the results of its operations and changes in contract owners’ equity of the active and closed sub-accounts for each of the two years in the period then ended (or years since inception), and the financial highlights for each of the five years in the period then ended (or years since inception), in conformity with U.S. generally accepted accounting principles.
Chartered Accountants
Licensed Public Accountants
Toronto, Canada
7
John Hancock Life Insurance Company of New York Separate Account B
Statements of Assets and Contract Owners’ Equity
Assets |
||||
Investments at fair value: |
||||
Sub-accounts invested in John Hancock Variable Insurance Trust portfolios: |
||||
500 Index Trust B Series 0 - 289,932 shares (cost $5,297,145) |
$ | 6,764,116 | ||
Active Bond Trust Series 0 - 68,105 shares (cost $684,679) |
653,806 | |||
Active Bond Trust Series 1 - 32,818 shares (cost $315,049) |
315,051 | |||
All Cap Core Trust Series 0 - 3,289 shares (cost $56,092) |
82,745 | |||
All Cap Core Trust Series 1 - 11,882 shares (cost $177,312) |
298,820 | |||
All Cap Value Trust Series 0 |
— | |||
All Cap Value Trust Series 1 |
— | |||
Alpha Opportunities Trust Series 0 - 5,763 shares (cost $82,628) |
93,480 | |||
American Asset Allocation Trust Series 1 - 98,968 shares (cost $1,167,997) |
1,506,292 | |||
American Global Growth Trust Series 1 - 5,218 shares (cost $62,855) |
81,821 | |||
American Global Small Capitalization Trust Series 1 |
— | |||
American Growth Trust Series 1 - 111,386 shares (cost $1,705,515) |
2,499,497 | |||
American Growth-Income Trust Series 1 - 127,419 shares (cost $1,910,017) |
2,798,113 | |||
American High-Income Bond Trust Series 1 |
— | |||
American International Trust Series 1 - 89,582 shares (cost $1,387,542) |
1,722,671 | |||
American New World Trust Series 1 - 23,192 shares (cost $305,584) |
345,333 | |||
Blue Chip Growth Trust Series 0 - 81,742 shares (cost $1,602,744) |
2,795,578 | |||
Blue Chip Growth Trust Series 1 - 29,260 shares (cost $556,599) |
1,001,567 | |||
Bond Trust Series 0 - 13,887 shares (cost $192,719) |
184,560 | |||
Bond Trust Series 1 |
— | |||
Capital Appreciation Trust Series 0 - 303,838 shares (cost $3,583,868) |
4,797,597 | |||
Capital Appreciation Trust Series 1 - 21,747 shares (cost $243,265) |
343,169 | |||
Capital Appreciation Value Trust Series 0 - 85,386 shares (cost $1,030,130) |
1,110,013 | |||
Core Allocation Plus Trust Series 0 |
— | |||
Core Bond Trust Series 0 - 39,333 shares (cost $547,320) |
503,461 | |||
Core Bond Trust Series 1 - 10,562 shares (cost $134,336) |
135,720 | |||
Core Strategy Trust Series 0 - 389,023 shares (cost $5,360,832) |
5,636,940 | |||
Disciplined Diversification Trust Series 0 |
— | |||
Emerging Markets Value Trust Series 0 - 298,564 shares (cost $3,613,984) |
2,955,779 | |||
Emerging Markets Value Trust Series 1 - 611 shares (cost $7,019) |
6,059 | |||
Equity-Income Trust Series 0 - 350,273 shares (cost $5,209,051) |
6,921,388 | |||
Equity-Income Trust Series 1 - 40,672 shares (cost $604,851) |
806,115 | |||
Financial Services Trust Series 0 - 28,263 shares (cost $329,226) |
447,400 | |||
Financial Services Trust Series 1 - 8,965 shares (cost $104,463) |
142,093 | |||
Franklin Templeton Founding Allocation Trust Series 0 - 145,000 shares (cost $1,566,504) |
1,890,794 | |||
Franklin Templeton Founding Allocation Trust Series 1 - 165 shares (cost $2,164) |
2,156 | |||
Fundamental All Cap Core Trust Series 0 - 25,676 shares (cost $400,532) |
530,987 | |||
Fundamental All Cap Core Trust Series 1 - 1,704 shares (cost $34,058) |
35,115 | |||
Fundamental Holdings Trust Series 1 |
— | |||
Fundamental Large Cap Value Trust Series 0 - 78,575 shares (cost $1,174,600) |
1,252,483 | |||
Fundamental Large Cap Value Trust Series 1 - 8,477 shares (cost $131,425) |
135,126 | |||
Fundamental Value Trust Series 0 - 14,371 shares (cost $206,390) |
289,723 |
8
John Hancock Life Insurance Company of New York Separate Account B
Statements of Assets and Contract Owners’ Equity
Assets (continued) |
||||
Investments at fair value: |
||||
Sub-accounts invested in John Hancock Variable Insurance Trust portfolios: |
||||
Fundamental Value Trust Series 1 - 30,546 shares (cost $380,089) |
$ | 617,642 | ||
Global Bond Trust Series 0 - 74,721 shares (cost $958,243) |
921,315 | |||
Global Bond Trust Series 1 - 13,739 shares (cost $168,751) |
170,232 | |||
Global Diversification Trust Series 1 |
— | |||
Global Trust Series 0 - 6,361 shares (cost $95,557) |
130,202 | |||
Global Trust Series 1 - 5,040 shares (cost $71,414) |
103,317 | |||
Health Sciences Trust Series 0 - 28,361 shares (cost $623,546) |
832,668 | |||
Health Sciences Trust Series 1 - 10,027 shares (cost $176,074) |
292,696 | |||
High Yield Trust Series 0 - 260,065 shares (cost $1,593,059) |
1,570,793 | |||
High Yield Trust Series 1 - 37,632 shares (cost $246,180) |
229,554 | |||
International Core Trust Series 0 - 32,006 shares (cost $305,196) |
373,513 | |||
International Core Trust Series 1 - 6,699 shares (cost $55,266) |
78,377 | |||
International Equity Index Trust B Series 0 - 271,580 shares (cost $4,221,266) |
4,652,174 | |||
International Equity Index Trust B Series 1 - 16,259 shares (cost $240,184) |
278,688 | |||
International Growth Stock Trust Series 0 - 37,927 shares (cost $530,745) |
639,451 | |||
International Growth Stock Trust Series 1 - 12,477 shares (cost $174,128) |
210,237 | |||
International Small Company Trust Series 0 - 36,897 shares (cost $362,042) |
464,898 | |||
International Small Company Trust Series 1 - 3,957 shares (cost $36,856) |
49,900 | |||
International Value Trust Series 0 - 29,206 shares (cost $351,333) |
428,737 | |||
International Value Trust Series 1 - 22,408 shares (cost $269,672) |
331,196 | |||
Investment Quality Bond Trust Series 0 - 13,818 shares (cost $163,866) |
157,106 | |||
Investment Quality Bond Trust Series 1 - 19,467 shares (cost $224,260) |
222,114 | |||
Lifestyle Aggressive Trust Series 0 - 896,506 shares (cost $7,465,114) |
9,780,876 | |||
Lifestyle Aggressive Trust Series 1 - 55,631 shares (cost $415,183) |
606,938 | |||
Lifestyle Balanced Trust Series 0 - 1,907,424 shares (cost $22,858,936) |
26,169,856 | |||
Lifestyle Balanced Trust Series 1 - 368,766 shares (cost $4,472,986) |
5,048,408 | |||
Lifestyle Conservative Trust Series 0 - 265,374 shares (cost $3,425,814) |
3,346,371 | |||
Lifestyle Conservative Trust Series 1 - 11,884 shares (cost $143,676) |
149,499 | |||
Lifestyle Growth Trust Series 0 - 2,011,508 shares (cost $23,429,345) |
28,643,878 | |||
Lifestyle Growth Trust Series 1 - 159,666 shares (cost $1,913,668) |
2,272,044 | |||
Lifestyle Moderate Trust Series 0 - 415,144 shares (cost $5,266,295) |
5,683,325 | |||
Lifestyle Moderate Trust Series 1 - 70,244 shares (cost $825,589) |
960,936 | |||
Mid Cap Index Trust Series 0 - 167,394 shares (cost $3,126,017) |
3,652,538 | |||
Mid Cap Index Trust Series 1 - 15,316 shares (cost $246,596) |
334,200 | |||
Mid Cap Stock Trust Series 0 - 43,022 shares (cost $640,903) |
911,647 | |||
Mid Cap Stock Trust Series 1 - 18,601 shares (cost $249,155) |
391,932 | |||
Mid Value Trust Series 0 - 68,089 shares (cost $747,590) |
949,157 | |||
Mid Value Trust Series 1 - 16,211 shares (cost $164,880) |
226,791 | |||
Money Market Trust B Series 0 - 6,536,519 shares (cost $6,536,519) |
6,536,519 | |||
Money Market Trust Series 1 - 2,730,900 shares (cost $2,730,900) |
2,730,900 | |||
Natural Resources Trust Series 0 - 111,007 shares (cost $1,131,127) |
1,127,832 | |||
Natural Resources Trust Series 1 - 15,773 shares (cost $157,887) |
162,934 |
9
John Hancock Life Insurance Company of New York Separate Account B
Statements of Assets and Contract Owners’ Equity
Assets (continued) |
||||
Investments at fair value: |
||||
Sub-accounts invested in John Hancock Variable Insurance Trust portfolios: |
||||
Real Estate Securities Trust Series 0 - 215,064 shares (cost $2,610,418) |
$ | 2,959,281 | ||
Real Estate Securities Trust Series 1 - 36,528 shares (cost $457,299) |
505,546 | |||
Real Return Bond Trust Series 0 - 78,192 shares (cost $986,833) |
910,159 | |||
Real Return Bond Trust Series 1 - 3,005 shares (cost $36,481) |
35,456 | |||
Science & Technology Trust Series 0 - 27,695 shares (cost $476,354) |
688,221 | |||
Science & Technology Trust Series 1 - 9,217 shares (cost $122,933) |
227,926 | |||
Short Term Government Income Trust Series 0 - 34,452 shares (cost $446,394) |
430,654 | |||
Short Term Government Income Trust Series 1 - 31,954 shares (cost $412,283) |
399,419 | |||
Small Cap Growth Trust Series 0 - 37,346 shares (cost $381,699) |
481,384 | |||
Small Cap Growth Trust Series 1 - 2,238 shares (cost $21,464) |
28,691 | |||
Small Cap Index Trust Series 0 - 183,810 shares (cost $2,433,421) |
2,911,545 | |||
Small Cap Index Trust Series 1 - 9,703 shares (cost $124,302) |
153,601 | |||
Small Cap Opportunities Trust Series 0 - 32,913 shares (cost $936,855) |
1,010,418 | |||
Small Cap Opportunities Trust Series 1 - 4,110 shares (cost $81,776) |
126,761 | |||
Small Cap Value Trust Series 0 - 28,449 shares (cost $569,644) |
740,817 | |||
Small Cap Value Trust Series 1 - 2,398 shares (cost $57,212) |
62,567 | |||
Small Company Value Trust Series 0 - 33,190 shares (cost $561,954) |
837,044 | |||
Small Company Value Trust Series 1 - 13,759 shares (cost $205,802) |
347,540 | |||
Smaller Company Growth Trust Series 0 |
— | |||
Smaller Company Growth Trust Series 1 |
— | |||
Strategic Income Opportunities Trust Series 0 - 328,119 shares (cost $4,423,686) |
4,311,480 | |||
Strategic Income Opportunities Trust Series 1 - 21,487 shares (cost $295,077) |
283,198 | |||
Total Bond Market Trust B Series 0 - 35,140 shares (cost $370,460) |
354,564 | |||
Total Return Trust Series 0 - 148,355 shares (cost $2,121,842) |
2,010,204 | |||
Total Return Trust Series 1 - 47,986 shares (cost $674,369) |
652,605 | |||
Total Stock Market Index Trust Series 0 - 62,908 shares (cost $827,519) |
1,074,462 | |||
Total Stock Market Index Trust Series 1 - 10,270 shares (cost $119,615) |
175,418 | |||
Ultra Short Term Bond Trust Series 0 - 11,868 shares (cost $143,749) |
142,183 | |||
U.S. Equity Trust Series 0 - 46,889 shares (cost $657,356) |
830,873 | |||
U.S. Equity Trust Series 1 - 3,887 shares (cost $54,453) |
68,841 | |||
Utilities Trust Series 0 - 53,759 shares (cost $660,759) |
828,969 | |||
Utilities Trust Series 1 - 4,584 shares (cost $55,068) |
70,782 | |||
Value Trust Series 0 - 23,476 shares (cost $443,682) |
608,489 | |||
Value Trust Series 1 - 12,447 shares (cost $169,186) |
323,011 |
10
John Hancock Life Insurance Company of New York Separate Account B
Statements of Assets and Contract Owners’ Equity
Assets (continued) |
||||
Investments at fair value: |
||||
Sub-accounts invested in Outside Trust portfolios: |
||||
All Asset Portfolio - 442,848 shares (cost $4,954,957) |
$ | 4,889,041 | ||
Brandes International Equity - 8,440 shares (cost $102,812) |
110,980 | |||
Frontier Capital Appreciation - 1,841 shares (cost $53,646) |
54,710 | |||
Large Cap Growth - 5,511 shares (cost $111,114) |
136,344 | |||
Large Cap Value - 6,147 shares (cost $79,452) |
84,641 | |||
|
|
|||
Total Assets |
$ | 191,394,784 | ||
|
|
|||
Contract Owners’ Equity |
||||
|
|
|||
Variable universal life insurance contracts |
$ | 191,394,784 | ||
|
|
See accompanying notes.
11
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
Sub-Account | ||||||||||||
500 Index Trust B Series 0 | 500 Index Trust Series 1 | |||||||||||
Year Ended | Year Ended | Year Ended | ||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/12 (y) | ||||||||||
Income: |
||||||||||||
Dividend income distribution |
$ | 108,176 | $ | 37,737 | $ | 25,942 | ||||||
|
|
|
|
|
|
|||||||
Net investment income (loss) |
108,176 | 37,737 | 25,942 | |||||||||
|
|
|
|
|
|
|||||||
Realized gains (losses) on investments: |
||||||||||||
Capital gain distributions |
11,849 | — | 55,467 | |||||||||
Net realized gains (losses) |
223,636 | 107,664 | (8,858 | ) | ||||||||
|
|
|
|
|
|
|||||||
Realized gains (losses) |
235,485 | 107,664 | 46,609 | |||||||||
Unrealized appreciation (depreciation) during the period |
1,062,289 | 339,246 | (1,306 | ) | ||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in assets from operations |
1,405,950 | 484,647 | 71,245 | |||||||||
|
|
|
|
|
|
|||||||
Changes from principal transactions: |
||||||||||||
Transfer of net premiums |
487,089 | 495,381 | 32,904 | |||||||||
Transfer on terminations |
(936,885 | ) | (185,940 | ) | (28,620 | ) | ||||||
Transfer on policy loans |
(34,708 | ) | (17,916 | ) | (3,445 | ) | ||||||
Net interfund transfers |
1,491,960 | 626,019 | (583,863 | ) | ||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in assets from principal transactions |
1,007,456 | 917,544 | (583,024 | ) | ||||||||
|
|
|
|
|
|
|||||||
Total increase (decrease) in assets |
2,413,406 | 1,402,191 | (511,779 | ) | ||||||||
Assets, beginning of period |
4,350,710 | 2,948,519 | 511,779 | |||||||||
|
|
|
|
|
|
|||||||
Assets, end of period |
$ | 6,764,116 | $ | 4,350,710 | — | |||||||
|
|
|
|
|
|
(y) | Terminated as an investment option and funds transferred to 500 Index Trust B Series 0 on November 5, 2012. |
(bg) | Fund has no Series. Previously presented as Series 0 and Series 1. |
See accompanying notes.
12
Sub-Account | ||||||||||||||||||||||
Active Bond Trust Series 0 | Active Bond Trust Series 1 | All Asset Portfolio | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 (bg) |
Year Ended Dec. 31/12 (bg) |
|||||||||||||||||
$ | 38,679 | $ | 24,942 | $ | 17,777 | $ | 10,908 | $ | 208,525 | $ | 160,170 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
38,679 | 24,942 | 17,777 | 10,908 | 208,525 | 160,170 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | 3,923 | — | 1,765 | — | — | |||||||||||||||||
1,707 | 1,011 | 568 | 1,332 | 5,979 | 6,320 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
1,707 | 4,934 | 568 | 3,097 | 5,979 | 6,320 | |||||||||||||||||
(39,231 | ) | 13,052 | (17,898 | ) | 9,903 | (220,102 | ) | 159,654 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
1,155 | 42,928 | 447 | 23,908 | (5,598 | ) | 326,144 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
33,074 | 31,156 | 13,105 | 14,948 | 57,614 | 68,780 | |||||||||||||||||
(24,842 | ) | (15,681 | ) | (12,741 | ) | (12,761 | ) | (152,419 | ) | (68,367 | ) | |||||||||||
2,051 | (657 | ) | 260 | (4,905 | ) | (289 | ) | (273 | ) | |||||||||||||
32,508 | 256,052 | 45,768 | 3,008 | 21,475 | 4,387,526 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
42,791 | 270,870 | 46,392 | 290 | (73,619 | ) | 4,387,666 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
43,946 | 313,798 | 46,839 | 24,198 | (79,217 | ) | 4,713,810 | ||||||||||||||||
609,860 | 296,062 | 268,212 | 244,014 | 4,968,258 | 254,448 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 653,806 | $ | 609,860 | $ | 315,051 | $ | 268,212 | $ | 4,889,041 | $ | 4,968,258 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
13
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
All Cap Core Trust Series 0 | All Cap Core Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 1,004 | $ | 616 | $ | 6,611 | $ | 4,684 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
1,004 | 616 | 6,611 | 4,684 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
4,601 | 22,940 | 45,028 | (1,487 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
4,601 | 22,940 | 45,028 | (1,487 | ) | |||||||||||
Unrealized appreciation (depreciation) during the period |
15,175 | 98,654 | 85,963 | 58,163 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
20,780 | 122,210 | 137,602 | 61,360 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
14,426 | 9,324 | 9,553 | 8,716 | ||||||||||||
Transfer on terminations |
(7,820 | ) | (11,740 | ) | (13,365 | ) | (12,576 | ) | ||||||||
Transfer on policy loans |
(7,349 | ) | (1,799 | ) | (251,756 | ) | 7 | |||||||||
Net interfund transfers |
7,313 | (1,041,889 | ) | (11,819 | ) | (234 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
6,570 | (1,046,104 | ) | (267,387 | ) | (4,087 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
27,350 | (923,894 | ) | (129,785 | ) | 57,273 | ||||||||||
Assets, beginning of period |
55,395 | 979,289 | 428,605 | 371,332 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 82,745 | $ | 55,395 | $ | 298,820 | $ | 428,605 | ||||||||
|
|
|
|
|
|
|
|
(m) | Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013. |
See accompanying notes.
14
Sub-Account | ||||||||||||||||||||||
All Cap Value Trust Series 0 | All Cap Value Trust Series 1 | Alpha Opportunities Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 (m) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 (m) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 10,367 | $ | 4,449 | $ | 2,293 | $ | 1,412 | $ | 545 | $ | 273 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
10,367 | 4,449 | 2,293 | 1,412 | 545 | 273 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
401,391 | 19,775 | 82,624 | 6,706 | 5,700 | 2,981 | |||||||||||||||||
(216,104 | ) | 1,181 | (11,198 | ) | (9,132 | ) | 390 | (102,348 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
185,287 | 20,956 | 71,426 | (2,426 | ) | 6,090 | (99,367 | ) | |||||||||||||||
(21,405 | ) | 21,011 | (15,917 | ) | 25,157 | 11,584 | 246,898 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
174,249 | 46,416 | 57,802 | 24,143 | 18,219 | 147,804 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
93,683 | 104,568 | 5,615 | 5,354 | 6,120 | 6,055 | |||||||||||||||||
(31,905 | ) | (25,119 | ) | (40,905 | ) | (8,339 | ) | (3,634 | ) | (6,416 | ) | |||||||||||
— | — | — | (21,643 | ) | — | — | ||||||||||||||||
(749,492 | ) | 5,943 | (170,866 | ) | (101,634 | ) | 24,238 | (961,902 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(687,714 | ) | 85,392 | (206,156 | ) | (126,262 | ) | 26,724 | (962,263 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(513,465 | ) | 131,808 | (148,354 | ) | (102,119 | ) | 44,943 | (814,459 | ) | |||||||||||||
513,465 | 381,657 | 148,354 | 250,473 | 48,537 | 862,996 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | $ | 513,465 | — | $ | 148,354 | $ | 93,480 | $ | 48,537 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
15
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||
American Asset Allocation Trust Series 1 | American Blue Chip Income and Growth Trust Series 1 | |||||||||||||
Year Ended | Year Ended | Year Ended | ||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/12 (v) | ||||||||||||
Income: |
||||||||||||||
Dividend income distribution |
$ | 15,134 | $ | 15,780 | — | |||||||||
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
15,134 | 15,780 | — | |||||||||||
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||
Capital gain distributions |
— | — | 104,496 | |||||||||||
Net realized gains (losses) |
30,194 | 14,086 | (33,533 | ) | ||||||||||
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
30,194 | 14,086 | 70,963 | |||||||||||
Unrealized appreciation (depreciation) during the period |
210,494 | 79,861 | (16,479 | ) | ||||||||||
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
255,822 | 109,727 | 54,484 | |||||||||||
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||
Transfer of net premiums |
205,615 | 189,870 | 54,991 | |||||||||||
Transfer on terminations |
(117,857 | ) | (71,989 | ) | (41,608 | ) | ||||||||
Transfer on policy loans |
(1,714 | ) | (5,271 | ) | (119 | ) | ||||||||
Net interfund transfers |
132,229 | 240,768 | (363,264 | ) | ||||||||||
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
218,273 | 353,378 | (350,000 | ) | ||||||||||
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
474,095 | 463,105 | (295,516 | ) | ||||||||||
Assets, beginning of period |
1,032,197 | 569,092 | 295,516 | |||||||||||
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 1,506,292 | $ | 1,032,197 | — | |||||||||
|
|
|
|
|
|
(v) | Terminated as an investment option and funds transferred to American Growth-Income Trust Series 1 on November 5, 2012. |
(bh) | Terminated as an investment option and funds transferred to American Global Growth Trust Series 1 on April 29, 2013. |
See accompanying notes.
16
Sub-Account | ||||||||||||||||||||||
American Global Growth Trust Series 1 | American Global
Small Capitalization Trust Series 1 |
American Growth Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 (bh) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 656 | $ | 180 | $ | 46 | $ | 164 | $ | 12,267 | $ | 7,791 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
656 | 180 | 46 | 164 | 12,267 | 7,791 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | — | — | |||||||||||||||||
1,812 | (2 | ) | 2,196 | (85 | ) | 101,324 | 75,326 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
1,812 | (2 | ) | 2,196 | (85 | ) | 101,324 | 75,326 | |||||||||||||||
13,796 | 6,136 | (213 | ) | 2,863 | 451,233 | 327,805 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
16,264 | 6,314 | 2,029 | 2,942 | 564,824 | 410,922 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
8,078 | 18,212 | 69 | 641 | 213,598 | 318,626 | |||||||||||||||||
(5,683 | ) | (3,237 | ) | (342 | ) | (855 | ) | (167,428 | ) | (362,764 | ) | |||||||||||
— | — | — | — | (3,325 | ) | (2,120 | ) | |||||||||||||||
23,922 | 3,074 | (21,208 | ) | 332 | (59,893 | ) | (782,593 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
26,317 | 18,049 | (21,481 | ) | 118 | (17,048 | ) | (828,851 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
42,581 | 24,363 | (19,452 | ) | 3,060 | 547,776 | (417,929 | ) | |||||||||||||||
39,240 | 14,877 | 19,452 | 16,392 | 1,951,721 | 2,369,650 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 81,821 | $ | 39,240 | — | $ | 19,452 | $ | 2,499,497 | $ | 1,951,721 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
17
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
American Growth-Income Trust Series 1 | American High-Income Bond Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 (l) |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 25,148 | $ | 26,448 | $ | 128 | $ | 9,917 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
25,148 | 26,448 | 128 | 9,917 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | 3,986 | — | ||||||||||||
Net realized gains (losses) |
83,364 | 33,188 | 389 | 223 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
83,364 | 33,188 | 4,375 | 223 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
595,570 | 149,339 | 199 | 1,754 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
704,082 | 208,975 | 4,702 | 11,894 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
182,414 | 125,999 | 4,415 | 9,541 | ||||||||||||
Transfer on terminations |
(175,680 | ) | (114,259 | ) | (3,675 | ) | (6,760 | ) | ||||||||
Transfer on policy loans |
(17,127 | ) | (8,124 | ) | (150 | ) | — | |||||||||
Net interfund transfers |
(26,925 | ) | 954,850 | (162,316 | ) | 118,822 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(37,318 | ) | 958,466 | (161,726 | ) | 121,603 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
666,764 | 1,167,441 | (157,024 | ) | 133,497 | |||||||||||
Assets, beginning of period |
2,131,349 | 963,908 | 157,024 | 23,527 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 2,798,113 | $ | 2,131,349 | — | $ | 157,024 | |||||||||
|
|
|
|
|
|
|
|
(l) | Terminated as an investment option and funds transferred to High Yield Trust Series 1 on April 29, 2013. |
(e) | Terminated as an investment option and funds transferred to Lifestyle Growth Trust on April 30, 2012. |
See accompanying notes.
18
Sub-Account | ||||||||||||||||||
American International Trust Series 1 | American New World Trust Series 1 | Balanced Trust Series 0 | ||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/12 (e) |
||||||||||||||
$ | 15,339 | $ | 14,745 | $ | 3,093 | $ | 1,224 | $ | 3,685 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
15,339 | 14,745 | 3,093 | 1,224 | 3,685 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
— | — | — | — | 84,208 | ||||||||||||||
67,910 | (37,967 | ) | 517 | 337 | (81,763 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
67,910 | (37,967 | ) | 517 | 337 | 2,445 | |||||||||||||
222,797 | 248,174 | 24,926 | 29,858 | 14,926 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
306,046 | 224,952 | 28,536 | 31,419 | 21,056 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
83,540 | 197,860 | 23,109 | 31,520 | 922 | ||||||||||||||
(493,773 | ) | (238,686 | ) | (15,468 | ) | (14,538 | ) | (2,299 | ) | |||||||||
(2,028 | ) | (791 | ) | — | — | — | ||||||||||||
401,643 | (88,137 | ) | 89,716 | (1,059 | ) | (265,602 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
(10,618 | ) | (129,754 | ) | 97,357 | 15,923 | (266,979 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
295,428 | 95,198 | 125,893 | 47,342 | (245,923 | ) | |||||||||||||
1,427,243 | 1,332,045 | 219,440 | 172,098 | 245,923 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||
$ | 1,722,671 | $ | 1,427,243 | $ | 345,333 | $ | 219,440 | — | ||||||||||
|
|
|
|
|
|
|
|
|
|
19
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||
Balanced Trust Series 1 | Blue Chip Growth Trust Series 0 | |||||||||||
Year Ended | Year Ended | Year Ended | ||||||||||
Dec. 31/12 (e) | Dec. 31/13 | Dec. 31/12 | ||||||||||
Income: |
||||||||||||
Dividend income distribution |
$ | 22 | $ | 7,544 | $ | 3,807 | ||||||
|
|
|
|
|
|
|||||||
Net investment income (loss) |
22 | 7,544 | 3,807 | |||||||||
|
|
|
|
|
|
|||||||
Realized gains (losses) on investments: |
||||||||||||
Capital gain distributions |
524 | — | — | |||||||||
Net realized gains (losses) |
(424 | ) | 233,627 | 230,513 | ||||||||
|
|
|
|
|
|
|||||||
Realized gains (losses) |
100 | 233,627 | 230,513 | |||||||||
Unrealized appreciation (depreciation) during the period |
13 | 621,444 | 396,479 | |||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in assets from operations |
135 | 862,615 | 630,799 | |||||||||
|
|
|
|
|
|
|||||||
Changes from principal transactions: |
||||||||||||
Transfer of net premiums |
— | 162,806 | 295,106 | |||||||||
Transfer on terminations |
(70 | ) | (1,130,590 | ) | (301,267 | ) | ||||||
Transfer on policy loans |
— | (19,312 | ) | (1,412 | ) | |||||||
Net interfund transfers |
(1,653 | ) | 24,485 | (1,055,105 | ) | |||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in assets from principal transactions |
(1,723 | ) | (962,611 | ) | (1,062,678 | ) | ||||||
|
|
|
|
|
|
|||||||
Total increase (decrease) in assets |
(1,588 | ) | (99,996 | ) | (431,879 | ) | ||||||
Assets, beginning of period |
1,588 | 2,895,574 | 3,327,453 | |||||||||
|
|
|
|
|
|
|||||||
Assets, end of period |
— | $ | 2,795,578 | $ | 2,895,574 | |||||||
|
|
|
|
|
|
(e) | Terminated as an investment option and funds transferred to Lifestyle Growth Trust on April 30, 2012. |
See accompanying notes.
20
Sub-Account | ||||||||||||||||||||||
Blue Chip Growth Trust Series 1 | Bond Trust Series 0 | Bond Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 2,534 | $ | 654 | $ | 5,709 | $ | 5,391 | — | $ | 577 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
2,534 | 654 | 5,709 | 5,391 | — | 577 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | 1,434 | 1,265 | — | 142 | |||||||||||||||||
52,826 | 35,959 | 13 | 218 | 141 | 4 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
52,826 | 35,959 | 1,447 | 1,483 | 141 | 146 | |||||||||||||||||
255,420 | 86,179 | (9,357 | ) | 4,095 | (157 | ) | 157 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
310,780 | 122,792 | (2,201 | ) | 10,969 | (16 | ) | 880 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
36,525 | 35,013 | 24,405 | 25,150 | — | — | |||||||||||||||||
(49,275 | ) | (87,078 | ) | (22,581 | ) | (13,618 | ) | (59 | ) | (279 | ) | |||||||||||
(36,519 | ) | (28,692 | ) | (56 | ) | (5,309 | ) | — | — | |||||||||||||
54,386 | (61,957 | ) | (12,693 | ) | 13,108 | (21,011 | ) | 20,485 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
5,117 | (142,714 | ) | (10,925 | ) | 19,331 | (21,070 | ) | 20,206 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
315,897 | (19,922 | ) | (13,126 | ) | 30,300 | (21,086 | ) | 21,086 | ||||||||||||||
685,670 | 705,592 | 197,686 | 167,386 | 21,086 | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,001,567 | $ | 685,670 | $ | 184,560 | $ | 197,686 | — | $ | 21,086 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
21
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Brandes International Equity | Capital Appreciation Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 2,259 | $ | 758 | $ | 10,417 | $ | 7,253 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
2,259 | 758 | 10,417 | 7,253 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
251 | (80 | ) | 46,663 | (72,321 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
251 | (80 | ) | 46,663 | (72,321 | ) | ||||||||||
Unrealized appreciation (depreciation) during the period |
5,713 | 5,505 | 1,246,404 | (38,106 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
8,223 | 6,183 | 1,303,484 | (103,174 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
10,407 | 10,667 | 25,678 | 27,676 | ||||||||||||
Transfer on terminations |
(1,939 | ) | (4,061 | ) | (79,981 | ) | (74,226 | ) | ||||||||
Transfer on policy loans |
— | — | — | — | ||||||||||||
Net interfund transfers |
54,791 | 251 | (65,034 | ) | 3,489,141 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
63,259 | 6,857 | (119,337 | ) | 3,442,591 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
71,482 | 13,040 | 1,184,147 | 3,339,417 | ||||||||||||
Assets, beginning of period |
39,498 | 26,458 | 3,613,450 | 274,033 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 110,980 | $ | 39,498 | $ | 4,797,597 | $ | 3,613,450 | ||||||||
|
|
|
|
|
|
|
|
(z) | Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. |
See accompanying notes.
22
Sub-Account | ||||||||||||||||||||||
Capital Appreciation Trust Series 1 | Capital Appreciation Value Trust Series 0 | Core Allocation Plus Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 (z) |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 741 | $ | 582 | $ | 13,847 | $ | 12,245 | $ | 28,663 | $ | 9,206 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
741 | 582 | 13,847 | 12,245 | 28,663 | 9,206 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | 89,178 | 77,176 | 294,959 | 38,780 | |||||||||||||||||
60,293 | 18,317 | 7,016 | 1,744 | (202,039 | ) | (135 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
60,293 | 18,317 | 96,194 | 78,920 | 92,920 | 38,645 | |||||||||||||||||
41,364 | 22,340 | 86,598 | 1,409 | 23,954 | 21,509 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
102,398 | 41,239 | 196,639 | 92,574 | 145,537 | 69,360 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
24,705 | 27,536 | 130,894 | 111,080 | 139,011 | 108,358 | |||||||||||||||||
(58,703 | ) | (56,574 | ) | (79,744 | ) | (49,131 | ) | (36,500 | ) | (29,689 | ) | |||||||||||
98 | (4,767 | ) | (6,655 | ) | (3,052 | ) | (1,004 | ) | (424 | ) | ||||||||||||
(83,602 | ) | 106,738 | 28,517 | 137,726 | (918,946 | ) | 41,493 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(117,502 | ) | 72,933 | 73,012 | 196,623 | (817,439 | ) | 119,738 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(15,104 | ) | 114,172 | 269,651 | 289,197 | (671,902 | ) | 189,098 | |||||||||||||||
358,273 | 244,101 | 840,362 | 551,165 | 671,902 | 482,804 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 343,169 | $ | 358,273 | $ | 1,110,013 | $ | 840,362 | — | $ | 671,902 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
23
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Core Bond Trust Series 0 | Core Bond Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 10,784 | $ | 11,972 | $ | 2,943 | $ | 3,807 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
10,784 | 11,972 | 2,943 | 3,807 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
18,987 | 9,928 | 5,281 | 3,745 | ||||||||||||
Net realized gains (losses) |
(2,192 | ) | 43,119 | 273 | 1,391 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
16,795 | 53,047 | 5,554 | 5,136 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
(37,644 | ) | (5,047 | ) | (11,527 | ) | (19 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
(10,065 | ) | 59,972 | (3,030 | ) | 8,924 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
38,629 | 46,042 | — | — | ||||||||||||
Transfer on terminations |
(18,079 | ) | (20,904 | ) | (2,650 | ) | (3,739 | ) | ||||||||
Transfer on policy loans |
(2,058 | ) | (7,431 | ) | — | — | ||||||||||
Net interfund transfers |
24,896 | 215,445 | — | (9,594 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
43,388 | 233,152 | (2,650 | ) | (13,333 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
33,323 | 293,124 | (5,680 | ) | (4,409 | ) | ||||||||||
Assets, beginning of period |
470,138 | 177,014 | 141,400 | 145,809 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 503,461 | $ | 470,138 | $ | 135,720 | $ | 141,400 | ||||||||
|
|
|
|
|
|
|
|
(z) | Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. |
See accompanying notes.
24
Sub-Account | ||||||||||||||||||||||
Core Strategy Trust Series 0 | Disciplined Diversification Trust Series 0 | Emerging Markets Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 (z) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 35,171 | $ | 70,005 | $ | 23,057 | $ | 11,570 | $ | 39,627 | $ | 30,299 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
35,171 | 70,005 | 23,057 | 11,570 | 39,627 | 30,299 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
310,312 | — | 264,402 | 5,954 | 101,028 | 186,981 | |||||||||||||||||
33,119 | 132,969 | (165,433 | ) | 3,229 | (45,954 | ) | (100,657 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
343,431 | 132,969 | 98,969 | 9,183 | 55,074 | 86,324 | |||||||||||||||||
173,080 | 236,612 | (44,219 | ) | 32,695 | (191,614 | ) | 245,927 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
551,682 | 439,586 | 77,807 | 53,448 | (96,913 | ) | 362,550 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
378,869 | 260,161 | 43,660 | 37,964 | 117,372 | 103,211 | |||||||||||||||||
(329,052 | ) | (195,602 | ) | (31,280 | ) | (29,330 | ) | (92,796 | ) | (77,900 | ) | |||||||||||
(9,154 | ) | (1,487 | ) | (4,109 | ) | (1,277 | ) | (2,144 | ) | (1,742 | ) | |||||||||||
2,464,153 | (1,855,121 | ) | (586,715 | ) | 28,408 | 60,142 | 731,362 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
2,504,816 | (1,792,049 | ) | (578,444 | ) | 35,765 | 82,574 | 754,931 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3,056,498 | (1,352,463 | ) | (500,637 | ) | 89,213 | (14,339 | ) | 1,117,481 | ||||||||||||||
2,580,442 | 3,932,905 | 500,637 | 411,424 | 2,970,118 | 1,852,637 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 5,636,940 | $ | 2,580,442 | — | $ | 500,637 | $ | 2,955,779 | $ | 2,970,118 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
25
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Emerging Markets Value Trust Series 1 | Equity-Income Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 79 | $ | 70 | $ | 123,309 | $ | 124,224 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
79 | 70 | 123,309 | 124,224 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
209 | 462 | — | — | ||||||||||||
Net realized gains (losses) |
(50 | ) | (7,513 | ) | 152,807 | (11,333 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
159 | (7,051 | ) | 152,807 | (11,333 | ) | ||||||||||
Unrealized appreciation (depreciation) during the period |
(439 | ) | 8,930 | 1,347,859 | 360,237 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
(201 | ) | 1,949 | 1,623,975 | 473,128 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
— | 59 | 172,781 | 406,980 | ||||||||||||
Transfer on terminations |
(383 | ) | (10,210 | ) | (831,703 | ) | (338,332 | ) | ||||||||
Transfer on policy loans |
— | — | (14,747 | ) | (324 | ) | ||||||||||
Net interfund transfers |
122 | (10,952 | ) | (44,846 | ) | 3,639,456 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(261 | ) | (21,103 | ) | (718,515 | ) | 3,707,780 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(462 | ) | (19,154 | ) | 905,460 | 4,180,908 | ||||||||||
Assets, beginning of period |
6,521 | 25,675 | 6,015,928 | 1,835,020 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 6,059 | $ | 6,521 | $ | 6,921,388 | $ | 6,015,928 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
26
Sub-Account | ||||||||||||||||||||||
Equity-Income Trust Series 1 | Financial Services Trust Series 0 | Financial Services Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 15,080 | $ | 14,008 | $ | 2,773 | $ | 2,502 | $ | 827 | $ | 851 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
15,080 | 14,008 | 2,773 | 2,502 | 827 | 851 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | 4,213 | — | 1,368 | — | |||||||||||||||||
91,548 | 14,801 | 8,646 | 63,967 | (1,413 | ) | (2,153 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
91,548 | 14,801 | 12,859 | 63,967 | (45 | ) | (2,153 | ) | |||||||||||||||
103,365 | 75,635 | 84,638 | 23,403 | 33,053 | 18,683 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
209,993 | 104,444 | 100,270 | 89,872 | 33,835 | 17,381 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
52,014 | 59,077 | 41,037 | 52,294 | 1,173 | 1,031 | |||||||||||||||||
(116,461 | ) | (48,467 | ) | (40,685 | ) | (36,261 | ) | (3,982 | ) | (4,418 | ) | |||||||||||
— | (95 | ) | 322 | (49 | ) | — | — | |||||||||||||||
(37,722 | ) | (5,820 | ) | 33,983 | (149,508 | ) | (48 | ) | (37 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(102,169 | ) | 4,695 | 34,657 | (133,524 | ) | (2,857 | ) | (3,424 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
107,824 | 109,139 | 134,927 | (43,652 | ) | 30,978 | 13,957 | ||||||||||||||||
698,291 | 589,152 | 312,473 | 356,125 | 111,115 | 97,158 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 806,115 | $ | 698,291 | $ | 447,400 | $ | 312,473 | $ | 142,093 | $ | 111,115 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
27
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Franklin Templeton Founding Allocation Trust Series 0 |
Franklin Templeton Founding Allocation Trust Series 1 |
|||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (r) |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 43,350 | $ | 36,409 | $ | 48 | — | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
43,350 | 36,409 | 48 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
21,845 | 3,411 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
21,845 | 3,411 | — | — | ||||||||||||
Unrealized appreciation (depreciation) during the period |
265,970 | 98,419 | (8 | ) | — | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
331,165 | 138,239 | 40 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
309,406 | 275,782 | — | — | ||||||||||||
Transfer on terminations |
(122,258 | ) | (74,932 | ) | (31 | ) | — | |||||||||
Transfer on policy loans |
(6,219 | ) | (6,470 | ) | — | — | ||||||||||
Net interfund transfers |
162,229 | 267,395 | 2,147 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
343,158 | 461,775 | 2,116 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
674,323 | 600,014 | 2,156 | — | ||||||||||||
Assets, beginning of period |
1,216,471 | 616,457 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 1,890,794 | $ | 1,216,471 | $ | 2,156 | — | |||||||||
|
|
|
|
|
|
|
|
(r) | Fund available but no activity. |
See accompanying notes.
28
Sub-Account | ||||||||||||||||||||||
Frontier Capital Appreciation | Fundamental All Cap Core Trust Series 0 | Fundamental All Cap Core Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
— | $ | 14 | $ | 4,329 | $ | 1,290 | $ | 11 | $ | 3 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | 14 | 4,329 | 1,290 | 11 | 3 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
4,105 | 274 | — | — | — | — | |||||||||||||||||
73 | (4 | ) | 17,070 | 45,829 | 132 | 88 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
4,178 | 270 | 17,070 | 45,829 | 132 | 88 | |||||||||||||||||
1,180 | 265 | 96,360 | 110,860 | 1,044 | (21 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
5,358 | 549 | 117,759 | 157,979 | 1,187 | 70 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
1,666 | 1,498 | 24,725 | 25,479 | 2,119 | 2,133 | |||||||||||||||||
(557 | ) | (343 | ) | (29,215 | ) | (30,149 | ) | (1,596 | ) | (2,402 | ) | |||||||||||
— | — | 1,373 | (590 | ) | — | (96 | ) | |||||||||||||||
43,738 | 97 | 243,029 | (1,023,578 | ) | 33,009 | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
44,847 | 1,252 | 239,912 | (1,028,838 | ) | 33,532 | (365 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
50,205 | 1,801 | 357,671 | (870,859 | ) | 34,719 | (295 | ) | |||||||||||||||
4,505 | 2,704 | 173,316 | 1,044,175 | 396 | 691 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 54,710 | $ | 4,505 | $ | 530,987 | $ | 173,316 | $ | 35,115 | $ | 396 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
29
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Fundamental Holdings Trust Series 1 | Fundamental Large Cap Value Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 (z) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 3,860 | $ | 2,846 | $ | 4,371 | $ | 385 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
3,860 | 2,846 | 4,371 | 385 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
74,040 | — | — | — | ||||||||||||
Net realized gains (losses) |
(43,649 | ) | 995 | 5,349 | 324 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
30,391 | 995 | 5,349 | 324 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
(10,369 | ) | 13,164 | 76,131 | 3,344 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
23,882 | 17,005 | 85,851 | 4,053 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
28,081 | 25,120 | 28,493 | 2,758 | ||||||||||||
Transfer on terminations |
(39,480 | ) | (14,842 | ) | (24,822 | ) | (3,013 | ) | ||||||||
Transfer on policy loans |
(2,939 | ) | (4,909 | ) | (7,164 | ) | — | |||||||||
Net interfund transfers |
(177,470 | ) | 15,752 | 1,134,681 | 19,124 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(191,808 | ) | 21,121 | 1,131,188 | 18,869 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(167,926 | ) | 38,126 | 1,217,039 | 22,922 | |||||||||||
Assets, beginning of period |
167,926 | 129,800 | 35,444 | 12,522 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
— | $ | 167,926 | $ | 1,252,483 | $ | 35,444 | |||||||||
|
|
|
|
|
|
|
|
(z) | Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. |
(n) | Fund available in prior year but no activity. |
See accompanying notes.
30
Sub-Account | ||||||||||||||||||||||
Fundamental Large Cap Value Trust Series 1 | Fundamental Value Trust Series 0 | Fundamental Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (n) |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
— | — | $ | 3,521 | $ | 3,347 | $ | 7,633 | $ | 4,502 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | 3,521 | 3,347 | 7,633 | 4,502 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | — | — | |||||||||||||||||
3 | 357 | 35,391 | 17,647 | 30,135 | 66,513 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3 | 357 | 35,391 | 17,647 | 30,135 | 66,513 | |||||||||||||||||
3,701 | — | 41,763 | 17,553 | 125,374 | 1,457 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3,704 | 357 | 80,675 | 38,547 | 163,142 | 72,472 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
97 | 111 | 42,458 | 75,917 | 41,608 | 47,108 | |||||||||||||||||
(320 | ) | (24,707 | ) | (181,480 | ) | (47,459 | ) | (77,680 | ) | (173,634 | ) | |||||||||||
— | — | (2,759 | ) | (1 | ) | (263 | ) | (365 | ) | |||||||||||||
131,645 | 24,239 | (2,134 | ) | (3,617 | ) | 215 | (63,157 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
131,422 | (357 | ) | (143,915 | ) | 24,840 | (36,120 | ) | (190,048 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
135,126 | — | (63,240 | ) | 63,387 | 127,022 | (117,576 | ) | |||||||||||||||
— | — | 352,963 | 289,576 | 490,620 | 608,196 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 135,126 | — | $ | 289,723 | $ | 352,963 | $ | 617,642 | $ | 490,620 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
31
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Global Bond Trust Series 0 | Global Bond Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 4,809 | $ | 124,872 | $ | 838 | $ | 16,084 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
4,809 | 124,872 | 838 | 16,084 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
(45,803 | ) | 1,429 | 1,436 | (7,158 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
(45,803 | ) | 1,429 | 1,436 | (7,158 | ) | ||||||||||
Unrealized appreciation (depreciation) during the period |
(62,403 | ) | (419 | ) | (14,038 | ) | 7,104 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
(103,397 | ) | 125,882 | (11,764 | ) | 16,030 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
82,960 | 89,939 | 9,107 | 9,196 | ||||||||||||
Transfer on terminations |
(72,010 | ) | (82,955 | ) | (56,212 | ) | (10,181 | ) | ||||||||
Transfer on policy loans |
(5,828 | ) | (2,641 | ) | — | — | ||||||||||
Net interfund transfers |
(763,526 | ) | 933,784 | (6,309 | ) | (53,711 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(758,404 | ) | 938,127 | (53,414 | ) | (54,696 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(861,801 | ) | 1,064,009 | (65,178 | ) | (38,666 | ) | |||||||||
Assets, beginning of period |
1,783,116 | 719,107 | 235,410 | 274,076 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 921,315 | $ | 1,783,116 | $ | 170,232 | $ | 235,410 | ||||||||
|
|
|
|
|
|
|
|
(z) | Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. |
See accompanying notes.
32
Sub-Account | ||||||||||||||||||||||
Global Diversification Trust Series 1 | Global Trust Series 0 | Global Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 (z) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 7,469 | $ | 4,859 | $ | 1,828 | $ | 1,430 | $ | 1,424 | $ | 19,267 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
7,469 | 4,859 | 1,828 | 1,430 | 1,424 | 19,267 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
104,512 | — | — | — | — | — | |||||||||||||||||
(46,006 | ) | 1,112 | 2,384 | 1,430 | 186,652 | 3,040 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
58,506 | 1,112 | 2,384 | 1,430 | 186,652 | 3,040 | |||||||||||||||||
(22,528 | ) | 31,757 | 24,185 | 10,067 | (87,485 | ) | 151,944 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
43,447 | 37,728 | 28,397 | 12,927 | 100,591 | 174,251 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
57,702 | 39,760 | 15,984 | 13,587 | 589 | 633 | |||||||||||||||||
(63,616 | ) | (32,902 | ) | (9,349 | ) | (8,934 | ) | (10,679 | ) | (31,087 | ) | |||||||||||
(5,522 | ) | (1,295 | ) | — | — | — | (386 | ) | ||||||||||||||
(325,881 | ) | 25,826 | 26,412 | (14,039 | ) | (944,520 | ) | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(337,317 | ) | 31,389 | 33,047 | (9,386 | ) | (954,610 | ) | (30,840 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(293,870 | ) | 69,117 | 61,444 | 3,541 | (854,019 | ) | 143,411 | |||||||||||||||
293,870 | 224,753 | 68,758 | 65,217 | 957,336 | 813,925 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | $ | 293,870 | $ | 130,202 | $ | 68,758 | $ | 103,317 | $ | 957,336 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
33
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Health Sciences Trust Series 0 | Health Sciences Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
55,120 | 25,345 | 21,030 | 15,376 | ||||||||||||
Net realized gains (losses) |
16,597 | 42,990 | 18,428 | 17,158 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
71,717 | 68,335 | 39,458 | 32,534 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
168,342 | 10,237 | 60,864 | 27,649 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
240,059 | 78,572 | 100,322 | 60,183 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
38,658 | 41,544 | 3,278 | 3,771 | ||||||||||||
Transfer on terminations |
(44,168 | ) | (22,678 | ) | (18,940 | ) | (15,307 | ) | ||||||||
Transfer on policy loans |
(8,363 | ) | (59 | ) | (22,311 | ) | (32,771 | ) | ||||||||
Net interfund transfers |
172,099 | 164,567 | 20,714 | 10,196 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
158,226 | 183,374 | (17,259 | ) | (34,111 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
398,285 | 261,946 | 83,063 | 26,072 | ||||||||||||
Assets, beginning of period |
434,383 | 172,437 | 209,633 | 183,561 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 832,668 | $ | 434,383 | $ | 292,696 | $ | 209,633 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
34
Sub-Account | ||||||||||||||||||||||
High Yield Trust Series 0 | High Yield Trust Series 1 | International Core Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 94,016 | $ | 433,187 | $ | 16,825 | $ | 17,372 | $ | 9,462 | $ | 14,925 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
94,016 | 433,187 | 16,825 | 17,372 | 9,462 | 14,925 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | — | — | |||||||||||||||||
213,969 | (55,761 | ) | (23,426 | ) | (6,347 | ) | 33,315 | 2,241 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
213,969 | (55,761 | ) | (23,426 | ) | (6,347 | ) | 33,315 | 2,241 | ||||||||||||||
(48,715 | ) | 356,285 | 26,649 | 26,705 | 35,429 | 56,552 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
259,270 | 733,711 | 20,048 | 37,730 | 78,206 | 73,718 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
120,001 | 109,509 | 7,966 | 9,123 | 23,252 | 72,366 | |||||||||||||||||
(332,464 | ) | (140,798 | ) | (26,163 | ) | (10,896 | ) | (358,036 | ) | (21,685 | ) | |||||||||||
(3,451 | ) | (5,491 | ) | — | — | (7,587 | ) | — | ||||||||||||||
(4,308,247 | ) | 2,928,548 | (7,281 | ) | 803 | 79,168 | (184,635 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(4,524,161 | ) | 2,891,768 | (25,478 | ) | (970 | ) | (263,203 | ) | (133,954 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(4,264,891 | ) | 3,625,479 | (5,430 | ) | 36,760 | (184,997 | ) | (60,236 | ) | |||||||||||||
5,835,684 | 2,210,205 | 234,984 | 198,224 | 558,510 | 618,746 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,570,793 | $ | 5,835,684 | $ | 229,554 | $ | 234,984 | $ | 373,513 | $ | 558,510 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
35
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||
International Core Trust Series 1 | International Equity Index Trust A Series 0 | |||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|
Year Ended Dec. 31/12 (u) |
|||||||||||
Income: |
||||||||||||||
Dividend income distribution |
$ | 2,395 | $ | 2,203 | $ | 11,000 | ||||||||
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
2,395 | 2,203 | 11,000 | |||||||||||
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||
Capital gain distributions |
— | — | 19,485 | |||||||||||
Net realized gains (losses) |
6,789 | (2,685 | ) | (130,662 | ) | |||||||||
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
6,789 | (2,685 | ) | (111,177 | ) | |||||||||
Unrealized appreciation (depreciation) during the period |
9,724 | 10,903 | 141,923 | |||||||||||
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
18,908 | 10,421 | 41,746 | |||||||||||
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||
Transfer of net premiums |
4,616 | 6,292 | 30,772 | |||||||||||
Transfer on terminations |
(20,412 | ) | (7,711 | ) | (21,119 | ) | ||||||||
Transfer on policy loans |
(4,323 | ) | 11 | (10 | ) | |||||||||
Net interfund transfers |
(594 | ) | 13 | (425,904 | ) | |||||||||
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(20,713 | ) | (1,395 | ) | (416,261 | ) | ||||||||
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(1,805 | ) | 9,026 | (374,515 | ) | |||||||||
Assets, beginning of period |
80,182 | 71,156 | 374,515 | |||||||||||
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 78,377 | $ | 80,182 | — | |||||||||
|
|
|
|
|
|
(u) | Terminated as an investment option and funds transferred to International Equity Index Trust B on November 5, 2012. |
(s) | Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012. |
See accompanying notes.
36
Sub-Account | ||||||||||||||||||||
International Equity Index Trust A Series 1 | International Equity Index Trust B Series 0 | International Equity Index Trust B Series 1 | ||||||||||||||||||
Year Ended Dec. 31/12 (u) |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (s) |
||||||||||||||||
$ | 6,621 | $ | 106,275 | $ | 48,154 | $ | 6,366 | $ | 2,797 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
6,621 | 106,275 | 48,154 | 6,366 | 2,797 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
11,740 | — | — | — | — | ||||||||||||||||
(88,158 | ) | 53,848 | (159,639 | ) | 2,684 | 12 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(76,418 | ) | 53,848 | (159,639 | ) | 2,684 | 12 | ||||||||||||||
97,105 | 418,558 | 773,701 | 26,449 | 12,054 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
27,308 | 578,681 | 662,216 | 35,499 | 14,863 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
9,877 | 192,792 | 180,702 | 10,998 | 1,386 | ||||||||||||||||
(8,052 | ) | (154,861 | ) | (123,250 | ) | (7,722 | ) | (1,934 | ) | |||||||||||
— | (6,576 | ) | (9,902 | ) | — | — | ||||||||||||||
(288,640 | ) | (180,027 | ) | (450,958 | ) | (22,313 | ) | 247,911 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(286,815 | ) | (148,672 | ) | (403,408 | ) | (19,037 | ) | 247,363 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(259,507 | ) | 430,009 | 258,808 | 16,462 | 262,226 | |||||||||||||||
259,507 | 4,222,165 | 3,963,357 | 262,226 | — | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | $ | 4,652,174 | $ | 4,222,165 | $ | 278,688 | $ | 262,226 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
37
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
International Growth Stock Trust Series 0 | International Growth Stock Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (s) |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (s) |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 7,141 | $ | 3,660 | $ | 2,329 | $ | 1,052 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
7,141 | 3,660 | 2,329 | 1,052 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
4,458 | 10 | 422 | 3 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
4,458 | 10 | 422 | 3 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
90,465 | 18,240 | 30,551 | 5,558 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
102,064 | 21,910 | 33,302 | 6,613 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
46,072 | 9,108 | 11,275 | 1,549 | ||||||||||||
Transfer on terminations |
(50,320 | ) | (3,292 | ) | (5,095 | ) | (805 | ) | ||||||||
Transfer on policy loans |
(1,959 | ) | (111 | ) | — | — | ||||||||||
Net interfund transfers |
(13,533 | ) | 529,512 | 1,299 | 162,099 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(19,740 | ) | 535,217 | 7,479 | 162,843 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
82,324 | 557,127 | 40,781 | 169,456 | ||||||||||||
Assets, beginning of period |
557,127 | — | 169,456 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 639,451 | $ | 557,127 | $ | 210,237 | $ | 169,456 | ||||||||
|
|
|
|
|
|
|
|
(s) | Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012. |
(t) | Terminated as an investment option and funds transferred to International Growth Stock Trust on November 5, 2012. |
See accompanying notes.
38
Sub-Account | ||||||||||||||||||
International Opportunities Trust Series 0 | International Opportunities Trust Series 1 | International Small Company Trust Series 0 | ||||||||||||||||
Year Ended Dec. 31/12 (t) |
Year Ended Dec. 31/12 (t) |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||
$ | 10,664 | $ | 3,185 | $ | 7,743 | $ | 4,108 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||||
10,664 | 3,185 | 7,743 | 4,108 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | |||||||||||||||
9,239 | (44,355 | ) | 5,804 | (59,498 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
9,239 | (44,355 | ) | 5,804 | (59,498 | ) | |||||||||||||
4,135 | 53,310 | 75,986 | 196,179 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
24,038 | 12,140 | 89,533 | 140,789 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
40,910 | 9,852 | 32,479 | 48,301 | |||||||||||||||
(31,611 | ) | (4,011 | ) | (23,933 | ) | (25,687 | ) | |||||||||||
(143 | ) | — | (2,908 | ) | (854 | ) | ||||||||||||
(305,904 | ) | (161,070 | ) | 44,338 | (715,814 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
(296,748 | ) | (155,229 | ) | 49,976 | (694,054 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
(272,710 | ) | (143,089 | ) | 139,509 | (553,265 | ) | ||||||||||||
272,710 | 143,089 | 325,389 | 878,654 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
— | — | $ | 464,898 | $ | 325,389 | |||||||||||||
|
|
|
|
|
|
|
|
39
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
International Small Company Trust Series 1 | International Value Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 908 | $ | 524 | $ | 6,132 | $ | 9,056 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
908 | 524 | 6,132 | 9,056 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
1,617 | 2,353 | 13,939 | (6,461 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
1,617 | 2,353 | 13,939 | (6,461 | ) | |||||||||||
Unrealized appreciation (depreciation) during the period |
8,705 | 7,106 | 53,163 | 56,391 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
11,230 | 9,983 | 73,234 | 58,986 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
4,708 | 4,198 | 38,028 | 47,629 | ||||||||||||
Transfer on terminations |
(1,950 | ) | (1,918 | ) | (50,662 | ) | (109,503 | ) | ||||||||
Transfer on policy loans |
(183 | ) | (178 | ) | (10,724 | ) | (466 | ) | ||||||||
Net interfund transfers |
(5,969 | ) | (25,895 | ) | 93,593 | (37,759 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(3,394 | ) | (23,793 | ) | 70,235 | (100,099 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
7,836 | (13,810 | ) | 143,469 | (41,113 | ) | ||||||||||
Assets, beginning of period |
42,064 | 55,874 | 285,268 | 326,381 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 49,900 | $ | 42,064 | $ | 428,737 | $ | 285,268 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
40
Sub-Account | ||||||||||||||||||||||
International Value Trust Series 1 | Investment Quality Bond Trust Series 0 | Investment Quality Bond Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 5,204 | $ | 25,731 | $ | 6,396 | $ | 51,559 | $ | 8,498 | $ | 4,432 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
5,204 | 25,731 | 6,396 | 51,559 | 8,498 | 4,432 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | 3,186 | — | 4,187 | — | |||||||||||||||||
49,640 | (12,287 | ) | (33,851 | ) | 1,379 | 370 | 6,313 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
49,640 | (12,287 | ) | (30,665 | ) | 1,379 | 4,557 | 6,313 | |||||||||||||||
26,387 | 153,609 | (52,283 | ) | 44,553 | (17,334 | ) | 5,448 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
81,231 | 167,053 | (76,552 | ) | 97,491 | (4,279 | ) | 16,193 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
22,377 | 24,922 | 28,091 | 25,097 | 7,050 | 4,882 | |||||||||||||||||
(45,770 | ) | (54,050 | ) | (52,679 | ) | (49,049 | ) | (6,355 | ) | (110,704 | ) | |||||||||||
119 | 183 | (2,220 | ) | (1,896 | ) | 225 | (12,835 | ) | ||||||||||||||
(765,066 | ) | 37,879 | (2,178,689 | ) | 2,238,256 | 7,621 | 79,053 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(788,340 | ) | 8,934 | (2,205,497 | ) | 2,212,408 | 8,541 | (39,604 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(707,109 | ) | 175,987 | (2,282,049 | ) | 2,309,899 | 4,262 | (23,411 | ) | ||||||||||||||
1,038,305 | 862,318 | 2,439,155 | 129,256 | 217,852 | 241,263 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 331,196 | $ | 1,038,305 | $ | 157,106 | $ | 2,439,155 | $ | 222,114 | $ | 217,852 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
41
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||
Large Cap Growth | Large Cap Trust Series 0 | |||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/12 (f) |
||||||||||||
Income: |
||||||||||||||
Dividend income distribution |
$ | 553 | $ | 27 | $ | 2,112 | ||||||||
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
553 | 27 | 2,112 | |||||||||||
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||
Capital gain distributions |
6,520 | — | — | |||||||||||
Net realized gains (losses) |
3,596 | 1,204 | 45,268 | |||||||||||
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
10,116 | 1,204 | 45,268 | |||||||||||
Unrealized appreciation (depreciation) during the period |
18,252 | 7,321 | (62 | ) | ||||||||||
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
28,921 | 8,552 | 47,318 | |||||||||||
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||
Transfer of net premiums |
22,726 | 22,693 | 15,818 | |||||||||||
Transfer on terminations |
(9,304 | ) | (8,377 | ) | (9,703 | ) | ||||||||
Transfer on policy loans |
— | — | (1 | ) | ||||||||||
Net interfund transfers |
38,154 | (77 | ) | (388,635 | ) | |||||||||
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
51,576 | 14,239 | (382,521 | ) | ||||||||||
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
80,497 | 22,791 | (335,203 | ) | ||||||||||
Assets, beginning of period |
55,847 | 33,056 | 335,203 | |||||||||||
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 136,344 | $ | 55,847 | — | |||||||||
|
|
|
|
|
|
(f) | Terminated as an investment option and funds transferred to U.S. Equity Trust on April 30, 2012. |
(ag) | Renamed on April 29, 2013. Previously known as Business Opportunity Value. |
See accompanying notes.
42
Sub-Account | ||||||||||||||||||||
Large Cap Trust Series 1 | Large Cap Value | Lifestyle Aggressive Trust Series 0 | ||||||||||||||||||
Year Ended Dec. 31/12 (f) |
Year Ended Dec. 31/13 (ag) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
||||||||||||||||
$ | 378 | $ | 1,444 | $ | 163 | $ | 225,358 | $ | 115,148 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
378 | 1,444 | 163 | 225,358 | 115,148 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | 6,574 | — | — | — | ||||||||||||||||
6,205 | 2,093 | 337 | 366,943 | (47,214 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
6,205 | 8,667 | 337 | 366,943 | (47,214 | ) | |||||||||||||||
2,640 | 2,236 | 2,509 | 1,416,586 | 917,828 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
9,223 | 12,347 | 3,009 | 2,008,887 | 985,762 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
2,306 | 5,532 | 5,255 | 1,531,534 | 1,638,827 | ||||||||||||||||
(2,091 | ) | (1,277 | ) | (1,422 | ) | (2,139,249 | ) | (534,252 | ) | |||||||||||
— | — | — | (78,293 | ) | (42,075 | ) | ||||||||||||||
(76,687 | ) | 46,577 | (210 | ) | 209,690 | 1,294,203 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(76,472 | ) | 50,832 | 3,623 | (476,318 | ) | 2,356,703 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
(67,249 | ) | 63,179 | 6,632 | 1,532,569 | 3,342,465 | |||||||||||||||
67,249 | 21,462 | 14,830 | 8,248,307 | 4,905,842 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | $ | 84,641 | $ | 21,462 | $ | 9,780,876 | $ | 8,248,307 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
43
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Lifestyle Aggressive Trust Series 1 | Lifestyle Balanced Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 13,725 | $ | 6,154 | $ | 708,124 | $ | 473,372 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
13,725 | 6,154 | 708,124 | 473,372 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
4,723 | (1,495 | ) | 544,396 | 143,339 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
4,723 | (1,495 | ) | 544,396 | 143,339 | |||||||||||
Unrealized appreciation (depreciation) during the period |
106,914 | 56,778 | 1,537,162 | 1,254,838 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
125,362 | 61,437 | 2,789,682 | 1,871,549 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
55,167 | 68,092 | 2,819,331 | 2,335,658 | ||||||||||||
Transfer on terminations |
(17,890 | ) | (16,772 | ) | (2,480,571 | ) | (1,531,256 | ) | ||||||||
Transfer on policy loans |
(8,036 | ) | (2,550 | ) | (93,347 | ) | (170,918 | ) | ||||||||
Net interfund transfers |
— | — | 1,891,725 | 4,884,895 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
29,241 | 48,770 | 2,137,138 | 5,518,379 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
154,603 | 110,207 | 4,926,820 | 7,389,928 | ||||||||||||
Assets, beginning of period |
452,335 | 342,128 | 21,243,036 | 13,853,108 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 606,938 | $ | 452,335 | $ | 26,169,856 | $ | 21,243,036 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
44
Sub-Account | ||||||||||||||||||||||
Lifestyle Balanced Trust Series 1 | Lifestyle Conservative Trust Series 0 | Lifestyle Conservative Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 137,801 | $ | 101,840 | $ | 117,616 | $ | 98,208 | $ | 5,194 | $ | 4,151 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
137,801 | 101,840 | 117,616 | 98,208 | 5,194 | 4,151 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | 109,843 | 67,053 | 4,798 | 3,143 | |||||||||||||||||
9,534 | (7,186 | ) | 25,960 | 24,686 | 61 | (88 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
9,534 | (7,186 | ) | 135,803 | 91,739 | 4,859 | 3,055 | ||||||||||||||||
432,583 | 400,993 | (121,378 | ) | 43,647 | (4,400 | ) | 4,562 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
579,918 | 495,647 | 132,041 | 233,594 | 5,653 | 11,768 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
44,990 | 41,200 | 344,345 | 501,612 | — | — | |||||||||||||||||
(160,023 | ) | (147,230 | ) | (881,229 | ) | (209,152 | ) | (4,996 | ) | (5,631 | ) | |||||||||||
(11,774 | ) | (56,093 | ) | 4,750 | (17,557 | ) | — | (100 | ) | |||||||||||||
3,220 | 289 | 264,576 | 749,827 | 1,758 | 1,443 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(123,587 | ) | (161,834 | ) | (267,558 | ) | 1,024,730 | (3,238 | ) | (4,288 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
456,331 | 333,813 | (135,517 | ) | 1,258,324 | 2,415 | 7,480 | ||||||||||||||||
4,592,077 | 4,258,264 | 3,481,888 | 2,223,564 | 147,084 | 139,604 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 5,048,408 | $ | 4,592,077 | $ | 3,346,371 | $ | 3,481,888 | $ | 149,499 | $ | 147,084 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
45
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Lifestyle Growth Trust Series 0 | Lifestyle Growth Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 678,193 | $ | 399,475 | $ | 53,092 | $ | 34,116 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
678,193 | 399,475 | 53,092 | 34,116 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
507,881 | 373,264 | (4,364 | ) | (14,796 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
507,881 | 373,264 | (4,364 | ) | (14,796 | ) | ||||||||||
Unrealized appreciation (depreciation) during the period |
3,243,650 | 1,874,699 | 319,982 | 213,504 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
4,429,724 | 2,647,438 | 368,710 | 232,824 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
3,184,960 | 3,214,879 | 104,723 | 95,921 | ||||||||||||
Transfer on terminations |
(2,186,250 | ) | (3,090,575 | ) | (81,691 | ) | (78,099 | ) | ||||||||
Transfer on policy loans |
(261,388 | ) | (188,888 | ) | (6,924 | ) | (22,617 | ) | ||||||||
Net interfund transfers |
1,631,124 | 431,707 | (10,245 | ) | 1,958 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
2,368,446 | 367,123 | 5,863 | (2,837 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
6,798,170 | 3,014,561 | 374,573 | 229,987 | ||||||||||||
Assets, beginning of period |
21,845,708 | 18,831,147 | 1,897,471 | 1,667,484 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 28,643,878 | $ | 21,845,708 | $ | 2,272,044 | $ | 1,897,471 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
46
Sub-Account | ||||||||||||||||||||||
Lifestyle Moderate Trust Series 0 | Lifestyle Moderate Trust Series 1 | Mid Cap Index Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 171,212 | $ | 100,854 | $ | 27,659 | $ | 22,378 | $ | 36,721 | $ | 37,331 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
171,212 | 100,854 | 27,659 | 22,378 | 36,721 | 37,331 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | 176,442 | 236,979 | |||||||||||||||||
78,474 | 10,746 | 773 | (13,890 | ) | 54,220 | 25,170 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
78,474 | 10,746 | 773 | (13,890 | ) | 230,662 | 262,149 | ||||||||||||||||
210,097 | 909,809 | 63,503 | 83,932 | 608,852 | (79,917 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
459,783 | 1,021,409 | 91,935 | 92,420 | 876,235 | 219,563 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
507,916 | 611,959 | 10,802 | 25,680 | 157,628 | 183,707 | |||||||||||||||||
(674,094 | ) | (392,594 | ) | (49,825 | ) | (26,328 | ) | (120,974 | ) | (87,705 | ) | |||||||||||
(13,970 | ) | (27,983 | ) | (1,626 | ) | (133,569 | ) | (11,651 | ) | (5,333 | ) | |||||||||||
1,368,386 | (12,535,903 | ) | — | — | 121,595 | 1,187,222 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
1,188,238 | (12,344,521 | ) | (40,649 | ) | (134,217 | ) | 146,598 | 1,277,891 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
1,648,021 | (11,323,112 | ) | 51,286 | (41,797 | ) | 1,022,833 | 1,497,454 | |||||||||||||||
4,035,304 | 15,358,416 | 909,650 | 951,447 | 2,629,705 | 1,132,251 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 5,683,325 | $ | 4,035,304 | $ | 960,936 | $ | 909,650 | $ | 3,652,538 | $ | 2,629,705 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
47
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Mid Cap Index Trust Series 1 | Mid Cap Stock Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 3,075 | $ | 3,403 | $ | 481 | — | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
3,075 | 3,403 | 481 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
15,241 | 23,023 | 13,126 | — | ||||||||||||
Net realized gains (losses) |
2,771 | 924 | 72,814 | 13,828 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
18,012 | 23,947 | 85,940 | 13,828 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
59,075 | 9,528 | 155,407 | 127,050 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
80,162 | 36,878 | 241,828 | 140,878 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
11,822 | 7,495 | 57,662 | 119,585 | ||||||||||||
Transfer on terminations |
(10,432 | ) | (11,844 | ) | (412,206 | ) | (64,448 | ) | ||||||||
Transfer on policy loans |
— | (5 | ) | (2,798 | ) | (916 | ) | |||||||||
Net interfund transfers |
9,955 | (2,706 | ) | 140,485 | 60,886 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
11,345 | (7,060 | ) | (216,857 | ) | 115,107 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
91,507 | 29,818 | 24,971 | 255,985 | ||||||||||||
Assets, beginning of period |
242,693 | 212,875 | 886,676 | 630,691 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 334,200 | $ | 242,693 | $ | 911,647 | $ | 886,676 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
48
Sub-Account | ||||||||||||||||||||||
Mid Cap Stock Trust Series 1 | Mid Value Trust Series 0 | Mid Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 129 | — | $ | 9,314 | $ | 10,691 | $ | 2,478 | $ | 1,659 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
129 | — | 9,314 | 10,691 | 2,478 | 1,659 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
6,443 | — | 58,094 | 91,886 | 16,190 | 15,001 | |||||||||||||||||
4,188 | (2,455 | ) | 62,046 | 14,061 | 24,272 | 28,021 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
10,631 | (2,455 | ) | 120,140 | 105,947 | 40,462 | 43,022 | ||||||||||||||||
97,629 | 59,034 | 118,368 | 68,582 | 19,359 | (5,623 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
108,389 | 56,579 | 247,822 | 185,220 | 62,299 | 39,058 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
16,461 | 17,817 | 45,989 | 146,914 | 16,291 | 16,956 | |||||||||||||||||
(24,967 | ) | (34,651 | ) | (586,821 | ) | (133,833 | ) | (52,552 | ) | (18,915 | ) | |||||||||||
(1,366 | ) | (387 | ) | (3,985 | ) | (782 | ) | (158 | ) | (139 | ) | |||||||||||
(2,465 | ) | 280 | 49,759 | 186,349 | (3,528 | ) | (60,981 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(12,337 | ) | (16,941 | ) | (495,058 | ) | 198,648 | (39,947 | ) | (63,079 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
96,052 | 39,638 | (247,236 | ) | 383,868 | 22,352 | (24,021 | ) | |||||||||||||||
295,880 | 256,242 | 1,196,393 | 812,525 | 204,439 | 228,460 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 391,932 | $ | 295,880 | $ | 949,157 | $ | 1,196,393 | $ | 226,791 | $ | 204,439 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
49
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Money Market Trust B Series 0 | Money Market Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 520 | $ | 2,931 | — | — | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
520 | 2,931 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
299 | 513 | 193 | 121 | ||||||||||||
Net realized gains (losses) |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
299 | 513 | 193 | 121 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
819 | 3,444 | 193 | 121 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
14,085,184 | 16,791,909 | 103,803 | 113,061 | ||||||||||||
Transfer on terminations |
(2,646,786 | ) | (919,757 | ) | (131,400 | ) | (592,394 | ) | ||||||||
Transfer on policy loans |
(14,679 | ) | (50,671 | ) | — | 1,873 | ||||||||||
Net interfund transfers |
(12,498,312 | ) | (16,750,304 | ) | 1,756,676 | 27,698 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(1,074,593 | ) | (928,823 | ) | 1,729,079 | (449,762 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(1,073,774 | ) | (925,379 | ) | 1,729,272 | (449,641 | ) | |||||||||
Assets, beginning of period |
7,610,293 | 8,535,672 | 1,001,628 | 1,451,269 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 6,536,519 | $ | 7,610,293 | $ | 2,730,900 | $ | 1,001,628 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
50
Sub-Account | ||||||||||||||||||||||
Natural Resources Trust Series 0 | Natural Resources Trust Series 1 | Real Estate Securities Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 7,037 | $ | 22,458 | $ | 904 | $ | 1,266 | $ | 60,874 | $ | 54,523 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
7,037 | 22,458 | 904 | 1,266 | 60,874 | 54,523 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | — | — | |||||||||||||||||
(1,748 | ) | (145,468 | ) | 13,614 | (27,572 | ) | 159,013 | 77,743 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(1,748 | ) | (145,468 | ) | 13,614 | (27,572 | ) | 159,013 | 77,743 | ||||||||||||||
26,790 | 75,543 | (10,567 | ) | 28,157 | (210,236 | ) | 259,499 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
32,079 | (47,467 | ) | 3,951 | 1,851 | 9,651 | 391,765 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
179,561 | 168,338 | 6,858 | 7,079 | 113,231 | 160,363 | |||||||||||||||||
(117,618 | ) | (118,027 | ) | (23,169 | ) | (7,721 | ) | (488,904 | ) | (116,146 | ) | |||||||||||
(9,983 | ) | (2,784 | ) | (9,711 | ) | (23 | ) | (13,977 | ) | (2,288 | ) | |||||||||||
(66,224 | ) | (476,324 | ) | 24,229 | (20,367 | ) | 101,147 | 764,883 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(14,264 | ) | (428,797 | ) | (1,793 | ) | (21,032 | ) | (288,503 | ) | 806,812 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
17,815 | (476,264 | ) | 2,158 | (19,181 | ) | (278,852 | ) | 1,198,577 | ||||||||||||||
1,110,017 | 1,586,281 | 160,776 | 179,957 | 3,238,133 | 2,039,556 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 1,127,832 | $ | 1,110,017 | $ | 162,934 | $ | 160,776 | $ | 2,959,281 | $ | 3,238,133 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
51
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Real Estate Securities Trust Series 1 | Real Return Bond Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 9,889 | $ | 7,962 | $ | 26,096 | $ | 19,891 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
9,889 | 7,962 | 26,096 | 19,891 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
(9,818 | ) | (22,761 | ) | 8,182 | 29,651 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
(9,818 | ) | (22,761 | ) | 8,182 | 29,651 | ||||||||||
Unrealized appreciation (depreciation) during the period |
(434 | ) | 84,501 | (128,483 | ) | 44,991 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
(363 | ) | 69,702 | (94,205 | ) | 94,533 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
14,600 | 15,227 | 60,627 | 120,641 | ||||||||||||
Transfer on terminations |
(15,816 | ) | (12,979 | ) | (387,802 | ) | (52,745 | ) | ||||||||
Transfer on policy loans |
(52 | ) | 1,154 | (3,343 | ) | (23 | ) | |||||||||
Net interfund transfers |
27,136 | 1,383 | 82,474 | 152,393 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
25,868 | 4,785 | (248,044 | ) | 220,266 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
25,505 | 74,487 | (342,249 | ) | 314,799 | |||||||||||
Assets, beginning of period |
480,041 | 405,554 | 1,252,408 | 937,609 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 505,546 | $ | 480,041 | $ | 910,159 | $ | 1,252,408 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
52
Sub-Account | ||||||||||||||||||||||
Real Return Bond Trust Series 1 | Science & Technology Trust Series 0 | Science & Technology Trust Series 1 | ||||||||||||||||||||
Year
Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 968 | $ | 729 | — | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
968 | 729 | — | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | — | — | |||||||||||||||||
264 | 209 | 51,210 | 5,045 | 16,066 | 9,210 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
264 | 209 | 51,210 | 5,045 | 16,066 | 9,210 | |||||||||||||||||
(4,883 | ) | 2,542 | 164,926 | 23,903 | 58,939 | 9,534 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(3,651 | ) | 3,480 | 216,136 | 28,948 | 75,005 | 18,744 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
1,379 | 1,491 | 56,352 | 51,322 | 22,515 | 19,236 | |||||||||||||||||
(4,519 | ) | (3,070 | ) | (58,947 | ) | (40,298 | ) | (35,239 | ) | (26,371 | ) | |||||||||||
— | — | (2,317 | ) | (3,647 | ) | (8,873 | ) | 454 | ||||||||||||||
841 | — | (749 | ) | 191,939 | (672 | ) | (33,267 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(2,299 | ) | (1,579 | ) | (5,661 | ) | 199,316 | (22,269 | ) | (39,948 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(5,950 | ) | 1,901 | 210,475 | 228,264 | 52,736 | (21,204 | ) | |||||||||||||||
41,406 | 39,505 | 477,746 | 249,482 | 175,190 | 196,394 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 35,456 | $ | 41,406 | $ | 688,221 | $ | 477,746 | $ | 227,926 | $ | 175,190 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
53
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Short Term Government Income Trust Series 0 | Short Term Government Income Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 9,886 | $ | 8,538 | $ | 8,118 | $ | 6,369 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
9,886 | 8,538 | 8,118 | 6,369 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
(2,714 | ) | 651 | (169 | ) | 316 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
(2,714 | ) | 651 | (169 | ) | 316 | ||||||||||
Unrealized appreciation (depreciation) during the period |
(10,634 | ) | (3,358 | ) | (11,413 | ) | (2,062 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
(3,462 | ) | 5,831 | (3,464 | ) | 4,623 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
70,844 | 63,186 | 28,247 | 20,045 | ||||||||||||
Transfer on terminations |
(53,577 | ) | (43,375 | ) | (17,752 | ) | (35,793 | ) | ||||||||
Transfer on policy loans |
(60 | ) | (149 | ) | 134 | (4,722 | ) | |||||||||
Net interfund transfers |
(81,745 | ) | 3,993 | 6,672 | 2,863 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(64,538 | ) | 23,655 | 17,301 | (17,607 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(68,000 | ) | 29,486 | 13,837 | (12,984 | ) | ||||||||||
Assets, beginning of period |
498,654 | 469,168 | 385,582 | 398,566 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 430,654 | $ | 498,654 | $ | 399,419 | $ | 385,582 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
54
Sub-Account | ||||||||||||||||||||||
Small Cap Growth Trust Series 0 | Small Cap Growth Trust Series 1 | Small Cap Index Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
— | — | — | — | $ | 38,718 | $ | 47,255 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | 38,718 | 47,255 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
16,834 | 30,217 | 1,032 | 1,949 | 181,903 | 382,835 | |||||||||||||||||
13,195 | 8,583 | 1,786 | 808 | 3,228 | (3,499 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
30,029 | 38,800 | 2,818 | 2,757 | 185,131 | 379,336 | |||||||||||||||||
96,964 | (10,254 | ) | 5,047 | (514 | ) | 600,791 | (115,824 | ) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
126,993 | 28,546 | 7,865 | 2,243 | 824,640 | 310,767 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
47,951 | 63,743 | 4,769 | 1,291 | 70,075 | 115,196 | |||||||||||||||||
(38,981 | ) | (27,654 | ) | (1,706 | ) | (2,037 | ) | (448,340 | ) | (60,793 | ) | |||||||||||
(2,511 | ) | (3,349 | ) | — | — | (5,109 | ) | (1,805 | ) | |||||||||||||
86,866 | 43,958 | 2,581 | (36 | ) | 79,217 | 1,402,022 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
93,325 | 76,698 | 5,644 | (782 | ) | (304,157 | ) | 1,454,620 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
220,318 | 105,244 | 13,509 | 1,461 | 520,483 | 1,765,387 | |||||||||||||||||
261,066 | 155,822 | 15,182 | 13,721 | 2,391,062 | 625,675 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 481,384 | $ | 261,066 | $ | 28,691 | $ | 15,182 | $ | 2,911,545 | $ | 2,391,062 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
55
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Small Cap Index Trust Series 1 | Small Cap Opportunities Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 1,983 | $ | 2,233 | $ | 876 | — | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
1,983 | 2,233 | 876 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
9,541 | 18,694 | — | — | ||||||||||||
Net realized gains (losses) |
(446 | ) | (1,185 | ) | 3,782 | 2,185 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
9,095 | 17,509 | 3,782 | 2,185 | ||||||||||||
Unrealized appreciation (depreciation) during the period |
32,599 | (2,889 | ) | 58,634 | 10,179 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
43,677 | 16,853 | 63,292 | 12,364 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
4,172 | 4,058 | 18,054 | 16,392 | ||||||||||||
Transfer on terminations |
(5,914 | ) | (6,101 | ) | (12,674 | ) | (8,702 | ) | ||||||||
Transfer on policy loans |
— | (5 | ) | (676 | ) | — | ||||||||||
Net interfund transfers |
(2,886 | ) | (7,212 | ) | 852,872 | 444 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(4,628 | ) | (9,260 | ) | 857,576 | 8,134 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
39,049 | 7,593 | 920,868 | 20,498 | ||||||||||||
Assets, beginning of period |
114,552 | 106,959 | 89,550 | 69,052 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 153,601 | $ | 114,552 | $ | 1,010,418 | $ | 89,550 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
56
Sub-Account | ||||||||||||||||||||||
Small Cap Opportunities Trust Series 1 | Small Cap Value Trust Series 0 | Small Cap Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 801 | — | $ | 3,726 | $ | 3,554 | $ | 411 | $ | 331 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
801 | — | 3,726 | 3,554 | 411 | 331 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | 33,852 | 17,361 | 3,767 | 1,744 | |||||||||||||||||
14,786 | (2,385 | ) | 16,581 | 5,191 | 10,337 | 13,153 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
14,786 | (2,385 | ) | 50,433 | 22,552 | 14,104 | 14,897 | ||||||||||||||||
26,609 | 19,134 | 108,043 | 25,553 | 2,980 | (10,098 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
42,196 | 16,749 | 162,202 | 51,659 | 17,495 | 5,130 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
6,631 | 7,199 | 51,073 | 56,930 | 1,146 | 1,295 | |||||||||||||||||
(57,984 | ) | (18,804 | ) | (34,688 | ) | (26,166 | ) | (41,131 | ) | (27,207 | ) | |||||||||||
47 | — | (13,387 | ) | (50 | ) | — | — | |||||||||||||||
28,946 | (503 | ) | 160,403 | 38,708 | 44,818 | 26,663 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(22,360 | ) | (12,108 | ) | 163,401 | 69,422 | 4,833 | 751 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
19,836 | 4,641 | 325,603 | 121,081 | 22,328 | 5,881 | |||||||||||||||||
106,925 | 102,284 | 415,214 | 294,133 | 40,239 | 34,358 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 126,761 | $ | 106,925 | $ | 740,817 | $ | 415,214 | $ | 62,567 | $ | 40,239 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
57
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Small Company Value Trust Series 0 | Small Company Value Trust Series 1 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 12,800 | $ | 1,663 | $ | 5,798 | $ | 783 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
12,800 | 1,663 | 5,798 | 783 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
13,728 | (148,563 | ) | 27,091 | (695 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
13,728 | (148,563 | ) | 27,091 | (695 | ) | ||||||||||
Unrealized appreciation (depreciation) during the period |
170,156 | 60,495 | 58,567 | 46,021 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
196,684 | (86,405 | ) | 91,456 | 46,109 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
38,404 | 40,132 | 27,192 | 25,211 | ||||||||||||
Transfer on terminations |
(41,928 | ) | (153,414 | ) | (58,344 | ) | (25,239 | ) | ||||||||
Transfer on policy loans |
(7,673 | ) | (2,684 | ) | 450 | (30,132 | ) | |||||||||
Net interfund transfers |
38,270 | 452,165 | (5,694 | ) | (20,777 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
27,073 | 336,199 | (36,396 | ) | (50,937 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
223,757 | 249,794 | 55,060 | (4,828 | ) | |||||||||||
Assets, beginning of period |
613,287 | 363,493 | 292,480 | 297,308 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 837,044 | $ | 613,287 | $ | 347,540 | $ | 292,480 | ||||||||
|
|
|
|
|
|
|
|
(af) | Terminated as an investment option and funds transferred to Small Cap Opportunities Trust on December 9, 2013. |
See accompanying notes.
58
Sub-Account | ||||||||||||||||||||||
Smaller Company Growth Trust Series 0 | Smaller Company Growth Trust Series 1 | Strategic Income Opportunities Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 (af) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 (af) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
— | — | — | — | $ | 241,672 | $ | 263,802 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | 241,672 | 263,802 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
50,804 | 51,944 | 1,845 | 3,612 | — | — | |||||||||||||||||
232,469 | 3,382 | 11,638 | 359 | 42,395 | (23,764 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
283,273 | 55,326 | 13,483 | 3,971 | 42,395 | (23,764 | ) | ||||||||||||||||
(65,620 | ) | 35,199 | (3,259 | ) | 493 | (101,538 | ) | 41,544 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
217,653 | 90,525 | 10,224 | 4,464 | 182,529 | 281,582 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
14,070 | 14,976 | 800 | 1,647 | 104,973 | 99,914 | |||||||||||||||||
(31,849 | ) | (25,829 | ) | (1,826 | ) | (1,859 | ) | (122,017 | ) | (98,557 | ) | |||||||||||
(1,055 | ) | (75 | ) | (1,572 | ) | 195 | (5,701 | ) | (5,509 | ) | ||||||||||||
(839,231 | ) | (463 | ) | (52,809 | ) | 20,210 | 1,043,660 | 2,291,128 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(858,065 | ) | (11,391 | ) | (55,407 | ) | 20,193 | 1,020,915 | 2,286,976 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(640,412 | ) | 79,134 | (45,183 | ) | 24,657 | 1,203,444 | 2,568,558 | |||||||||||||||
640,412 | 561,278 | 45,183 | 20,526 | 3,108,036 | 539,478 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | $ | 640,412 | — | $ | 45,183 | $ | 4,311,480 | $ | 3,108,036 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
59
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Strategic Income Opportunities Trust Series 1 | Total Bond Market Trust B Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 16,771 | $ | 20,426 | $ | 12,499 | $ | 3,638 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
16,771 | 20,426 | 12,499 | 3,638 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
(5,422 | ) | (1,385 | ) | (16,582 | ) | 8,775 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
(5,422 | ) | (1,385 | ) | (16,582 | ) | 8,775 | |||||||||
Unrealized appreciation (depreciation) during the period |
110 | 16,813 | (19,011 | ) | 2,175 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
11,459 | 35,854 | (23,094 | ) | 14,588 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
9,090 | 10,071 | 27,804 | 36,838 | ||||||||||||
Transfer on terminations |
(51,841 | ) | (15,099 | ) | (23,863 | ) | (19,122 | ) | ||||||||
Transfer on policy loans |
— | (404 | ) | 4,221 | (2,136 | ) | ||||||||||
Net interfund transfers |
2,654 | 619 | (785,735 | ) | 905,346 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(40,097 | ) | (4,813 | ) | (777,573 | ) | 920,926 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(28,638 | ) | 31,041 | (800,667 | ) | 935,514 | ||||||||||
Assets, beginning of period |
311,836 | 280,795 | 1,155,231 | 219,717 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 283,198 | $ | 311,836 | $ | 354,564 | $ | 1,155,231 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
60
Sub-Account | ||||||||||||||||||||||
Total Return Trust Series 0 | Total Return Trust Series 1 | Total Stock Market Index Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 72,282 | $ | 43,507 | $ | 21,327 | $ | 14,482 | $ | 14,320 | $ | 8,500 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
72,282 | 43,507 | 21,327 | 14,482 | 14,320 | 8,500 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
52,217 | — | 15,619 | — | 13,617 | 1,374 | |||||||||||||||||
(2,595 | ) | 431 | 8,566 | 2,626 | 40,230 | 8,810 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
49,622 | 431 | 24,185 | 2,626 | 53,847 | 10,184 | |||||||||||||||||
(160,510 | ) | 120,665 | (59,798 | ) | 42,395 | 159,243 | 44,999 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(38,606 | ) | 164,603 | (14,286 | ) | 59,503 | 227,410 | 63,683 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
276,094 | 339,025 | 36,478 | 37,850 | 95,502 | 98,973 | |||||||||||||||||
(461,974 | ) | (215,675 | ) | (107,474 | ) | (65,782 | ) | (66,499 | ) | (45,306 | ) | |||||||||||
(17,288 | ) | (14,630 | ) | — | 1 | 4,859 | (76 | ) | ||||||||||||||
50,149 | 30,125 | 1,900 | 270 | 255,216 | 77,067 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(153,019 | ) | 138,845 | (69,096 | ) | (27,661 | ) | 289,078 | 130,658 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(191,625 | ) | 303,448 | (83,382 | ) | 31,842 | 516,488 | 194,341 | |||||||||||||||
2,201,829 | 1,898,381 | 735,987 | 704,145 | 557,974 | 363,633 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 2,010,204 | $ | 2,201,829 | $ | 652,605 | $ | 735,987 | $ | 1,074,462 | $ | 557,974 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
61
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Total Stock Market Index Trust Series 1 | Ultra Short Term Bond Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 2,245 | $ | 2,046 | $ | 1,742 | $ | 637 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
2,245 | 2,046 | 1,742 | 637 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
2,208 | 346 | — | — | ||||||||||||
Net realized gains (losses) |
1,729 | 5,726 | (729 | ) | 9 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
3,937 | 6,072 | (729 | ) | 9 | |||||||||||
Unrealized appreciation (depreciation) during the period |
38,695 | 11,228 | (980 | ) | (560 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
44,877 | 19,346 | 33 | 86 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
1,329 | 1,014 | 68,083 | 3,993 | ||||||||||||
Transfer on terminations |
(6,043 | ) | (54,449 | ) | (12,798 | ) | (4,620 | ) | ||||||||
Transfer on policy loans |
— | (5 | ) | — | — | |||||||||||
Net interfund transfers |
(2,304 | ) | 46,941 | 22,351 | 63,471 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(7,018 | ) | (6,499 | ) | 77,636 | 62,844 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
37,859 | 12,847 | 77,669 | 62,930 | ||||||||||||
Assets, beginning of period |
137,559 | 124,712 | 64,514 | 1,584 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 175,418 | $ | 137,559 | $ | 142,183 | $ | 64,514 | ||||||||
|
|
|
|
|
|
|
|
(g) | Reflects the period from commencement of operations on April 30, 2012 through December 31, 2012. |
See accompanying notes.
62
Sub-Account | ||||||||||||||||||||||
U.S. Equity Trust Series 0 | U.S. Equity Trust Series 1 | Utilities Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (g) |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (g) |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||||||
$ | 13,023 | $ | 9,205 | $ | 1,450 | $ | 1,104 | $ | 16,064 | $ | 21,565 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
13,023 | 9,205 | 1,450 | 1,104 | 16,064 | 21,565 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
— | — | — | — | — | — | |||||||||||||||||
6,318 | 280 | 6,030 | 36 | 35,333 | (3,170 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
6,318 | 280 | 6,030 | 36 | 35,333 | (3,170 | ) | ||||||||||||||||
163,403 | 10,114 | 13,437 | 952 | 80,270 | 101,220 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
182,744 | 19,599 | 20,917 | 2,092 | 131,667 | 119,615 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
47,015 | 43,934 | 3,421 | 3,044 | 69,657 | 77,999 | |||||||||||||||||
(45,169 | ) | (27,714 | ) | (22,646 | ) | (4,946 | ) | (77,011 | ) | (60,697 | ) | |||||||||||
(2,760 | ) | (103 | ) | — | 153 | (12,499 | ) | (778 | ) | |||||||||||||
4,334 | 608,993 | (9,826 | ) | 76,632 | 89,217 | (960,113 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3,420 | 625,110 | (29,051 | ) | 74,883 | 69,364 | (943,589 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
186,164 | 644,709 | (8,134 | ) | 76,975 | 201,031 | (823,974 | ) | |||||||||||||||
644,709 | — | 76,975 | — | 627,938 | 1,451,912 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | 830,873 | $ | 644,709 | $ | 68,841 | $ | 76,975 | $ | 828,969 | $ | 627,938 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
63
John Hancock Life Insurance Company of New York Separate Account B
Statements of Operations and Changes in Contract Owners’ Equity
(continued)
Sub-Account | ||||||||||||||||
Utilities Trust Series 1 | Value Trust Series 0 | |||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||||
Income: |
||||||||||||||||
Dividend income distribution |
$ | 1,713 | $ | 3,320 | $ | 4,585 | $ | 2,930 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net investment income (loss) |
1,713 | 3,320 | 4,585 | 2,930 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) on investments: |
||||||||||||||||
Capital gain distributions |
— | — | — | — | ||||||||||||
Net realized gains (losses) |
2,658 | (253 | ) | 15,574 | 4,959 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Realized gains (losses) |
2,658 | (253 | ) | 15,574 | 4,959 | |||||||||||
Unrealized appreciation (depreciation) during the period |
12,873 | 8,452 | 117,660 | 30,031 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from operations |
17,244 | 11,519 | 137,819 | 37,920 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Changes from principal transactions: |
||||||||||||||||
Transfer of net premiums |
2,740 | 2,596 | 29,988 | 30,683 | ||||||||||||
Transfer on terminations |
(7,669 | ) | (4,128 | ) | (25,375 | ) | (16,654 | ) | ||||||||
Transfer on policy loans |
(16,934 | ) | (182 | ) | (9,190 | ) | (3,136 | ) | ||||||||
Net interfund transfers |
(19,634 | ) | (29 | ) | 122,111 | 138,604 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in assets from principal transactions |
(41,497 | ) | (1,743 | ) | 117,534 | 149,497 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total increase (decrease) in assets |
(24,253 | ) | 9,776 | 255,353 | 187,417 | |||||||||||
Assets, beginning of period |
95,035 | 85,259 | 353,136 | 165,719 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Assets, end of period |
$ | 70,782 | $ | 95,035 | $ | 608,489 | $ | 353,136 | ||||||||
|
|
|
|
|
|
|
|
See accompanying notes.
64
Sub-Account | ||||||||||||||
Value Trust Series 1 | Total | |||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
|||||||||||
$ | 2,567 | $ | 2,196 | $ | 3,958,167 | $ | 3,515,712 | |||||||
|
|
|
|
|
|
|
|
|||||||
2,567 | 2,196 | 3,958,167 | 3,515,712 | |||||||||||
|
|
|
|
|
|
|
|
|||||||
— | — | 2,660,103 | 1,624,293 | |||||||||||
22,164 | 726 | 3,640,195 | 398,999 | |||||||||||
|
|
|
|
|
|
|
|
|||||||
22,164 | 726 | 6,300,298 | 2,023,292 | |||||||||||
65,867 | 37,064 | 17,018,126 | 12,813,931 | |||||||||||
|
|
|
|
|
|
|
|
|||||||
90,598 | 39,986 | 27,276,591 | 18,352,935 | |||||||||||
|
|
|
|
|
|
|
|
|||||||
2,849 | 4,570 | 28,818,159 | 32,366,430 | |||||||||||
(50,015 | ) | (12,471 | ) | (22,751,339 | ) | (13,317,889 | ) | |||||||
(20,892 | ) | 236 | (1,172,152 | ) | (999,605 | ) | ||||||||
25,432 | 18,530 | (9,157,394 | ) | (3,538,031 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||
(42,626 | ) | 10,865 | (4,262,726 | ) | 14,510,905 | |||||||||
|
|
|
|
|
|
|
|
|||||||
47,972 | 50,851 | 23,013,865 | 32,863,840 | |||||||||||
275,039 | 224,188 | 168,380,919 | 135,517,079 | |||||||||||
|
|
|
|
|
|
|
|
|||||||
$ | 323,011 | $ | 275,039 | $ | 191,394,784 | $ | 168,380,919 | |||||||
|
|
|
|
|
|
|
|
65
John Hancock Life Insurance Company of New York Separate Account B
1. | Organization |
John Hancock Life Insurance Company of New York Separate Account B (the “Account”) is a separate account administered and sponsored by John Hancock Life Insurance Company of New York (the “Company”). The Account operates as a Unit Investment Trust registered under the Investment Company Act of 1940, as amended (the “Act”) and has 108 active investment sub-accounts that invest in shares of a particular John Hancock Variable Insurance Trust (the “Trust”), which was formerly known as the John Hancock Trust, portfolio and 5 sub-accounts that invest in shares of other outside investment trusts as of December 31, 2013. The Trust is registered under the Act as an open-end management investment company, commonly known as a mutual fund, which does not transact with the general public. Instead, the Trust deals primarily with insurance companies by providing the investment medium for variable contracts. The Account is a funding vehicle for the allocation of net premiums under single premium variable life and variable universal life insurance contracts (the “Contracts”) issued by the Company.
The Company is a wholly owned subsidiary of John Hancock Life Insurance Company (U.S.A.) (“JHUSA”) which in turn is an indirect, wholly owned subsidiary of Manulife Financial Corporation (“MFC”), a Canadian-based publicly traded stock life insurance company.
The Company is required to maintain assets in the Account with a total fair value at least equal to the reserves and other liabilities relating to the variable benefits under all Contracts participating in the Account. These assets may not be charged with liabilities which arise from any other business the Company conducts. However, all obligations under the Contracts are general corporate obligations of the Company.
Additional assets are held in the Company’s general account to cover the contingency that the guaranteed minimum death benefit might exceed the death benefit which would have been payable in the absence of such guarantee.
Each sub-account that invests in portfolios of the Trust may offer two classes of units to fund the Contracts issued by the Company. These classes, Series 1 and Series 0, represent an interest in the same Trust portfolio but in different share classes of that portfolio. Series 1 represents interests in Series 1 shares of the Trust’s portfolio and Series 0 represents interests in Series NAV shares of the Trust’s portfolio. Series 1 and Series NAV shares differ in the level of 12b-1 fees and other expenses assessed against the portfolio’s assets.
As the result of a portfolio change, the following sub-account of the Account was renamed as follows:
Previous Name |
New Name |
Effective Date | ||
Business Opportunity Value | Large Cap Value | April 29, 2013 |
66
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
The following sub-accounts of the Account were commenced as investment options:
New Sub-Accounts |
Effective Date | |
Lifestyle Aggressive Trust PS Series NAV | December 9, 2013 | |
Lifestyle Balanced Trust PS Series NAV | December 9, 2013 | |
Lifestyle Conservative Trust PS Series NAV | December 9, 2013 | |
Lifestyle Growth Trust PS Series NAV | December 9, 2013 | |
Lifestyle Moderate Trust PS Series NAV | December 9, 2013 |
The following sub-accounts of the Account were terminated as investment options and the funds were transferred to existing sub-accounts as follows:
Terminated |
Transferred To |
Effective Date | ||
All Cap Value Trust | Fundamental Large Cap Value Trust | December 9, 2013 | ||
American Global Small Capitalization Trust Series 1 | American Global Growth Trust Series 1 | April 29, 2013 | ||
American High Income Bond Trust Series 1 | High Yield Trust Series 1 | April 29, 2013 | ||
Core Allocation Plus Trust | Core Strategy Trust | December 9, 2013 | ||
Disciplined Diversification Trust | Core Strategy Trust | December 9, 2013 | ||
Fundamental Holdings Trust Series 1 | Core Strategy Trust Series 1 | December 9, 2013 | ||
Global Diversification Trust Series 1 | Core Strategy Trust Series 1 | December 9, 2013 | ||
Smaller Company Growth Trust | Small Cap Opportunities Trust | December 9, 2013 |
Where a sub-account has two series, the changes noted above apply to both Series 0 and Series 1.
2. | Significant Accounting Policies |
Investments of each sub-account consist of shares in the respective portfolios of the Trust. These shares are carried at fair value which is calculated using the fair value of the investment securities underlying each Trust portfolio. Transactions are recorded on the trade date. Income from dividends is recorded on the ex-dividend date. Realized gains and losses on the sale of investments are computed on the basis of the specifically identified cost of the investment sold.
In addition to the Account, a contract holder may also allocate funds to the fixed account contained within the Company’s general account. Because of exemptive and exclusionary provisions, interests in the fixed account have not been registered under the Securities Act of 1933 and the Company’s general account has not been registered as an investment company under the Act. Net interfund transfers include interfund transfers between separate and general accounts.
67
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
The operations of the Account are included in the federal income tax return of the Company, which is taxed as a life insurance company under the provisions of the Internal Revenue Code (the “Code”). Under the current provisions of the Code, the Company does not expect to incur federal income taxes on the earnings of the Account to the extent the earnings are credited under the Contracts. Based on this, no charge is being made currently to the Account for federal income taxes. The Company will periodically reassess this position taking into account changes in the tax law. Such a charge may be made in future years for any federal income taxes that would be attributable to the Contracts.
FASB ASC Topic 820 - Fair Value Measurement and Disclosure (“ASC 820”) provides a single definition of fair value for accounting purposes, establishes a consistent framework for measuring fair value and expands disclosure requirements about fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit value. An exit value is not a forced liquidation or distressed sale. Assets not measured at fair value are excluded from ASC 820 note disclosure, including Policy Loans which are held to maturity and accounted for at cost.
Following ASC 820 guidance, the Account has categorized its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Account’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:
• | Level 1 – Fair value measurements that reflect unadjusted, quoted prices in active markets for identical assets and liabilities that the Account has the ability to access at the measurement date. |
• | Level 2 – Fair value measurements using inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. |
• | Level 3 – Fair value measurements using significant non-market observable inputs. |
Assets owned by the Account are primarily open-ended mutual fund investments issued by the Trust. These are classified within Level 1, as fair values of the underlying funds are based upon reported net asset values (“NAV”), which represent the values at which each sub-account can redeem its investments.
The following table presents the Account’s assets that are measured at fair value on a recurring basis by fair value hierarchy level under ASC 820, as of December 31, 2013.
Mutual Funds | ||||
Level 1 |
$ | 191,394,784 | ||
Level 2 |
— | |||
Level 3 |
— | |||
|
|
|||
$ | 191,394,784 | |||
|
|
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported herein. Actual results could differ from those estimates.
68
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
3. | Contract Charges |
The Company deducts certain charges from gross premiums before placing the remaining net premiums in the sub-account. In the event of a surrender by the contract holder, surrender charges may be levied by the Company against the contract value at the time of termination to cover sales and administrative expenses associated with the underwriting and issuing of the Contract. Additionally, each month a deduction consisting of an administration charge, a charge for cost of insurance, a charge for mortality and expense risks and charges for supplementary benefits is deducted from the contract value. Contract charges are paid through the redemption of sub-account units and are reflected as terminations.
4. | Federal Income Taxes |
The Account does not file separate tax returns. The taxable income of the Account is consolidated with that of the Company within the consolidated federal tax return. Any tax contingencies arising from the taxable income generated by the Account are the responsibility of the Company and the Company holds any and all tax contingencies on its financial statements. The Account is not a party to the consolidated tax sharing agreement thus no amount of income taxes or tax contingencies are passed through to the Account. The legal form of the Account is not taxable in any state or foreign jurisdictions.
The Income Taxes topic of the FASB Accounting Standard Codification establishes a minimum threshold for financial statement recognition of the benefit of positions taken, or expected to be taken, in filing tax returns (including whether the Account is taxable in certain jurisdictions). The topic requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether tax positions are “more-likely-than not” of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold would be recorded as tax expense or benefit.
The Account complies with the provisions of FASB ASC Topic 740, Income Taxes. As of December 31, 2013, the Account did not have a liability for any uncertain tax positions. The Account recognizes interest and penalties, if any, related to tax liabilities as income tax expense in the Statements of Operations.
5. | Purchases and Sales of Investments |
The cost of purchases and proceeds from sales of investments for the year ended December 31, 2013 were as follows:
Purchases | Sales | |||||||
Sub-accounts: |
||||||||
500 Index Trust B Series 0 |
$ | 2,278,406 | $ | 1,150,926 | ||||
Active Bond Trust Series 0 |
104,962 | 23,491 | ||||||
Active Bond Trust Series 1 |
75,364 | 11,194 | ||||||
All Cap Core Trust Series 0 |
21,136 | 13,562 | ||||||
All Cap Core Trust Series 1 |
13,854 | 274,629 | ||||||
All Cap Value Trust Series 0 |
608,934 | 884,890 | ||||||
All Cap Value Trust Series 1 |
156,773 | 278,013 | ||||||
Alpha Opportunities Trust Series 0 |
42,316 | 9,347 |
69
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
Purchases | Sales | |||||||
Sub-accounts: |
||||||||
American Asset Allocation Trust Series 1 |
$ | 348,772 | $ | 115,365 | ||||
American Global Growth Trust Series 1 |
35,121 | 8,147 | ||||||
American Global Small Capitalization Trust Series 1 |
1,524 | 22,959 | ||||||
American Growth Trust Series 1 |
290,248 | 295,030 | ||||||
American Growth-Income Trust Series 1 |
195,057 | 207,228 | ||||||
American High-Income Bond Trust Series 1 |
14,917 | 172,530 | ||||||
American International Trust Series 1 |
603,047 | 598,326 | ||||||
American New World Trust Series 1 |
111,328 | 10,878 | ||||||
Blue Chip Growth Trust Series 0 |
278,658 | 1,233,726 | ||||||
Blue Chip Growth Trust Series 1 |
175,609 | 167,957 | ||||||
Bond Trust Series 0 |
34,443 | 38,226 | ||||||
Bond Trust Series 1 |
— | 21,071 | ||||||
Capital Appreciation Trust Series 0 |
164,541 | 273,461 | ||||||
Capital Appreciation Trust Series 1 |
53,164 | 169,924 | ||||||
Capital Appreciation Value Trust Series 0 |
261,102 | 85,065 | ||||||
Core Allocation Plus Trust Series 0 |
539,040 | 1,032,857 | ||||||
Core Bond Trust Series 0 |
107,059 | 33,900 | ||||||
Core Bond Trust Series 1 |
8,224 | 2,650 | ||||||
Core Strategy Trust Series 0 |
3,149,438 | 299,138 | ||||||
Disciplined Diversification Trust Series 0 |
390,280 | 681,265 | ||||||
Emerging Markets Value Trust Series 0 |
384,760 | 161,532 | ||||||
Emerging Markets Value Trust Series 1 |
408 | 382 | ||||||
Equity-Income Trust Series 0 |
483,232 | 1,078,438 | ||||||
Equity-Income Trust Series 1 |
114,429 | 201,518 | ||||||
Financial Services Trust Series 0 |
77,673 | 36,031 | ||||||
Financial Services Trust Series 1 |
4,303 | 4,965 | ||||||
Franklin Templeton Founding Allocation Trust Series 0 |
503,633 | 117,126 | ||||||
Franklin Templeton Founding Allocation Trust Series 1 |
2,185 | 21 | ||||||
Fundamental All Cap Core Trust Series 0 |
291,411 | 47,169 | ||||||
Fundamental All Cap Core Trust Series 1 |
34,950 | 1,407 | ||||||
Fundamental Holdings Trust Series 1 |
133,384 | 247,292 | ||||||
Fundamental Large Cap Value Trust Series 0 |
1,164,847 | 29,289 | ||||||
Fundamental Large Cap Value Trust Series 1 |
131,664 | 241 | ||||||
Fundamental Value Trust Series 0 |
43,857 | 184,252 | ||||||
Fundamental Value Trust Series 1 |
40,586 | 69,073 | ||||||
Global Bond Trust Series 0 |
157,772 | 911,367 | ||||||
Global Bond Trust Series 1 |
13,541 | 66,117 | ||||||
Global Diversification Trust Series 1 |
292,514 | 517,850 | ||||||
Global Trust Series 0 |
42,785 | 7,910 | ||||||
Global Trust Series 1 |
1,966 | 955,153 | ||||||
Health Sciences Trust Series 0 |
262,267 | 48,922 | ||||||
Health Sciences Trust Series 1 |
54,416 | 50,645 | ||||||
High Yield Trust Series 0 |
657,833 | 5,087,979 | ||||||
High Yield Trust Series 1 |
27,835 | 36,489 | ||||||
International Core Trust Series 0 |
116,483 | 370,223 | ||||||
International Core Trust Series 1 |
6,101 | 24,419 | ||||||
International Equity Index Trust B Series 0 |
593,347 | 635,745 | ||||||
International Equity Index Trust B Series 1 |
21,807 | 34,478 | ||||||
International Growth Stock Trust Series 0 |
56,693 | 69,292 | ||||||
International Growth Stock Trust Series 1 |
14,214 | 4,407 |
70
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
Purchases | Sales | |||||||
Sub-accounts: |
||||||||
International Small Company Trust Series 0 |
$ | 86,488 | $ | 28,769 | ||||
International Small Company Trust Series 1 |
4,043 | 6,530 | ||||||
International Value Trust Series 0 |
135,544 | 59,176 | ||||||
International Value Trust Series 1 |
56,051 | 839,186 | ||||||
Investment Quality Bond Trust Series 0 |
50,369 | 2,246,283 | ||||||
Investment Quality Bond Trust Series 1 |
26,866 | 5,639 | ||||||
Lifestyle Aggressive Trust Series 0 |
1,903,753 | 2,154,713 | ||||||
Lifestyle Aggressive Trust Series 1 |
64,518 | 21,553 | ||||||
Lifestyle Balanced Trust Series 0 |
6,277,552 | 3,432,290 | ||||||
Lifestyle Balanced Trust Series 1 |
176,424 | 162,211 | ||||||
Lifestyle Conservative Trust Series 0 |
1,173,572 | 1,213,671 | ||||||
Lifestyle Conservative Trust Series 1 |
11,462 | 4,708 | ||||||
Lifestyle Growth Trust Series 0 |
6,153,764 | 3,107,125 | ||||||
Lifestyle Growth Trust Series 1 |
145,957 | 87,002 | ||||||
Lifestyle Moderate Trust Series 0 |
1,989,767 | 630,318 | ||||||
Lifestyle Moderate Trust Series 1 |
34,211 | 47,201 | ||||||
Mid Cap Index Trust Series 0 |
727,400 | 367,639 | ||||||
Mid Cap Index Trust Series 1 |
45,488 | 15,826 | ||||||
Mid Cap Stock Trust Series 0 |
223,061 | 426,312 | ||||||
Mid Cap Stock Trust Series 1 |
20,652 | 26,417 | ||||||
Mid Value Trust Series 0 |
169,090 | 596,740 | ||||||
Mid Value Trust Series 1 |
31,966 | 53,244 | ||||||
Money Market Trust B Series 0 |
13,191,007 | 14,264,781 | ||||||
Money Market Trust Series 1 |
1,872,571 | 143,299 | ||||||
Natural Resources Trust Series 0 |
169,909 | 177,136 | ||||||
Natural Resources Trust Series 1 |
33,787 | 34,677 | ||||||
Real Estate Securities Trust Series 0 |
267,464 | 495,093 | ||||||
Real Estate Securities Trust Series 1 |
62,602 | 26,846 | ||||||
Real Return Bond Trust Series 0 |
230,130 | 452,077 | ||||||
Real Return Bond Trust Series 1 |
3,053 | 4,382 | ||||||
Science & Technology Trust Series 0 |
116,373 | 122,032 | ||||||
Science & Technology Trust Series 1 |
17,584 | 39,854 | ||||||
Short Term Government Income Trust Series 0 |
94,253 | 148,905 | ||||||
Short Term Government Income Trust Series 1 |
42,622 | 17,202 | ||||||
Small Cap Growth Trust Series 0 |
150,795 | 40,636 | ||||||
Small Cap Growth Trust Series 1 |
10,303 | 3,626 | ||||||
Small Cap Index Trust Series 0 |
495,227 | 578,763 | ||||||
Small Cap Index Trust Series 1 |
14,218 | 7,322 | ||||||
Small Cap Opportunities Trust Series 0 |
870,334 | 11,884 | ||||||
Small Cap Opportunities Trust Series 1 |
36,786 | 58,345 | ||||||
Small Cap Value Trust Series 0 |
255,659 | 54,680 | ||||||
Small Cap Value Trust Series 1 |
53,439 | 44,429 | ||||||
Small Company Value Trust Series 0 |
85,296 | 45,424 | ||||||
Small Company Value Trust Series 1 |
29,710 | 60,308 | ||||||
Smaller Company Growth Trust Series 0 |
62,681 | 869,942 | ||||||
Smaller Company Growth Trust Series 1 |
2,640 | 56,203 | ||||||
Strategic Income Opportunities Trust Series 0 |
6,310,205 | 5,047,618 | ||||||
Strategic Income Opportunities Trust Series 1 |
31,792 | 55,117 | ||||||
Total Bond Market Trust B Series 0 |
3,959,313 | 4,724,388 |
71
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
Purchases | Sales | |||||||
Sub-accounts: |
||||||||
Total Return Trust Series 0 |
$ | 875,042 | $ | 903,563 | ||||
Total Return Trust Series 1 |
74,701 | 106,851 | ||||||
Total Stock Market Index Trust Series 0 |
464,172 | 147,158 | ||||||
Total Stock Market Index Trust Series 1 |
5,768 | 8,331 | ||||||
Ultra Short Term Bond Trust Series 0 |
134,851 | 55,473 | ||||||
U.S. Equity Trust Series 0 |
63,216 | 46,774 | ||||||
U.S. Equity Trust Series 1 |
3,994 | 31,594 | ||||||
Utilities Trust Series 0 |
179,451 | 94,023 | ||||||
Utilities Trust Series 1 |
3,885 | 43,671 | ||||||
Value Trust Series 0 |
181,039 | 58,921 | ||||||
Value Trust Series 1 |
34,195 | 74,254 | ||||||
All Asset Portfolio |
295,566 | 160,660 | ||||||
Brandes International Equity |
68,107 | 2,588 | ||||||
Frontier Capital Appreciation |
49,520 | 568 | ||||||
Large Cap Growth |
73,319 | 14,670 | ||||||
Large Cap Value |
65,819 | 6,970 | ||||||
|
|
|
|
|||||
$ | 66,344,609 | $ | 63,989,078 | |||||
|
|
|
|
6. | Transaction with Affiliates |
John Hancock Distributors LLC, a registered broker-dealer and wholly owned subsidiary of JHUSA, acts as the principal underwriter of the Contracts pursuant to a distribution agreement with the Company. Contracts are sold by registered representatives of either John Hancock Distributors LLC or other broker-dealers having distribution agreements with John Hancock Distributors LLC who are also authorized as variable life insurance agents under applicable state insurance laws. Registered representatives are compensated on a commission basis.
JHUSA has a formal service agreement with its ultimate parent company, MFC, which can be terminated by either party upon two months’ notice. Under this agreement, JHUSA pays for legal, actuarial, investment and certain other administrative services.
The majority of the investments held by the Account are invested in the Trust (Note 1).
7. | Diversification Requirements |
The Internal Revenue Service has issued regulations under Section 817(h) of the Internal Revenue Code (the “Code”). Under the provisions of Section 817(h) of the Code, a variable life contract will not be treated as a life contract for federal tax purposes for any period for which the investments of the Account on which the contract is based are not adequately diversified. The Code provides that the “adequately diversified” requirement may be met if the underlying investments satisfy either a statutory safe harbour test or diversification requirements set forth in regulations issued by the Secretary of Treasury. JHUSA believes that the Account satisfies the current requirements of the regulations, and the Account will continue to meet such requirements.
72
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
8. | Subsequent Events |
In accordance with the provision set forth in FASB ASC Topic 855 - Subsequent Events (“ASC 855”), management has evaluated the possibility of subsequent events existing in the Account’s financial statements through March 28, 2014 and has determined that no events have occurred that require additional disclosure.
73
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
500 Index Trust B Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
164,881 | 119,719 | 79,667 | 87,318 | 38,794 | |||||||||||||||
Units issued |
66,058 | 78,636 | 64,579 | 54,685 | 80,467 | |||||||||||||||
Units redeemed |
(37,728 | ) | (33,474 | ) | (24,527 | ) | (62,336 | ) | (31,943 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
193,211 | 164,881 | 119,719 | 79,667 | 87,318 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
23.54 to 37.65 | 17.83 to 28.52 | 15.40 to 24.63 | 15.12 to 24.18 | 21.05 | |||||||||||||||
Assets, end of period $ |
6,764,116 | 4,350,710 | 2,948,519 | 1,914,656 | 1,828,011 | |||||||||||||||
Investment income ratio* |
2.17 | % | 1.13 | % | 2.13 | % | 1.59 | % | 2.37 | % | ||||||||||
Total return, lowest to highest** |
32.02% to 32.03 | % | 8.03% to 15.80 | % | 1.86% to 1.87 | % | 14.85% to 14.86 | % | 24.08% to 31.02 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Active Bond Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
9,197 | 4,900 | 1,410 | 975 | 334 | |||||||||||||||
Units issued |
997 | 4,521 | 3,631 | 1,681 | 707 | |||||||||||||||
Units redeemed |
(354 | ) | (224 | ) | (141 | ) | (1,246 | ) | (66 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
9,840 | 9,197 | 4,900 | 1,410 | 975 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
66.44 | 66.31 | 60.42 | 57.02 | 50.05 | |||||||||||||||
Assets, end of period $ |
653,806 | 609,860 | 296,062 | 80,380 | 48,772 | |||||||||||||||
Investment income ratio* |
5.99 | % | 5.15 | % | 11.40 | % | 7.43 | % | 8.48 | % | ||||||||||
Total return, lowest to highest** |
0.19 | % | 5.32% to 9.76 | % | 5.97 | % | 13.91 | % | 18.30% to 24.86 | % |
74
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Active Bond Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
13,176 | 13,151 | 13,969 | 13,951 | 20,634 | |||||||||||||||
Units issued |
2,813 | 976 | 805 | 759 | 1,167 | |||||||||||||||
Units redeemed |
(550 | ) | (951 | ) | (1,623 | ) | (741 | ) | (7,850 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
15,439 | 13,176 | 13,151 | 13,969 | 13,951 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
20.41 | 20.36 | 18.56 | 17.54 | 15.41 | |||||||||||||||
Assets, end of period $ |
315,051 | 268,212 | 244,014 | 244,979 | 214,909 | |||||||||||||||
Investment income ratio* |
6.44 | % | 4.20 | % | 5.40 | % | 7.62 | % | 6.87 | % | ||||||||||
Total return, lowest to highest** |
0.24 | % | 9.71 | % | 5.81 | % | 13.84 | % | 24.81 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
All Asset Portfolio | ||||||||||||||||||||
Year Ended Dec. 31/13 (bg) |
Year Ended Dec. 31/12 (bg) |
Year Ended Dec. 31/11 (bg) |
Year Ended Dec. 31/10 (bg) |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
313,212 | 17,548 | 10,032 | 9,068 | 2,123 | |||||||||||||||
Units issued |
5,459 | 301,263 | 9,120 | 3,705 | 10,323 | |||||||||||||||
Units redeemed |
(9,370 | ) | (5,599 | ) | (1,604 | ) | (2,741 | ) | (3,378 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
309,301 | 313,212 | 17,548 | 10,032 | 9,068 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.81 to 22.31 | 15.82 to 22.34 | 13.80 to 19.48 | 13.58 to 19.16 | 12.05 to 17.00 | |||||||||||||||
Assets, end of period $ |
4,889,041 | 4,968,258 | 254,448 | 138,475 | 116,677 | |||||||||||||||
Investment income ratio* |
4.24 | % | 6.73 | % | 7.29 | % | 6.98 | % | 7.71 | % | ||||||||||
Total return, lowest to highest** |
(0.10%) to (0.10 | %) | 9.24% to 14.65 | % | 1.66 | % | 12.71 | % | 14.85% to 21.32 | % |
(bg) | Fund has no Series. Previously presented as Series 0 and Series 1. |
75
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
All Cap Core Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
4,035 | 83,259 | 2,836 | 2,602 | 1,325 | |||||||||||||||
Units issued |
1,254 | 1,655 | 81,932 | 596 | 1,703 | |||||||||||||||
Units redeemed |
(806 | ) | (80,879 | ) | (1,509 | ) | (362 | ) | (426 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
4,483 | 4,035 | 83,259 | 2,836 | 2,602 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
18.44 | 13.72 | 11.76 | 11.71 | 10.36 | |||||||||||||||
Assets, end of period $ |
82,745 | 55,395 | 979,289 | 33,255 | 26,974 | |||||||||||||||
Investment income ratio* |
1.38 | % | 0.24 | % | 1.62 | % | 1.18 | % | 1.70 | % | ||||||||||
Total return, lowest to highest** |
34.44 | % | 10.44% to 16.62 | % | 0.40 | % | 13.09 | % | 24.46% to 33.05 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
All Cap Core Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
37,068 | 37,436 | 38,944 | 40,951 | 34,833 | |||||||||||||||
Units issued |
536 | 681 | 876 | 1,171 | 8,929 | |||||||||||||||
Units redeemed |
(18,366 | ) | (1,049 | ) | (2,384 | ) | (3,178 | ) | (2,811 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
19,238 | 37,068 | 37,436 | 38,944 | 40,951 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.53 | 11.56 | 9.92 | 9.88 | 8.74 | |||||||||||||||
Assets, end of period $ |
298,820 | 428,605 | 371,332 | 384,712 | 357,886 | |||||||||||||||
Investment income ratio* |
1.34 | % | 1.15 | % | 1.03 | % | 1.07 | % | 1.68 | % | ||||||||||
Total return, lowest to highest** |
34.31 | % | 16.57 | % | 0.42 | % | 13.03 | % | 28.46 | % |
76
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
All Cap Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 (m) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
32,924 | 27,144 | 11,363 | 8,332 | 5,913 | |||||||||||||||
Units issued |
10,547 | 7,879 | 18,411 | 4,022 | 3,819 | |||||||||||||||
Units redeemed |
(43,471 | ) | (2,099 | ) | (2,630 | ) | (991 | ) | (1,400 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 32,924 | 27,144 | 11,363 | 8,332 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
20.42 | 15.60 | 14.06 | 14.67 | 12.38 | |||||||||||||||
Assets, end of period $ |
— | 513,465 | 381,657 | 166,715 | 103,167 | |||||||||||||||
Investment income ratio* |
1.62 | % | 0.96 | % | 0.52 | % | 0.51 | % | 0.63 | % | ||||||||||
Total return, lowest to highest** |
30.93 | % | 6.24% to 10.92 | % | (4.17 | %) | 18.50 | % | 22.43% to 31.77 | % | ||||||||||
(m) Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
All Cap Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 (m) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
6,878 | 12,885 | 7,937 | 8,263 | 10,031 | |||||||||||||||
Units issued |
2,997 | 210 | 5,225 | 333 | 501 | |||||||||||||||
Units redeemed |
(9,875 | ) | (6,217 | ) | (277 | ) | (659 | ) | (2,269 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 6,878 | 12,885 | 7,937 | 8,263 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
28.21 | 21.57 | 19.44 | 20.29 | 17.15 | |||||||||||||||
Assets, end of period $ |
— | 148,354 | 250,473 | 161,055 | 141,658 | |||||||||||||||
Investment income ratio* |
1.06 | % | 0.76 | % | 0.48 | % | 0.37 | % | 0.52 | % | ||||||||||
Total return, lowest to highest** |
30.78 | % | 10.95 | % | (4.21 | %) | 18.35 | % | 26.61 | % |
(m) | Terminated as an investment option and funds transferred to Fundamental Large Cap Value Trust on December 9, 2013. |
77
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||
Alpha Opportunities Trust Series 0 | ||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 (n) |
|||||||||||||
Units, beginning of period |
2,919 | 63,000 | 1,887 | — | ||||||||||||
Units issued |
1,711 | 714 | 63,239 | 1,903 | ||||||||||||
Units redeemed |
(483 | ) | (60,795 | ) | (2,126 | ) | (16 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Units, end of period |
4,147 | 2,919 | 63,000 | 1,887 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Unit value, end of period $ |
22.54 | 16.63 | 13.70 | 14.89 | ||||||||||||
Assets, end of period $ |
93,480 | 48,537 | 862,996 | 28,103 | ||||||||||||
Investment income ratio* |
0.92 | % | 0.12 | % | 0.28 | % | 0.96 | % | ||||||||
Total return, lowest to highest** |
35.58 | % | 9.62% to 21.38 | % | (8.02 | %) | 16.98 | % |
(n) | Fund available in prior year but no activity. |
Sub-Account | ||||||||||||||||||||
American Asset Allocation Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
87,850 | 56,070 | 37,305 | 24,158 | 157 | |||||||||||||||
Units issued |
24,729 | 38,456 | 23,086 | 15,778 | 25,418 | |||||||||||||||
Units redeemed |
(8,602 | ) | (6,676 | ) | (4,321 | ) | (2,631 | ) | (1,417 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
103,977 | 87,850 | 56,070 | 37,305 | 24,158 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
14.49 | 11.75 | 10.15 | 10.06 | 8.98 | |||||||||||||||
Assets, end of period $ |
1,506,292 | 1,032,197 | 569,092 | 375,193 | 216,820 | |||||||||||||||
Investment income ratio* |
1.24 | % | 1.94 | % | 2.05 | % | 2.00 | % | 3.54 | % | ||||||||||
Total return, lowest to highest** |
23.30 | % | 8.80% to 15.77 | % | 0.91 | % | 12.07 | % | 18.28% to 25.85 | % |
78
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||
American Global Growth Trust Series 1 | ||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 (n) |
||||||||||
Units, beginning of period |
3,506 | 1,623 | — | |||||||||
Units issued |
2,825 | 2,434 | 1,660 | |||||||||
Units redeemed |
(648 | ) | (551 | ) | (37 | ) | ||||||
|
|
|
|
|
|
|||||||
Units, end of period |
5,683 | 3,506 | 1,623 | |||||||||
|
|
|
|
|
|
|||||||
Unit value, end of period $ |
14.40 | 11.19 | 9.17 | |||||||||
Assets, end of period $ |
81,821 | 39,240 | 14,877 | |||||||||
Investment income ratio* |
1.04 | % | 0.54 | % | 2.45 | % | ||||||
Total return, lowest to highest** |
28.63 | % | 13.48% to 22.12 | % | (9.24 | %) | ||||||
(n) Fund available in prior year but no activity. |
| |||||||||||
Sub-Account | ||||||||||||
American Global Small Capitalization Trust Series 1 | ||||||||||||
Year Ended Dec. 31/13 (bh) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 (n) |
||||||||||
Units, beginning of period |
2,018 | 2,002 | — | |||||||||
Units issued |
141 | 105 | 2,046 | |||||||||
Units redeemed |
(2,159 | ) | (89 | ) | (44 | ) | ||||||
|
|
|
|
|
|
|||||||
Units, end of period |
— | 2,018 | 2,002 | |||||||||
|
|
|
|
|
|
|||||||
Unit value, end of period $ |
10.64 | 9.64 | 8.19 | |||||||||
Assets, end of period $ |
— | 19,452 | 16,392 | |||||||||
Investment income ratio* |
0.70 | % | 0.91 | % | 2.24 | % | ||||||
Total return, lowest to highest** |
10.37 | % | 9.07% to 17.71 | % | (19.43 | %) |
(bh) | Terminated as an investment option and funds transferred to American Global Growth Trust Series 1 on April 29, 2013. |
(n) | Fund available in prior year but no activity. |
79
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
American Growth Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
116,603 | 175,103 | 94,221 | 91,492 | 56,137 | |||||||||||||||
Units issued |
15,422 | 37,768 | 97,231 | 59,196 | 50,848 | |||||||||||||||
Units redeemed |
(14,925 | ) | (96,268 | ) | (16,349 | ) | (56,467 | ) | (15,493 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
117,100 | 116,603 | 175,103 | 94,221 | 91,492 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
19.58 to 29.48 | 15.11 to 22.75 | 12.86 to 19.36 | 13.48 to 20.30 | 11.40 | |||||||||||||||
Assets, end of period $ |
2,499,497 | 1,951,721 | 2,369,650 | 1,421,047 | 1,153,106 | |||||||||||||||
Investment income ratio* |
0.57 | % | 0.38 | % | 0.27 | % | 0.36 | % | 0.34 | % | ||||||||||
Total return, lowest to highest** |
29.61% to 29.61 | % | 8.11% to 17.49 | % | (4.63 | %) | 18.23% to 18.24 | % | 25.08% to 42.05 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
American Growth-Income Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
143,577 | 71,930 | 70,155 | 60,898 | 88,850 | |||||||||||||||
Units issued |
10,133 | 80,514 | 12,692 | 14,882 | 65,625 | |||||||||||||||
Units redeemed |
(11,625 | ) | (8,867 | ) | (10,917 | ) | (5,625 | ) | (93,577 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
142,085 | 143,577 | 71,930 | 70,155 | 60,898 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
18.11 to 27.04 | 13.62 to 20.33 | 11.62 to 17.35 | 11.87 to 17.72 | 10.69 | |||||||||||||||
Assets, end of period $ |
2,798,113 | 2,131,349 | 963,908 | 998,842 | 796,589 | |||||||||||||||
Investment income ratio* |
1.02 | % | 2.01 | % | 1.19 | % | 1.22 | % | 0.74 | % | ||||||||||
Total return, lowest to highest** |
33.01% to 33.02 | % | 10.27% to 17.16 | % | (2.10%) to (2.09 | %) | 11.05% to 11.06 | % | 23.68% to 33.69 | % |
80
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||
American High-Income Bond Trust Series 1 | ||||||||||||
Year Ended Dec. 31/13 (l) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 (n) |
||||||||||
Units, beginning of period |
13,661 | 2,315 | — | |||||||||
Units issued |
926 | 13,744 | 2,411 | |||||||||
Units redeemed |
(14,587 | ) | (2,398 | ) | (96 | ) | ||||||
|
|
|
|
|
|
|||||||
Units, end of period |
— | 13,661 | 2,315 | |||||||||
|
|
|
|
|
|
|||||||
Unit value, end of period $ |
11.83 | 11.49 | 10.16 | |||||||||
Assets, end of period $ |
— | 157,024 | 23,527 | |||||||||
Investment income ratio* |
0.25 | % | 10.57 | % | 20.05 | % | ||||||
Total return, lowest to highest** |
2.90 | % | 6.30% to 13.11 | % | 1.46 | % |
(l) | Terminated as an investment option and funds transferred to High Yield Trust Series 1 on April 29, 2013. |
(n) | Fund available in prior year but no activity. |
Sub-Account | ||||||||||||||||||||
American International Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
81,137 | 89,381 | 76,308 | 51,505 | 42,851 | |||||||||||||||
Units issued |
34,067 | 19,210 | 34,549 | 52,695 | 34,474 | |||||||||||||||
Units redeemed |
(33,108 | ) | (27,454 | ) | (21,476 | ) | (27,892 | ) | (25,820 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
82,096 | 81,137 | 89,381 | 76,308 | 51,505 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
18.85 to 33.19 | 15.55 to 27.39 | 13.24 to 23.31 | 15.45 to 27.21 | 14.46 | |||||||||||||||
Assets, end of period $ |
1,722,671 | 1,427,243 | 1,332,045 | 1,349,296 | 855,948 | |||||||||||||||
Investment income ratio* |
1.03 | % | 1.06 | % | 1.51 | % | 1.97 | % | 1.20 | % | ||||||||||
Total return, lowest to highest** |
21.20% to 21.20 | % | 13.22% to 17.50 | % | (14.34 | %) | 6.88 | % | 27.67% to 46.99 | % |
81
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
American New World Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (a) |
||||||||||||||||
Units, beginning of period |
13,912 | 12,806 | 4,109 | 11,999 | — | |||||||||||||||
Units issued |
6,499 | 2,231 | 11,580 | 3,543 | 12,025 | |||||||||||||||
Units redeemed |
(668 | ) | (1,125 | ) | (2,883 | ) | (11,433 | ) | (26 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
19,743 | 13,912 | 12,806 | 4,109 | 11,999 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.49 | 15.77 | 13.44 | 15.69 | 13.36 | |||||||||||||||
Assets, end of period $ |
345,333 | 219,440 | 172,098 | 64,457 | 160,289 | |||||||||||||||
Investment income ratio* |
1.22 | % | 0.64 | % | 2.18 | % | 0.65 | % | 7.30 | % | ||||||||||
Total return, lowest to highest** |
10.89 | % | 12.53% to 17.37 | % | (14.33 | %) | 17.43 | % | 30.38% to 33.58 | % | ||||||||||
(a) Reflects the period from commencement of operations on May 4, 2009 through December 31, 2009. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Blue Chip Growth Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
36,543 | 49,717 | 31,138 | 27,629 | 7,243 | |||||||||||||||
Units issued |
2,924 | 8,580 | 32,665 | 14,495 | 24,326 | |||||||||||||||
Units redeemed |
(14,522 | ) | (21,754 | ) | (14,086 | ) | (10,986 | ) | (3,940 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
24,945 | 36,543 | 49,717 | 31,138 | 27,629 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
112.07 | 79.24 | 66.93 | 65.97 | 56.75 | |||||||||||||||
Assets, end of period $ |
2,795,578 | 2,895,574 | 3,327,453 | 2,054,232 | 1,567,863 | |||||||||||||||
Investment income ratio* |
0.32 | % | 0.13 | % | 0.02 | % | 0.09 | % | 0.20 | % | ||||||||||
Total return, lowest to highest** |
41.43 | % | 5.30% to 18.39 | % | 1.45 | % | 16.25 | % | 26.87% to 46.21 | % |
82
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Blue Chip Growth Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
44,353 | 54,004 | 52,381 | 51,352 | 58,485 | |||||||||||||||
Units issued |
10,344 | 3,448 | 9,561 | 4,833 | 12,872 | |||||||||||||||
Units redeemed |
(8,855 | ) | (13,099 | ) | (7,938 | ) | (3,804 | ) | (20,005 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
45,842 | 44,353 | 54,004 | 52,381 | 51,352 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.84 | 15.46 | 13.06 | 12.88 | 11.09 | |||||||||||||||
Assets, end of period $ |
1,001,567 | 685,670 | 705,592 | 674,666 | 569,454 | |||||||||||||||
Investment income ratio* |
0.28 | % | 0.09 | % | 0.01 | % | 0.08 | % | 0.15 | % | ||||||||||
Total return, lowest to highest** |
41.33 | % | 18.31 | % | 1.44 | % | 16.15 | % | 42.89 | % |
Sub-Account | ||||||||||||
Bond Trust Series 0 | ||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 (c) |
||||||||||
Units, beginning of period |
18,444 | 16,603 | — | |||||||||
Units issued |
2,564 | 3,451 | 16,794 | |||||||||
Units redeemed |
(3,559 | ) | (1,610 | ) | (191 | ) | ||||||
|
|
|
|
|
|
|||||||
Units, end of period |
17,449 | 18,444 | 16,603 | |||||||||
|
|
|
|
|
|
|||||||
Unit value, end of period $ |
10.58 | 10.72 | 10.08 | |||||||||
Assets, end of period $ |
184,560 | 197,686 | 167,386 | |||||||||
Investment income ratio* |
2.99 | % | 2.96 | % | 14.80 | % | ||||||
Total return, lowest to highest** |
(1.32 | %) | 2.99% to 6.31 | % | 0.82 | % |
(c) | Reflects the period from commencement of operations on October 31, 2011 through December 31, 2011. |
83
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||
Bond Trust Series 1 | ||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 (c) |
||||||||||
Units, beginning of period |
1,967 | — | — | |||||||||
Units issued |
— | 1,991 | 1,851 | |||||||||
Units redeemed |
(1,967 | ) | (24 | ) | (1,851 | ) | ||||||
|
|
|
|
|
|
|||||||
Units, end of period |
— | 1,967 | — | |||||||||
|
|
|
|
|
|
|||||||
Unit value, end of period $ |
10.57 | 10.72 | 10.08 | |||||||||
Assets, end of period $ |
— | 21,086 | — | |||||||||
Investment income ratio* |
0.00 | % | 3.38 | % | 0.00 | % | ||||||
Total return, lowest to highest** |
(1.36 | %) | 6.34 | % | 0.78 | % |
(c) | Reflects the period from commencement of operations on October 31, 2011 through December 31, 2011. |
Sub-Account | ||||||||||||||||||||
Brandes International Equity | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
1,292 | 1,044 | 678 | 815 | 63 | |||||||||||||||
Units issued |
1,909 | 405 | 4,422 | 712 | 824 | |||||||||||||||
Units redeemed |
(80 | ) | (157 | ) | (4,056 | ) | (849 | ) | (72 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
3,121 | 1,292 | 1,044 | 678 | 815 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
35.56 | 30.57 | 25.33 | 29.30 | 28.01 | |||||||||||||||
Assets, end of period $ |
110,980 | 39,498 | 26,458 | 19,895 | 22,847 | |||||||||||||||
Investment income ratio* |
3.81 | % | 2.44 | % | 2.86 | % | 4.07 | % | 5.05 | % | ||||||||||
Total return, lowest to highest** |
16.32 | % | 14.03% to 20.68 | % | (13.56 | %) | 4.61 | % | 19.34% to 25.28 | % |
84
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Capital Appreciation Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
224,074 | 19,715 | 6,573 | 3,745 | 2,731 | |||||||||||||||
Units issued |
7,827 | 257,019 | 14,224 | 3,932 | 2,202 | |||||||||||||||
Units redeemed |
(15,543 | ) | (52,660 | ) | (1,082 | ) | (1,104 | ) | (1,188 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
216,358 | 224,074 | 19,715 | 6,573 | 3,745 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.17 | 16.13 | 13.90 | 13.88 | 12.41 | |||||||||||||||
Assets, end of period $ |
4,797,597 | 3,613,450 | 274,033 | 91,282 | 46,488 | |||||||||||||||
Investment income ratio* |
0.26 | % | 0.24 | % | 0.15 | % | 0.22 | % | 0.34 | % | ||||||||||
Total return, lowest to highest** |
37.50 | % | 3.07% to 16.03 | % | 0.11 | % | 11.88 | % | 28.49% to 44.66 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Capital Appreciation Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
21,787 | 17,216 | 24,852 | 20,403 | 18,768 | |||||||||||||||
Units issued |
2,618 | 7,586 | 1,756 | 6,440 | 7,646 | |||||||||||||||
Units redeemed |
(9,218 | ) | (3,015 | ) | (9,392 | ) | (1,991 | ) | (6,011 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
15,187 | 21,787 | 17,216 | 24,852 | 20,403 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.60 | 16.44 | 14.18 | 14.17 | 12.67 | |||||||||||||||
Assets, end of period $ |
343,169 | 358,273 | 244,101 | 352,086 | 258,477 | |||||||||||||||
Investment income ratio* |
0.24 | % | 0.16 | % | 0.07 | % | 0.14 | % | 0.28 | % | ||||||||||
Total return, lowest to highest** |
37.41 | % | 15.98 | % | 0.07 | % | 11.83 | % | 42.28 | % |
85
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Capital Appreciation Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (n) |
||||||||||||||||
Units, beginning of period |
65,861 | 49,574 | 7,785 | 4,309 | — | |||||||||||||||
Units issued |
11,050 | 21,760 | 43,226 | 3,814 | 4,378 | |||||||||||||||
Units redeemed |
(5,780 | ) | (5,473 | ) | (1,437 | ) | (338 | ) | (69 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
71,131 | 65,861 | 49,574 | 7,785 | 4,309 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.60 | 12.76 | 11.12 | 10.79 | 9.47 | |||||||||||||||
Assets, end of period $ |
1,110,013 | 840,362 | 551,165 | 83,962 | 40,797 | |||||||||||||||
Investment income ratio* |
1.39 | % | 1.68 | % | 2.52 | % | 1.96 | % | 4.08 | % | ||||||||||
Total return, lowest to highest** |
22.29 | % | 7.74% to 14.77 | % | 3.09 | % | 13.91 | % | 19.68% to 30.98 | % | ||||||||||
(n) Fund available in prior year but no activity. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Core Allocation Plus Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 (z) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
63,214 | 51,573 | 12,952 | 2,056 | 25 | |||||||||||||||
Units issued |
17,999 | 14,390 | 40,590 | 11,390 | 2,075 | |||||||||||||||
Units redeemed |
(81,213 | ) | (2,749 | ) | (1,969 | ) | (494 | ) | (44 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 63,214 | 51,573 | 12,952 | 2,056 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
12.75 | 10.63 | 9.36 | 9.58 | 8.66 | |||||||||||||||
Assets, end of period $ |
— | 671,902 | 482,804 | 124,047 | 17,817 | |||||||||||||||
Investment income ratio* |
3.72 | % | 1.54 | % | 1.66 | % | 1.64 | % | 3.21 | % | ||||||||||
Total return, lowest to highest** |
20.00 | % | 7.77% to 13.53 | % | (2.26 | %) | 10.57 | % | 17.53% to 27.67 | % |
(z) | Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. |
86
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Core Bond Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
30,002 | 12,035 | 8,084 | 174 | 5 | |||||||||||||||
Units issued |
5,022 | 130,590 | 6,894 | 8,238 | 302 | |||||||||||||||
Units redeemed |
(2,201 | ) | (112,623 | ) | (2,943 | ) | (328 | ) | (133 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
32,823 | 30,002 | 12,035 | 8,084 | 174 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.34 | 15.67 | 14.71 | 13.58 | 12.67 | |||||||||||||||
Assets, end of period $ |
503,461 | 470,138 | 177,014 | 109,761 | 2,208 | |||||||||||||||
Investment income ratio* |
2.25 | % | 1.81 | % | 3.79 | % | 5.76 | % | 3.31 | % | ||||||||||
Total return, lowest to highest** |
(2.12 | %) | 3.76% to 6.54 | % | 8.32 | % | 7.17 | % | 5.61% to 9.93 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Core Bond Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
7,239 | 7,947 | 7,576 | 7,642 | 7,548 | |||||||||||||||
Units issued |
— | — | 578 | 138 | 330 | |||||||||||||||
Units redeemed |
(138 | ) | (708 | ) | (207 | ) | (204 | ) | (236 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
7,101 | 7,239 | 7,947 | 7,576 | 7,642 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
19.11 | 19.53 | 18.35 | 16.94 | 15.82 | |||||||||||||||
Assets, end of period $ |
135,720 | 141,400 | 145,809 | 128,333 | 120,893 | |||||||||||||||
Investment income ratio* |
2.13 | % | 2.67 | % | 3.31 | % | 2.71 | % | 2.42 | % | ||||||||||
Total return, lowest to highest** |
(2.15 | %) | 6.46 | % | 8.32 | % | 7.08 | % | 9.94 | % |
87
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Core Strategy Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (az) |
||||||||||||||||
Units, beginning of period |
221,775 | 380,508 | 33,777 | 15,262 | 267 | |||||||||||||||
Units issued |
207,562 | 105,814 | 362,230 | 23,078 | 32,585 | |||||||||||||||
Units redeemed |
(23,224 | ) | (264,547 | ) | (15,499 | ) | (4,563 | ) | (17,590 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
406,113 | 221,775 | 380,508 | 33,777 | 15,262 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
13.88 | 11.64 | 10.34 | 10.32 | 9.17 | |||||||||||||||
Assets, end of period $ |
5,636,940 | 2,580,442 | 3,932,905 | 348,482 | 139,885 | |||||||||||||||
Investment income ratio* |
1.15 | % | 2.47 | % | 2.63 | % | 3.19 | % | 3.19 | % | ||||||||||
Total return, lowest to highest** |
19.29 | % | 7.54% to 12.58 | % | 0.19 | % | 12.57 | % | 18.49% to 25.03 | % | ||||||||||
(az) Renamed on May 4, 2009. Previously known as Index Allocation Trust. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Disciplined Diversification Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 (z) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
43,479 | 40,301 | 34,328 | 30,638 | 70 | |||||||||||||||
Units issued |
8,168 | 5,592 | 8,493 | 5,086 | 31,069 | |||||||||||||||
Units redeemed |
(51,647 | ) | (2,414 | ) | (2,520 | ) | (1,396 | ) | (501 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 43,479 | 40,301 | 34,328 | 30,638 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
13.23 | 11.51 | 10.21 | 10.42 | 9.19 | |||||||||||||||
Assets, end of period $ |
— | 500,637 | 411,424 | 357,729 | 281,420 | |||||||||||||||
Investment income ratio* |
4.35 | % | 2.60 | % | 2.47 | % | 1.82 | % | 7.40 | % | ||||||||||
Total return, lowest to highest** |
14.89 | % | 8.54% to 12.79 | % | (2.04 | %) | 13.45 | % | 20.12% to 29.89 | % |
(z) | Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. |
88
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Emerging Markets Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
240,299 | 177,609 | 98,617 | 80,233 | 2,347 | |||||||||||||||
Units issued |
20,447 | 87,243 | 164,542 | 54,370 | 80,237 | |||||||||||||||
Units redeemed |
(13,757 | ) | (24,553 | ) | (85,550 | ) | (35,986 | ) | (2,351 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
246,989 | 240,299 | 177,609 | 98,617 | 80,233 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
11.97 | 12.36 | 10.43 | 14.29 | 11.61 | |||||||||||||||
Assets, end of period $ |
2,955,779 | 2,970,118 | 1,852,637 | 1,409,515 | 931,541 | |||||||||||||||
Investment income ratio* |
1.35 | % | 1.20 | % | 2.45 | % | 1.38 | % | 0.13 | % | ||||||||||
Total return, lowest to highest** |
(3.18 | %) | 14.09% to 18.49 | % | (27.02 | %) | 23.11 | % | 1.56% to 101.36 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Emerging Markets Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (n) |
||||||||||||||||
Units, beginning of period |
421 | 1,972 | 3,889 | 77 | — | |||||||||||||||
Units issued |
8 | 621 | 327 | 3,931 | 82 | |||||||||||||||
Units redeemed |
(25 | ) | (2,172 | ) | (2,244 | ) | (119 | ) | (5 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
404 | 421 | 1,972 | 3,889 | 77 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
14.93 | 15.42 | 13.01 | 17.84 | 14.50 | |||||||||||||||
Assets, end of period $ |
6,059 | 6,521 | 25,675 | 69,386 | 1,128 | |||||||||||||||
Investment income ratio* |
1.28 | % | 0.83 | % | 1.51 | % | 2.32 | % | 0.05 | % | ||||||||||
Total return, lowest to highest** |
(3.22 | %) | 18.53 | % | (27.06 | %) | 23.03 | % | 101.12 | % |
(n) | Fund available in prior year but no activity. |
89
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Equity-Income Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
183,533 | 65,762 | 38,933 | 38,620 | 19,617 | |||||||||||||||
Units issued |
9,138 | 156,871 | 38,362 | 18,265 | 34,992 | |||||||||||||||
Units redeemed |
(30,304 | ) | (39,100 | ) | (11,533 | ) | (17,952 | ) | (15,989 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
162,367 | 183,533 | 65,762 | 38,933 | 38,620 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
42.63 | 32.78 | 27.90 | 28.12 | 24.40 | |||||||||||||||
Assets, end of period $ |
6,921,388 | 6,015,928 | 1,835,020 | 1,094,709 | 942,394 | |||||||||||||||
Investment income ratio* |
2.00 | % | 2.46 | % | 2.22 | % | 2.01 | % | 2.39 | % | ||||||||||
Total return, lowest to highest** |
30.05 | % | 10.80% to 17.47 | % | (0.76 | %) | 15.23 | % | 24.57% to 30.76 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Equity-Income Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
35,163 | 34,818 | 21,579 | 23,852 | 34,606 | |||||||||||||||
Units issued |
4,304 | 2,977 | 18,762 | 2,793 | 9,623 | |||||||||||||||
Units redeemed |
(8,253 | ) | (2,632 | ) | (5,523 | ) | (5,066 | ) | (20,377 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
31,214 | 35,163 | 34,818 | 21,579 | 23,852 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
25.82 | 19.86 | 16.92 | 17.06 | 14.82 | |||||||||||||||
Assets, end of period $ |
806,115 | 698,291 | 589,152 | 368,113 | 353,455 | |||||||||||||||
Investment income ratio* |
1.85 | % | 2.12 | % | 2.09 | % | 1.86 | % | 2.06 | % | ||||||||||
Total return, lowest to highest** |
30.04 | % | 17.36 | % | (0.81 | %) | 15.11 | % | 25.72 | % |
90
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Financial Services Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
15,608 | 20,995 | 13,850 | 20,156 | 5,401 | |||||||||||||||
Units issued |
3,021 | 49,061 | 40,001 | 4,459 | 16,641 | |||||||||||||||
Units redeemed |
(1,551 | ) | (54,448 | ) | (32,856 | ) | (10,765 | ) | (1,886 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
17,078 | 15,608 | 20,995 | 13,850 | 20,156 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
26.20 | 20.02 | 16.96 | 18.72 | 16.68 | |||||||||||||||
Assets, end of period $ |
447,400 | 312,473 | 356,125 | 259,280 | 336,237 | |||||||||||||||
Investment income ratio* |
0.74 | % | 0.68 | % | 1.37 | % | 0.32 | % | 1.48 | % | ||||||||||
Total return, lowest to highest** |
30.86 | % | 8.06% to 18.03 | % | (9.39 | %) | 12.22 | % | 25.68% to 49.06 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Financial Services Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
6,673 | 6,888 | 7,907 | 8,149 | 7,699 | |||||||||||||||
Units issued |
117 | 68 | 147 | 807 | 1,904 | |||||||||||||||
Units redeemed |
(263 | ) | (283 | ) | (1,166 | ) | (1,049 | ) | (1,454 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
6,527 | 6,673 | 6,888 | 7,907 | 8,149 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.77 | 16.65 | 14.10 | 15.59 | 13.89 | |||||||||||||||
Assets, end of period $ |
142,093 | 111,115 | 97,158 | 123,250 | 113,149 | |||||||||||||||
Investment income ratio* |
0.65 | % | 0.80 | % | 1.61 | % | 0.34 | % | 0.75 | % | ||||||||||
Total return, lowest to highest** |
30.75 | % | 18.05 | % | (9.51 | %) | 12.26 | % | 41.41 | % |
91
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Franklin Templeton Founding Allocation Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
107,295 | 63,253 | 14,641 | 2,821 | 204 | |||||||||||||||
Units issued |
35,637 | 49,595 | 51,040 | 12,964 | 2,762 | |||||||||||||||
Units redeemed |
(8,984 | ) | (5,553 | ) | (2,428 | ) | (1,144 | ) | (145 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
133,948 | 107,295 | 63,253 | 14,641 | 2,821 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
14.12 | 11.34 | 9.75 | 9.89 | 8.93 | |||||||||||||||
Assets, end of period $ |
1,890,794 | 1,216,471 | 616,457 | 144,801 | 25,206 | |||||||||||||||
Investment income ratio* |
2.82 | % | 4.11 | % | 4.91 | % | 7.41 | % | 6.77 | % | ||||||||||
Total return, lowest to highest** |
24.51 | % | 12.32% to 16.33 | % | (1.45 | %) | 10.71 | % | 25.33% to 32.61 | % |
Sub-Account | ||||||||||||||||
Franklin Templeton Founding Allocation Trust Series 1 | ||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (r) |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 (n) |
|||||||||||||
Units, beginning of period |
— | — | 346 | — | ||||||||||||
Units issued |
155 | — | — | 364 | ||||||||||||
Units redeemed |
(2 | ) | — | (346 | ) | (18 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Units, end of period |
153 | — | — | 346 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Unit value, end of period $ |
14.09 | 11.32 | 9.74 | 9.88 | ||||||||||||
Assets, end of period $ |
2,156 | — | — | 3,420 | ||||||||||||
Investment income ratio* |
21.24 | % | 0.00 | % | 0.00 | % | 6.97 | % | ||||||||
Total return, lowest to highest** |
24.43 | % | 16.26 | % | (1.41 | %) | 10.66 | % |
(r) | Fund available but no activity. |
(n) | Fund available in prior year but no activity. |
92
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Frontier Capital Appreciation | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
84 | 59 | 6 | 2 | 31 | |||||||||||||||
Units issued |
649 | 29 | 131 | 5 | 2 | |||||||||||||||
Units redeemed |
(9 | ) | (4 | ) | (78 | ) | (1 | ) | (31 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
724 | 84 | 59 | 6 | 2 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
75.67 | 54.36 | 46.29 | 49.89 | 39.29 | |||||||||||||||
Assets, end of period $ |
54,710 | 4,505 | 2,704 | 275 | 91 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.39 | % | 0.00 | % | 0.15 | % | 0.15 | % | ||||||||||
Total return, lowest to highest** |
39.20 | % | 8.43% to 17.43 | % | (7.22 | %) | 27.00 | % | 29.61% to 50.68 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Fundamental All Cap Core Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 (j) | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
11,939 | 88,943 | 9,318 | 7,099 | 6,594 | |||||||||||||||
Units issued |
17,627 | 3,671 | 83,048 | 4,103 | 3,624 | |||||||||||||||
Units redeemed |
(2,645 | ) | (80,675 | ) | (3,423 | ) | (1,884 | ) | (3,119 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
26,921 | 11,939 | 88,943 | 9,318 | 7,099 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
19.73 | 14.52 | 11.74 | 11.98 | 10.02 | |||||||||||||||
Assets, end of period $ |
530,987 | 173,316 | 1,044,175 | 111,639 | 71,151 | |||||||||||||||
Investment income ratio* |
1.14 | % | 0.35 | % | 1.32 | % | 1.35 | % | 1.44 | % | ||||||||||
Total return, lowest to highest** |
35.87 | % | 15.03% to 23.67 | % | (2.02 | %) | 19.55 | % | 26.61% to 31.86 | % |
(j) | Renamed on June 27, 2011. Previously known as Optimized All Cap Trust. |
93
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Fundamental All Cap Core Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 (j) | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
17 | 36 | 66 | 67 | 218 | |||||||||||||||
Units issued |
1,091 | 123 | 110 | 119 | 723 | |||||||||||||||
Units redeemed |
(50 | ) | (142 | ) | (140 | ) | (120 | ) | (874 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
1,058 | 17 | 36 | 66 | 67 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
33.23 | 24.46 | 19.80 | 20.22 | 16.91 | |||||||||||||||
Assets, end of period $ |
35,115 | 396 | 691 | 1,320 | 1,127 | |||||||||||||||
Investment income ratio* |
0.34 | % | 0.47 | % | 0.75 | % | 1.11 | % | 0.28 | % | ||||||||||
Total return, lowest to highest** |
35.88 | % | 23.52 | % | (2.08 | %) | 19.55 | % | 28.27 | % |
(j) | Renamed on June 27, 2011. Previously known as Optimized All Cap Trust. |
Sub-Account | ||||||||||||||||||||
Fundamental Holdings Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 (z) | Dec. 31/12 | Dec. 31/11 (p) | Dec. 31/10 | Dec. 31/09 (a) | ||||||||||||||||
Units, beginning of period |
11,450 | 9,969 | 72,846 | 2,833 | — | |||||||||||||||
Units issued |
3,428 | 2,529 | 5,645 | 71,620 | 2,841 | |||||||||||||||
Units redeemed |
(14,878 | ) | (1,048 | ) | (68,522 | ) | (1,607 | ) | (8 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 11,450 | 9,969 | 72,846 | 2,833 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
16.67 | 14.66 | 13.02 | 13.15 | 11.92 | |||||||||||||||
Assets, end of period $ |
— | 167,926 | 129,800 | 958,309 | 33,778 | |||||||||||||||
Investment income ratio* |
2.20 | % | 1.91 | % | 1.38 | % | 3.14 | % | 12.79 | % | ||||||||||
Total return, lowest to highest** |
13.66 | % | 7.22% to 12.65 | % | (1.05 | %) | 10.36 | % | 18.47% to 19.20 | % |
(z) | Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. |
(p) | Renamed on October 31, 2011. Previously known as American Fundamental Holdings Trust Series 1. |
(a) | Reflects the period from commencement of operations on May 4, 2009 through December 31, 2009. |
94
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Fundamental Large Cap Value Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 (o) | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
2,603 | 1,145 | 1,107 | 711 | 635 | |||||||||||||||
Units issued |
68,598 | 1,644 | 129 | 458 | 118 | |||||||||||||||
Units redeemed |
(1,775 | ) | (186 | ) | (91 | ) | (62 | ) | (42 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
69,426 | 2,603 | 1,145 | 1,107 | 711 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
18.04 | 13.62 | 10.94 | 10.74 | 9.46 | |||||||||||||||
Assets, end of period $ |
1,252,483 | 35,444 | 12,522 | 11,885 | 6,727 | |||||||||||||||
Investment income ratio* |
1.49 | % | 2.01 | % | 1.09 | % | 2.55 | % | 2.26 | % | ||||||||||
Total return, lowest to highest** |
32.46 | % | 16.71% to 24.48 | % | 1.90 | % | 13.51 | % | 22.60% to 28.80 | % |
(o) | Renamed on June 27, 2011. Previously known as Optimized Value Trust. |
Sub-Account | ||||||||
Fundamental Large Cap Value Trust Series 1 | ||||||||
Year Ended | Year Ended | |||||||
Dec. 31/13 | Dec. 31/12 (n) | |||||||
Units, beginning of period |
— | — | ||||||
Units issued |
5,280 | 1,417 | ||||||
Units redeemed |
(10 | ) | (1,417 | ) | ||||
|
|
|
|
|||||
Units, end of period |
5,270 | — | ||||||
|
|
|
|
|||||
Unit value, end of period $ |
25.64 | 19.36 | ||||||
Assets, end of period $ |
135,126 | — | ||||||
Investment income ratio* |
0.00 | % | 0.00 | % | ||||
Total return, lowest to highest** |
32.41 | % | 24.43 | % |
(n) | Fund available in prior year but no activity. |
95
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Fundamental Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
27,028 | 25,146 | 100,018 | 19,978 | 12,508 | |||||||||||||||
Units issued |
2,603 | 7,590 | 7,502 | 87,250 | 15,795 | |||||||||||||||
Units redeemed |
(13,028 | ) | (5,708 | ) | (82,374 | ) | (7,210 | ) | (8,325 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
16,603 | 27,028 | 25,146 | 100,018 | 19,978 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.45 | 13.06 | 11.52 | 11.96 | 10.57 | |||||||||||||||
Assets, end of period $ |
289,723 | 352,963 | 289,576 | 1,196,553 | 211,149 | |||||||||||||||
Investment income ratio* |
1.36 | % | 1.06 | % | 0.82 | % | 2.00 | % | 1.18 | % | ||||||||||
Total return, lowest to highest** |
33.62 | % | 6.37% to 13.40 | % | (3.74 | %) | 13.20 | % | 24.46% to 38.50 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Fundamental Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
26,876 | 37,776 | 36,464 | 37,304 | 51,202 | |||||||||||||||
Units issued |
1,580 | 2,090 | 5,148 | 3,423 | 3,228 | |||||||||||||||
Units redeemed |
(3,115 | ) | (12,990 | ) | (3,836 | ) | (4,263 | ) | (17,126 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
25,341 | 26,876 | 37,776 | 36,464 | 37,304 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
24.37 | 18.25 | 16.10 | 16.73 | 14.79 | |||||||||||||||
Assets, end of period $ |
617,642 | 490,620 | 608,196 | 610,130 | 551,908 | |||||||||||||||
Investment income ratio* |
1.33 | % | 0.85 | % | 0.86 | % | 1.15 | % | 0.87 | % | ||||||||||
Total return, lowest to highest** |
33.52 | % | 13.38 | % | (3.78 | %) | 13.10 | % | 31.78 | % |
96
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Global Bond Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
56,000 | 24,198 | 22,412 | 14,823 | 16,578 | |||||||||||||||
Units issued |
5,022 | 37,731 | 4,734 | 9,135 | 24,214 | |||||||||||||||
Units redeemed |
(30,392 | ) | (5,929 | ) | (2,948 | ) | (1,546 | ) | (25,969 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
30,630 | 56,000 | 24,198 | 22,412 | 14,823 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
30.08 | 31.84 | 29.72 | 27.24 | 24.68 | |||||||||||||||
Assets, end of period $ |
921,315 | 1,783,116 | 719,107 | 610,575 | 365,776 | |||||||||||||||
Investment income ratio* |
0.34 | % | 8.14 | % | 6.68 | % | 4.16 | % | 9.15 | % | ||||||||||
Total return, lowest to highest** |
(5.54 | %) | 4.53% to 7.15 | % | 9.08 | % | 10.40 | % | 13.91% to 15.41 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Global Bond Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
10,561 | 13,161 | 14,516 | 14,975 | 21,752 | |||||||||||||||
Units issued |
602 | 425 | 1,138 | 1,011 | 1,141 | |||||||||||||||
Units redeemed |
(3,089 | ) | (3,025 | ) | (2,493 | ) | (1,470 | ) | (7,918 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
8,074 | 10,561 | 13,161 | 14,516 | 14,975 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.08 | 22.28 | 20.82 | 19.09 | 17.31 | |||||||||||||||
Assets, end of period $ |
170,232 | 235,410 | 274,076 | 277,123 | 259,180 | |||||||||||||||
Investment income ratio* |
0.42 | % | 6.83 | % | 6.18 | % | 3.58 | % | 12.39 | % | ||||||||||
Total return, lowest to highest** |
(5.42 | %) | 7.03 | % | 9.08 | % | 10.30 | % | 15.39 | % |
97
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Global Diversification Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 (z) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 (q) |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (a) |
||||||||||||||||
Units, beginning of period |
19,135 | 16,953 | 6,614 | 2,302 | — | |||||||||||||||
Units issued |
10,687 | 4,116 | 11,703 | 4,740 | 2,303 | |||||||||||||||
Units redeemed |
(29,822 | ) | (1,934 | ) | (1,364 | ) | (428 | ) | (1 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 19,135 | 16,953 | 6,614 | 2,302 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.42 | 15.36 | 13.26 | 14.18 | 12.59 | |||||||||||||||
Assets, end of period $ |
— | 293,870 | 224,753 | 93,765 | 28,990 | |||||||||||||||
Investment income ratio* |
2.29 | % | 1.87 | % | 3.07 | % | 3.98 | % | 49.21 | % | ||||||||||
Total return, lowest to highest** |
13.46 | % | 9.32% to 15.84 | % | (6.49 | %) | 12.57 | % | 23.51% to 25.94 | % | ||||||||||
(z) Terminated as an investment option and funds transferred to Core Strategy Trust on December 9, 2013. (q) Renamed on October 31, 2011. Previously known as American Global Diversification Trust Series 1. (a) Reflects the period from commencement of operations on May 4, 2009 through December 31, 2009. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Global Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
5,089 | 5,881 | 5,566 | 4,180 | 6,917 | |||||||||||||||
Units issued |
2,767 | 1,193 | 1,408 | 1,799 | 1,715 | |||||||||||||||
Units redeemed |
(501 | ) | (1,985 | ) | (1,093 | ) | (413 | ) | (4,452 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
7,355 | 5,089 | 5,881 | 5,566 | 4,180 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.70 | 13.51 | 11.09 | 11.79 | 10.94 | |||||||||||||||
Assets, end of period $ |
130,202 | 68,758 | 65,217 | 65,634 | 45,718 | |||||||||||||||
Investment income ratio* |
1.77 | % | 2.10 | % | 2.19 | % | 1.91 | % | 1.68 | % | ||||||||||
Total return, lowest to highest** |
31.04 | % | 18.78% to 21.82 | % | (5.96 | %) | 7.82 | % | 25.95% to 34.80 | % |
98
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Global Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
64,693 | 66,962 | 61,120 | 49,303 | 14,977 | |||||||||||||||
Units issued |
34 | 12 | 11,042 | 13,256 | 43,211 | |||||||||||||||
Units redeemed |
(59,402 | ) | (2,281 | ) | (5,200 | ) | (1,439 | ) | (8,885 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
5,325 | 64,693 | 66,962 | 61,120 | 49,303 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
19.40 | 14.80 | 12.15 | 12.93 | 12.00 | |||||||||||||||
Assets, end of period $ |
103,317 | 957,336 | 813,925 | 790,323 | 591,609 | |||||||||||||||
Investment income ratio* |
0.27 | % | 2.18 | % | 2.08 | % | 1.65 | % | 4.69 | % | ||||||||||
Total return, lowest to highest** |
31.08 | % | 21.75 | % | (6.00 | %) | 7.76 | % | 31.36 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Health Sciences Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
16,097 | 8,430 | 6,190 | 23,192 | 5,783 | |||||||||||||||
Units issued |
5,685 | 12,370 | 3,130 | 3,034 | 20,674 | |||||||||||||||
Units redeemed |
(1,379 | ) | (4,703 | ) | (890 | ) | (20,036 | ) | (3,265 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
20,403 | 16,097 | 8,430 | 6,190 | 23,192 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
40.81 | 26.99 | 20.45 | 18.48 | 15.96 | |||||||||||||||
Assets, end of period $ |
832,668 | 434,383 | 172,437 | 114,424 | 370,136 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
51.24 | % | 12.19% to 31.93 | % | 10.66 | % | 15.81 | % | 29.89% to 34.30 | % |
99
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Health Sciences Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
6,047 | 6,987 | 7,361 | 7,371 | 11,054 | |||||||||||||||
Units issued |
742 | 859 | 106 | 408 | 685 | |||||||||||||||
Units redeemed |
(1,201 | ) | (1,799 | ) | (480 | ) | (418 | ) | (4,368 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
5,588 | 6,047 | 6,987 | 7,361 | 7,371 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
52.38 | 34.67 | 26.28 | 23.76 | 20.54 | |||||||||||||||
Assets, end of period $ |
292,696 | 209,633 | 183,561 | 174,926 | 151,406 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
51.07 | % | 31.95 | % | 10.57 | % | 15.70 | % | 31.81 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
High Yield Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
300,098 | 135,322 | 38,750 | 20,085 | 25,611 | |||||||||||||||
Units issued |
27,426 | 192,996 | 106,412 | 24,650 | 38,737 | |||||||||||||||
Units redeemed |
(253,174 | ) | (28,220 | ) | (9,840 | ) | (5,985 | ) | (44,263 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
74,350 | 300,098 | 135,322 | 38,750 | 20,085 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.14 | 19.45 | 16.33 | 16.15 | 14.20 | |||||||||||||||
Assets, end of period $ |
1,570,793 | 5,835,684 | 2,210,205 | 625,808 | 285,178 | |||||||||||||||
Investment income ratio* |
3.08 | % | 9.08 | % | 10.00 | % | 56.47 | % | 11.12 | % | ||||||||||
Total return, lowest to highest** |
8.68 | % | 9.73% to 19.07 | % | 1.14 | % | 13.75 | % | 31.02% to 54.51 | % |
100
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
High Yield Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
11,431 | 11,474 | 11,213 | 9,668 | 10,542 | |||||||||||||||
Units issued |
508 | 434 | 886 | 2,428 | 1,151 | |||||||||||||||
Units redeemed |
(1,650 | ) | (477 | ) | (625 | ) | (883 | ) | (2,025 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
10,289 | 11,431 | 11,474 | 11,213 | 9,668 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.30 | 20.54 | 17.27 | 17.11 | 15.04 | |||||||||||||||
Assets, end of period $ |
229,554 | 234,984 | 198,224 | 192,003 | 145,523 | |||||||||||||||
Investment income ratio* |
6.83 | % | 7.93 | % | 8.79 | % | 44.62 | % | 11.71 | % | ||||||||||
Total return, lowest to highest** |
8.53 | % | 18.98 | % | 0.90 | % | 13.78 | % | 54.51 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
International Core Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
40,566 | 51,752 | 39,058 | 26,018 | 15,838 | |||||||||||||||
Units issued |
6,784 | 14,236 | 23,871 | 24,641 | 31,640 | |||||||||||||||
Units redeemed |
(25,669 | ) | (25,422 | ) | (11,177 | ) | (11,601 | ) | (21,460 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
21,681 | 40,566 | 51,752 | 39,058 | 26,018 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.23 | 13.77 | 11.96 | 13.22 | 12.05 | |||||||||||||||
Assets, end of period $ |
373,513 | 558,510 | 618,746 | 516,316 | 313,626 | |||||||||||||||
Investment income ratio* |
3.16 | % | 3.11 | % | 3.03 | % | 2.23 | % | 2.54 | % | ||||||||||
Total return, lowest to highest** |
25.13 | % | 15.16% to 16.10 | % | (9.55 | %) | 9.67 | % | 18.62% to 22.55 | % |
101
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
International Core Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
6,183 | 6,313 | 7,935 | 9,009 | 7,100 | |||||||||||||||
Units issued |
266 | 376 | 347 | 525 | 3,877 | |||||||||||||||
Units redeemed |
(1,613 | ) | (506 | ) | (1,969 | ) | (1,599 | ) | (1,968 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
4,836 | 6,183 | 6,313 | 7,935 | 9,009 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
16.21 | 12.97 | 11.28 | 12.47 | 11.38 | |||||||||||||||
Assets, end of period $ |
78,377 | 80,182 | 71,156 | 98,921 | 102,502 | |||||||||||||||
Investment income ratio* |
2.80 | % | 2.96 | % | 2.08 | % | 1.84 | % | 2.63 | % | ||||||||||
Total return, lowest to highest** |
24.99 | % | 15.05 | % | (9.57 | %) | 9.58 | % | 18.64 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
International Equity Index Trust B Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
101,611 | 112,325 | 38,114 | 23,162 | 5,553 | |||||||||||||||
Units issued |
10,966 | 20,421 | 82,664 | 17,369 | 18,556 | |||||||||||||||
Units redeemed |
(14,827 | ) | (31,135 | ) | (8,453 | ) | (2,417 | ) | (947 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
97,750 | 101,611 | 112,325 | 38,114 | 23,162 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
47.59 | 41.55 | 35.28 | 41.02 | 36.81 | |||||||||||||||
Assets, end of period $ |
4,652,174 | 4,222,165 | 3,963,357 | 1,563,604 | 852,707 | |||||||||||||||
Investment income ratio* |
2.52 | % | 1.30 | % | 4.79 | % | 2.96 | % | 6.68 | % | ||||||||||
Total return, lowest to highest** |
14.54 | % | 15.48% to 17.76 | % | (13.99 | %) | 11.43 | % | 27.56% to 43.56 | % |
102
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||
International Equity Index Trust B Series 1 | ||||||||
Year Ended | Year Ended | |||||||
Dec. 31/13 | Dec. 31/12 (s) | |||||||
Units, beginning of period |
24,734 | — | ||||||
Units issued |
1,353 | 24,949 | ||||||
Units redeemed |
(3,140 | ) | (215 | ) | ||||
|
|
|
|
|||||
Units, end of period |
22,947 | 24,734 | ||||||
|
|
|
|
|||||
Unit value, end of period $ |
12.14 | 10.60 | ||||||
Assets, end of period $ |
278,688 | 262,226 | ||||||
Investment income ratio* |
2.50 | % | 6.95 | % | ||||
Total return, lowest to highest** |
14.56 | % | 6.02 | % |
(s) | Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012. |
Sub-Account | ||||||||
International Growth Stock Trust Series 0 | ||||||||
Year Ended | Year Ended | |||||||
Dec. 31/13 | Dec. 31/12 (s) | |||||||
Units, beginning of period |
53,510 | — | ||||||
Units issued |
4,449 | 53,738 | ||||||
Units redeemed |
(6,430 | ) | (228 | ) | ||||
|
|
|
|
|||||
Units, end of period |
51,529 | 53,510 | ||||||
|
|
|
|
|||||
Unit value, end of period $ |
12.41 | 10.41 | ||||||
Assets, end of period $ |
639,451 | 557,127 | ||||||
Investment income ratio* |
1.23 | % | 4.25 | % | ||||
Total return, lowest to highest** |
19.18 | % | 4.12 | % |
(s) | Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012. |
103
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||
International Growth Stock Trust Series 1 | ||||||||
Year Ended | Year Ended | |||||||
Dec. 31/13 | Dec. 31/12 (s) | |||||||
Units, beginning of period |
16,283 | — | ||||||
Units issued |
1,073 | 16,354 | ||||||
Units redeemed |
(395 | ) | (71 | ) | ||||
|
|
|
|
|||||
Units, end of period |
16,961 | 16,283 | ||||||
|
|
|
|
|||||
Unit value, end of period $ |
12.40 | 10.41 | ||||||
Assets, end of period $ |
210,237 | 169,456 | ||||||
Investment income ratio* |
1.25 | % | 4.01 | % | ||||
Total return, lowest to highest** |
19.10 | % | 4.08 | % |
(s) | Reflects the period from commencement of operations on November 5, 2012 through December 31, 2012. |
Sub-Account | ||||||||||||||||||||
International Small Company Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 (ax) | ||||||||||||||||
Units, beginning of period |
26,976 | 86,864 | 28,843 | 24,956 | — | |||||||||||||||
Units issued |
5,682 | 4,628 | 68,494 | 8,832 | 26,279 | |||||||||||||||
Units redeemed |
(2,140 | ) | (64,516 | ) | (10,473 | ) | (4,945 | ) | (1,323 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
30,518 | 26,976 | 86,864 | 28,843 | 24,956 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.23 | 12.06 | 10.12 | 12.07 | 9.84 | |||||||||||||||
Assets, end of period $ |
464,898 | 325,389 | 878,654 | 348,068 | 245,594 | |||||||||||||||
Investment income ratio* |
2.04 | % | 0.93 | % | 1.82 | % | 2.90 | % | 0.79 | % | ||||||||||
Total return, lowest to highest** |
26.30 | % | 12.82% to 19.23 | % | (16.18 | %) | 22.62 | % | (1.59 | %) |
(ax) | Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009. |
104
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
International Small Company Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (ax) |
||||||||||||||||
Units, beginning of period |
3,493 | 5,530 | 5,981 | 6,159 | — | |||||||||||||||
Units issued |
240 | 267 | 246 | 392 | 6,197 | |||||||||||||||
Units redeemed |
(453 | ) | (2,304 | ) | (697 | ) | (570 | ) | (38 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
3,280 | 3,493 | 5,530 | 5,981 | 6,159 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.22 | 12.04 | 10.10 | 12.06 | 9.83 | |||||||||||||||
Assets, end of period $ |
49,900 | 42,064 | 55,874 | 72,140 | 60,545 | |||||||||||||||
Investment income ratio* |
1.89 | % | 1.26 | % | 1.60 | % | 2.80 | % | 0.79 | % | ||||||||||
Total return, lowest to highest** |
26.34 | % | 19.20 | % | (16.23 | %) | 22.70 | % | (1.70 | %) | ||||||||||
(ax) Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
International Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
20,409 | 27,869 | 61,670 | 30,587 | 9,516 | |||||||||||||||
Units issued |
7,890 | 3,983 | 7,031 | 66,946 | 22,519 | |||||||||||||||
Units redeemed |
(3,996 | ) | (11,443 | ) | (40,832 | ) | (35,863 | ) | (1,448 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
24,303 | 20,409 | 27,869 | 61,670 | 30,587 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.64 | 13.98 | 11.71 | 13.43 | 12.43 | |||||||||||||||
Assets, end of period $ |
428,737 | 285,268 | 326,381 | 828,160 | 380,313 | |||||||||||||||
Investment income ratio* |
1.95 | % | 2.82 | % | 1.69 | % | 2.42 | % | 3.06 | % | ||||||||||
Total return, lowest to highest** |
26.21 | % | 19.36% to 19.59 | % | (12.80 | %) | 8.00 | % | 26.96% to 39.98 | % |
105
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
International Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
47,850 | 47,442 | 42,358 | 34,764 | 14,922 | |||||||||||||||
Units issued |
2,006 | 3,037 | 7,317 | 9,213 | 26,779 | |||||||||||||||
Units redeemed |
(37,755 | ) | (2,629 | ) | (2,233 | ) | (1,619 | ) | (6,937 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
12,101 | 47,850 | 47,442 | 42,358 | 34,764 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
27.37 | 21.70 | 18.18 | 20.86 | 19.32 | |||||||||||||||
Assets, end of period $ |
331,196 | 1,038,305 | 862,318 | 883,441 | 671,440 | |||||||||||||||
Investment income ratio* |
0.79 | % | 2.76 | % | 2.49 | % | 2.07 | % | 5.37 | % | ||||||||||
Total return, lowest to highest** |
26.15 | % | 19.38 | % | (12.85 | %) | 7.98 | % | 35.77 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Investment Quality Bond Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
158,062 | 9,019 | 24,390 | 18,767 | 16,199 | |||||||||||||||
Units issued |
2,682 | 188,465 | 4,092 | 8,263 | 3,085 | |||||||||||||||
Units redeemed |
(150,372 | ) | (39,422 | ) | (19,463 | ) | (2,640 | ) | (517 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
10,372 | 158,062 | 9,019 | 24,390 | 18,767 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.14 | 15.43 | 14.33 | 13.26 | 12.33 | |||||||||||||||
Assets, end of period $ |
157,106 | 2,439,155 | 129,256 | 323,517 | 231,488 | |||||||||||||||
Investment income ratio* |
0.41 | % | 3.52 | % | 2.78 | % | 5.97 | % | 5.26 | % | ||||||||||
Total return, lowest to highest** |
(1.88 | %) | 4.09% to 7.66 | % | 8.06 | % | 7.54 | % | 9.70% to 12.43 | % |
106
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Investment Quality Bond Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
9,770 | 11,641 | 13,459 | 15,281 | 20,496 | |||||||||||||||
Units issued |
643 | 3,983 | 541 | 379 | 594 | |||||||||||||||
Units redeemed |
(256 | ) | (5,854 | ) | (2,359 | ) | (2,201 | ) | (5,809 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
10,157 | 9,770 | 11,641 | 13,459 | 15,281 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.87 | 22.29 | 20.72 | 19.18 | 17.85 | |||||||||||||||
Assets, end of period $ |
222,114 | 217,852 | 241,263 | 258,119 | 272,726 | |||||||||||||||
Investment income ratio* |
3.90 | % | 1.92 | % | 4.12 | % | 4.99 | % | 4.69 | % | ||||||||||
Total return, lowest to highest** |
(1.92 | %) | 7.59 | % | 8.07 | % | 7.46 | % | 12.45 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Large Cap Growth | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (ba) |
||||||||||||||||
Units, beginning of period |
1,668 | 1,178 | 576 | 237 | 101 | |||||||||||||||
Units issued |
1,699 | 767 | 1,688 | 417 | 189 | |||||||||||||||
Units redeemed |
(376 | ) | (277 | ) | (1,086 | ) | (78 | ) | (53 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
2,991 | 1,668 | 1,178 | 576 | 237 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
45.56 | 33.46 | 28.04 | 28.27 | 22.97 | |||||||||||||||
Assets, end of period $ |
136,344 | 55,847 | 33,056 | 16,291 | 5,454 | |||||||||||||||
Investment income ratio* |
0.61 | % | 0.05 | % | 0.00 | % | 0.31 | % | 0.82 | % | ||||||||||
Total return, lowest to highest** |
36.15 | % | 7.49% to 19.31 | % | (0.80 | %) | 23.06 | % | 24.69% to 41.05 | % |
(ba) | Renamed on November 16, 2009. Previously known as Turner Core Growth Trust. |
107
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Large Cap Value | ||||||||||||||||||||
Year Ended Dec. 31/13 (ag) |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
1,325 | 1,074 | 620 | 422 | 178 | |||||||||||||||
Units issued |
2,926 | 353 | 956 | 276 | 310 | |||||||||||||||
Units redeemed |
(358 | ) | (102 | ) | (502 | ) | (78 | ) | (66 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
3,893 | 1,325 | 1,074 | 620 | 422 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.75 | 16.20 | 13.81 | 14.41 | 13.18 | |||||||||||||||
Assets, end of period $ |
84,641 | 21,462 | 14,830 | 8,930 | 5,565 | |||||||||||||||
Investment income ratio* |
3.52 | % | 0.88 | % | 0.39 | % | 0.82 | % | 1.03 | % | ||||||||||
Total return, lowest to highest** |
34.22 | % | 10.97% to 17.29 | % | (4.11 | %) | 9.27 | % | 19.01% to 27.24 | % | ||||||||||
(ag) Renamed on April 29, 2013. Previously known as Business Opportunity Value. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Lifestyle Aggressive Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
568,585 | 394,551 | 504,312 | 802,573 | 573,191 | |||||||||||||||
Units issued |
102,618 | 220,007 | 171,543 | 82,576 | 288,873 | |||||||||||||||
Units redeemed |
(139,386 | ) | (45,973 | ) | (281,304 | ) | (380,837 | ) | (59,491 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
531,817 | 568,585 | 394,551 | 504,312 | 802,573 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
18.39 | 14.51 | 12.43 | 13.29 | 11.41 | |||||||||||||||
Assets, end of period $ |
9,780,876 | 8,248,307 | 4,905,842 | 6,703,568 | 9,157,825 | |||||||||||||||
Investment income ratio* |
2.74 | % | 1.68 | % | 1.85 | % | 1.57 | % | 1.28 | % | ||||||||||
Total return, lowest to highest** |
26.77 | % | 9.51% to 16.67 | % | (6.46 | %) | 16.50 | % | 26.59% to 40.08 | % |
108
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Lifestyle Aggressive Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
28,457 | 25,099 | 23,381 | 22,149 | 23,308 | |||||||||||||||
Units issued |
2,836 | 4,311 | 2,499 | 4,231 | 8,806 | |||||||||||||||
Units redeemed |
(1,160 | ) | (953 | ) | (781 | ) | (2,999 | ) | (9,965 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
30,133 | 28,457 | 25,099 | 23,381 | 22,149 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
20.14 | 15.90 | 13.63 | 14.58 | 12.52 | |||||||||||||||
Assets, end of period $ |
606,938 | 452,335 | 342,128 | 340,892 | 277,321 | |||||||||||||||
Investment income ratio* |
2.58 | % | 1.50 | % | 1.80 | % | 1.99 | % | 0.94 | % | ||||||||||
Total return, lowest to highest** |
26.72 | % | 16.61 | % | (6.50 | %) | 16.45 | % | 35.62 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Lifestyle Balanced Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
1,423,172 | 1,038,503 | 1,301,355 | 837,827 | 570,851 | |||||||||||||||
Units issued |
346,414 | 515,242 | 345,463 | 550,331 | 384,712 | |||||||||||||||
Units redeemed |
(216,603 | ) | (130,573 | ) | (608,315 | ) | (86,803 | ) | (117,736 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
1,552,983 | 1,423,172 | 1,038,503 | 1,301,355 | 837,827 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
16.85 | 14.93 | 13.34 | 13.25 | 11.85 | |||||||||||||||
Assets, end of period $ |
26,169,856 | 21,243,036 | 13,853,108 | 17,243,464 | 9,931,974 | |||||||||||||||
Investment income ratio* |
3.07 | % | 2.62 | % | 3.79 | % | 3.50 | % | 5.27 | % | ||||||||||
Total return, lowest to highest** |
12.89 | % | 6.76% to 11.90 | % | 0.67 | % | 11.78 | % | 21.41% to 31.35 | % |
109
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Lifestyle Balanced Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
230,822 | 239,441 | 249,006 | 256,294 | 253,510 | |||||||||||||||
Units issued |
1,801 | 1,522 | 1,924 | 2,992 | 23,124 | |||||||||||||||
Units redeemed |
(7,624 | ) | (10,141 | ) | (11,489 | ) | (10,280 | ) | (20,340 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
224,999 | 230,822 | 239,441 | 249,006 | 256,294 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.44 | 19.90 | 17.79 | 17.68 | 15.82 | |||||||||||||||
Assets, end of period $ |
5,048,408 | 4,592,077 | 4,258,264 | 4,400,961 | 4,053,664 | |||||||||||||||
Investment income ratio* |
2.86 | % | 2.28 | % | 3.33 | % | 2.78 | % | 4.49 | % | ||||||||||
Total return, lowest to highest** |
12.79 | % | 11.87 | % | 0.63 | % | 11.75 | % | 30.76 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Lifestyle Conservative Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
231,764 | 160,667 | 111,014 | 54,770 | 11,323 | |||||||||||||||
Units issued |
61,958 | 94,054 | 87,150 | 63,991 | 63,564 | |||||||||||||||
Units redeemed |
(79,548 | ) | (22,957 | ) | (37,497 | ) | (7,747 | ) | (20,117 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
214,174 | 231,764 | 160,667 | 111,014 | 54,770 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
15.62 | 15.02 | 13.84 | 13.27 | 12.15 | |||||||||||||||
Assets, end of period $ |
3,346,371 | 3,481,888 | 2,223,564 | 1,473,461 | 665,378 | |||||||||||||||
Investment income ratio* |
3.65 | % | 3.29 | % | 5.16 | % | 3.98 | % | 9.89 | % | ||||||||||
Total return, lowest to highest** |
3.99 | % | 4.72% to 8.55 | % | 4.27 | % | 9.25 | % | 15.08% to 21.63 | % |
110
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Lifestyle Conservative Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
6,953 | 7,161 | 5,741 | 5,335 | 24,145 | |||||||||||||||
Units issued |
69 | 53 | 1,761 | 763 | 894 | |||||||||||||||
Units redeemed |
(218 | ) | (261 | ) | (341 | ) | (357 | ) | (19,704 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
6,804 | 6,953 | 7,161 | 5,741 | 5,335 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.98 | 21.16 | 19.50 | 18.71 | 17.14 | |||||||||||||||
Assets, end of period $ |
149,499 | 147,084 | 139,604 | 107,368 | 91,438 | |||||||||||||||
Investment income ratio* |
3.50 | % | 2.87 | % | 4.70 | % | 2.91 | % | 2.55 | % | ||||||||||
Total return, lowest to highest** |
3.88 | % | 8.52 | % | 4.23 | % | 9.13 | % | 21.71 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Lifestyle Growth Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
1,480,274 | 1,453,499 | 1,374,170 | 1,270,440 | 897,691 | |||||||||||||||
Units issued |
340,603 | 334,817 | 968,939 | 566,038 | 479,069 | |||||||||||||||
Units redeemed |
(195,059 | ) | (308,042 | ) | (889,610 | ) | (462,308 | ) | (106,320 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
1,625,818 | 1,480,274 | 1,453,499 | 1,374,170 | 1,270,440 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.62 | 14.76 | 12.96 | 13.16 | 11.64 | |||||||||||||||
Assets, end of period $ |
28,643,878 | 21,845,708 | 18,831,147 | 18,083,931 | 14,788,574 | |||||||||||||||
Investment income ratio* |
2.71 | % | 2.00 | % | 2.82 | % | 2.84 | % | 4.01 | % | ||||||||||
Total return, lowest to highest** |
19.38 | % | 7.98% to 13.91 | % | (1.55 | %) | 13.04 | % | 23.39% to 35.36 | % |
111
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Lifestyle Growth Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
105,854 | 105,925 | 101,677 | 100,138 | 100,452 | |||||||||||||||
Units issued |
4,817 | 3,612 | 7,046 | 6,832 | 8,782 | |||||||||||||||
Units redeemed |
(4,464 | ) | (3,683 | ) | (2,798 | ) | (5,293 | ) | (9,096 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
106,207 | 105,854 | 105,925 | 101,677 | 100,138 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.40 | 17.93 | 15.74 | 16.00 | 14.16 | |||||||||||||||
Assets, end of period $ |
2,272,044 | 1,897,471 | 1,667,484 | 1,626,663 | 1,417,539 | |||||||||||||||
Investment income ratio* |
2.54 | % | 1.87 | % | 2.81 | % | 2.47 | % | 3.40 | % | ||||||||||
Total return, lowest to highest** |
19.34 | % | 13.87 | % | (1.60 | %) | 13.02 | % | 33.31 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Lifestyle Moderate Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
270,413 | 1,139,379 | 153,964 | 79,197 | 64,876 | |||||||||||||||
Units issued |
114,596 | 92,490 | 1,027,707 | 88,997 | 47,142 | |||||||||||||||
Units redeemed |
(39,635 | ) | (961,456 | ) | (42,292 | ) | (14,230 | ) | (32,821 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
345,374 | 270,413 | 1,139,379 | 153,964 | 79,197 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
16.45 | 14.92 | 13.48 | 13.17 | 11.90 | |||||||||||||||
Assets, end of period $ |
5,683,325 | 4,035,304 | 15,358,416 | 2,027,303 | 942,124 | |||||||||||||||
Investment income ratio* |
3.70 | % | 1.66 | % | 5.20 | % | 3.87 | % | 6.04 | % | ||||||||||
Total return, lowest to highest** |
10.26 | % | 5.97% to 10.70 | % | 2.38 | % | 10.69 | % | 19.31% to 27.32 | % |
112
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Lifestyle Moderate Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
45,128 | 52,235 | 51,917 | 51,867 | 42,377 | |||||||||||||||
Units issued |
314 | 858 | 1,259 | 1,001 | 10,587 | |||||||||||||||
Units redeemed |
(2,190 | ) | (7,965 | ) | (941 | ) | (951 | ) | (1,097 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
43,252 | 45,128 | 52,235 | 51,917 | 51,867 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.22 | 20.16 | 18.22 | 17.80 | 16.10 | |||||||||||||||
Assets, end of period $ |
960,936 | 909,650 | 951,447 | 924,144 | 835,131 | |||||||||||||||
Investment income ratio* |
2.93 | % | 2.38 | % | 3.67 | % | 2.72 | % | 5.08 | % | ||||||||||
Total return, lowest to highest** |
10.22 | % | 10.67 | % | 2.33 | % | 10.55 | % | 27.26 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Mid Cap Index Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
138,736 | 70,214 | 115,650 | 11,782 | 41,283 | |||||||||||||||
Units issued |
22,799 | 95,530 | 63,595 | 107,379 | 78,745 | |||||||||||||||
Units redeemed |
(16,744 | ) | (27,008 | ) | (109,031 | ) | (3,511 | ) | (108,246 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
144,791 | 138,736 | 70,214 | 115,650 | 11,782 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
25.23 | 18.95 | 16.13 | 16.48 | 13.07 | |||||||||||||||
Assets, end of period $ |
3,652,538 | 2,629,705 | 1,132,251 | 1,905,779 | 154,005 | |||||||||||||||
Investment income ratio* |
1.18 | % | 1.69 | % | 0.62 | % | 2.22 | % | 0.64 | % | ||||||||||
Total return, lowest to highest** |
33.09 | % | 8.00% to 17.54 | % | (2.14 | %) | 26.06 | % | 29.11% to 42.62 | % |
113
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Mid Cap Index Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
8,389 | 8,644 | 9,539 | 10,178 | 12,269 | |||||||||||||||
Units issued |
763 | 245 | 440 | 562 | 994 | |||||||||||||||
Units redeemed |
(468 | ) | (500 | ) | (1,335 | ) | (1,201 | ) | (3,085 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
8,684 | 8,389 | 8,644 | 9,539 | 10,178 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
38.49 | 28.93 | 24.63 | 25.19 | 20.00 | |||||||||||||||
Assets, end of period $ |
334,200 | 242,693 | 212,875 | 240,331 | 203,541 | |||||||||||||||
Investment income ratio* |
1.08 | % | 1.47 | % | 0.67 | % | 1.05 | % | 1.04 | % | ||||||||||
Total return, lowest to highest** |
33.03 | % | 17.48 | % | (2.25 | %) | 25.98 | % | 36.76 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Mid Cap Stock Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
17,793 | 15,484 | 12,671 | 12,510 | 9,511 | |||||||||||||||
Units issued |
3,444 | 5,483 | 5,515 | 4,725 | 7,805 | |||||||||||||||
Units redeemed |
(7,868 | ) | (3,174 | ) | (2,702 | ) | (4,564 | ) | (4,806 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
13,369 | 17,793 | 15,484 | 12,671 | 12,510 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
68.19 | 49.83 | 40.73 | 44.84 | 36.43 | |||||||||||||||
Assets, end of period $ |
911,647 | 886,676 | 630,691 | 568,179 | 455,808 | |||||||||||||||
Investment income ratio* |
0.07 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
36.84 | % | 8.31% to 22.34 | % | (9.16 | %) | 23.07 | % | 29.99% to 34.85 | % |
114
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Mid Cap Stock Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
12,913 | 13,667 | 13,851 | 15,055 | 18,269 | |||||||||||||||
Units issued |
557 | 632 | 822 | 1,118 | 1,670 | |||||||||||||||
Units redeemed |
(968 | ) | (1,386 | ) | (1,006 | ) | (2,322 | ) | (4,884 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
12,502 | 12,913 | 13,667 | 13,851 | 15,055 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
31.35 | 22.92 | 18.75 | 20.65 | 16.78 | |||||||||||||||
Assets, end of period $ |
391,932 | 295,880 | 256,242 | 286,016 | 252,575 | |||||||||||||||
Investment income ratio* |
0.04 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
36.82 | % | 22.21 | % | (9.20 | %) | 23.08 | % | 31.35 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Mid Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
43,627 | 35,419 | 68,428 | 22,660 | 11,409 | |||||||||||||||
Units issued |
3,136 | 18,031 | 19,833 | 55,069 | 24,863 | |||||||||||||||
Units redeemed |
(20,437 | ) | (9,823 | ) | (52,842 | ) | (9,301 | ) | (13,612 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
26,326 | 43,627 | 35,419 | 68,428 | 22,660 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
36.05 | 27.42 | 22.94 | 24.10 | 20.74 | |||||||||||||||
Assets, end of period $ |
949,157 | 1,196,393 | 812,525 | 1,648,879 | 470,071 | |||||||||||||||
Investment income ratio* |
1.10 | % | 1.00 | % | 0.57 | % | 3.34 | % | 0.73 | % | ||||||||||
Total return, lowest to highest** |
31.47 | % | 12.75% to 19.54 | % | (4.80 | %) | 16.16 | % | 32.28% to 49.15 | % |
115
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Mid Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 (n) |
||||||||||||||||
Units, beginning of period |
11,435 | 15,275 | 14,468 | 15,456 | — | |||||||||||||||
Units issued |
652 | 829 | 2,541 | 1,467 | 16,343 | |||||||||||||||
Units redeemed |
(2,433 | ) | (4,669 | ) | (1,734 | ) | (2,455 | ) | (887 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
9,654 | 11,435 | 15,275 | 14,468 | 15,456 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
23.49 | 17.88 | 14.96 | 15.73 | 13.54 | |||||||||||||||
Assets, end of period $ |
226,791 | 204,439 | 228,460 | 227,611 | 209,332 | |||||||||||||||
Investment income ratio* |
1.06 | % | 0.82 | % | 0.77 | % | 2.07 | % | 0.49 | % | ||||||||||
Total return, lowest to highest** |
31.39 | % | 19.53 | % | (4.93 | %) | 16.15 | % | 35.44 | % | ||||||||||
(n) Fund available in prior year but no activity. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Money Market Trust B Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
438,090 | 491,597 | 470,488 | 359,102 | 362,321 | |||||||||||||||
Units issued |
759,455 | 846,867 | 698,976 | 550,328 | 719,950 | |||||||||||||||
Units redeemed |
(821,330 | ) | (900,374 | ) | (677,867 | ) | (438,942 | ) | (723,169 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
376,215 | 438,090 | 491,597 | 470,488 | 359,102 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.37 | 17.37 | 17.36 | 17.35 | 17.34 | |||||||||||||||
Assets, end of period $ |
6,536,519 | 7,610,293 | 8,535,672 | 8,162,330 | 6,227,080 | |||||||||||||||
Investment income ratio* |
0.01 | % | 0.04 | % | 0.00 | % | 0.04 | % | 0.48 | % | ||||||||||
Total return, lowest to highest** |
0.01 | % | 0.03 | % | 0.08 | % | 0.03 | % | 0.20% to 0.47 | % |
116
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Money Market Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
74,418 | 107,837 | 106,998 | 129,525 | 128,986 | |||||||||||||||
Units issued |
139,128 | 16,789 | 11,456 | 11,284 | 51,332 | |||||||||||||||
Units redeemed |
(10,648 | ) | (50,208 | ) | (10,617 | ) | (33,811 | ) | (50,793 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
202,898 | 74,418 | 107,837 | 106,998 | 129,525 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
13.46 | 13.46 | 13.46 | 13.45 | 13.45 | |||||||||||||||
Assets, end of period $ |
2,730,900 | 1,001,628 | 1,451,269 | 1,438,933 | 1,741,838 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.20 | % | ||||||||||
Total return, lowest to highest** |
0.01 | % | 0.01 | % | 0.07 | % | 0.00 | % | 0.19 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Natural Resources Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
65,421 | 94,037 | 116,645 | 81,225 | 24,905 | |||||||||||||||
Units issued |
9,457 | 85,851 | 27,482 | 47,755 | 62,686 | |||||||||||||||
Units redeemed |
(10,387 | ) | (114,467 | ) | (50,090 | ) | (12,335 | ) | (6,366 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
64,491 | 65,421 | 94,037 | 116,645 | 81,225 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.49 | 16.97 | 16.87 | 21.16 | 18.36 | |||||||||||||||
Assets, end of period $ |
1,127,832 | 1,110,017 | 1,586,281 | 2,468,009 | 1,491,187 | |||||||||||||||
Investment income ratio* |
0.62 | % | 0.97 | % | 0.60 | % | 0.89 | % | 1.30 | % | ||||||||||
Total return, lowest to highest** |
3.07 | % | 0.58% to 7.03 | % | (20.27 | %) | 15.25 | % | 28.14% to 59.35 | % |
117
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Natural Resources Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
4,002 | 4,502 | 4,312 | 4,332 | 3,577 | |||||||||||||||
Units issued |
806 | 140 | 773 | 220 | 1,346 | |||||||||||||||
Units redeemed |
(869 | ) | (640 | ) | (583 | ) | (240 | ) | (591 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
3,939 | 4,002 | 4,502 | 4,312 | 4,332 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
41.37 | 40.18 | 39.97 | 50.15 | 43.52 | |||||||||||||||
Assets, end of period $ |
162,934 | 160,776 | 179,957 | 216,262 | 188,565 | |||||||||||||||
Investment income ratio* |
0.61 | % | 0.78 | % | 0.51 | % | 0.66 | % | 1.14 | % | ||||||||||
Total return, lowest to highest** |
2.97 | % | 0.52 | % | (20.29 | %) | 15.21 | % | 59.19 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Real Estate Securities Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
30,697 | 22,685 | 16,370 | 8,690 | 5,802 | |||||||||||||||
Units issued |
1,874 | 11,223 | 8,506 | 9,377 | 11,654 | |||||||||||||||
Units redeemed |
(4,503 | ) | (3,211 | ) | (2,191 | ) | (1,697 | ) | (8,766 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
28,068 | 30,697 | 22,685 | 16,370 | 8,690 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
105.43 | 105.48 | 89.90 | 82.05 | 63.50 | |||||||||||||||
Assets, end of period $ |
2,959,281 | 3,238,133 | 2,039,556 | 1,343,174 | 551,907 | |||||||||||||||
Investment income ratio* |
1.97 | % | 1.96 | % | 1.78 | % | 2.45 | % | 4.29 | % | ||||||||||
Total return, lowest to highest** |
(0.05 | %) | 4.78% to 17.33 | % | 9.58 | % | 29.20 | % | 30.26% to 54.31 | % |
118
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Real Estate Securities Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
12,592 | 12,475 | 13,098 | 12,592 | 12,704 | |||||||||||||||
Units issued |
1,360 | 1,087 | 444 | 1,169 | 1,781 | |||||||||||||||
Units redeemed |
(677 | ) | (970 | ) | (1,067 | ) | (663 | ) | (1,893 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
13,275 | 12,592 | 12,475 | 13,098 | 12,592 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
38.08 | 38.12 | 32.51 | 29.70 | 22.99 | |||||||||||||||
Assets, end of period $ |
505,546 | 480,041 | 405,554 | 388,985 | 289,444 | |||||||||||||||
Investment income ratio* |
1.98 | % | 1.77 | % | 1.51 | % | 1.96 | % | 3.53 | % | ||||||||||
Total return, lowest to highest** |
(0.10 | %) | 17.26 | % | 9.47 | % | 29.19 | % | 30.17 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Real Return Bond Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
79,808 | 65,041 | 42,266 | 32,641 | 24,234 | |||||||||||||||
Units issued |
13,520 | 50,315 | 30,677 | 16,387 | 19,828 | |||||||||||||||
Units redeemed |
(29,421 | ) | (35,548 | ) | (7,902 | ) | (6,762 | ) | (11,421 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
63,907 | 79,808 | 65,041 | 42,266 | 32,641 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
14.24 | 15.69 | 14.41 | 12.85 | 11.81 | |||||||||||||||
Assets, end of period $ |
910,159 | 1,252,408 | 937,609 | 543,299 | 385,612 | |||||||||||||||
Investment income ratio* |
2.70 | % | 1.81 | % | 4.86 | % | 12.47 | % | 9.40 | % | ||||||||||
Total return, lowest to highest** |
(9.25 | %) | 4.13% to 8.86 | % | 12.14 | % | 8.82 | % | 10.55% to 19.54 | % |
119
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Real Return Bond Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
1,816 | 1,886 | 1,825 | 1,761 | 1,497 | |||||||||||||||
Units issued |
95 | 59 | 832 | 171 | 398 | |||||||||||||||
Units redeemed |
(197 | ) | (129 | ) | (771 | ) | (107 | ) | (134 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
1,714 | 1,816 | 1,886 | 1,825 | 1,761 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
20.69 | 22.80 | 20.95 | 18.70 | 17.18 | |||||||||||||||
Assets, end of period $ |
35,456 | 41,406 | 39,505 | 34,110 | 30,248 | |||||||||||||||
Investment income ratio* |
2.56 | % | 1.76 | % | 3.72 | % | 11.63 | % | 9.20 | % | ||||||||||
Total return, lowest to highest** |
(9.28 | %) | 8.86 | % | 12.02 | % | 8.83 | % | 19.47 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Science & Technology Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
28,839 | 16,648 | 13,853 | 19,639 | 18,978 | |||||||||||||||
Units issued |
6,106 | 13,942 | 4,059 | 7,393 | 42,811 | |||||||||||||||
Units redeemed |
(6,006 | ) | (1,751 | ) | (1,264 | ) | (13,179 | ) | (42,150 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
28,939 | 28,839 | 16,648 | 13,853 | 19,639 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
23.78 | 16.57 | 14.99 | 16.24 | 13.02 | |||||||||||||||
Assets, end of period $ |
688,221 | 477,746 | 249,482 | 224,965 | 255,779 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
43.55 | % | 1.76% to 10.54 | % | (7.72 | %) | 24.69 | % | 35.42% to 64.57 | % |
120
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Science & Technology Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
17,629 | 21,828 | 27,956 | 27,933 | 31,760 | |||||||||||||||
Units issued |
1,490 | 1,582 | 1,824 | 3,473 | 6,540 | |||||||||||||||
Units redeemed |
(3,139 | ) | (5,781 | ) | (7,952 | ) | (3,450 | ) | (10,367 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
15,980 | 17,629 | 21,828 | 27,956 | 27,933 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
14.26 | 9.94 | 9.00 | 9.75 | 7.82 | |||||||||||||||
Assets, end of period $ |
227,926 | 175,190 | 196,394 | 272,650 | 218,621 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
43.52 | % | 10.45 | % | (7.74 | %) | 24.62 | % | 64.48 | % |
Sub-Account | ||||||||||||||||
Short Term Government Income Trust Series 0 | ||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | |||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 (bf) | |||||||||||||
Units, beginning of period |
47,036 | 44,778 | 74,042 | — | ||||||||||||
Units issued |
8,005 | 10,165 | 9,317 | 83,678 | ||||||||||||
Units redeemed |
(14,117 | ) | (7,907 | ) | (38,581 | ) | (9,636 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Units, end of period |
40,924 | 47,036 | 44,778 | 74,042 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Unit value, end of period $ |
10.52 | 10.60 | 10.48 | 10.19 | ||||||||||||
Assets, end of period $ |
430,654 | 498,654 | 469,168 | 754,552 | ||||||||||||
Investment income ratio* |
1.97 | % | 1.71 | % | 1.75 | % | 1.52 | % | ||||||||
Total return, lowest to highest** |
(0.74 | %) | 0.55% to 1.18 | % | 2.83 | % | 1.91 | % |
(bf) | Reflects the period from commencement of operations on May 3, 2010 through December 31, 2010. |
121
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||
Short Term Government Income Trust Series 1 | ||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | |||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 (bf) | |||||||||||||
Units, beginning of period |
36,394 | 38,074 | 40,356 | — | ||||||||||||
Units issued |
3,266 | 2,314 | 7,099 | 43,587 | ||||||||||||
Units redeemed |
(1,632 | ) | (3,994 | ) | (9,381 | ) | (3,231 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Units, end of period |
38,028 | 36,394 | 38,074 | 40,356 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Unit value, end of period $ |
10.50 | 10.59 | 10.47 | 10.19 | ||||||||||||
Assets, end of period $ |
399,419 | 385,582 | 398,566 | 411,062 | ||||||||||||
Investment income ratio* |
2.07 | % | 1.65 | % | 2.26 | % | 1.47 | % | ||||||||
Total return, lowest to highest** |
(0.86 | %) | 1.21 | % | 2.77 | % | 1.86 | % |
(bf) | Reflects the period from commencement of operations on May 3, 2010 through December 31, 2010. |
Sub-Account | ||||||||||||||||||||
Small Cap Growth Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
12,358 | 8,595 | 6,726 | 6,800 | 13,321 | |||||||||||||||
Units issued |
4,985 | 5,077 | 3,690 | 1,706 | 18,171 | |||||||||||||||
Units redeemed |
(1,542 | ) | (1,314 | ) | (1,821 | ) | (1,780 | ) | (24,692 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
15,801 | 12,358 | 8,595 | 6,726 | 6,800 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
30.46 | 21.12 | 18.13 | 19.45 | 15.92 | |||||||||||||||
Assets, end of period $ |
481,384 | 261,066 | 155,822 | 130,819 | 108,283 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
44.22 | % | 4.70% to 16.53 | % | (6.80 | %) | 22.14 | % | 33.17% to 40.36 | % |
122
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Small Cap Growth Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
853 | 897 | 1,368 | 1,285 | 2,148 | |||||||||||||||
Units issued |
417 | 71 | 158 | 161 | 202 | |||||||||||||||
Units redeemed |
(152 | ) | (115 | ) | (629 | ) | (78 | ) | (1,065 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
1,118 | 853 | 897 | 1,368 | 1,285 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
25.69 | 17.83 | 15.31 | 16.43 | 13.46 | |||||||||||||||
Assets, end of period $ |
28,691 | 15,182 | 13,721 | 22,471 | 17,291 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
44.08 | % | 16.47 | % | (6.81 | %) | 22.08 | % | 34.57 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Small Cap Index Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
133,813 | 40,642 | 122,660 | 20,653 | 21,026 | |||||||||||||||
Units issued |
12,750 | 99,749 | 41,298 | 110,194 | 42,423 | |||||||||||||||
Units redeemed |
(29,130 | ) | (6,578 | ) | (123,316 | ) | (8,187 | ) | (42,796 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
117,433 | 133,813 | 40,642 | 122,660 | 20,653 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
24.79 | 17.87 | 15.40 | 16.10 | 12.74 | |||||||||||||||
Assets, end of period $ |
2,911,545 | 2,391,062 | 625,675 | 1,974,975 | 263,036 | |||||||||||||||
Investment income ratio* |
1.55 | % | 2.96 | % | 0.66 | % | 0.97 | % | 0.90 | % | ||||||||||
Total return, lowest to highest** |
38.75 | % | 10.12% to 16.06 | % | (4.37 | %) | 26.43 | % | 26.70% to 35.11 | % |
123
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Small Cap Index Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
5,108 | 5,537 | 5,645 | 6,740 | 8,191 | |||||||||||||||
Units issued |
103 | 130 | 243 | 391 | 846 | |||||||||||||||
Units redeemed |
(270 | ) | (559 | ) | (351 | ) | (1,486 | ) | (2,297 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
4,941 | 5,108 | 5,537 | 5,645 | 6,740 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
31.10 | 22.43 | 19.32 | 20.24 | 16.01 | |||||||||||||||
Assets, end of period $ |
153,601 | 114,552 | 106,959 | 114,197 | 107,917 | |||||||||||||||
Investment income ratio* |
1.47 | % | 2.02 | % | 1.15 | % | 0.47 | % | 0.84 | % | ||||||||||
Total return, lowest to highest** |
38.61 | % | 16.09 | % | (4.50 | %) | 26.36 | % | 26.64 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Small Cap Opportunities Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
6,622 | 5,968 | 3,707 | 2,631 | 15,740 | |||||||||||||||
Units issued |
47,355 | 1,423 | 98,758 | 1,481 | 29,648 | |||||||||||||||
Units redeemed |
(715 | ) | (769 | ) | (96,497 | ) | (405 | ) | (42,757 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
53,262 | 6,622 | 5,968 | 3,707 | 2,631 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
18.97 | 13.52 | 11.57 | 11.94 | 9.21 | |||||||||||||||
Assets, end of period $ |
1,010,418 | 89,550 | 69,052 | 44,272 | 24,224 | |||||||||||||||
Investment income ratio* |
0.51 | % | 0.00 | % | 0.02 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
40.28 | % | 10.99% to 16.88 | % | (3.13 | %) | 29.71 | % | 27.43% to 41.34 | % |
124
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Small Cap Opportunities Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
3,888 | 4,345 | 4,172 | 4,113 | 4,444 | |||||||||||||||
Units issued |
989 | 266 | 421 | 551 | 649 | |||||||||||||||
Units redeemed |
(1,588 | ) | (723 | ) | (248 | ) | (492 | ) | (980 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
3,289 | 3,888 | 4,345 | 4,172 | 4,113 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
38.54 | 27.50 | 23.54 | 24.31 | 18.74 | |||||||||||||||
Assets, end of period $ |
126,761 | 106,925 | 102,284 | 101,420 | 77,097 | |||||||||||||||
Investment income ratio* |
0.63 | % | 0.00 | % | 0.10 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
40.16 | % | 16.84 | % | (3.16 | %) | 29.67 | % | 33.87 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Small Cap Value Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
8,581 | 7,038 | 5,682 | 5,129 | 4,288 | |||||||||||||||
Units issued |
3,879 | 2,469 | 2,078 | 1,484 | 1,280 | |||||||||||||||
Units redeemed |
(977 | ) | (926 | ) | (722 | ) | (931 | ) | (439 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
11,483 | 8,581 | 7,038 | 5,682 | 5,129 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
64.51 | 48.39 | 41.79 | 41.32 | 32.75 | |||||||||||||||
Assets, end of period $ |
740,817 | 415,214 | 294,133 | 234,770 | 167,996 | |||||||||||||||
Investment income ratio* |
0.66 | % | 1.00 | % | 0.91 | % | 0.43 | % | 0.76 | % | ||||||||||
Total return, lowest to highest** |
33.33 | % | 10.07% to 15.78 | % | 1.15 | % | 26.15 | % | 28.08% to 36.59 | % |
125
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Small Cap Value Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
2,339 | 2,310 | 2,163 | 2,049 | 4,102 | |||||||||||||||
Units issued |
2,392 | 1,733 | 198 | 252 | 1,591 | |||||||||||||||
Units redeemed |
(2,004 | ) | (1,704 | ) | (51 | ) | (138 | ) | (3,644 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
2,727 | 2,339 | 2,310 | 2,163 | 2,049 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.95 | 17.21 | 14.88 | 14.72 | 11.68 | |||||||||||||||
Assets, end of period $ |
62,567 | 40,239 | 34,358 | 31,836 | 23,913 | |||||||||||||||
Investment income ratio* |
0.62 | % | 0.81 | % | 0.84 | % | 0.37 | % | 0.53 | % | ||||||||||
Total return, lowest to highest** |
33.31 | % | 15.70 | % | 1.04 | % | 26.10 | % | 28.65 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Small Company Value Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
35,450 | 24,458 | 22,129 | 14,175 | 10,204 | |||||||||||||||
Units issued |
3,492 | 127,871 | 4,454 | 19,254 | 5,322 | |||||||||||||||
Units redeemed |
(2,199 | ) | (116,879 | ) | (2,125 | ) | (11,300 | ) | (1,351 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
36,743 | 35,450 | 24,458 | 22,129 | 14,175 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.78 | 17.30 | 14.86 | 15.00 | 12.36 | |||||||||||||||
Assets, end of period $ |
837,044 | 613,287 | 363,493 | 331,996 | 175,185 | |||||||||||||||
Investment income ratio* |
1.78 | % | 0.18 | % | 0.65 | % | 1.51 | % | 0.44% | |||||||||||
Total return, lowest to highest** |
31.68 | % | 11.42% to 16.41 | % | (0.94 | %) | 21.39 | % | 27.82% to 35.35 | % |
126
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Small Company Value Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
9,649 | 11,407 | 11,649 | 11,776 | 14,462 | |||||||||||||||
Units issued |
686 | 786 | 1,546 | 1,851 | 2,711 | |||||||||||||||
Units redeemed |
(1,623 | ) | (2,544 | ) | (1,788 | ) | (1,978 | ) | (5,397 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
8,712 | 9,649 | 11,407 | 11,649 | 11,776 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
39.90 | 30.32 | 26.07 | 26.31 | 21.68 | |||||||||||||||
Assets, end of period $ |
347,540 | 292,480 | 297,308 | 306,459 | 255,268 | |||||||||||||||
Investment income ratio* |
1.71 | % | 0.26 | % | 0.58 | % | 1.46 | % | 0.39 | % | ||||||||||
Total return, lowest to highest** |
31.61 | % | 16.30 | % | (0.93 | %) | 21.35 | % | 27.69 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Smaller Company Growth Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 (af) | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 (ax) | ||||||||||||||||
Units, beginning of period |
45,010 | 45,865 | 44,688 | 45,193 | — | |||||||||||||||
Units issued |
732 | 1,069 | 42,853 | 2,133 | 45,380 | |||||||||||||||
Units redeemed |
(45,742 | ) | (1,924 | ) | (41,676 | ) | (2,638 | ) | (187 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 45,010 | 45,865 | 44,688 | 45,193 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
19.23 | 14.23 | 12.24 | 13.16 | 10.52 | |||||||||||||||
Assets, end of period $ |
— | 640,412 | 561,278 | 588,313 | 475,523 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
35.12 | % | 7.90% to 16.27 | % | (7.04 | %) | 25.12 | % | 5.22 | % |
(af) | Terminated as an investment option and funds transferred to Small Cap Opportunities Trust on December 9, 2013. |
(ax) | Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009. |
127
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Smaller Company Growth Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 (af) | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 (ax) | ||||||||||||||||
Units, beginning of period |
3,180 | 1,679 | 3,322 | 4,016 | — | |||||||||||||||
Units issued |
45 | 1,622 | 138 | 310 | 4,320 | |||||||||||||||
Units redeemed |
(3,225 | ) | (121 | ) | (1,781 | ) | (1,004 | ) | (304 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
— | 3,180 | 1,679 | 3,322 | 4,016 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
19.19 | 14.21 | 12.22 | 13.16 | 10.52 | |||||||||||||||
Assets, end of period $ |
— | 45,183 | 20,526 | 43,717 | 42,261 | |||||||||||||||
Investment income ratio* |
0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | 0.00 | % | ||||||||||
Total return, lowest to highest** |
35.06 | % | 16.22 | % | (7.10 | %) | 25.04 | % | 5.22 | % | ||||||||||
(af) Terminated as an investment option and funds transferred to Small Cap Opportunities Trust on December 9, 2013. (ax) Reflects the period from commencement of operations on November 16, 2009 through December 31, 2009.
|
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Strategic Income Opportunities Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 (be) | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
177,119 | 34,725 | 22,410 | 7,408 | 2,701 | |||||||||||||||
Units issued |
337,638 | 417,618 | 15,955 | 17,686 | 5,624 | |||||||||||||||
Units redeemed |
(278,056 | ) | (275,224 | ) | (3,640 | ) | (2,684 | ) | (917 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
236,701 | 177,119 | 34,725 | 22,410 | 7,408 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
18.22 | 17.55 | 15.54 | 15.22 | 13.13 | |||||||||||||||
Assets, end of period $ |
4,311,480 | 3,108,036 | 539,478 | 341,040 | 97,268 | |||||||||||||||
Investment income ratio* |
5.95 | % | 9.07 | % | 12.57 | % | 14.80 | % | 7.36 | % | ||||||||||
Total return, lowest to highest** |
3.81 | % | 7.30% to 12.94 | % | 2.08 | % | 15.91 | % | 18.51% to 26.78 | % |
(be) | Renamed on May 3, 2010. Previously known as Strategic Income Trust. |
128
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Strategic Income Opportunities Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 (be) | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
13,170 | 13,384 | 11,607 | 2,439 | 7,495 | |||||||||||||||
Units issued |
617 | 403 | 5,160 | 10,986 | 52 | |||||||||||||||
Units redeemed |
(2,267 | ) | (617 | ) | (3,383 | ) | (1,818 | ) | (5,108 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
11,520 | 13,170 | 13,384 | 11,607 | 2,439 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
24.58 | 23.68 | 20.98 | 20.56 | 17.74 | |||||||||||||||
Assets, end of period $ |
283,198 | 311,836 | 280,795 | 238,694 | 43,292 | |||||||||||||||
Investment income ratio* |
5.48 | % | 6.85 | % | 11.52 | % | 26.88 | % | 4.47 | % | ||||||||||
Total return, lowest to highest** |
3.82 | % | 12.86 | % | 2.03 | % | 15.89 | % | 26.64 | % | ||||||||||
(be) Renamed on May 3, 2010. Previously known as Strategic Income Trust. |
| |||||||||||||||||||
Sub-Account | ||||||||||||||||||||
Total Bond Market Trust B Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
50,602 | 10,018 | 7,181 | 5,247 | 3,382 | |||||||||||||||
Units issued |
172,979 | 127,517 | 5,492 | 2,881 | 2,969 | |||||||||||||||
Units redeemed |
(207,661 | ) | (86,933 | ) | (2,655 | ) | (947 | ) | (1,104 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
15,920 | 50,602 | 10,018 | 7,181 | 5,247 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
22.27 | 22.83 | 21.94 | 20.39 | 19.14 | |||||||||||||||
Assets, end of period $ |
354,564 | 1,155,231 | 219,717 | 146,368 | 100,415 | |||||||||||||||
Investment income ratio* |
3.15 | % | 1.09 | % | 5.18 | % | 5.21 | % | 5.27 | % | ||||||||||
Total return, lowest to highest** |
(2.44 | %) | 2.03% to 4.08 | % | 7.60 | % | 6.49 | % | 4.86% to 6.29 | % |
129
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Total Return Trust Series 0 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
125,330 | 117,320 | 106,097 | 187,153 | 24,859 | |||||||||||||||
Units issued |
43,266 | 59,676 | 56,501 | 210,002 | 216,140 | |||||||||||||||
Units redeemed |
(51,871 | ) | (51,666 | ) | (45,278 | ) | (291,058 | ) | (53,846 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
116,725 | 125,330 | 117,320 | 106,097 | 187,153 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
17.22 | 17.57 | 16.18 | 15.57 | 14.46 | |||||||||||||||
Assets, end of period $ |
2,010,204 | 2,201,829 | 1,898,381 | 1,651,112 | 2,705,660 | |||||||||||||||
Investment income ratio* |
3.59 | % | 2.12 | % | 4.82 | % | 2.18 | % | 5.59 | % | ||||||||||
Total return, lowest to highest** |
(1.98 | %) | 4.25% to 8.57 | % | 3.97 | % | 7.66 | % | 8.24% to 13.71 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Total Return Trust Series 1 | ||||||||||||||||||||
Year Ended | Year Ended | Year Ended | Year Ended | Year Ended | ||||||||||||||||
Dec. 31/13 | Dec. 31/12 | Dec. 31/11 | Dec. 31/10 | Dec. 31/09 | ||||||||||||||||
Units, beginning of period |
25,157 | 26,111 | 31,488 | 28,377 | 25,743 | |||||||||||||||
Units issued |
1,306 | 1,107 | 1,923 | 6,420 | 8,930 | |||||||||||||||
Units redeemed |
(3,693 | ) | (2,061 | ) | (7,300 | ) | (3,309 | ) | (6,296 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
22,770 | 25,157 | 26,111 | 31,488 | 28,377 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
28.66 | 29.26 | 26.97 | 25.95 | 24.11 | |||||||||||||||
Assets, end of period $ |
652,605 | 735,987 | 704,145 | 817,175 | 684,132 | |||||||||||||||
Investment income ratio* |
3.08 | % | 1.97 | % | 4.12 | % | 2.45 | % | 4.20 | % | ||||||||||
Total return, lowest to highest** |
(2.03 | %) | 8.49 | % | 3.91 | % | 7.64 | % | 13.60 | % |
130
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Total Stock Market Index Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
10,411 | 7,841 | 6,243 | 4,647 | 1,449 | |||||||||||||||
Units issued |
6,921 | 3,303 | 2,309 | 2,347 | 4,630 | |||||||||||||||
Units redeemed |
(2,309 | ) | (733 | ) | (711 | ) | (751 | ) | (1,432 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
15,023 | 10,411 | 7,841 | 6,243 | 4,647 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
71.52 | 53.59 | 46.38 | 46.23 | 39.42 | |||||||||||||||
Assets, end of period $ |
1,074,462 | 557,974 | 363,633 | 288,609 | 183,219 | |||||||||||||||
Investment income ratio* |
1.80 | % | 1.77 | % | 1.46 | % | 1.60 | % | 2.45 | % | ||||||||||
Total return, lowest to highest** |
33.45 | % | 7.92% to 15.56 | % | 0.33 | % | 17.26 | % | 25.14% to 33.63 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Total Stock Market Index Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
8,543 | 8,946 | 9,279 | 8,838 | 8,030 | |||||||||||||||
Units issued |
67 | 3,226 | 164 | 903 | 1,389 | |||||||||||||||
Units redeemed |
(443 | ) | (3,629 | ) | (497 | ) | (462 | ) | (581 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
8,167 | 8,543 | 8,946 | 9,279 | 8,838 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
21.48 | 16.10 | 13.94 | 13.90 | 11.86 | |||||||||||||||
Assets, end of period $ |
175,418 | 137,559 | 124,712 | 129,005 | 104,843 | |||||||||||||||
Investment income ratio* |
1.43 | % | 1.46 | % | 1.25 | % | 1.41 | % | 1.69 | % | ||||||||||
Total return, lowest to highest** |
33.39 | % | 15.50 | % | 0.28 | % | 17.19 | % | 28.86 | % |
131
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||
Ultra Short Term Bond Trust Series 0 | ||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 (n) |
||||||||||
Units, beginning of period |
6,408 | 159 | — | |||||||||
Units issued |
13,226 | 8,455 | 208 | |||||||||
Units redeemed |
(5,510 | ) | (2,206 | ) | (49 | ) | ||||||
|
|
|
|
|
|
|||||||
Units, end of period |
14,124 | 6,408 | 159 | |||||||||
|
|
|
|
|
|
|||||||
Unit value, end of period $ |
10.07 | 10.07 | 10.00 | |||||||||
Assets, end of period $ |
142,183 | 64,514 | 1,584 | |||||||||
Investment income ratio* |
1.67 | % | 1.88 | % | 2.22 | % | ||||||
Total return, lowest to highest** |
(0.02 | %) | 0.17% to 0.66 | % | 0.09 | % |
(n) | Fund available in prior year but no activity. |
Sub-Account | ||||||||
U.S. Equity Trust Series 0 | ||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (g) |
|||||||
Units, beginning of period |
62,708 | — | ||||||
Units issued |
4,238 | 65,879 | ||||||
Units redeemed |
(3,984 | ) | (3,171 | ) | ||||
|
|
|
|
|||||
Units, end of period |
62,962 | 62,708 | ||||||
|
|
|
|
|||||
Unit value, end of period $ |
13.20 | 10.28 | ||||||
Assets, end of period $ |
830,873 | 644,709 | ||||||
Investment income ratio* |
1.74 | % | 2.42 | % | ||||
Total return, lowest to highest** |
28.36 | % | 2.81% to 6.03 | % |
(g) | Reflects the period from commencement of operations on April 30, 2012 through December 31, 2012. |
132
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||
U.S. Equity Trust Series 1 | ||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 (g) |
|||||||
Units, beginning of period |
7,490 | — | ||||||
Units issued |
222 | 7,893 | ||||||
Units redeemed |
(2,488 | ) | (403 | ) | ||||
|
|
|
|
|||||
Units, end of period |
5,224 | 7,490 | ||||||
|
|
|
|
|||||
Unit value, end of period $ |
13.18 | 10.28 | ||||||
Assets, end of period $ |
68,841 | 76,975 | ||||||
Investment income ratio* |
1.68 | % | 2.13 | % | ||||
Total return, lowest to highest** |
28.22 | % | 2.77 | % |
(g) | Reflects the period from commencement of operations on April 30, 2012 through December 31, 2012. |
Sub-Account | ||||||||||||||||||||
Utilities Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
28,581 | 75,101 | 25,062 | 22,486 | 19,584 | |||||||||||||||
Units issued |
6,493 | 10,023 | 53,483 | 7,647 | 7,501 | |||||||||||||||
Units redeemed |
(3,801 | ) | (56,543 | ) | (3,444 | ) | (5,071 | ) | (4,599 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
31,273 | 28,581 | 75,101 | 25,062 | 22,486 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
26.50 | 21.97 | 19.33 | 18.10 | 15.88 | |||||||||||||||
Assets, end of period $ |
828,969 | 627,938 | 1,451,912 | 453,682 | 357,057 | |||||||||||||||
Investment income ratio* |
2.23 | % | 2.76 | % | 5.14 | % | 2.60 | % | 4.96 | % | ||||||||||
Total return, lowest to highest** |
20.65 | % | 10.75% to 13.63 | % | 6.80 | % | 14.00 | % | 28.79% to 33.58 | % |
133
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Utilities Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
3,458 | 3,526 | 3,575 | 3,624 | 4,524 | |||||||||||||||
Units issued |
71 | 47 | 58 | 70 | 374 | |||||||||||||||
Units redeemed |
(1,392 | ) | (115 | ) | (107 | ) | (119 | ) | (1,274 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
2,137 | 3,458 | 3,526 | 3,575 | 3,624 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
33.15 | 27.50 | 24.19 | 22.68 | 19.91 | |||||||||||||||
Assets, end of period $ |
70,782 | 95,035 | 85,259 | 81,064 | 72,139 | |||||||||||||||
Investment income ratio* |
1.95 | % | 3.70 | % | 3.79 | % | 2.45 | % | 4.69 | % | ||||||||||
Total return, lowest to highest** |
20.57 | % | 13.66 | % | 6.65 | % | 13.92 | % | 33.77 | % | ||||||||||
Sub-Account | ||||||||||||||||||||
Value Trust Series 0 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
19,350 | 10,669 | 7,383 | 5,549 | 4,556 | |||||||||||||||
Units issued |
8,029 | 9,613 | 4,940 | 3,195 | 3,288 | |||||||||||||||
Units redeemed |
(2,761 | ) | (932 | ) | (1,654 | ) | (1,361 | ) | (2,295 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
24,618 | 19,350 | 10,669 | 7,383 | 5,549 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
24.72 | 18.25 | 15.53 | 15.37 | 12.57 | |||||||||||||||
Assets, end of period $ |
608,489 | 353,136 | 165,719 | 113,505 | 69,753 | |||||||||||||||
Investment income ratio* |
0.98 | % | 1.07 | % | 1.24 | % | 1.19 | % | 1.40 | % | ||||||||||
Total return, lowest to highest** |
35.44 | % | 6.68% to 17.50 | % | 1.03 | % | 22.30 | % | 33.21% to 45.49 | % |
134
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
9. | Financial Highlights |
Sub-Account | ||||||||||||||||||||
Value Trust Series 1 | ||||||||||||||||||||
Year Ended Dec. 31/13 |
Year Ended Dec. 31/12 |
Year Ended Dec. 31/11 |
Year Ended Dec. 31/10 |
Year Ended Dec. 31/09 |
||||||||||||||||
Units, beginning of period |
10,300 | 9,858 | 12,416 | 13,661 | 20,879 | |||||||||||||||
Units issued |
919 | 951 | 180 | 310 | 1,720 | |||||||||||||||
Units redeemed |
(2,285 | ) | (509 | ) | (2,738 | ) | (1,555 | ) | (8,938 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Units, end of period |
8,934 | 10,300 | 9,858 | 12,416 | 13,661 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unit value, end of period $ |
36.16 | 26.70 | 22.74 | 22.52 | 18.43 | |||||||||||||||
Assets, end of period $ |
323,011 | 275,039 | 224,188 | 279,615 | 251,718 | |||||||||||||||
Investment income ratio* |
0.84 | % | 0.85 | % | 0.99 | % | 1.02 | % | 1.25 | % | ||||||||||
Total return, lowest to highest** |
35.39 | % | 17.42 | % | 0.98 | % | 22.22 | % | 41.18 | % |
135
John Hancock Life Insurance Company of New York Separate Account B
Notes to Financial Statements (continued)
(*) | These ratios, which are not annualized, represent the dividends, excluding distributions of capital gains, received by the sub-account from the underlying Trust portfolio, net of management fees assessed by the Trust portfolio adviser, divided by the average net assets of the sub-account. The recognition of investment income by the sub-account is affected by the timing of the declarations of dividends by the underlying Trust portfolio in which the sub-accounts invest. It is the practice of the Trust, for income tax reasons, to declare dividends in April for investment income received in the previous calendar year for all sub-accounts of the Trust except for the Money Market Trust which declares and reinvests dividends on a daily basis. Any dividend distribution received from a sub-account of the Trust is reinvested immediately, at the net asset value, in shares of that sub-account and retained as assets of the corresponding sub-account so that the unit value of the sub-account is not affected by the declaration and reinvestment of dividends. |
(**) | These ratios, which are not annualized, represent the total return for the period indicated, including changes in the value of the underlying Trust portfolio. There are no expenses of the Account that result in a direct reduction in unit values. The total return does not include any expenses assessed through the redemption of units; inclusion of these expenses in the calculation would result in a reduction in the total return presented. When no range is given, the lowest and highest values are the same. |
136
Item 26. Exhibits
The following exhibits are filed as part of this Registration Statement:
(a) Resolution of Board of Directors establishing Separate Account B is incorporated by reference to post-effective amendment number 1, file number 333-157213, filed with the Commission in April 2010.
(b) Not applicable.
(c) (1) Underwriting and Distribution Agreement between John Hancock Life Insurance Company of New York and John Hancock Distributors LLC dated December 1, 2009, incorporated by reference to pre-effective amendment number 1 file number 333-157213, filed with the Commission in April 2010.
(2)(a) Specimen General Agent and Broker-Dealer Selling Agreement by and among John Hancock Life Insurance Company
(U.S.A.), John Hancock Life Insurance Company of New York and John Hancock Distributors LLC effective August 2009, incorporated by reference to pre-effective amendment number 2, file number 333-157212, filed with the Commission in April 2011.
(b) List of third party broker-dealer firms included as Attachment A, incorporated by reference to post-effective amendment number 6, file number 333-179571, filed with the Commission on April 29,
2014.
(d)(1) Specimen Flexible Premium Variable Universal Life Insurance policy, filed herewith.
(2) Specimen Overloan Protection Rider, filed herewith.
(3) Specimen Accelerated Benefit Rider, filed herewith.
(e) Specimen policy application, filed herewith.
(f) (1) Declaration of Intention and Charter of First North American Life Assurance Company dated January 30, 1992, incorporated by reference to post-effective amendment number 7, file number 33-46217, filed with the Commission on February 25, 1998.
(a) Certificate of Amendment of the Declaration of Intention and Charter of First North American Life Assurance Company dated March 6, 1992, incorporated by reference to post-effective amendment number 7, file number 33-46217, filed with the Commission on February 25, 1998.
(b) Certificate of Amendment of the Declaration of Intention and Charter of the The Manufacturers Life Insurance Company of New York dated October 1, 1997, incorporated by reference to post-effective amendment number 7, file number 33-46217, filed with the Commission on February 25, 1998.
(c) Certificate of Amendment of the Declaration of Intention and Charter of The Manufacturers Life Insurance Company of New York dated January 1, 2005, incorporated by reference to pre-effective amendment number 1, file number 333-127543, filed with the Commission on November 16, 2005.
(d) Certificate of Amendment of the Declaration of Intention and Charter of John Hancock Life Insurance Company of New York dated July 26, 2006, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.
(e) Certificate of Amendment of the Declaration of Intention and Charter approved on August 20, 1997, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.
(f) Certificate of Amendment of the Declaration of Intention and Charter approved on August 28, 2002, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.
(g) Certificate of Amendment of the Declaration of Intention and Charter approved on November 20, 2009, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.
(2) By-laws of the John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York), incorporated by reference to Exhibit (6)(B) to post-effective amendment No. 7 file number 33-46217 filed with the Commission on February 25, 1998 on behalf of The Manufacturers Life Insurance Company of New York Separate Account A.
(a) Amendment to the By-Laws and Charter of John Hancock Life Insurance Company of New York dated November 17, 2005, incorporated by reference to post-effective amendment number 1 file number 333-131134 filed with the Commission in Apirl, 2007.
(b) Amended and Restated By-Laws of John Hancock Life Insurance Company of New York dated December 14, 2010, incorpoated by reference to pre-effective amendment no. 1, file number 333-179571, filed with the Commission in May, 2012.
(g) Specimen reinsurance agreement, is filed herewith.
(h) (1) Participation Agreement among The Manufacturers Life Insurance Company (U.S.A.), The Manufacturers Insurance Company of New York, PIMCO Variable Insurance Trust and PIMCO Advisors Distributors LLC dated April 30, 2004, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(2) Participation Agreement among John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, and John Hancock Trust dated April 20, 2005, incorporated by reference to pre-effective amendment number 1, file number 333-126668, filed with the Commission on October 12, 2005.
(3) Participation Agreement among John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, and M Financial Investment Advisers, Inc. dated November 13, 2009, incorporated by reference to file number 333-164150, filed with the Commission on January 4, 2010.
(4) Shareholder Information Agreement between John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, John Hancock Life Insurance Company, John Hancock Variable Life Insurance, and John Hancock Trust portfolios (except American Funds Insurance Series) dated April 16, 2007, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.
(5) Shareholder Information Agreement between John Hancock Life Insurance Company (U.S.A.), John Hancock Life Insurance Company of New York, John Hancock Life Insurance Company, John Hancock Variable Life Insurance, and John Hancock Trust on behalf of series of the Trust that are feeder funds of the American Funds Insurance Series dated April 16, 2007, incorporated by reference to post-effective amendment number 9, file number 333-85284, filed with the Commission in April, 2007.
(i) (1) Administrative Services Agreement between John Hancock Life Insurance Company (U.S.A.) (formerly, The Manufacturers Life Insurance Company (U.S.A.)) and John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York) dated January 1, 2001, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.
(a) Amendment No. 1 to Administrative Services Agreement between John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York effective May 1, 2005, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.
(2) Investment Services Agreement between John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York) and The Manufacturers Life Insurance Company dated October 1, 1997, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.
(a) Amendment No. 1 to Investment Services Agreement between John Hancock Life Insurance Company of New York (formerly, The Manufacturers Life Insurance Company of New York) and The Manufacturers Life Insurance Company dated August 31, 2000, incorporated by reference to post-effective amendment number 1, file number 333-131134, filed with the Commission in Apirl, 2007.
(j) Not Applicable.
(k) Opinion and consent of counsel regarding the legality of the securities being registered, filed herewith.
(l) Not Applicable.
(m) Not Applicable.
(n) Consents of Independent Registered Public Accounting Firm, filed herewith.
(n)(1) Not Applicable.
(o) Not Applicable.
(p) Not Applicable.
(q) Memorandum Regarding Issuance, Face Amount Increase, Redemption and Transfer Procedures for the Policies, incorporated by reference to pre-effective amendment number 1, file number, 333-33504 filed with the Commission on May 3, 2001.
(i) Powers of Attorney for Craig Bromley, Thomas Borshoff, Paul M. Connolly, Michael Doughty, Ruth Ann Fleming, James D. Gallagher, Scott S. Hartz, Rex Schlaybaugh, Jr., and John Vrysen, filed herewith.
Item 27. Directors and Officers of the Depositor
OFFICERS AND DIRECTORS OF JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK
Name and Principal Business Address | Position with Depositor |
Craig Bromley 601 Congress Street Boston, MA 02210 |
Director, Chairman and President |
Thomas Borshoff 536 Stone Road Pittsford, NY 14534 |
Director |
Paul M. Connolly 75 Indian Spring Road Milton, MA 02186 |
Director |
Michael Doughty 197 Clarendon Street Boston, MA 02116 |
Director |
Ruth Ann Fleming 205 Highland Avenue Short Hills, NJ 07078 |
Director |
James D. Gallagher 601 Congress Street Boston, MA 02210 |
Director, Executive Vice President, General Counsel and Chief Administrative Officer |
Scott S. Hartz 197 Clarendon Street Boston, MA 02116 |
Director, Executive Vice President and Chief Investment Officer |
Rex Schlaybaugh, Jr. 400 Renaissance Center Detroit, MI 48243 |
Director |
Name and Principal Business Address | Position with Depositor |
John G. Vrysen 601 Congress Street Boston, MA 02210 |
Director and Senior Vice President |
Executive Vice Presidents |
James D. Gallagher* | and General Counsel |
Michael Doughty** |
Steven Finch* | and Chief Financial Officer |
Scott S. Hartz** | and Chief Investment Officer – US Investments |
Senior Vice Presidents |
Andrew G. Arnott* |
Kevin J. Cloherty* |
Barry Evans**** |
Peter Gordon* |
Brian Heapps** |
Gregory Mack* |
Janis K. McDonough***** |
H. Steven Moore**** | and Treasurer |
James O’Brien
††† |
Sebastian Pariath* | and Head of Operations and Chief Information Officer |
Timothy W. Ramza* |
Alan R. Seghezzi** |
Anthony Teta** |
Brooks Tingle** |
Vice Presidents |
Emanuel Alves* | Counsel and Corporate Secretary |
John C.S. Anderson** |
Roy V. Anderson* |
Abigail M. Armstrong** |
Kevin Askew***** |
Ann E. Birle***** |
Stephen J. Blewitt** |
Robert Boyda** |
David Campbell*** |
Bob Carroll** |
Rick A. Carlson* |
Brian Collins* |
John J. Danello* |
Brent Dennis** |
Robert Donahue**** |
Paul Gallagher* |
Ann Gencarella** |
Richard Harris*** | and Appointed Actuary |
John Hatch* |
Eugene Xavier Hodge, Jr.* |
James C. Hoodlet** |
Roy Kapoor**** |
Mitchell Karman* | and Chief Compliance Officer & Counsel |
Frank Knox* | and Chief Compliance Officer – Retail Funds/Separate Accounts* |
Hung Ko*** | Vice President, Treasury |
Robert Leach* |
Scott Lively* |
Nathaniel I. Margolis** |
Cheryl Mallett**** |
John B. Maynard* |
Karen McCafferty* |
Name and Principal Business Address | Position with Depositor |
Scott A. McFetridge** |
William McPadden** |
Maureen Milet** | and Chief Compliance Officer – Investments |
Scott Morin* |
Jeffrey H. Nataupsky* |
Scott Navin** |
Betty Ng*** |
Nina Nicolosi* |
Jacques Ouimet** |
Jeffrey Packard** |
Gary M. Pelletier** |
Tracey Polsgrove* |
Krishna Ramdial**** | Vice President, Treasury |
S. Mark Ray** |
Jill Rebman*** |
George Revoir* |
Mark Rizza* |
Andrew Ross**** |
Lisa Anne Ryan
††† |
Thomas Samoluk* |
Martin Sheerin* |
Gordon Shone* |
Rob Stanley* |
Tony Todisco***** |
Simonetta Vendittelli***** | and Controller |
Peter de Vries*** |
Linda A. Watters* |
Jeffery Whitehead* |
Henry Wong** |
Leo Zerilli* |
Assistant Vice Presidents |
Cathy Addison |
Joanne Adkins |
Stacey Agretelis |
Patricia L. Allison |
Eynshteyn Averbukh |
Jack Barry |
Naomi S. Bazak |
P. J. Beltramini |
William D. Bertrand |
Daniel C. Budde |
Jennifer Toone Campanella |
Suzanne Cartledge |
Tabitha Chinniah |
Anjali Chitre |
Catherine Collins |
Thomas D. Crohan |
Diane Cronin |
Jaime Hertel Dasque |
Lorn C. Davis |
Todd D. Emmel |
Allan M. Fen |
Paul A. Fishbin |
Michael A. Foreman |
Arthur Francis |
Philip W. Freiberger |
Scott B. Garfield |
John M. Garrison |
Name and Principal Business Address | Position with Depositor |
Keith Gendron |
William A. Gottlieb |
Gerald C. Hanrahan, Jr. |
Teresa S. Hayes |
Charles Whitney Hill |
Recep C. Kendircioglu |
Bruce Kinna |
Sally Kwan |
Brigitte Labreche |
Thomas Loftus |
Timothy J. Malik |
Robert Maulden |
Kathleen E. McDonough |
Reid W. McLay |
Pamela Memishian |
John P. Monahan |
Geoffrey Norris |
John O’Connor |
E. David Pemsteim |
Charlie Philbrook | and Chief Risk Officer |
David Pickett |
Michael A. Pirrello |
Malcolm Pittman |
Jason M. Pratt |
David P. Previte |
Malcolm Quinn |
Hilary Quosai |
Kathryn Riley |
Josephine M. Rolka |
Timothy A. Roseen |
Louise Santosuosso |
Eileen Schindler | and Chief Accountant |
Mark Shannon |
Susan Simi |
Debbie Stickland |
Michael Traynor |
Joan Marie Uzdavinis |
John Wallace |
Sean A. Williams |
Jennifer L Wilson |
Sameh Youssef |
Aleksandar Zivanovic |
*Principal Business Office is 601 Congress Street, Boston, MA 02210
**Principal Business Office is 197 Clarendon Street, Boston, MA 02116
***Principal Business Office is 200 Bloor Street, Toronto, Canada M4W1E5
****Principal Business Office is 250 Bloor Street, Toronto, Canada M4W1E5
*****Principal Business Office is 380 Stuart Street, Boston, MA 02116
†Principal Business is 6400 Sheridan Drive, Williamsville, NY 14221
††Principal Business is 2001 Butterfield Road, Downers Grove, Illinois 60515
†††Principal Business is 200 Berkeley Street, Boston, MA 02116
††††Principal Business is 101 Huntington Avenue, Boston, MA 02116
Item 28. Persons Controlled by or Under Common Control with the Depositor or the Registrant
The Registrant is a separate account of the Depositor operating as a unit investment trust. The Registrant supports benefits payable under the Depositor’s variable life insurance policies by investing assets allocated to various investment options in shares of John Hancock Variable Insurance Trust (formerly, John Hancock Trust) and other mutual funds registered under the Investment Company Act of 1940 as open-end management investment companies of the “series” type.
On the effective date of the registration statement, the Company and its affilates are controlled by Manulife Financial Corporation.
Item 29. Indemnification
The Form of Selling Agreement or Service Agreement between John Hancock Distributors LLC and various broker-dealers may provide that the selling broker-dealer indemnify and hold harmless John Hancock Distributors LLC and the Company, including their affiliates, officers, directors, employees and agents against losses, claims, liabilities or expenses (including reasonable attorney’s fees), arising out of or based upon a breach of the Selling or Service Agreement, or any applicable law or regulation or any applicable rule of any self-regulatory organization or similar provision consistent with industry practice.
Insofar as indemnification for liability arising under the Securities Act of
1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant
will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
Item 30. Principal Underwriter
(a) Set forth below is information concerning other investment companies for which John Hancock Distributors LLC, the principal underwriter of the contracts, acts as investment adviser or principal underwriter.
Name of Investment Company | Capacity in Which Acting |
John Hancock Variable Life Separate Account S | Principal Underwriter |
John Hancock Variable Life Separate Account U | Principal Underwriter |
John Hancock Variable Life Separate Account V | Principal Underwriter |
John Hancock Variable Life Separate Account UV | Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account R |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account T |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account W |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account X |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account Q |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account A |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account N |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account H |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account I |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account J |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account K |
Principal Underwriter |
John Hancock Life Insurance Company (U.S.A.) Separate Account M |
Principal Underwriter |
John Hancock Life Insurance Company of New York Separate Account B |
Principal Underwriter |
John Hancock Life Insurance Company of New York Separate Account A |
Principal Underwriter |
(b) John Hancock Life Insurance Company (U.S.A.) is the sole member of John Hancock Distibutors LLC and the following comprise the Board of Managers and Officers of John Hancock Distributors LLC.
Name | Title |
Michael Doughty** | Chairman, Director |
Steven Finch* | Director |
James C. Hoodlet** | Director |
George Revoir* | Director, President and Chief Executive Officer |
Al Seghezzi** | Director |
Christopher Walker*** | Director, Vice President, Investments |
Emanuel Alves* | Secretary |
H. Steven Moore**** | Senior Vice President, Treasurer |
Brian Collins* | Vice President, US Taxation |
Kris Ramdial**** | Vice President, Treasury |
Jeffrey H. Long* | Assistant Vice President, Chief Financial Officer and Financial Operations Principal |
Michael Mahoney* | Assistant Vice President and Chief Compliance Officer |
David Pickett* | Assistant Vice President and General Counsel |
*Principal Business Office is 601 Congress Street, Boston, MA 02210
**Principal Business Office is 197 Clarendon Street, Boston, MA 02116
***Principal Business Office is 200 Bloor Street, Toronto, Canada M4W1E5
****Principal Business Office is 250 Bloor Street, Toronto, Canada M4W1E5
(c) John Hancock Distributors LLC
The information contained in the section titled “Principal Underwriter and Distributor” in the Statement of Additional Information, contained in this Registration Statement, is hereby incorporated by reference in response to Item 31.(c)(2-5).
Item 31. Location of Accounts and Records
The following entities prepare, maintain, and preserve the records required by Section 31(a) of the Act for the Registrant through written agreements between the parties to the effect that such services will be provided to the Registrant for such periods prescribed by the Rules and Regulations of the Commission under the Act and such records will be surrendered promptly on request: John Hancock Distributors LLC, John Hancock Place, Boston, Massachusetts 02117, serves as Registrant’s distributor and principal underwriter, and, in such capacities, keeps records regarding shareholders account records, canceled stock certificates. John Hancock (at the same address), in its capacity as Registrant’s depositor, and John Hancock Life Insurance Company of New York (at the same address), in its capacities as Registrant’s investment adviser, transfer agent, keep all other records required by Section 31 (a) of the Act.
Item 32. Management Services
All management services contracts are discussed in Part A or Part B.
Item 33. Fee Representation
Representation of Insurer Pursuant to Section 26 of the Investment Company Act of 1940.
John Hancock Life Insurance Company of New York hereby represents that the fees and charges deducted under the contracts issued pursuant to this registration statement, in the aggregate, are reasonable in relation to the services rendered, the expenses expected to be incurred, and the risks assumed by the Company.
Signatures
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has caused this Registration Statement to be signed on its behalf in the City of Boston, Commonwealth of Massachusetts, as of the 15th day of July, 2014.
JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK
John Hancock Life Insurance Company of New York Separate Account B
(Registrant)
JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK
By: /s/ Craig Bromley
Craig Bromley
Principal Executive Officer
JOHN HANCOCK LIFE INSURANCE COMPANY of NEW YORK
(Depositor)
By: /s/ Craig Bromley
Principal Executive Officer
Signatures
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated as of the 15th day of July, 2014.
Signatures | Title |
/s/ Simonetta Vendittelli Simonetta Vendittelli |
Vice President and Controller |
/s/ Steven Finch Steven Finch |
Executive Vice President and Chief Financial Officer |
* Craig Bromley |
Director |
* Thomas Borshoff |
Director |
* Paul M. Connolly |
Director |
* Ruth Ann Fleming |
Director |
* Michael Doughty |
Director |
* James D. Gallagher |
Director |
* Scott S. Hartz |
Director |
* Rex E. Schlaybaugh, Jr. |
Director |
* John G. Vrysen |
Director |
/s/James C. Hoodlet James C. Hoodlet |
This ‘N-6/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
4/30/17 | ||||
5/1/15 | 497 | |||
4/30/15 | ||||
7/25/14 | EFFECT | |||
Filed as of: | 7/16/14 | |||
Filed on: | 7/15/14 | |||
4/29/14 | 485BPOS | |||
3/28/14 | ||||
3/27/14 | ||||
1/1/14 | ||||
12/31/13 | 24F-2NT, NSAR-U | |||
12/15/13 | ||||
12/9/13 | 485BPOS, 497 | |||
7/17/13 | ||||
4/29/13 | 485BPOS | |||
1/1/13 | ||||
12/31/12 | 24F-2NT, NSAR-U | |||
11/5/12 | ||||
7/1/12 | ||||
4/30/12 | 485BPOS | |||
1/1/12 | ||||
12/31/11 | 24F-2NT, NSAR-U | |||
10/31/11 | 497 | |||
6/27/11 | ||||
1/1/11 | ||||
12/31/10 | 24F-2NT, NSAR-U | |||
12/14/10 | ||||
5/3/10 | 485BPOS | |||
1/4/10 | ||||
1/1/10 | ||||
12/31/09 | 24F-2NT, NSAR-U | |||
12/1/09 | ||||
11/20/09 | ||||
11/16/09 | 497 | |||
11/13/09 | ||||
5/4/09 | 497, EFFECT | |||
9/30/08 | ||||
1/1/08 | ||||
4/16/07 | ||||
7/26/06 | ||||
11/17/05 | ||||
11/16/05 | N-6/A | |||
10/12/05 | ||||
5/1/05 | 485BPOS | |||
4/20/05 | ||||
1/1/05 | ||||
4/30/04 | 485BPOS | |||
8/28/02 | ||||
5/3/01 | S-6/A | |||
1/1/01 | ||||
8/31/00 | ||||
2/25/98 | ||||
10/1/97 | ||||
8/20/97 | ||||
7/22/92 | ||||
3/6/92 | ||||
2/10/92 | ||||
1/30/92 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/21/23 John Hancock Life Ins Co of NY… B 485BPOS 5/01/23 5:1.5M Donnelley … Solutions/FA 4/22/22 John Hancock Life Ins Co of NY… B 485BPOS 4/25/22 5:4.6M Donnelley … Solutions/FA 4/23/21 John Hancock Life Ins Co of NY… B 485BPOS 4/26/21 6:6M Donnelley … Solutions/FA |